UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM 10-K
(Mark One) 
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended August 29, 201328, 2014
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from            to
Commission file number 1-10658
Micron Technology, Inc.
(Exact name of registrant as specified in its charter)
Delaware75-1618004
(State or other jurisdiction of incorporation or organization)(IRS Employer Identification No.)
8000 S. Federal Way, Boise, Idaho83716-9632
(Address of principal executive offices)(Zip Code)
Registrant's telephone number, including area code(208) 368-4000
Securities registered pursuant to Section 12(b) of the Act:
Title of each className of each exchange on which registered
Common Stock, par value $.10 per shareNASDAQ Global Select Market
Securities registered pursuant to Section 12(g) of the Act:
None
(Title of Class)
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes  T   No ¨    

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.  Yes  ¨   No  T

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  T   No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  T   No  ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  T

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act:
Large Accelerated Filer x
Accelerated Filer o
Non-Accelerated Filer o
(Do not check if a smaller reporting company)
Smaller Reporting Company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

The aggregate market value of the voting stock held by non-affiliates of the registrant, based upon the closing price of such stock on February 28, 2013,27, 2014, as reported by the NASDAQ Global Select Market, was approximately $6.521.3 billion.  Shares of common stock held by each executive officer and director and by each person who owns 5% or more of the outstanding common stock have been excluded in that such persons may be deemed to be affiliates.  This determination of affiliate status is not necessarily a conclusive determination for other purposes.

The number of outstanding shares of the registrant's common stock as of October 18, 2013,16, 2014, was 1,051,855,4501,073,455,204.

DOCUMENTS INCORPORATED BY REFERENCE: Portions of the Proxy Statement for the registrant’s Fiscal 20132014 Annual Meeting of Shareholders to be held on January 22, 2014,2015, are incorporated by reference into Part III of this Annual Report on Form 10-K.
     




Definitions of Commonly Used Terms
As used herein, "we," "our," "us" and similar terms include Micron Technology, Inc. and its subsidiaries, unless the context indicates otherwise. Abbreviations, terms or acronyms are commonly used or found in multiple locations throughout this report and include the following:

TermDefinitionTermDefinition
2019 Notes1.258% Secured Senior Notes due 2019MAIMicron Akita, Inc.
2022 Notes5.875% Senior Notes due 2022MbMegabit
2025 Notes5.500% Senior Notes due 2025MicronMicron Technology, Inc.
2031 NotesThe 2031A and 2031B NotesMITMicron Technology, Italia, S.r.l.
2031A Notes1.500% Convertible Senior Notes due 2031MLCMulti-Level Cell
2031B Notes1.875% Convertible Senior Notes due 2031MMJMicron Memory Japan, Inc.
2032 NotesThe 2032C and 2032D NotesMMJ CompaniesMicron Akita, Inc. and Micron Memory Japan, Inc.
2032C Notes2.375% Convertible Senior Notes due 2032MMJ GroupMMJ and its subsidiaries
2032D Notes3.125% Convertible Senior Notes due 2032MMTMicron Memory Taiwan Co., Ltd.
2033 NotesThe 2033E and 2033F NotesMP MaskMP Mask Technology Center, LLC
2033E Notes1.625% Convertible Senior Notes due 2033MTIMicron Technology, Inc.
2033F Notes2.125% Convertible Senior Notes due 2033NanyaNanya Technology Corporation
2043G Notes3.00% Convertible Senior Notes due 2043NumonyxNumonyx Holdings B.V.
AptinaAptina Imaging CorporationPhotronicsPhotronics, Inc.
DRAMDynamic Random Access MemoryPSRAMPseudo-static Dynamic Random Access Memory
ElpidaElpida Memory, Inc.QimondaQimonda AG
Gb1 gigabitR&DResearch and Development
GB1 gigabyteRexchipRexchip Electronics Corporation
HPHewlett-Packard CompanyRLDRAMReduced Latency Dynamic Random Access Memory
IM FlashIMFT and IMFSSECSecurities and Exchange Commission
IMFSIM Flash Singapore, LLPSG&ASelling, General and Administration
IMFTIM Flash Technologies, LLCSLCSingle-Level Cell
InoteraInotera Memories, Inc.SSDSolid-State Drive
IntelIntel CorporationSTSTMicroelectronics S.r.l.
Japan CourtTokyo District CourtTera ProbeTera Probe, Inc.
LIBORLondon Interbank Offered RateTLCTriple-Level Cell
LPDRAMMobile Low Power Dynamic Random Access MemoryVIEVariable Interest Entity




PART I


ITEM 1. BUSINESS


The following discussion contains trend information and other forward-looking statements that involve a number of risks and uncertainties.  Forward-looking statements include, but are not limited to, statements such as those made in "Overview" regarding the effect of the acquisition of Elpida on our market position; in "Products" regarding increased productionsales of DDR4 products, growth in demand for NAND Flash products and solid-state drives;SSDs and in "Manufacturing" regarding the transition to smaller line-width process technologies; in "Marketingtechnologies and Customers" regarding the effect of the Elpida acquisition on market concentrations; and in "Employees" regarding restructure costs associated with our Israel facility.3D NAND Flash. Our actual results could differ materially from our historical results and those discussed in the forward-looking statements.  Factors that could cause actual results to differ materially include, but are not limited to, those identified in "Item 1A. Risk Factors." All period references are to our fiscal periods unless otherwise indicated.


Corporate Information

Micron, Technology, Inc., a Delaware corporation, was incorporated in 1978.  As used herein, "we," "our," "us" and similar terms include Micron Technology, Inc. and its subsidiaries, unless the context indicates otherwise.  Our executive offices are located at 8000 South Federal Way, Boise, Idaho 83716-9632 and our telephone number is (208) 368-4000.  Information about us is available on the internet at www.micron.com.  Copies of our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, as well as any amendments to these reports, are available through our website as soon as reasonably practicable after they are electronically filed with or furnished to the Securities and Exchange Commission (the "SEC").SEC.  Materials filed by us with the SEC are also available at the SEC’s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549.  Information on the operation of the Public Reference Room is available by calling (800) SEC-0330.  Also available on our website are our:  Corporate Governance Guidelines, Governance Committee Charter, Compensation Committee Charter, Audit Committee Charter and Code of Business Conduct and Ethics.  Any amendments or waivers of our Code of Business Conduct and Ethics will also be posted on our website at www.micron.com within four business days of the amendment or waiver.  Copies of these documents are available to shareholders upon request.  Information contained or referenced on our website is not incorporated by reference and does not form a part of this Annual Report on Form 10-K.


Overview

We are one of the world's leading providers of advanced semiconductor solutions. Through our worldwide operations, we manufacture and market a full range of DRAM, NAND Flash and NOR Flash memory, as well as other innovative memory technologies, packaging solutions and semiconductor systems for use in leading-edge computing, consumer, networking, automotive, industrial, embedded and mobile products. We market our products through our internal sales force, independent sales representatives and distributors primarily to original equipment manufacturersOriginal Equipment Manufacturers ("OEMs") and retailers located around the world. Our success is largely dependent on the market acceptance of our diversified portfolio of semiconductor products, efficient utilization of our manufacturing infrastructure, successful ongoing development of advanced product and process technologies and generating a return on research and development ("R&D")&D investments.

We obtain products from three primary sources: (1) productionfor sale to our customers from our wholly-owned manufacturing facilities (2) production fromand our joint venture manufacturing facilities, and (3) to a lesser degree, from third party manufacturers.ventures. In recent years, we have increased our manufacturing scale and product diversity through strategic acquisitions and various partnering arrangements, including joint ventures.arrangements.

1




We make significant investments to develop the proprietary product and process technologies that are implemented in our worldwide manufacturing facilities and through our joint ventures. These investments enable our production of semiconductor products with increasing functionality and performance at lower costs. We generally reduce the manufacturing cost of each generation of product through advancements in product and process technologytechnologies, such as our leading-edge line-width process technology and innovative array architecture.technology. We continue to introduce new generations of products that offer improved performance characteristics, such as higher data transfer rates, reduced package size, lower power consumption, improved read/ write reliability and increased memory density. To leverage our significant investments in R&D, we have formed, and may continue to form, strategic joint ventures that allow us to share the costs of developing memory product and process technologies with joint venture partners. In addition, from time to time, we also sell and/or license technology to other parties. We continue to pursue additional opportunities to monetize our investment in intellectual property through partnering and other arrangements.


1



On July 31, 2013, we completed the acquisition of Elpida, Memory, Inc. ("Elpida"),now known as MMJ, and a Japanese corporation, pursuant to the terms and conditions of an Agreement on Support for Reorganization Companies (as amended, the "Sponsor Agreement") that we entered into on July 2, 2012, with the trustees of Elpida and one of its subsidiaries, Akita Elpida Memory, Inc., a Japanese corporation ("Akita" and, together with Elpida, the "Elpida Companies") pursuant to and in connection with the Elpida Companies' corporate reorganization proceedings under the Corporate Reorganization Act of Japan. We paid $615 million for the acquisition of 100% of Elpida's equity. On July 31, 2013, we also acquired a 24% ownershipcontrolling interest in Rexchip, Electronics Corporation ("Rexchip"), a Taiwanese corporation and manufacturing joint venture formed by Powerchip Technology Corporation ("Powerchip") and Elpida, from Powerchip and certain of its affiliates (the "Powerchip Group") pursuant to a share purchase agreement. We paid $334 million in cash fornow known as MMT (together, the shares. Elpida and its subsidiaries (the "Elpida Group""MMJ Acquisition") own approximately 65% of Rexchip's outstanding common stock. Therefore, as a result of the consummation of our acquisition of Elpida and the Rexchip shares from the Powerchip Group, we own approximately 89% of Rexchip's common stock.. The provisional fair values of assets and liabilities acquired include, among other items, cash and restricted cash aggregating $1,618 million; inventories of $962 million; property, plant and equipment of $935 million; net deferred tax assets of $917 million and debt of $2,134 million.

Elpida's assets include, among others:MMJ Acquisition included a 300mm DRAM wafer fabrication facility located in Hiroshima, Japan; its approximate 65% ownership interest in Rexchip, whose assets includeJapan, a 300mm DRAM wafer fabrication facility located in Taichung City, Taiwan;Taiwan and a 100% ownership interest in Akita, whose assets include an assembly and test facility located in Akita, Japan.

Elpida's semiconductor memory products include Mobile DRAM, targeted toward mobile phones and tablets. We believe that combining the complementary product portfolios These wafer fabrication facilities together represented approximately 30% of Micron and Elpida will strengthen our position in the memory market and enable us to provide customers with a wider portfolio of high-quality memory solutions. We also believe that our acquisition of Elpida will strengthen our market position in the memory industry through increased research and development and manufacturing scale, improved access to core memory market segments, and additionaltotal wafer capacity to balance among our DRAM, NAND Flash and NOR Flash memory solutions. Elpida'sfor 2014. The operations from the MMJ Acquisition, which are included primarily in our MBU and CNBU segments, include the DSGmanufacture of Mobile DRAM targeted to mobile phones and WSG segments.tablets and computing DRAM targeted to desktop PCs, servers, notebooks and workstations. In connection with the MMJ Acquisition, we recorded net assets of $2.60 billion, noncontrolling interests of $168 million and a gain on the transaction of $1.48 billion in 2013. (See "Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Micron Memory Japan, Inc." note.)

The ElpidaMMJ Companies are currently subject to corporate reorganization proceedings under the Corporate Reorganization Act of Japan. Because the plans of reorganization of the ElpidaMMJ Companies provide for ongoing payments to creditors following the closing of the Elpida acquisition,MMJ Acquisition, these proceedings are continuing and the ElpidaMMJ Companies remain subject to the oversight of the Tokyo DistrictJapan Court (the "Japan Court") and of the trustees appointed by the Japan Court (including a trustee designated by us, who we refer to as the business trustee, and a trustee designated by the Japan Court, who we refer to as the legal trustee), pending completion of the reorganization proceedings. As a result of this oversight and related consent rights of the Japan Court and the legal trustee, our ability to effectively integrate the ElpidaMMJ Companies as part of our global operations or to cause the ElpidaMMJ Companies to take certain actions that we deem advisable for their businesses could be adversely affected if the Japan Court or the legal trustee is unwilling to consent to various actions. For more information, see "Part I, Item 1A. Risk Factors" and "Part I, Item"Item 3. Legal Proceedings – Reorganization Proceedings of the Elpida Companies.MMJ Companies" and "Item 1A. Risk Factors."


2



Business Segments

In the third quarter of 2014, we reorganized our business units. All prior period amounts reflect this reorganization. Factors used to identify our segments include, among others, markets, customers and products.  Segment information reported herein is consistent with how it is reviewed and evaluated by our chief operating decision makers. We have the following four business units, which are our reportable segments:

DRAM Solutions GroupCompute and Networking Business Unit ("DSG"CNBU"): Includes DRAM and NOR Flash products sold to the PC, consumer electronics,compute, networking, graphics and cloud server markets.
NAND Solutions GroupMobile Business Unit ("NSG"): Includes high-volume NAND Flash products sold into data storage, personal music
players and the high-density computing market, as well as NAND Flash products sold to Intel Corporation ("Intel") through our IM Flash joint venture.
Wireless Solutions Group ("WSG"MBU"): Includes DRAM, NAND Flash and NOR Flash products including multi-chip packages, sold to the mobile devicesmartphone, feature phone and tablet mobile-device market.
Storage Business Unit ("SBU"): Includes NAND Flash components and SSDs sold into enterprise and client storage, cloud and removable storage markets. SBU also includes NAND Flash products sold to Intel through our IMFT joint venture.
Embedded Solutions GroupBusiness Unit ("ESG"EBU"): Includes DRAM, NAND Flash and NOR Flash products sold into automotive and industrial applications, as well as NORthe connected home and NAND Flash sold to consumer electronics networking, PC and server markets.

Our other operations do not meet the quantitative thresholds of a reportable segment and are reported under All Other.

For more information regarding our segments, see "Part I,II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Segment Information."


Products

Dynamic Random Access Memory ("DRAM")DRAM

DRAM products are high-density, low-cost-per-bit, random access memory devices that provide high-speed data storage and retrieval. DRAM sales products were 48%, 39% and 41% of our total net sales in 2013, 2012 and 2011, respectively. DRAM products are sold by our DSG, WSG and ESG segments and are used in computers, servers, tablets, mobile phones, communication equipment, computer peripherals, industrial, automotive and other electronic devices. We offer DRAM productsretrieval with a variety of performance, pricing and other characteristics including high-volume DDR4, DDR3characteristics. Sales of DRAM products were 68%, 48% and DDR239% of our total net sales in 2014, 2013 and 2012, respectively. DRAM products as well as specialty DRAM memory products including Mobile Low Power DRAM ("LPDRAM"), DDR, SDRAM, Reduced Latency DRAM ("RLDRAM")are sold by CNBU, MBU and Pseudo-static DRAM ("PSRAM").EBU.

DDR4, DDR3 and DDR2: DDR4, DDR3 and DDR2 areDRAM is a standardized, high-density, high-volume, DRAM products. DDR4, DDR3 and DDR2 products offerproduct, which offers high speed and high bandwidth at a relatively low cost. DDR3 sales were 31%, 20%products are primarily targeted at computers, servers, networking devices and 21% of our total net sales in 2013, 2012 and 2011, respectively. DDR2 sales were 7%, 9% and 10% of our total net sales in 2013, 2012 and 2011, respectively. We began sampling DDR4 products in 2013 and expect to begin commercial production of DDR4 products in significant volumes during 2014.

communications equipment. In 2013,2014, we offered DDR3 products in 1Gb, 2Gb and 4Gb densities and DDR2densities. We also offered next generation DDR4 DRAM products in 512 megabit ("Mb")2014 and we expect sales of these products to increase significantly in 2015 as they replace DDR3 DRAM products in many applications. Sales of DDR3 DRAM products were 40%, 1 gigabit ("Gb")31% and 2Gb densities. These densities enable us20% of our total net sales in 2014, 2013 and 2012, respectively.


2



LPDRAM products offer lower power consumption relative to meet customer demands for a broad array ofother DRAM products and we offered these products in multiple configurations, speeds and package types.

Specialty DRAM products: We also offer DRAM memory products including DDR and DDR2 Mobile LPDRAM, DDR, SDRAM, RLDRAM and PSRAM in densities ranging from 64Mb to 4Gb. LPDRAM products are used primarily in mobile phones, tablets, embedded applications, ultra-thin laptop computers and other mobile consumer devices that require low power consumption. OurWe offer DDR4, DDR3, DDR2 and DDR versions of LPDRAM. Sales of mobile LPDRAM products were 20%, 6% and 3% of our total net sales in 2014, 2013 and 2012, respectively.

We also offer other DRAM products targeted to specialty markets including DDR2 DRAM, DDR DRAM, GDDR5 DRAM, SDRAM, RLDRAM and PSRAM. These products are used primarily in networking devices, servers, consumer electronics, communications equipment, computer peripherals, automotive and industrial applications as well as computer memory upgrades. In September 2013,2014, we began samplingselling Hybrid Memory Cube ("HMC") products, which are are semiconductor memory devices where vertical stacks of DRAM die that are connected using through-silicon-via interconnects are placed above a small, high-speed logic layer. HMC enables ultra-high system performance with significantly lower power-per-bit. Aggregate sales of LPDRAM and our other specialty DRAM products were 10% of our total net sales in 2013, 2012 and 2011.


3



NAND Flash Memory

NAND Flash products are electrically re-writeable, non-volatile semiconductor memory devices that retain content when power is turned off. NAND Flash sales were 40%27%, 44%40% and 36%44% of our total net sales in 2014, 2013 and 2012, and 2011, respectively. NAND Flash products are sold by our NSG, WSG and ESG segments. NAND Flash is ideal for mass-storage devices due to its fast erase and write times, high density and low cost per bit relative to other solid-state memories. Embedded NAND Flash-based storage devices are utilized in mobile phones, solid-state drives ("SSDs"),SSDs, tablets, computers, industrial and automotive applications, MP3/4 playersnetworking and other personal and consumer applications. Removable storage devices, such as USB and Flash memory cards, are used with applications such as PCs, digital still cameras MP3/4 players and mobile phones. The market for NAND Flash products has grown rapidly and we expect it to continue to grow due to demand for these and other removableembedded and embeddedremovable storage devices. NAND Flash products are sold by SBU, EBU, MBU and CNBU.

Our NAND Flash products feature a small cell structure that enables higher densities for demanding applications. We offer Single-Level Cell ("SLC")high-speed SLC, MLC and TLC NAND Flash products as well as Multi-Level Cell ("MLC")that are compatible with advanced interfaces. MLC and Triple-Level Cell ("TLC") NAND FlashTLC products which have two and three times, respectively, the bit density of SLC NAND Flash products. In 2013,2014, we offered SLC NAND Flash products in 1 Gb1Gb to 64Gb densities. In addition, we offered 8Gb to 128Gbdensities; 2-bit-per-cell MLC NAND Flash products and 32Gbin 8Gb to 128Gb densities; and 3-bit-per-cell TLC NAND Flash products. We offer high-speed NAND Flash products that are compatible with advanced interfaces.in 64Gb to 128Gb densities.

We offer client and enterprise SSDs which feature higher performance, reduced powerreduced-power consumption and enhanced reliability as compared to typical hard disk drives. Our client SSDs are targeted at notebooknotebooks, desktops, workstations and other consumer applications. Using our NAND Flash process technology and a leading-edge SATA 6 Gb/sGb per second interface, our SSDs deliver read and write speeds that help improve boot and application load times and deliver higher performance than hard disk drives. Our client SSDs feature industry-leading encryption for corporate users and are offered in a 2.5-inch, M.2. and 1.8-inch form factors,mSATA modules, with densities up to 960 gigabytes ("GB").1 terabyte. Our enterprise SSDs are targeted at server and storage applications and incorporate our Extended Performance and Enhanced Reliability Technology (XPERT) architecture, which closely incorporates the storage and controller through highly optimized firmware algorithms and hardware enhancements. The end result is a set of market-focused enterprise features that deliver ultra-low latencies, improved data transfer time, power-loss protection and cost-effectiveness, along with higher capacities and power efficiency. We offer enterprise SSDs with capacities up to 1.4 terabytes. We expect that demand for both client and enterprise SSDs will continue to increase significantly over the next several years.

We also offer managed NAND and NAND-based multichip packagesMulti-Chip Package ("MCPs"MCP") products, which incorporate our NAND Flash. Our managed NAND products include e-MMC, e-MCP and embedded USB. Our e-MMC products combine NAND Flash with a logic controller that performs media management and error code correctionError Code Correction ("ECC"), which provides reduced ECC complexity, better system performance, improved reliability, easy integration and lower overall system costs. Our managed NANDe-MCP products includecombine e-MMC memory, embedded USB, and ClearNAND. Our NAND-based MCPs combine NAND Flash with DRAM and/or other memory devices in a single package,LPDRAM on the same substrate, which improves overall functionality and performance while simplifying system design.
 
Through our Lexar® brand, we sell high-performance digital media products and other flash-based storage products through retail and OEM channels. Our digital media products include a variety of flash memory cards and JumpDrive™ products with a range of speeds, capacities and value-added features. We offer flash memory cards in a variety of speeds and capacities and in all major media formats, including:including CompactFlash, Memory Stick and Secure Digital ("SD"). CompactFlash and Memory Stick products sold by us incorporate our patented controller technology. Other products, including SD memory cards and some JumpDrive products, incorporate third party controllers. We also manufacture products that are sold under other brand names and resell flash memory products that are purchased from other NAND Flash suppliers.


43



NOR Flash Memory

NOR Flash products are electrically re-writeable, non-volatile semiconductor memory devices that retain content when power is turned off, offer fast read times due to random access capability and have execute-in-place ("XiP") capability that enables processors to read NOR Flash without first accessing RAM. These capabilities make NOR ideal for storing program code in wireless and embedded applications. Our NOR Flash sales were 9%3%, 12%9% and 18%12% of our total net sales for 2014, 2013 2012 and 2011,2012, respectively. NOR Flash products are sold primarily by our WSGEBU and ESG segments.CNBU.

We offer both parallel and serial interface NOR Flash products in a broad range of densities, packages and features. Our parallel NOR Flash products are constructed to meet the needs of the consumer electronics, industrial, wired and wireless communications, computing and automotive applications. These products offer high densities, XiP performance, architectural flexibility and proven reliability in rigorous industrial settings. Our serial NOR Flash products are designed to meet the needs of consumer electronics, industrial, automotive, wired and wireless communications and computing applications. These products offer industry-standard packaging, pinouts, command sets and chipset compatibility.


Partnering Arrangements

The following is a summary of our partnering arrangements as of August 29, 2013:28, 2014:

 Member or Partner
Micron
Ownership Interest
Formed/
Acquired
Product Market
Consolidated Entities 
Entity  Member or Partner 
Micron
Ownership Interest
 
Formed/
Acquired
 Product Market
Consolidated entities:Consolidated entities: 
IMFT(1) Intel Corporation51%2006NAND Flash(1) Intel Corporation 51% 2006 NAND Flash
MP Mask(2) Photronics, Inc.50%2006Photomasks(2) Photronics, Inc. 50% 2006 Photomasks
  
Equity Method Investments   
Equity method investments:Equity method investments: 
Inotera(3) Nanya Technology Corporation35%2009DRAM(3) Nanya Technology Corporation 33% 2009 DRAM
Tera Probe(4) Various40%2013Wafer Probe(4) Various 40% 2013 Wafer Probe

(1)
IMFT: We partner with Intel for the design, development and manufacture of NAND Flash and certain emerging memory products.  In connection therewith, we formed a joint venture with Intel, IM Flash Technologies, LLC ("IMFT"),IMFT, to manufacture NAND Flash memory products for the exclusive use of the members.  The members share the output of IMFT generally in proportion to their investment.  We sell NAND Flash products to Intel through IMFT at long-term negotiated prices approximating cost.  We generally share product design and other research and development costs for NAND Flash and certain emerging memory technologies equally with Intel.  The IMFT joint venture agreement extends through 2024 and includes certain buy-sell rights with an Intel put right, commencing in January 2015, and our call right commencing in January 2018, pursuant to which Intel may elect to sell to us, or we may elect to purchase from Intel, Intel's interest in IMFT. If Intel elects to sell to us, we would set the closing date of the transaction within two years following such election and could elect to receive financing of the purchase price from Intel for one to two years from the closing date. (See "Item"Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Consolidated Variable Interest EntitiesEquityIM Flash"Noncontrolling Interests in Subsidiaries – IMFT" note.)

(2)
MP Mask: We produce photomasks for leading-edge and advanced next generation semiconductors through MP Mask, Technology Center, LLC ("MP Mask"), a joint venture with Photronics, Inc. ("Photronics").Photronics.  The MP Mask joint venture agreement allows either party to terminate the joint venture in either May 2016, provided notice is given prior to May 2015, or in each five-year successive period following May 2016, provided such notice is given at least twelve months prior to the end of the successive five-year period. We and Photronics also have supply arrangements wherein we purchase a substantial majority of the reticles produced by MP Mask.  (See "Item"Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Consolidated Variable Interest EntitiesEquity – Noncontrolling Interests in Subsidiaries – MP Mask" note.)


54




(3)
Inotera: We partner with Nanya Technology Corporation ("Nanya") for the manufacture of DRAM products, and through December 2012, the joint development of DRAM process technology.products.  In connection therewith, we have partnered with Nanya in Inotera, a DRAM memory company in Taiwan, Inotera Memories, Inc. ("Inotera").Taiwan.  Through December 2012, we hadpurchased 50% of Inotera's wafer production capacity based on a supply agreement withmargin-sharing formula among Nanya, Inotera and Nanya which gave us the right and obligation to purchase 50% of Inotera's semiconductor memory capacity subject to specific terms and conditions.  Under the formula for this supply agreement, all parties' manufacturing costs related to wafers supplied by Inotera, as well as our and Nanya's revenue for the resale of products from wafers supplied by Inotera, were considered in determining costs for wafers purchased by us from Inotera. Effective beginningus. Since January 2013, we are obligated to purchase for an initial period through January 2016,have purchased substantially all of Inotera's DRAM output at a purchase price based on a discount from market prices for our comparable components.components under a new supply agreement (the "Inotera Supply Agreement"). The Inotera Supply Agreement has a three-year term (currently through December 2016) that contemplates annual negotiations with respect to potential successive one-year extensions. If the parties do not agree to an extension, the agreement will terminate following the end of the then-existing term plus a subsequent three-year wind-down period. In the event of a wind-down, our share of Inotera's capacity would decline over the wind-down period. We are currently in negotiations regarding the extension of the Inotera Supply Agreement. (See "Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Equity Method Investments – Inotera" note.)

In connection with the partnering agreement, we have also deployed and licensed certain intellectual property related to the manufacture of DRAM products to Nanya and licensed certain intellectual property from Nanya.  Through December 2012, we partnered with Nanya to jointly develop process technology and designs to manufacture DRAM products under a cost-sharing arrangement effective beginning in April 2010, under which we shared DRAM development costs with Nanya.  Effective beginning January 2013, Nanya ceased participating in the joint development program. We receive royalties from Nanya for sales of DRAM products manufactured by or for Nanya with technology developed prior to April 2010.  (See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Equity Method Investments – Inotera" note.)

(4)
Tera Probe: We have an approximate 40% ownership interest in Tera Probe, Inc., an entity that provides semiconductor probe and test services. Tera Probe provides wafer probetesting services for our Elpidato us and Rexchip subsidiaries.others.


Manufacturing

Our manufacturing facilities are located in the United States, China, Israel, Japan, Malaysia, Puerto Rico, Singapore and Taiwan. Our Inotera joint venture also has a wafer fabrication facility in Taiwan. In September 2013, we entered into an agreement to sellNearly all of our 200mm wafer fabrication equipmentproducts are manufactured on 300mm wafers in Kiryat Gat, Israel to Intel and to terminate the related facility lease with Intel. If this transaction is completed, Intel will manufacture wafers for us at the Kiryat Gat facility through 2014 through a series of arrangements. In 2011, we sold our wafer fabrication facility in Japan to Tower Semiconductor Ltd. ("Tower") and entered into a supply agreement for Tower to manufacture products for us in the facility through approximately May 2014. Our manufacturing facilities that generally operate 24 hours per day, 7 days per week. Semiconductor manufacturing is extremely capital intensive, requiring large investments in sophisticated facilities and equipment. A significant portion of our semiconductor equipment is replaced every three to five years with increasingly advanced equipment. DRAM, NAND Flash DRAM and NOR Flash products share a number of common manufacturing processes, enabling us to leverage our product and process technologies and manufacturing infrastructure across these product lines. In 2014, we transitioned one of our Singapore wafer fabrication facilities from production of DRAM to NAND Flash.

Our process for manufacturing semiconductor products is complex, involving a number of precise steps, including wafer fabrication, assembly and test. Efficient production of semiconductor products requires utilization of advanced semiconductor manufacturing techniques and effective deployment of these techniques across multiple facilities. The primary determinants of manufacturing cost are process line-width, number of mask layers, number of fabrication steps and number of good die produced on each wafer. Other factors that contribute to manufacturing costs are wafer size, cost and sophistication of manufacturing equipment, equipment utilization, process complexity, cost of raw materials, labor productivity, package type and cleanliness of the manufacturing environment. We continuously enhance our production processes, reducing die sizes and transitioning to higher density products. In 2013,2014, the majority of our DRAM production was manufactured on our 30nm line-width process technology. In connection with our acquisition of Elpida, weWe expect that in 20142015 that a significant portionthe majority of our DRAM production will be manufactured on our 25nm and 20nm line-width process technology.technologies. In the fourth quarter of 2013,2014, a majority of our NAND Flash memory products wereproduction was manufactured on 20nm line-width process technology. We expect that in 2015 a majority of our NAND Flash production will be manufactured on our 20nm16nm line-width process technology. We expect to begin transitioning oursampling 3D NAND Flash production to our 16nm line-width process technology in 2014. Our NOR Flash memory products in 2013 were manufactured on our 65nmthe fourth quarter of calendar 2014 and 45nm line-width process technologies. We manufacture allto begin volume production in the second half of our high-volume NAND Flash and DRAM products on 300mm wafers. In 2013, we manufactured NOR Flash, some specialty DRAM and non-memory products on 200mm wafers.calendar 2015.


6



Wafer fabrication occurs in a highly controlled, clean environment to minimize dust and other yield-yield and quality-limiting contaminants. Despite stringent manufacturing controls, individual circuits may be nonfunctional or wafers may need to be scrapped due to equipment errors, minute impurities in materials, defects in photomasks, circuit design marginalities or defects and dust particles can lead to wafers being scrapped and individual circuits being nonfunctional.particles. Success of our manufacturing operations depends largely on minimizing defects to maximize yield of high-quality circuits. In this regard, we employ rigorous quality controls throughout the manufacturing, screening and testing processes. We are able to recover certain devices by testing and grading them to their highest level of functionality.

We test our products at various stages in the manufacturing process, perform high temperature burn-in on finished products and conduct numerous quality control inspections throughout the entire production flow. In addition, we use our proprietary AMBYX™ line of intelligent test and burn-in systems to perform simultaneous circuit tests of semiconductor memory die during the burn-in process, capturing quality and reliability data and reducing testing time and cost.

We sell semiconductor products in both packaged and unpackaged (i.e. "bare die") forms. Our packaged products include memory modules, MCP's,SSDs, MCPs, managed NAND, SSDs, memory cards and USB devices. We assemble many products in-house and, in some cases, we outsource assembly services where we can reduce costs and minimize our capital investment. We contract with independent foundries and assembly and testing organizationscompanies to manufacture NAND Flash media products such as memory cards and USB devices.

5



In recent years, we have produced an increasingly broad portfolio of products, which enhances our ability to allocate resources to our most profitable products but also increases the complexity of our manufacturing operations. Although our product lines generally use similar manufacturing processes, our overall cost efficiency can be affected by frequent conversions to new products, the allocation of manufacturing capacity to more complex, smaller-volume parts and the reallocation of manufacturing capacity across various product lines.


Availability of Raw Materials

Our operations require raw materials that meet exacting standards. We generally have multiple sources of supply for our raw materials. However, only a limited number of suppliers are capable of delivering certain raw materials that meet our standards. In some cases, materials are provided by a single supplier. Various factors could reduce the availability of raw materials such as silicon wafers, photomasks, chemicals, gases, including helium, photoresist, lead frames and molding compound. Shortages may occur from time to time in the future. We and/or our suppliers could be affected by laws and regulations enacted in response to concerns regarding climate change, which could increase the cost and limit the supply of our raw materials. In addition, disruptions in transportation lines could delay our receipt of raw materials. Lead times for the supply of raw materials have been extended in the past. If our supply of raw materials is disrupted or our lead times extended, our business, results of operations or financial condition could be materially adversely affected.


Marketing and Customers

Our products are sold into computing, consumer, networking, telecommunications,compute and graphics, mobile, SSD and other storage, automotive, industrial, medical and mobileother embedded and server markets. Market concentrations from 20132014 net sales were approximately as follows: computing30% for compute and graphics (including desktop PCs, servers, notebooks and workstations),; 30%20%; mobile, 15%; consumer electronics, 15%; SSDs, 15% for mobile; 20% for SSD and networkingother storage; 10% for automotive, industrial, medical and storage, other embedded; and 10%. for server. Sales to Kingston, primarily DRAM, were 10% of our net sales in 2014. Sales to Intel, primarily NAND Flash products through IM Flash, were 10%8% of our net sales in 2013, 12% of our net sales in 2012, and 10% of our net sales in 2011. Sales to Hewlett-Packard Company, primarily of DRAM, were2014, 10% of our net sales in 2013 and 12% of our net sales in 2012. Sales to HP, primarily DRAM, were 9% of our net sales in 2014, 10% of our net sales in 2013 and 8% of our net sales in 2012 and 9% of our net sales in 2011. We expect that our acquisition of Elpida will increase our concentration of sales to mobile, graphics and computing markets in 2014.2012.

Our semiconductor memory products are offered under the Micron, Lexar®, Crucial™, SpecTek® and Elpida brand names and private labels. We market our semiconductor memory products primarily through our own direct sales force and maintain sales or representative offices in our primary markets around the world. We sell Lexar-branded NAND Flash memory products primarily through retail channels and our Crucial-branded products through a web-based customer direct sales channel as well as through channel and distribution partners. Our products are also offered through independent sales representatives and distributors. Independent sales representatives obtain orders subject to final acceptance by us and are compensated on a commission basis. We make shipments against these orders directly to the customer. Distributors carry our products in inventory and typically sell a variety of other semiconductor products, including competitors' products. We maintain inventory at locations in close proximity to certain key customers to facilitate rapid delivery of products. Many of our customers require a thorough review or qualification of semiconductor products, which may take several months.


Backlog

Because of volatile industry conditions, customers are reluctant to enter into long-term, fixed-price contracts.  Accordingly, new order volumes for our semiconductor products fluctuate significantly.  We typically accept orders with acknowledgment that the terms may be adjusted to reflect market conditions at the date of shipment.  For these reasons, we do not believe that our order backlog as of any particular date is a reliable indicator of actual sales for any succeeding period.




6



Product Warranty

Because the design and manufacturing process for semiconductor products is highly complex, it is possible that we may produce products that do not comply with customer specifications, contain defects or are otherwise incompatible with end uses.  In accordance with industry practice, we generally provide a limited warranty that our products are in compliance with our specifications existing at the time of delivery.  Under our general terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items or return of, or a credit with respect to, amounts paid for such items.  Under certain circumstances, we provide more extensive limited warranty coverage than that provided under our general terms and conditions.


Competition

We face intense competition in the semiconductor memory market from a number of companies, including Samsung Electronics Co., Ltd.; SanDisk Corporation; SK Hynix Inc.; Spansion Inc. and Toshiba Corporation. Some of our competitors are large corporations or conglomerates that may have greater resources to withstand downturns in the semiconductor markets in which we compete, invest in technology and capitalize on growth opportunities. Our competitors seek to increase silicon capacity, improve yields, reduce die size and minimize mask levels in their product designs resulting in significantly increased worldwide supply and downward pressure on prices. Many of our high-volume memory products are manufactured to industry standard specifications and as such have similar performance characteristics to those of our competitors. For these high-volume memory products, the principal competitive factors are generally price and performance characteristics including: operating speed, power consumption, reliability, compatibility, size and form factors. For our other memory products, the aforementioned performance characteristics generally take precedence to pricing.


Research and Development

Our process technology R&D efforts are focused primarily on development of successively smaller line-width process technologies, as well as new, fundamentally different memory structures, materials and packages, which are designed to facilitate our transition to next generation memory products. Additional process technology R&D efforts focus on the enablement of advanced computing and mobile memory architectures, the investigation of new opportunities that leverage our core semiconductor expertise and the development of new manufacturing materials. Product design and development efforts include our high density DDR3 and DDR4 DRAM and Mobile Low Power DDR DRAMLPDRAM products as well as high density and mobile NAND Flash memory (including 3D NAND and MLC and TLC technologies), NOR Flash memory, specialty memory, SSDs, hybrid memory cubesHMCs and other memory technologies and systems.

Our R&D expenses were $1.37 billion, $931 million and $918 million in 2014, 2013 and $791 million in 2013, 2012, and 2011, respectively. We generally share certain R&D process technology and design costs for NAND Flash with Intel. We also share R&D costs for certainand emerging memory technologies with Intel. We generally shared R&D process and design costs for DRAM with Nanya through December 2012, when our cost-sharing agreement was terminated. As a result of reimbursements under our Intel and Nanya cost-sharing arrangements, our overall R&D expenses were reduced by $137 million, $146 million and $225 million in 2014, 2013 and $236 million in 2013, 2012, and 2011, respectively.


7



To compete in the semiconductor memory industry, we must continue to develop technologically advanced products and processes. We believe that expansion of our semiconductor product offerings is necessary to meet expected market demand for specific memory solutions. Our process, design and package development efforts occur at multiple locations across the world, with our largest R&D centers located in Boise, IdahoIdaho; Hiroshima, Japan; Hashimoto, Japan; and Hiroshima, Japan. Our largest design center is also located at our corporate headquarters in Boise, Idaho.Milpitas, California. We have several additional product design centers in other strategic locations around the world. In 2012, we commenced operation of our new R&D facility in Boise, which was designed to accommodate 450mm wafer manufacturing. In addition, we develop photolithography mask technology at our MP Mask joint venture facility in Boise.

R&D expenses vary primarily with the number of development wafers processed, the cost of advanced equipment dedicated to new product and process development and personnel costs. Because of the lead times necessary to manufacture our products, we typically begin to process wafers before completion of performance and reliability testing. We deem development of a product complete once the product has been thoroughly reviewed and tested for performance and reliability. R&D expenses can vary significantly depending on the timing of product qualification.




7



Geographic Information

Sales to customers outside the United States totaled $7.6$13.81 billion for 20132014 and included $3.8sales of $6.72 billion in sales in China, $980 million in sales$2.31 billion in Taiwan, $820 million$1.25 billion in salesJapan, $1.25 billion in Europe $193 million in sales in Malaysia and $1.3$1.79 billion in sales in the rest of the Asia Pacific region (excluding China, MalaysiaJapan and Taiwan).  Sales to customers outside the United States totaled $7.0$7.56 billion for 20122013 and $7.4$6.97 billion for 2011.2012.  As of August 29, 2013,28, 2014, we had net property, plant and equipment of $3.2 billion in Singapore, $3.0$3.28 billion in the United States, $615$3.10 billion in Singapore, $1.22 billion in Japan, $761 million in Japan, $350Taiwan, $242 million in China, $307 million in Taiwan, $28 million in Israel, $18 million in Italy and $42$75 million in other countries.  (See "Item"Part II – Item 8. Financial Statements and Supplementary Data –Notes– Notes to Consolidated Financial Statements – Geographic Information" note and "Item 1A. Risk Factors.")


Patents and Licenses

In recent years, we have been recognized as a leader in per capita and quality of patents issued.  As of August 29, 201328, 2014, we owned approximately 16,20016,500 U.S. patents and 3,7004,000 foreign patents.  In addition, we have numerousthousands of U.S. and foreign patent applications pending.  Our patents have various terms expiring through 2032.2033.

We have a number of patent and intellectual property license agreements and have from time to time licensed or sold our intellectual property to third parties.  Some of these license agreements require us to make one-time or periodic payments while others have resulted in us receiving payments. We may need to obtain additional patent licenses or renew existing license agreements in the future and we may enter into additional sales or licenses of intellectual property and potential partnering arrangements.  We are unable to predict whether these license agreements can be obtained or renewed on acceptable terms.


Employees

As of August 29, 2013,28, 2014, we had approximately 30,900 employees, of which approximately 19,600 were outside the United States, including approximately 7,500 in Singapore, 3,700 in Japan, 2,700 in China, 2,100 in Taiwan, 1,100 in Italy, 1,000 in Israel and 1,000 in Malaysia.  Our employees include approximately 1,700 in our IMFT joint venture, primarily located in the United States and 5,700 from our acquisition of Elpida and Rexchip, primarily located in Japan and Taiwan.  In September 2013, we entered into an agreement to sell our 200mm wafer fabrication equipment in Kiryat Gat, Israel to Intel and to terminate the related facility lease with Intel. If this transaction is completed, most of our employees in Israel will terminate their employment with us and be transferred to Intel. As of August 29, 2013, we do not anticipate incurring any significant additional costs for this restructure activity. Our employment levels can vary depending on market conditions and the level of our production, research and product and process development.  Many of our employees are highly skilled and our continued success depends in part upon our ability to attract and retain such30,400 employees.  The loss of key personnel could have a material adverse effect on our business, results of operations or financial condition.




8



Environmental Compliance

Government regulations impose various environmental controls on raw materials and discharges, emissions and solid wastes from our manufacturing processes.  In 2013,2014, our wafer fabrication facilities continued to conform to the requirements of ISO 14001 certification.  To continue certification, we metmust meet annual requirements in environmental policy, compliance, planning, management, structure and responsibility, training, communication, document control, operational control, emergency preparedness and response, record keeping and management review.  While we have not experienced any material adverse effects to our operations from environmental regulations, changes in the regulations could necessitate additional capital expenditures, modification of our operations or other compliance actions.


Directors and Executive Officers of the Registrant

Our executive officers are appointed annually by the Board of Directors and our directors are elected annually by our shareholders. Any directors appointed by the Board of Directors to fill vacancies on the Board serve until the next election by the shareholders. All officers and directors serve until their successors are duly chosen or elected and qualified, except in the case of earlier death, resignation or removal.

As of August 29, 2013,28, 2014, the following executive officers and directors were subject to the reporting requirements of Section 16(a) of the Securities Exchange Act of 1934, as amended.


8



Name Age Position
Mark W. Adams 4950 President
Scott J. DeBoer 4748 Vice President of Research & Development
D. Mark Durcan 5253 Director and Chief Executive Officer
Thomas T. Eby52Vice President of Embedded Solutions
Ronald C. Foster 6263 Vice President of Finance and Chief Financial Officer
Glen W. HawkPatrick T. Otte 51 Vice President of NAND SolutionsHuman Resources
Roderic W. LewisJoel L. Poppen 5850 Vice President of Legal Affairs, General Counsel, and Corporate Secretary
Patrick T. Otte50Vice President of Human Resources
Michael J. Rayfield52Vice President of Wireless Solutions
Michael W. Sadler55Vice President of Corporate Development
Brian J. Shields51Vice President of Worldwide Operations
Brian M. Shirley 4445 Vice President of DRAMMemory Technology and Solutions
Steven L. Thorsen, Jr. 4849 Vice President of Worldwide Sales and Corporate Marketing
Robert L. Bailey 5657 Director
Richard M. Beyer 6465 Director
Patrick J. Byrne 5253 Director
D. Warren A. East 5152 Director
Mercedes Johnson 5960 Director
Lawrence N. Mondry 5354 Director
Robert E. Switz 6667 Chairman

Mark W. Adams joined us in June 2006 and served as our Vice President of Digital Media and Vice President of Worldwide Sales before being appointed our President in February 2012. From January 2006, until he joined us, Mr. Adams was the Chief Operating Officer of Lexar Media, Inc. Mr. Adams served as the Vice President of Sales and Marketing for Creative Labs, Inc. from December 2002 to January 2006. From March 2000 to September 2002, Mr. Adams was the Chief Executive Officer of Coresma, Inc. Mr. Adams holds a BA in Economics from Boston College and an MBA from Harvard Business School.

Scott J. DeBoer joined us in February 1995 as a process development engineer and has served in various leadership positions since that time. Dr. DeBoer became an officer in May 2007 and, in January 2013, he was appointed our Vice President of Research & Development. Dr. DeBoer holds a PhD in Electrical Engineering and aan MS in Physics from Iowa State University. He completed his undergraduate degree at Hastings College.

D. Mark Durcan joined us in June 1984 and has served in various positions since that time.  Mr. Durcan was appointed our Chief Operating Officer in February 2006, President in June 2007 and Director and Chief Executive Officer in February 2012. Mr. Durcan has been an officer since 1996.  Mr. Durcan is a member of the Board of Directors of MWI Veterinary Supply, Inc. and Freescale Semiconductor, Inc. Mr. Durcan holds a BS and MChE in Chemical Engineering from Rice University. Mr. Durcan has served on our Board of Directors since February 2012.

9




Thomas T. Eby joined us in September 2010 and serves as our Vice President of Embedded Solutions. Mr. Eby was with Spansion Inc. from October 2005 to September 2010 where he held leading roles in strategy and communications, sales and marketing, and integration. He was also the General Manager and Executive Vice President of Spansion's embedded group. Mr. Eby previously held a variety of positions in sales and marketing and strategy with AMD. Mr. Eby holds a BS degree in Electrical Engineering and Computer Science from Princeton University.

Ronald C. Foster joined us in April 2008 and is the Chief Financial Officer and Vice President of Finance.  He was appointed to his current position in 2008 after serving as a member of the Company’sour Board of Directors from June 2004 to April 2005.  Before joining Micron, Mr. Foster was the Chief Financial Officer of FormFactor, Inc.  He previously served as the Chief Financial Officer for JDS Uniphase, Inc., and Novell, Inc.  Mr. Foster holds a BA in Economics from Whitman College and an MBA from the University of Chicago.

Glen W. Hawk joined us in May 2010 and serves as our Vice President of NAND Solutions.  Mr. Hawk served as the Vice President and General Manager of the Embedded Business Group for Numonyx from 2008 to May 2010.  Prior to Numonyx, Mr. Hawk served as General Manager of the Flash Product Group for Intel Corporation.  Mr. Hawk holds a BS in Chemical Engineering from the University of California, Berkeley.

Roderic W. Lewis joined us in August 1991 and has served in various capacities since that time.  Mr. Lewis has served as our Vice President of Legal Affairs, General Counsel and Corporate Secretary since July 1996.  Mr. Lewis holds a BA in Economics and Asian Studies from Brigham Young University and a JD from Columbia University School of Law.

Patrick T. Otte joined us in October 1987 and has served in various positions, including production and operations manager in several of our fabrication facilities and site director for our facility in Manassas, Virginia.  Mr. Otte has served as our Vice President of Human Resources since March 2007.  Mr. Otte holds a BA in Religious Education from St. Paul Bible College.

Michael J. RayfieldJoel L. Poppen joined us in September 2012October 1995 and serves as our Vice Presidenthas held various positions of Wireless Solutions.increased responsibility, including Deputy General Counsel.  He was appointed to his current position in December 2013. Mr. Rayfield served as the Vice President and General Manager of NVIDIA, Inc.'s Mobile Business Unit from September 2005 to August 2012. Mr. Rayfield also held executive positions at Stretch, Inc., Reshape, Inc., Cisco Systems, Growth Networks and Texas Instruments. Mr. RayfieldPoppen holds a BS in Electrical Engineering from the University of Vermont.

Michael W. Sadler joined us in September 1992 asIllinois and a regional sales manager and has served in various leadership positions since that time, including Vice President of Worldwide Sales for us and Executive Vice President of Inotera Memories, Inc. In June 2010, Mr. Sadler was appointed our Vice President of Corporate Development. Mr. Sadler holds a BS in Decision Science and an MBAJD from the Duke University School of Santa Clara.

Brian J. Shields joined us in November 1986 and has served in various operational leadership positions since that time.  Mr. Shields first became an officer in March 2003 and has served as our Vice President of Worldwide Operations since June 2010.Law.

Brian M. Shirley joined us in August 1992 and has served in various leadership positions since that time.  Mr. Shirley became Vice President of Memory in February 2006, Vice President of DRAM Solutions in June 2010 and has served as Vice President of DRAMMemory Technology and Solutions from June 2010.since April 2014.  Mr. Shirley holds a BS in Electrical Engineering from Stanford University.

Steven L. Thorsen, Jr. joined us in September 1988 and has served in various leadership positions since that time including Vice President and Chief Procurement Officer. Mr. Thorsen became Vice President of Worldwide Sales and Corporate Marketing in April 2012. Mr. Thorsen holds a BA in Business Administration from Washington State University.


9



Robert L. Bailey was the Chairman of the Board of Directors of PMC-Sierra ("PMC") from 2005 until May 2011 and also served as PMC's Chairman from February 2000 until February 2003.  Mr. Bailey has served as a director of PMC since October 1996.  He also served as the President and Chief Executive Officer of PMC Sierra, Ltd. from July 1997 until May 2008.  PMC is a leading provider of broadband communication and semiconductor storage solutions for the next-generation Internet.  Mr. Bailey currently serves on the Board of Directors of Entropic Communications.  Mr. Bailey holds a BS in Electrical Engineering from the University of Bridgeport and an MBA from the University of Dallas.  He has served on our Board of Directors since 2007.


10



Richard M. Beyer was Chairman and CEO of Freescale Semiconductor from 2008 through June 2012 and continues to serve as a Director with Freescale. Prior to Freescale, Mr. Beyer was President, Chief Executive Officer and Director of Intersil Corporation from 2002 to 2008. He has also previously served in executive management roles at FVC.com, VLSI Technology and National Semiconductor Corporation. He currently serves on the Board of Directors of Dialog Semiconductor.Semiconductor and Analog Devices. Mr. Beyer served three years as an officer in the United States Marine Corps. He holds a BA and aan MA in Russian from Georgetown University and aan MBA in Marketing and International Business from Columbia University Graduate School of Business. Mr. Beyer joined our Board of Directors in January 2013.

Patrick J. Byrne has beenserved as the President of Tektronix, Inc., a subsidiary of Danaher Corporation, since July 2014. Mr. Byrne was Vice President of Strategy and Business Development and Chief Technical Officer of Danaher Corporation sincefrom November 1, 2012.2012 to July 2014. Danaher Corporation designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. Prior to that, Mr. Byrne was the Director, President and Chief Executive Officer of Intermec, Inc. from 2007 to May 2012.  Mr. Byrne was with Agilent Technologies, Inc. from 1999 to 2007 and served in various management positions.  Mr. Byrne is also a member of the Board of Directors of Flow International Corporation.  Mr. Byrne holds a BS in Electrical Engineering from the University of California, Berkeley, and an MS degree in Electrical Engineering from Stanford University.  Mr. Byrne joined our Board of Directors in April 2011.

D. Warren A. East was the CEO of ARM Holdings PLC from October 2001 to July 2013. He originally joined ARM in 1994, and served in various roles prior to being appointed CEO. He currently serves on the board of BT Group plc, De La Rule PLC, Inc. and Rolls Royce plc. Mr. East is a chartered engineer, Distinguished Fellow of the British Computer Society, Fellow of the Institution of Engineering and Technology, Fellow of the Royal Academy of Engineering and a Companion of the Chartered Management Institute. Mr. East holds a BA BSc(Eng) and an MBA MEng in Engineering Science from Oxford University and an MBA and honorary doctorate from Cranfield University. Mr. East joined our Board of Directors in July 2013.

Mercedes Johnson was the Senior Vice President and Chief Financial Officer of Avago Technologies Limited, a supplier of analog interface components for communications, industrial and consumer applications, from December 2005 to August 2008.  She also served as the Senior Vice President, Finance, of Lam Research Corporation ("Lam") from June 2004 to January 2005 and as Lam's Chief Financial Officer from May 1997 to May 2004.  Ms. Johnson holds a degree in Accounting from the University of Buenos Aires and currently serves on the Board of Directors for Intersil Corporation, and Juniper Networks, Inc. and Teradyne, Inc.  Ms. Johnson is the Chairman of the Board's Audit Committee and has served on our Board of Directors since 2005.

Lawrence N. Mondry has been the Chief Executive Officer of Apollo Brands, a consumer products portfolio company, since February 2014. Mr Mondry was the Chief Executive Officer of Flexi Compras Corporation, a rent-to-own retailer, sincefrom June 2013.2013 to February 2014. Mr. Mondry was the President and Chief Executive Officer of CSK Auto Corporation ("CSK"), a specialty retailer of automotive aftermarket parts, from August 2007 to July 2008.  Prior to his appointment at CSK, Mr. Mondry served as the Chief Executive Officer of CompUSA Inc. from November 2003 to May 2006.  Mr. Mondry joined CompUSA in 1990.  Mr. Mondry is the Chairman of the Board's Governance Committee and Compensation Committee. He has served on our Board of Directors since 2005.

Robert E. Switz was the Chairman, President and Chief Executive Officer of ADC Telecommunications, Inc., ("ADC"), a supplier of network infrastructure products and services from August 2003 until December 2010, when Tyco Electronics Ltd. acquired ADC.  Mr. Switz joined ADC in 1994 and throughout his career there held numerous leadership positions.  Mr. Switz holds an MBA from the University of Bridgeport as well asand a BS in Business Administration from Quinnipiac University.  Mr. Switz also serves on the Board of Directors for Broadcom Corporation, Cyan Optics, Inc., GT Advanced Technologies and Leap Wireless International, Inc.Pulse Electronics Corporation.  He has served on our Board of Directors since 2006 and was appointed Chairman of the Board in February 2012.

There are no family relationships between any of our directors or executive officers.

1110



ITEM 1A. RISK FACTORS


In addition to the factors discussed elsewhere in this Form 10-K, the following are important factors which could cause actual results or events to differ materially from those contained in any forward-looking statements made by or on behalf of us.

We have experienced dramatic declines in average selling prices for our semiconductor memory products which have adversely affected our business.

If average selling prices for our memory products decrease faster than we can decrease per gigabit costs, our business, results of operations or financial condition could be materially adversely affected. We have experienced significant decreases in our average selling prices per gigabit in recent years as noted in the table below and may continue to experience such decreases in the future. In some prior periods, average selling prices for our memory products have been below our manufacturing costs and we may experience such circumstances in the future.

 DRAM Trade NAND Flash* DRAM Trade NAND Flash*
 (percentage change in average selling prices) 
 (percentage change in average selling prices)
2014 from 2013 6% (23)%
2013 from 2012 (11)% (18)% (11)% (18)%
2012 from 2011 (45)% (55)% (45)% (55)%
2011 from 2010 (39)% (12)% (39)% (12)%
2010 from 2009 28% 26%
2009 from 2008 (52)% (52)%
* Trade NAND Flash excludes sales to Intel from IM Flash. 
* Trade NAND Flash excludes sales to Intel from IMFT. 

We may be unable to reduce our per gigabit manufacturing costs at the rate average selling prices decline.maintain or improve gross margins.

Our gross margins are dependent upon continuing decreases in per gigabit manufacturing costs achieved through improvements in our manufacturing processes, including reducing the die size of our existing products. In future periods, we may be unable to reduce our per gigabit manufacturing costs at sufficient levels to improvemaintain or maintainimprove gross margins. Factors that may limit our ability to reduce costs include, but are not limited to, strategic product diversification decisions affecting product mix, the increasing complexity of manufacturing processes, difficulty in transitioning to smaller line-width process technologies, technological barriers and changes in process technologies or products that may require relatively larger die sizes. Per gigabit manufacturing costs may also be affected by the relatively smaller production quantities and shorter product lifecycles of certain specialty memory products.

The semiconductor memory industry is highly competitive.

We face intense competition in the semiconductor memory market from a number of companies, including Samsung Electronics Co., Ltd.; SanDisk Corporation; SK Hynix Inc.; Spansion Inc. and Toshiba Corporation. Some of our competitors are large corporations or conglomerates that may have greater resources to withstand downturns in the semiconductor markets in which we compete, invest in technology and capitalize on growth opportunities. Consolidation of industry competitors could put us at a competitive disadvantage. In addition, some governments, such as China, may be considering providing, or have provided, significant financial assistance to some of our competitors or to new entrants. Our competitors seek to increase silicon capacity, improve yields, reduce die size and minimize mask levels in their product designs. Transitions to smaller line-width process technologies and product and process improvements have resulted in significant increases in the worldwide supply of semiconductor memory. Increases in worldwide supply of semiconductor memory also result from semiconductor memory fab capacity expansions, either by way of new facilities, increased capacity utilization or reallocation of other semiconductor production to semiconductor memory production. Our competitors may increase capital expenditures resulting in future increases in worldwide supply. Increases in worldwide supply of semiconductor memory, if not accompanied withby commensurate increases in demand, would lead to further declines in average selling prices for our products and would materially adversely affect our business, results of operations or financial condition.


1211



Our acquisitions of Elpida and Rexchip involveInotera Supply Agreement involves numerous risks.

On July 31, 2013,We have a supply agreement with Inotera (the "Inotera Supply Agreement") under which we completedare obligated to purchase substantially all of Inotera's DRAM output over an initial three-year term at a purchase price based on a discount from market prices for our comparable components, currently through December 2016. The Inotera Supply Agreement contemplates annual negotiations with respect to potential successive one-year extensions, and if the acquisition of Elpida, pursuantparties do not agree to an extension, the terms and conditionsagreement will terminate following the end of the Sponsor Agreementthen-existing term plus a subsequent three-year wind-down period. In the event of a wind-down, our share of Inotera's capacity would decline over the wind-down period. We are currently in negotiations regarding the extension of the Inotera Supply Agreement. There can be no assurance that we entered into on July 2, 2012, withwill be able to reach an agreement. Our Inotera Supply Agreement involves numerous additional risks including the trustees of the Elpida Companies pursuant to and in connection with the Elpida Companies' pending corporate reorganization proceedingsfollowing:

higher costs for supply obtained under the Corporate Reorganization ActInotera Supply Agreement as compared to our wholly-owned facilities;
difficulties and delays in ramping production at Inotera;
difficulties in transferring technology to Inotera; and
difficulties in coming to an agreement with Nanya regarding major corporate decisions, such as capital expenditures or capital structure.

For 2014, we purchased $2.68 billion of Japan. We paid $615 millionDRAM products from Inotera and our supply from Inotera accounted for the acquisition of 100% of Elpida's equity. On July 31, 2013, we also acquired a 24% ownership interest in Rexchip from the Powerchip Group pursuant to a share purchase agreement. We paid $334 million in cash for the shares. The Elpida Group owns approximately 65% of Rexchip's outstanding common stock. Therefore, as a result of the consummation38% of our acquisitionaggregate DRAM gigabit production. If our supply of Elpida and the Rexchip sharesDRAM from the Powerchip Group, we own approximately 89% of Rexchip's common stock. The provisional fair values of assets and liabilities acquired include, among other items, cash and restricted cash aggregating $1,618 million, inventories of $962 million; property, plant and equipment of $935 million; net deferred tax assets of $917 million and debt of $2,134 million.

In addition to the acquisition risks described elsewhere, these acquisitions are expected to involve the following significant risks:

we may be unable to maintain customers, successfully execute our integration strategies, or achieve planned synergies;
we may be unable to accurately forecast the anticipated financial results of the combined business;
our consolidated financial condition may be adverselyInotera is impacted, by the increased leverage resulting from the transactions;
increased exposure to the DRAM market, which experienced significant declines in pricing during the first quarter of 2013 as well as 2012 and 2011;
deterioration of Elpida's and Rexchip's operations and customer base following closing;
increased exposure to operating costs denominated in yen and New Taiwan dollar;
integration issues with Elpida's and Rexchip's primary manufacturing operations in Japan and Taiwan;
integration issues of our product and process technology with Elpida and Rexchip;
integration of business systems and processes; and
an overlap in customers.

Our acquisitions of Elpida and Rexchip are inherently risky, may not be successful and may materially adversely affect our business, results of operations or financial condition.

The operations of the Elpida Companies will be subject to continued oversight by the Japan Court during the pendency of the corporate reorganization proceedings.

Because the plans of reorganization of the Elpida Companies provide for ongoing payments to creditors following the closing of our acquisition of Elpida, the Japan Proceedings are continuing, and the Elpida Companies remain subject to the oversight of the Japan Court and of the trustees (including a trustee designated by us, who we refer to as the business trustee, and a trustee designated by the Japan Court, who we refer to as the legal trustee), pending completion of the Japan Proceedings. The Japan Proceedings and oversight of the Japan Court are expected to continue until the final creditor payment is made under the Elpida Companies' plans of reorganization, which is scheduled to occur in December 2019, but may occur on a later date to the extent any claims of creditors remain unfixed on the final scheduled installment payment date. Although we may be able to petition the court to terminate the Japan Proceedings once two-thirds of all payments under the plans of reorganization are made, there can be no assurance that the Japan Court will grant any such petition.

During the pendency of the Japan Proceedings, the Elpida Companies are obligated to provide periodic financial reports to the Japan Court and may be required to obtain the consent of the Japan Court prior to taking a number of significant actions relating to their businesses, including transferring or disposing of, or acquiring, certain material assets, incurring or guaranteeing material indebtedness, settling disputes or entering into certain material agreements. The consent of the legal trustee may also be required for matters that would likely have a material impact on the operations or assets of the Elpida Companies and their subsidiaries or for transfers of material assets, to the extent the matters or transfers would reasonably be expected to materially and adversely affect execution of the plans of reorganization of the Elpida Companies. Accordingly, during the pendency of the Japan Proceedings, our ability to effectively integrate the Elpida Companies as part of our global operations or to cause the Elpida Companies to take certain actions that we deem advisable for their businessescondition could be materially adversely affected if the Japan Court or the legal trustee is unwilling to consent to various actions that we may wish to take with respect to the Elpida Companies.


13



Our acquisitions of Elpida and Rexchip expose us to significant risks from changes in currency exchange rates.

Under the Sponsor Agreement, we committed to support plans of reorganization for Elpida that provide for payments to the secured and unsecured creditors of Elpida in an aggregate amount of 200 billion yen. The U.S. dollar amount of this payment obligation could increase if the yen strengthens against the U.S. dollar. Additionally, a significant portion of Elpida's and Rexchip's operating costs are paid in Yen and New Taiwan dollars so our operating results subsequent to the acquisition could also be adversely impacted if these currencies strengthen against the U.S. dollar.

Our acquisitions of Elpida and Rexchip may increase our risk of significant deficiencies or material weaknesses in our internal controls over financial reporting.

Elpida and Rexchip have not performed an assessment of the effectiveness of the design and operation of their internal control over financial reporting. In addition, Elpida and Rexchip have not historically prepared their financial statements under U.S. generally accepted accounting standards. Elpida and Rexchip were not required to be included in our assessment of internal controls for 2013 but will be included in our assessment for 2014, which may increase our risk for material weaknesses in our internal control over financial reporting.affected.

Debt obligations could adversely affect our financial condition.

We are engaged in a capital intensive business subject to significant changes in supply and demand and product pricing and recent periods of consolidation, any of which could result in our incurrence or assumption of indebtedness. In recent periods, our debt levels have increased. As of August 29, 2013,28, 2014, we had $6.0debt with a carrying value of $6.59 billion. In addition, the conversion value in excess of principal amount for our convertible notes outstanding as of August 28, 2014 was $2.99 billion. In 2014, we paid $2.30 billion of debt, including $485 millionto repurchase and settle conversion obligations for convertible notes with a principal amount of $1.09 billion. In the first quarter of 2015, we paid $389 million to settle conversion obligations for convertible senior notes due inwith a principal amount of $114 million as of August 28, 2014. As of August 29, 2013,28, 2014, we had two credit facilities available that providesprovide for up to $408 million of additional financing, subject to outstanding balances of trade receivables and other conditions. Events and circumstances may occur which would cause us to not be able to satisfy the applicable drawdown conditions and utilize either of these facilities. We have in the past and expect in the future to continue to incur additional debt to finance our capital investments, including debt incurred in connection with asset-backed financing.

The plans of reorganization of the Elpida Companies provide for payments by the Elpida Companies to their secured and unsecured creditors in an aggregate amount of 200 billion yen (or the equivalent of approximately $2.05 billion), less certain expenses of the Japan Proceedings and certain other items. If the resolution of certain unfixed claims under the plans of reorganization, primarily comprised of outstanding litigation claims, would result in payments in respect of those claims in excess of amounts reserved under the plans of reorganization to satisfy such claims, there is a possibility that the Elpida Companies would be required to pay more than 200 billion yen to their pre-petition creditors under the plans of reorganization. In addition, if these unfixed claims are resolved pursuant to settlement arrangements or other post-petition agreements, a substantial portion of the amounts payable with respect to the claims may have to be funded by the Elpida Companies outside of the installment payments provided for by the plans of reorganization.

Our debt and our guarantee obligations could adversely impact us. For example, these obligations could:

require us to use a large portion of our cash flow to pay principal and interest on debt, which will reduce the amount of cash flow available to fund working capital, capital expenditures, acquisitions, research and development expenditures and other business activities;
continue to dilute our earnings per share as a result of the conversion provisions in our convertible notes;
require us to continue to pay cash amounts substantially in excess of the principal amounts upon settlement of our convertible notes to minimize dilution of our earnings per share;
limit our future ability to raise funds for capital expenditures, strategic acquisitions or business opportunities, research and development and other general corporate requirements;
contribute to a future downgrade of our credit rating, which could increase future borrowing costs; and
increase our vulnerability to adverse economic and semiconductor memory industry conditions.

Our ability to meet our payment obligations under our debt instruments depends on our ability to generate significant cash flow in the future. This, to some extent, is subject to general economic, financial, competitive, legislative and regulatory factors as well as other factors that are beyond our control. There can be no assurance that our business will generate cash flow from operations, or that additional capital will be available to us, in an amount sufficient to enable us to meet our debt payment obligations and to fund other liquidity needs. If we are unable to generate sufficient cash flow to service our debt obligations, we may need to refinance or restructure our debt, sell assets, reduce or delay capital investments, or seek to raise additional capital. If we were unable to implement one or more of these alternatives, we may be unable to meet our debt payment obligations, which could have a material adverse effect on our business and results of operations.


1412



We may be unable to generate sufficient cash flows or obtain access to external financing necessary to fund our operations, make scheduled debt payments and make adequate capital investments.

Our cash flows from operations depend primarily on the volume of semiconductor memory sold, average selling prices and per unit manufacturing costs. To develop new product and process technologies, support future growth, achieve operating efficiencies and maintain product quality, we must make significant capital investments in manufacturing technology, capital equipment, facilities, R&D and product and process technology. We estimate that capital spending for 20142015 will be approximately $2.6$3.6 billion to $3.2$4.0 billion. In addition, as a result of the Elpida acquisition,MMJ Acquisition, we believe that our future capital spending will be higher than our historical levels as we integrate our manufacturing operations and support the increase of capacity resulting from the Elpida transaction. As of August 29, 2013,28, 2014, we had cash and equivalents of $2,880 million,$4.15 billion, short-term investments of $221$384 million and long-term marketable investments of $499$819 million. Cash and investments included $1,094 million$1.60 billion held by ElpidaMMJ and its consolidated subsidiaries and $62$84 million held by IM Flash Technologies, LLC ("IMFT"),IMFT, none of which is generally available to finance our other operations.

As a result of the corporate reorganization proceedings with the Japan Proceedings,Court under the Corporate Reorganization Act of Japan (the "Japan Proceedings"), for so long as such proceedings are continuing, the ElpidaMMJ Companies and their subsidiaries are subject to certain restrictions on dividends, loans and advances. The plans of reorganization of the ElpidaMMJ Companies prohibit the ElpidaMMJ Companies from paying dividends, including any cash dividends, to us and require that excess earnings be used in their businesses or to fund the ElpidaMMJ Companies' installment payments. These prohibitions would also effectively prevent the subsidiaries of the ElpidaMMJ Companies from paying cash dividends to us in respect of the shares of such subsidiaries owned by the ElpidaMMJ Companies, as any such dividends would have to be first paid to the ElpidaMMJ Companies which are prohibited from repaying those amounts to us as dividends under the plans of reorganization. In addition, pursuant to an order of the Japan Court, the ElpidaMMJ Companies cannot make loans or advances, other than certain ordinary course advances, to us without the consent of the Japan Court. Moreover, loans or advances by subsidiaries of the ElpidaMMJ Companies may be considered outside of the ordinary course of business and subject to approval of the legal trustees and Japan Court. As a result, the assets of the ElpidaMMJ Companies and their subsidiaries, while available to satisfy the ElpidaMMJ Companies' installment payments and the other obligations, capital expenditures and other operating needs of the ElpidaMMJ Companies and their subsidiaries, are not available for use by us in our other operations. Moreover,Furthermore, certain uses of the assets of the ElpidaMMJ Companies, including investments in certain capital expenditures and in Rexchip,MMT, may require consent of Elpida'sMMJ's trustees and/or the Japan Court.

In the past we have utilized external sources of financing when needed. As a result of our current debt levels, expected debt amortization and general economic conditions, it may be difficult for us to obtain financing on terms acceptable to us. There can be no assurance that we will be able to generate sufficient cash flows, use cash held by ElpidaMMJ to fund its capital expenditures, access capital markets or find other sources of financing to fund our operations, make debt amortization payments and make adequate capital investments to remain competitive in terms of technology development and cost efficiency. Our inability to do the foregoing could have a material adverse effect on our business and results of operations.

OurThe acquisition of our ownership interest in Inotera Supply Agreement involves numerous risks.from Qimonda has been challenged by the administrator of the insolvency proceedings for Qimonda.

On January 17, 2013, we entered into20, 2011, Dr. Michael Jaffé, administrator for Qimonda insolvency proceedings, filed suit against MTI and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void under Section 133 of the German Insolvency Act a new supplyshare purchase agreement with Inotera (the "Inotera Supply Agreement") underbetween Micron B.V. and Qimonda signed in fall 2008 pursuant to which we are obligated to purchaseMicron B.V. purchased substantially all of Inotera's output at a purchase price based on a discount from market pricesQimonda's shares of Inotera Memories, Inc. (the "Inotera Shares"), representing approximately 55% of our total shares in Inotera, and seeks an order requiring us to retransfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for our comparable components. Our Inotera Supply Agreement involves numerous risks including the following:

higher costs for supply obtained under the market-based provisionsalleged value of the Inotera Supply Agreement;
difficulties and delays in ramping production atjoint venture relationship with Inotera and delays into terminate under Sections 103 or 133 of the future;German Insolvency Code a patent cross-license between us and
difficulties in transferring technology to Inotera.

Inotera's financial situation may adversely impact Qimonda entered into at the value of our interest and our supplysame time as the share purchase agreement.

As of June 30, 2013, Inotera's current liabilities exceeded its current assets by $1.0 billion, which exposes Inotera to liquidity risk. Additionally, Inotera incurred net losses of $541 million for its fiscal year ended December 31, 2012. As of June 30, 2013, Inotera was not in compliance with certain loan covenants, and had not been in compliance for the past several years, which may result in its lenders requiring repayment of such loans during the next year. Inotera has applied for a waiver from complying with the June 30, 2013 financial covenants. Inotera's management has implemented plans to improve its liquidity and for its six-month period ended June 30, 2013, Inotera generated net income of $91 million; however, there can be no assurance that Inotera will be successful in sufficiently improving its liquidity and complying with their loan covenants, which may result in its lenders requiring repayment of such loans during the next year. If Inotera is unable to continue to improve its liquidity, we may have to impair our investment in Inotera.


1513



On January 17, 2013, we entered into agreementsFollowing a series of hearings with Nanyapleadings, arguments and witnesses on behalf of the Qimonda estate, on March 13, 2014, the Court issued judgments:  (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on such shares and all other benefits; (4) denying Qimonda’s claims against Micron Technology Corporation ("Nanya")for any damages relating to amend the joint venture relationship involving Inotera. Underwith Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are cancelled. In addition, the Court issued interlocutory judgments ordering, among other things:  (1) that Micron B.V. transfer to the Qimonda estate the Inotera Supply AgreementShares still owned by it and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by it from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we purchase substantially allexpect to be able to continue to operate with full control of Inotera's output atthe Inotera Shares subject to further developments in the case. We have filed a purchase pricenotice of appeal, and the parties have submitted briefs to the appeals court. A hearing on the matter is scheduled for February 2, 2015.

We are unable to predict the outcome of the matter and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera shares or equivalent monetary damages, unspecified damages based on the benefits derived by Micron B.V. from the ownership of the Inotera Shares, and/or the termination of the patent cross-license, which could have a discount from actualmaterial adverse effect on our business, results of operation or financial condition.  As of August 28, 2014, the Inotera Shares had a carrying value for purposes of our financial reporting of $505 million and a market prices for comparable components. The Inotera Supply Agreement was retroactively effective beginningvalue of $2.06 billion.

Our future success depends on January 1, 2013. For the fourth quarter of 2013, we purchased $518 millionour ability to develop and produce competitive new memory technologies.

Our key semiconductor memory technologies of DRAM, NAND Flash and NOR Flash face technological barriers to continue to meet long-term customer needs. These barriers include potential limitations on the ability to shrink products in order to reduce costs, meet higher density requirements and improve power consumption and reliability. To meet these requirements, we expect that new memory technologies will be developed by the semiconductor memory industry. Our competitors are working to develop new memory technologies that may offer performance and/or cost advantages to our existing memory technologies and render existing technologies obsolete. Accordingly, our future success may depend on our ability to develop and produce viable and competitive new memory technologies. There can be no assurance of the following:

that we will be successful in developing competitivenew semiconductor memory technologies;
that we will be able to cost-effectively manufacture new products;
that we will be able to successfully market these technologies; and
that margins generated from Inotera and our supply from Inotera accounted for 50%sales of our aggregate DRAM gigabit production. these products will allow us to recover costs of development efforts.

If our supply of DRAM from Inotera is impacted,efforts to develop new semiconductor memory technologies are unsuccessful, our business, results of operations or financial condition couldmay be materially adversely affected.

ChangesNew product development may be unsuccessful.

We are developing new products that complement our traditional memory products or leverage their underlying design or process technology. We have made significant investments in foreign currency exchange ratesproduct and process technologies and anticipate expending significant resources for new semiconductor product development, including system-level memory products, over the next several years. The process to develop DRAM, NAND Flash, NOR Flash and certain specialty memory products requires us to demonstrate advanced functionality and performance, many times well in advance of a planned ramp of production, in order to secure design wins with our customers. There can be no assurance that our product development efforts will be successful, that we will be able to cost-effectively manufacture new products, that we will be able to successfully market these products or that margins generated from sales of these products will allow us to recover costs of development efforts.


14



Products that fail to meet specifications, are defective or that are otherwise incompatible with end uses could impose significant costs on us.

Products that do not meet specifications or that contain, or are perceived by our customers to contain, defects or that are otherwise incompatible with end uses could impose significant costs on us or otherwise materially adversely affect our business, results of operations or financial condition. From time to time we experience problems with nonconforming, defective or incompatible products after we have shipped such products. In recent periods we have further diversified and expanded our product offerings which could potentially increase the chance that one or more of our products could fail to meet specifications in a particular application. As a result of these problems we could be adversely affected in several ways, including the following:

we may be required to compensate customers for costs incurred or damages caused by defective or incompatible product or replace products;
we could incur a decrease in revenue or adjustment to pricing commensurate with the reimbursement of such costs or alleged damages; and
we may encounter adverse publicity, which could cause a decrease in sales of our products.

A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could materially adversely affect our business, results of operations or financial condition.

AcrossAs is typical in the semiconductor and other high technology industries, from time to time others have asserted, and may in the future assert, that our multi-nationalproducts or manufacturing processes infringe their intellectual property rights. We are unable to predict the outcome of assertions of infringement made against us. A court determination that our products or manufacturing processes infringe the intellectual property rights of others could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing results could have a material adverse effect on our business, results of operations thereor financial condition. (See "Item 1. Legal Proceedings.")

We have a number of intellectual property license agreements. Some of these license agreements require us to make one time or periodic payments. We may need to obtain additional patent licenses or renew existing license agreements in the future. We are transactionsunable to predict whether these license agreements can be obtained or renewed on acceptable terms.

Our joint ventures and balances denominatedstrategic relationships involve numerous risks.

We have entered into strategic relationships to manufacture products and develop new manufacturing process technologies and products. These relationships include our IMFT NAND Flash joint venture with Intel, our Inotera DRAM joint venture with Nanya and our MP Mask joint venture with Photronics. These joint ventures and strategic relationships are subject to various risks that could adversely affect the value of our investments and our results of operations. These risks include the following:

our interests could diverge from our partners or we may not be able to agree with partners on ongoing manufacturing and operational activities, or on the amount, timing or nature of further investments in currencies other thanour joint venture;
we may experience difficulties in transferring technology to joint ventures;
we may experience difficulties and delays in ramping production at joint ventures;
our control over the U.S. dollar (our reporting currency), primarily the Singapore dollar, euro, shekel and yen. We recorded netoperations of our joint ventures is limited;
we may recognize losses from our equity method investments in future periods;
due to financial constraints, our joint venture partners may be unable to meet their commitments to us or our joint ventures and may pose credit risks for our transactions with them;
due to differing business models or long-term business goals, our partners may decide not to join us in funding capital investment by our joint ventures, which may result in higher levels of cash expenditures by us;
cash flows may be inadequate to fund increased capital requirements;
we may experience difficulties or delays in collecting amounts due to us from our joint ventures and partners;
the terms of our partnering arrangements may turn out to be unfavorable; and
changes in currency exchange rates of $229 million for 2013, $6 million for 2012tax, legal or regulatory requirements may necessitate changes in the agreements with our partners.

If our joint ventures and $6 million for 2011. Based onstrategic relationships are unsuccessful, our foreign currency exposures from monetary assets and liabilities, offset by balance sheet hedges, we estimate that a 10% adverse change in exchange rates versus the U.S. dollar would result in losses of approximately $19 million as of August 29, 2013. In the event that the U.S. dollar weakens significantly compared to the Singapore dollar, euro, shekel or yen, ourbusiness, results of operations or financial condition may be materially adversely affected.


15



The operations of the MMJ Companies will be subject to continued oversight by the Japan Court during the pendency of the corporate reorganization proceedings.

In connection withBecause the Elpida Sponsor Agreement and Rexchip Share Purchase Agreement, we entered into currency hedgesplans of reorganization of the MMJ Companies provide for ongoing payments to mitigatecreditors following the risk that increases in exchange rates have on our planned yen payments. In 2013, we recognized lossesclosing of $228 million on these hedges and made payments of $222 million to settle these hedges. As of August 29, 2013, to hedge certain yen-denominated payments resulting from our acquisition of Elpida,MMJ, the Japan Proceedings are continuing, and the MMJ Companies remain subject to the oversight of the Japan Court and of the trustees (including a trustee designated by us, who we had an outstanding forward contractrefer to purchase 20 billion yen on November 28, 2014 at a yen per U.S. dollar exchange rate of 98.53as the business trustee, and a forward contracttrustee designated by the Japan Court, who we refer to purchase 10 billion yenas the legal trustee), pending completion of the Japan Proceedings. The Japan Proceedings and oversight of the Japan Court are expected to continue until the final creditor payment is made under the MMJ Companies' plans of reorganization, which is scheduled to occur in December 2019, but may occur on November 27, 2015 at a yen per U.S. dollar exchange ratelater date to the extent any claims of 97.25.creditors remain unfixed on the final scheduled installment payment date. Although we may be able to petition the court to terminate the Japan Proceedings once two-thirds of all payments under the plans of reorganization are made, there can be no assurance that the Japan Court will grant any such petition.

The financial crisis and overall downturn inDuring the worldwide economy may harm our business.

The financial crisis and the overall downturn in the worldwide economy have had an adverse effect on our business. A continuation or further deterioration of depressed economic conditions could have an even greater adverse effect on our business, including any economic downturn resulting from the shutdownpendency of the U.S. federal governmentJapan Proceedings, the MMJ Companies are obligated to provide periodic financial reports to the Japan Court and may be required to obtain the consent of the Japan Court prior to taking a number of significant actions relating to their businesses, including transferring or any default bydisposing of, or acquiring, certain material assets, incurring or guaranteeing material indebtedness, settling disputes or entering into certain material agreements. The consent of the U.S. federal governmentlegal trustee may also be required for matters that would likely have a material impact on anythe operations or assets of its debtthe MMJ Companies and their subsidiaries or other obligations. Adverse economic conditionsfor transfers of material assets, to the extent the matters or transfers would reasonably be expected to materially and adversely affect demand for devices that incorporate our products, such as personal computers, networking products and mobile devices. Reduced demand for these products could result in significant decreases in our average selling prices and product sales. A deteriorationexecution of current conditions in worldwide credit markets would limitthe plans of reorganization of the MMJ Companies. Accordingly, during the pendency of the Japan Proceedings, our ability to obtain external financingeffectively integrate the MMJ Companies as part of our global operations or to fund our operations and capital expenditures. In addition,cause the MMJ Companies to take certain actions that we deem advisable for their businesses could be adversely affected if the Japan Court or the legal trustee is unwilling to consent to various actions that we may experience losses onwish to take with respect to the MMJ Companies.

If our holdings of cash and investments due to failures of financial institutions and other parties. Difficult economic conditions may also result in a higher rate of loss on our accounts receivables due to credit defaults. As a result,manufacturing process is disrupted, our business, results of operations or financial condition could be materially adversely affected.

We manufacture products using highly complex processes that require technologically advanced equipment and continuous modification to improve yields and performance. Difficulties in the manufacturing process or the effects from a shift in product mix can reduce yields or disrupt production and may increase our per gigabit manufacturing costs. We maintain operations and continuously implement new product and process technology at our manufacturing operations which are widely dispersed in multiple locations in several countries including the U.S., Singapore, Taiwan, Japan and China. Additionally, our control over operations at our IMFT, Inotera, MP Mask and Tera Probe joint ventures is limited by our agreements with our partners. From time to time, we have experienced disruptions in our manufacturing process as a result of power outages, improperly functioning equipment, equipment failures, earthquakes or other environmental acts. If production at a fabrication facility is disrupted for any reason, manufacturing yields may be adversely affected or we may be unable to meet our customers' requirements and they may purchase products from other suppliers. This could result in a significant increase in manufacturing costs or loss of revenues or damage to customer relationships, any of which could materially adversely affect our business, results of operations or financial condition.

We may incur additional material restructure or other charges in future periods.

In response to severe downturns in the semiconductor memory industry and global economic conditions,recent periods, we have implemented restructure activities and may implement restructure initiatives in future periods. We may restructure or dispose of assets as we continue to optimize our manufacturing operations, including the wind-down of 200-millimeter wafer capacity as we migrate more products to 300-millimeter wafer production. As a result, we could incur restructure charges (including but not limited to severance and other termination benefits, losses on disposition or impairment of equipment or other long-lived assets and inventory write downs), lose production output, lose key personnel and experience disruptions in our operations and difficulties in the timely delivery of products. In connection with these actions, we recorded charges of $40 million for 2014 and $126 million in 2013 andfor 2013. We do not anticipate incurring any significant additional costs for these prior restructure activities. We may incur additional restructure charges or other losses associated with other initiatives in future periods.


16



Changes in foreign currency exchange rates could materially adversely affect our business, results of operations or financial condition.

Across our multi-national operations, there are transactions and balances denominated in currencies other than the U.S. dollar (our reporting currency), primarily the euro, the Singapore dollar, the New Taiwan dollar, the yen and the yuan. We recorded net losses from changes in currency exchange rates of $28 million for 2014 and $229 million for 2013. Based on our foreign currency exposures from monetary assets and liabilities, offset by balance sheet hedges, we estimate that a 10% adverse change in exchange rates versus the U.S. dollar would result in losses of approximately $7 million as of August 28, 2014. In addition, a significant portion of our manufacturing costs are denominated in foreign currencies. Exchange rates for some of these currencies against the U.S. dollar, particularly the yen, have been volatile in recent periods. If these currencies strengthen against the U.S. dollar, our manufacturing costs could significantly increase. In the event that the exchange rates for U.S. dollar adversely change against our foreign currency exposures in the euro, Singapore dollar, New Taiwan dollar, the yen and the yuan, our results of operations or financial condition may be adversely affected.

We may make future acquisitions and/or alliances, which involve numerous risks.

Acquisitions and the formation or operation of alliances, such as joint ventures and other partnering arrangements, involve numerous risks including the following:

integrating the operations, technologies and products of acquired or newly formed entities into our operations;
increasing capital expenditures to upgrade and maintain facilities;
increased debt levels;

16



the assumption of unknown or underestimated liabilities;
the use of cash to finance a transaction, which may reduce the availability of cash to fund working capital, capital expenditures, research and development expenditures and other business activities;
diverting management's attention from normal daily operations;
managing larger or more complex operations and facilities and employees in separate and diverse geographic areas;
hiring and retaining key employees;
requirements imposed by governmental authorities in connection with the regulatory review of a transaction, which may include, among other things, divestitures or restrictions on the conduct of our business or the acquired business;
inability to realize synergies or other expected benefits;
failure to maintain customer, vendor and other relationships;
inadequacy or ineffectiveness of an acquired company's internal financial controls, disclosure controls and procedures, and/or environmental, health and safety, anti-corruption, human resource, or other policies or practices; and
impairment of acquired intangible assets and goodwill as a result of changing business conditions, technological advancements or worse-than-expected performance of the acquired business.

In recent years, supply of memory products has significantly exceeded customer demand resulting in significant declines in average selling prices for DRAM, NAND Flash and NOR Flash products. Resulting operating losses have led to the deterioration in the financial condition of a number of industry participants, including the liquidation of Qimonda AG and the 2012 bankruptcy filing by Elpida Memory, Inc.(now known as MMJ). These types of proceedings often lead to confidential court-directed processes involving the sale of related businesses or assets. We believe the global memory industry is experiencing a period of consolidation as a result of these market conditions and other factors, and we may engage in discussions regarding potential acquisitions and similar opportunities arising out of these industry conditions. To the extent we are successful in completing any such transactions, we could be subject to some or all of the risks described above, including the risks pertaining to funding, assumption of liabilities, integration challenges and increases in debt that may accompany such transactions. Acquisitions of, or alliances with, high-technology companies are inherently risky and may not be successful and may materially adversely affect our business, results of operations or financial condition.

Our future success depends on our ability to develop and produce competitive new memory technologies.

Our key semiconductor memory technologies of DRAM, NAND Flash and NOR Flash face technological barriers to continue to meet long-term customer needs. These barriers include potential limitations on the ability to shrink products in order to reduce costs, meet higher density requirements and improve power consumption and reliability. To meet these requirements, we expect that new memory technologies will be developed by the semiconductor memory industry. Our competitors are working to develop new memory technologies that may offer performance and/or cost advantages to our existing memory technologies and render existing technologies obsolete. Accordingly, our future success may depend on our ability to develop and produce viable and competitive new memory technologies. There can be no assurance of the following:

that we will be successful in developing competitivenew semiconductor memory technologies;
that we will be able to cost-effectively manufacture new products;
that we will be able to successfully market these technologies; and
that margins generated from sales of these products will allow us to recover costs of development efforts.

If our efforts to develop new semiconductor memory technologies are unsuccessful, our business, results of operations or financial condition may be adversely affected.


17



The acquisition of our ownership interest in Inotera from Qimonda has been legally challenged by the administrator of the insolvency proceedings for Qimonda.

On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda AG ("Qimonda") insolvency proceedings, filed suit against us and Micron Semiconductor B.V., our Netherlands subsidiary, in the District Court of Munich, Civil Chamber. The complaint seeks to void under Section 133 of the German Insolvency Act a share purchase agreement between us and Qimonda signed in fall 2008 pursuant to which we purchased all of Qimonda's shares of Inotera Memories, Inc. and seeks an order requiring us to retransfer the Inotera shares purchased from Qimonda to the Qimonda estate. The complaint also seeks to terminate under Sections 103 or 133 of the German Insolvency Code a patent cross license between us and Qimonda entered into at the same time as the share purchase agreement. A three-judge panel will render a decision after a series of hearings with pleadings, arguments and witnesses. Hearings were held on September 25, 2012, February 5, 2013, June 11, 2013 and July 2, 2013. An additional hearing is scheduled for November 12, 2013. We are unable to predict the outcome of this lawsuit and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera shares or equivalent monetary damages and the termination of the patent cross license, which could have a material adverse effect on our business, results of operation or financial condition. As of August 29, 2013, the Inotera shares purchased from Qimonda had a carrying value of $190 million.

Our joint ventures and strategic relationships involve numerous risks.

We have entered into strategic relationships to manufacture products and develop new manufacturing process technologies and products. These relationships include our IMFT NAND Flash joint venture with Intel Corporation ("Intel"), our Inotera DRAM joint venture with Nanya and our MP Mask joint venture with Photronics. These joint ventures and strategic relationships are subject to various risks that could adversely affect the value of our investments and our results of operations. These risks include the following:

our interests could diverge from our partners or we may not be able to agree with partners on ongoing manufacturing and operational activities, or on the amount, timing or nature of further investments in our joint venture;
we may experience difficulties in transferring technology to joint ventures;
we may experience difficulties and delays in ramping production at joint ventures;
our control over the operations of our joint ventures is limited;
we may recognize losses from equity investment Inotera in our future results of operations;
due to financial constraints, our joint venture partners may be unable to meet their commitments to us or our joint ventures and may pose credit risks for our transactions with them;
due to differing business models or long-term business goals, our partners may decide not to join us in funding capital investment by our joint ventures, which may result in higher levels of cash expenditures by us;
cash flows may be inadequate to fund increased capital requirements;
we may experience difficulties or delays in collecting amounts due to us from our joint ventures and partners;
the terms of our partnering arrangements may turn out to be unfavorable; and
changes in tax, legal or regulatory requirements may necessitate changes in the agreements with our partners.

If our joint ventures and strategic relationships are unsuccessful, our business, results of operations or financial condition may be adversely affected.


18



An adverse outcome relating to allegations of anticompetitive conduct could materially adversely affect our business, results of operations or financial condition.

On May 5, 2004, Rambus, Inc. ("Rambus") filed a complaint in the Superior Court of the State of California (San Francisco County) against us and other DRAM suppliers which alleged that the defendants harmed Rambus by engaging in concerted and unlawful efforts affecting Rambus DRAM by eliminating competition and stifling innovation in the market for computer memory technology and computer memory chips.  Rambus' complaint alleged various causes of action under California state law including, among other things, a conspiracy to restrict output and fix prices, a conspiracy to monopolize, intentional interference with prospective economic advantage, and unfair competition. Rambus sought a judgment for damages of approximately $3.9 billion, joint and several liability, trebling of damages awarded, punitive damages, a permanent injunction enjoining the defendants from the conduct alleged in the complaint, interest, and attorneys' fees and costs. Trial began on June 20, 2011, and the case went to the jury on September 21, 2011. On November 16, 2011, the jury found for us on all claims. On April 2, 2012, Rambus filed a notice of appeal to the California 1st District Court of Appeal.

We are unable to predict the outcome of this matter. An adverse court determination of any lawsuit alleging violations of antitrust laws could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition.

An adverse determination that our products or manufacturing processes infringe the intellectual property rights of others could materially adversely affect our business, results of operations or financial condition.

On January 13, 2006, Rambus filed a lawsuit against us in the U.S. District Court for the Northern District of California. Rambus alleges that certain of our DDR2, DDR3, RLDRAM, and RLDRAM II products infringe as many as fourteen Rambus patents and seeks monetary damages, treble damages, and injunctive relief. The accused products account for a significant portion of our net sales. On June 2, 2006, we filed an answer and counterclaim against Rambus alleging, among other things, antitrust and fraud claims. On January 9, 2009, in another lawsuit involving us and Rambus and involving allegations by Rambus of patent infringement against us in the U.S. District Court for the District of Delaware, Judge Robinson entered an opinion in favor of us holding that Rambus had engaged in spoliation and that the twelve Rambus patents in the suit were unenforceable against us. Rambus subsequently appealed the Delaware Court's decision to the U.S. Court of Appeals for the Federal Circuit. On May 13, 2011, the Federal Circuit affirmed Judge Robinson's finding of spoliation, but vacated the dismissal sanction and remanded the case to the Delaware District Court for analysis of the remedy based on the Federal Circuit's decision. On January 2, 2013, Judge Robinson entered a new opinion in our favor holding that Rambus had engaged in spoliation, that Rambus' spoliation was done in bad faith, that the spoliation prejudiced us, and that the appropriate sanction was to declare the twelve Rambus patents in the suit unenforceable against us. On March 27, 2013, Rambus filed a notice of appeal to the U.S. Court of Appeals for the Federal Circuit. The Northern District of California Court stayed the trial of the patent phase of the Northern District of California case upon appeal of the spoliation issue to the Federal Circuit. In addition, others have asserted, and may assert in the future, that our products or manufacturing processes infringe their intellectual property rights. (See "Item 1. Legal Proceedings" for additional details on these lawsuits.)

We are unable to predict the outcome of assertions of infringement made against us. A court determination that our products or manufacturing processes infringe the intellectual property rights of others could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing results could have a material adverse effect on our business, results of operations or financial condition.

We have a number of patent and intellectual property license agreements. Some of these license agreements require us to make one time or periodic payments. We may need to obtain additional patent licenses or renew existing license agreements in the future. We are unable to predict whether these license agreements can be obtained or renewed on acceptable terms.

Products that fail to meet specifications, are defective or that are otherwise incompatible with end uses could impose significant costs on us.

Products that do not meet specifications or that contain, or are perceived by our customers to contain, defects or that are otherwise incompatible with end uses could impose significant costs on us or otherwise materially adversely affect our business, results of operations or financial condition. From time to time we experience problems with nonconforming, defective or incompatible products after we have shipped such products. In recent periods we have further diversified and expanded our product offerings which could potentially increase the chance that one or more of our products could fail to meet specifications in a particular application. As a result of these problems we could be adversely affected in several ways, including the following:

19



we may be required to compensate customers for costs incurred or damages caused by defective or incompatible product or replace products;
we could incur a decrease in revenue or adjustment to pricing commensurate with the reimbursement of such costs or alleged damages; and
we may encounter adverse publicity, which could cause a decrease in sales of our products.

New product development may be unsuccessful.

We are developing new products that complement our traditional memory products or leverage their underlying design or process technology. We have made significant investments in product and process technologies and anticipate expending significant resources for new semiconductor product development over the next several years. The process to develop DRAM, NAND Flash, NOR Flash and certain specialty memory products requires us to demonstrate advanced functionality and performance, many times well in advance of a planned ramp of production, in order to secure design wins with our customers. There can be no assurance that our product development efforts will be successful, that we will be able to cost-effectively manufacture new products, that we will be able to successfully market these products or that margins generated from sales of these products will allow us to recover costs of development efforts.

If our manufacturing process is disrupted, our business, results of operations or financial condition could be materially adversely affected.

We manufacture products using highly complex processes that require technologically advanced equipment and continuous modification to improve yields and performance. Difficulties in the manufacturing process or the effects from a shift in product mix can reduce yields or disrupt production and may increase our per gigabit manufacturing costs. We maintain operations and continuously implement new product and process technology at our manufacturing operations which are widely dispersed in multiple locations in several countries including the U.S., Singapore, Taiwan, Japan, Israel and China. Additionally, our control over operations at our IMFT, Inotera and MP Mask and Tera Probe joint ventures is limited by our agreements with our partners. From time to time, we have experienced disruptions in our manufacturing process as a result of power outages, improperly functioning equipment and equipment failures. If production at a fabrication facility is disrupted for any reason, manufacturing yields may be adversely affected or we may be unable to meet our customers' requirements and they may purchase products from other suppliers. This could result in a significant increase in manufacturing costs or loss of revenues or damage to customer relationships, which could materially adversely affect our business, results of operations or financial condition.

Consolidation of industry participants and governmental assistance to some of our competitors may contribute to uncertainty in the semiconductor memory industry and negatively impact our ability to compete.

In recent years, supply of memory products has significantly exceeded customer demand resulting in significant declines in average selling prices of DRAM, NAND Flash and NOR Flash products and substantial operating losses by us and our competitors. The operating losses as well as limited access to sources of financing have led to the deterioration in the financial condition of a number of industry participants and significant recent consolidation and, in certain cases, liquidation. Some of our competitors may try to enhance their capacity and lower their cost structure through consolidation. In addition, some governments have provided, and may be considering providing, significant financial assistance to some of our competitors. Consolidation of industry competitors could put us at a competitive disadvantage.

The limited availability of raw materials, supplies or capital equipment could materially adversely affect our business, results of operations or financial condition.

Our operations require raw materials, and in certain cases, third party services, that meet exacting standards. We generally have multiple sources of supply for our raw materials.materials and services. However, only a limited number of suppliers are capable of delivering certain raw materials and services that meet our standards. In some cases, materials, components or services are provided by a single supplier. Various factors could reduce the availability of raw materials or components such as silicon wafers, controllers, photomasks, chemicals, gases, including helium, photoresist, lead frames and molding compound. Shortages may occur from time to time in the future. We and/or our suppliers could be affected by laws and regulations enacted in response to concerns regarding climate change, which could increase the cost and limit the supply of our raw materials. In addition, disruptions in transportation lines could delay our receipt of raw materials. Lead times for the supply of raw materials have been extended in the past. If our supply of raw materials or services is disrupted or our lead times extended, our business, results of operations or financial condition could be materially adversely affected.


20



Our operations are dependent on our ability to procure advanced semiconductor manufacturing equipment that enables the transition to lower cost manufacturing processes. For certain key types of equipment, including photolithography tools, we are sometimes dependent on a single supplier. In recent periodsFrom time to time we have experienced difficulties in obtaining some equipment on a timely basis due to the supplier's limited capacity. Our inability to timely obtain this equipment could adversely affect our ability to transition to next generation manufacturing processes and reduce costs. Delays in obtaining equipment could also impede our ability to ramp production at new facilities and increase our overall costs of the ramp. If we are unable to timely obtain advanced semiconductor manufacturing equipment, our business, results of operations or financial condition could be materially adversely affected.

We may incur additional tax expense or become subject to additional tax exposure.

We are subject to income taxes in the United States and numerous foreign jurisdictions, including among others, Singapore, where we currently have arrangements that allow us to compute our tax provision at rates below the local statutory rates. Our domestic and international taxes are dependent upon the distribution of our earnings among these different jurisdictions. Our provision for income taxes and cash tax liabilities in the future could be adversely affected by numerous factors, including challenges by tax authorities to our tax structure, income before taxes being lower than anticipated in countries with lower statutory tax rates and higher than anticipated in countries with higher statutory tax rates, changes in the valuation of deferred tax assets and liabilities and changes in tax laws and regulations. We and our subsidiaries file income tax returns with the U.S. federal government, various U.S. states and various foreign jurisdictions throughout the world.  Our U.S. federal and state tax returns remain open to examination for 2010 through 2014.  In addition, tax returns open to examination in multiple foreign taxing jurisdictions range from the years 2005 to 2014. The results of audits and examinations of previously filed tax returns and continuing assessments of our tax exposures may have an adverse effect on our provision for income taxes and cash tax liability.

We may not utilize all of our net deferred tax assets.

We have substantial deferred tax assets, which include, among others, net operating loss and credit carryforwards. As of August 28, 2014, our U.S. federal and state net operating loss carryforwards, including uncertain tax benefits, were $3.89 billion and $1.71 billion, respectively, which, if not utilized, will expire at various dates from 2015 through 2033. As of August 28, 2014, our foreign net operating loss carryforwards were $5.37 billion, including $3.95 billion pertaining to Japan, which, if not utilized, substantially all will expire at various dates from 2018 through 2023. As of August 28, 2014, we had valuation allowances of $1.29 billion and $979 million against our net deferred tax assets in the U.S. and Japan, respectively.

A downturn in the worldwide economy may harm our business.

Downturns in the worldwide economy have harmed our business in the past and future downturns could also adversely affect our business. Adverse economic conditions affect demand for devices that incorporate our products, such as personal computers, mobile devices, solid-state drives and servers. Reduced demand for these products could result in significant decreases in our average selling prices and product sales. A deterioration of current conditions in worldwide credit markets could limit our ability to obtain external financing to fund our operations and capital expenditures. In addition, we may experience losses on our holdings of cash and investments due to failures of financial institutions and other parties. Difficult economic conditions may also result in a higher rate of loss on our accounts receivables due to credit defaults. As a result, our business, results of operations or financial condition could be materially adversely affected.


18



Our results of operations could be affected by natural disasters and other events in the locations in which we or our customers or suppliers operate.

We have manufacturing and other operations in locations subject to natural occurrences such as severe weather and geological events including earthquakes or tsunamis that could disrupt operations.  In addition, our suppliers and customers also have operations in such locations.  A natural disaster, fire, chemical explosion or other event that results in a prolonged disruption to our operations, or the operations of our customers or suppliers, may materially adversely affect our business, results of operations or financial condition.

Our net operating loss and tax credit carryforwards may be limited.

We have a valuation allowance against substantially all U.S. net deferred tax assets as well as $1.5 billion related to our foreign subsidiaries. As of August 29, 2013, our federal and state net operating loss carryforwards were $4.2 billion and $2.2 billion, respectively.  If not utilized, our federal and state net operating loss carryforwards will expire at various dates through 2033.  As of August 29, 2013, our federal and state tax credit carryforwards were $238 million and $203 million, respectively.  If not utilized, our federal and state tax credit carryforwards will expire at various dates through 2033. As of August 29, 2013, our foreign net operating loss carryforwards were $7.0 billion, of which $5.9 billion pertains to Elpida. We have placed a valuation allowance against $4.7 billion of these foreign net operating loss carryforwards, of which $3.8 billion pertains to Elpida.  If not utilized, our foreign net operating loss carryforwards will expire at various dates through 2023.

We face risks associated with our international sales and operations that could materially adversely affect our business, results of operations or financial condition.

Sales to customers outside the United States approximated 83%84% of our consolidated net sales for 2013.2014. In addition, a substantial portion of our manufacturing operations are located outside the United States. In particular, a significant portion of our manufacturing operations are concentrated in Singapore.Taiwan, Singapore and Japan. Our international sales and operations are subject to a variety of risks, including:

export and import duties, changes to import and export regulations, customs regulations and processes and restrictions on the transfer of funds;
compliance with U.S. and international laws involving international operations, including the Foreign Corrupt Practices Act, export control laws and similar rules and regulations;
political and economic instability;
problems with the transportation or delivery of our products;
issues arising from cultural or language differences and labor unrest;
longer payment cycles and greater difficulty in collecting accounts receivable;
compliance with trade, technical standards and other laws in a variety of jurisdictions;
contractual and regulatory limitations on our ability to maintain flexibility with our staffing levels;
disruptions to our manufacturing operations as a result of actions imposed by foreign governments;
changes in economic policies of foreign governments; and
difficulties in staffing and managing international operations.

These factors may materially adversely affect our business, results of operations or financial condition.


21



Breaches of our network security could expose us to losses.

We manage and store on our network systems various proprietary information and sensitive or confidential data relating to our operations. We also process, store, and transmit large amounts of data forrelating to our customers and employees, including sensitive personal information. Computer programmers and hackers may be able to gain unauthorized access to our network system and steal proprietary information, compromise confidential information, create system disruptions, or cause shutdowns. These parties may also be able to develop and deploy viruses, worms, and other malicious software programs that disrupt our operations and create security vulnerabilities. Attacks on our network systems could result in significant losses and damage our reputation with customers.

We are subject to counterparty default risks.

We have numerous arrangements with financial institutions that subject us to counterparty default risks, including cash deposits, investments, foreign currency option and forward contracts, and capped-call contracts on our stock.stock and derivative instruments. As a result, we are subject to the risk that the counterparty to one or more of these arrangements will default on its performance obligations. A counterparty may not comply with their contractual commitments which could then lead to their defaulting on their obligations with little or no notice to us, which could limit our ability to take action to mitigate our exposure. Additionally, our ability to mitigate our exposures may be constrained by the terms of our contractual arrangements or because market conditions prevent us from taking effective action. If one of our counterparties becomes insolvent or files for bankruptcy, our ability to recover any losses suffered as a result of that counterparty's default may be limited by the liquidity of the counterparty or the applicable laws governing the bankruptcy proceeding. In the event of such default, we could incur significant losses, which could adversely impact our business, results of operations or financial condition.


19



Compliance with new regulations regarding the use of conflict minerals could limit the supply and increase the cost of certain metals used in manufacturing our products.

Increased focus on environmental protection and social responsibility initiatives led to the passage of Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the "Dodd-Frank Act"), and its implementing SEC regulations.  The Dodd-Frank Act imposes new supply chain diligence and disclosure requirements for certain manufacturers of products containing specific minerals that may originate in or near the Democratic Republic of the Congo (the "DRC") and finance or benefit local armed groups. These "conflict minerals" are commonly found in materials used in the manufacture of semiconductors. The implementation of these new regulations may limit the sourcing and availability of some of these materials. This in turn may affect our ability to obtain materials necessary for the manufacture of our products in sufficient quantities and may affect related material pricing.  Some of our customers may elect to disqualify us as a supplier if we are unable to verify that our products are DRC conflict free.



ITEM 1B. UNRESOLVED STAFF COMMENTS


None.





22



ITEM 2. PROPERTIES


Our corporate headquarters are located in Boise, Idaho.  The following is a summary of our principal facilities as of August 29, 2013:28, 2014:

Location Principal Operations
Boise, Idaho R&D, including wafer fabrication; reticle manufacturing; test and module assembly
Lehi, Utah Wafer fabrication
Manassas, Virginia Wafer fabrication
Singapore Three wafer fabrication facilities and a test, assembly and module assembly facility
Aguadilla, Puerto Rico Module assembly and test
Xi’an, China Module assembly and test
Kiryat Gat, IsraelWafer fabrication
Muar, Malaysia Assembly and test
Taichung City, Taiwan Wafer fabrication
Hiroshima, Japan Wafer fabrication
Akita, Japan Module assembly and test

Substantially all of of the capacity of the facilities listed above areis fully utilized. Our Inotera joint venture also has a 300mm wafer fabrication facility in Kueishan, Taiwan. Under our supply agreement with Inotera, we purchase substantially all of the output of Inotera. We also own and lease a number of other facilities in locations throughout the world that are used for design, research and development, and sales and marketing activities.

In SeptemberDecember 2013, we entered into an agreement to sellsold our 200mm wafer fabrication equipment in Kiryat Gat, Israel to Intel and to terminateterminated the related facility lease with Intel. If this transaction is completed, Intel will manufacturemanufactured wafers for us at the Kiryat Gat facility through 2014 through a series of arrangements.

Our facility in Lehi is owned and operated by our IMFT joint venture with Intel.  (See "Item"Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Consolidated Variable Interest EntitiesEquityIM Flash"Noncontrolling Interests in Subsidiaries – IMFT" note.)

We believe that our existing facilities are suitable and adequate for our present purposes.  We do not identify or allocate assets by operating segment.  (See "Item"Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Geographic Information" note.)

20



ITEM 3.  LEGAL PROCEEDINGS


Reorganization Proceedings of the ElpidaMMJ Companies

On July 31, 2013, we completed the acquisition of Elpida, Memory, Inc. ("Elpida"),now known as MMJ, a Japanese corporation, pursuant to the terms and conditions of an Agreement on Support for Reorganization Companies (as amended, the "Sponsor Agreement") that we entered into on July 2, 2012 with the trustees of Elpida and one of its subsidiaries, Akita Elpida Memory, Inc., a Japanese corporation ("Akita" and, together with Elpida, the "Elpida Companies") pursuant to and in connection with the ElpidaMMJ Companies' pending corporate reorganization proceedings under the Corporate Reorganization Act of Japan.

The ElpidaMMJ Companies filed petitions for commencement of corporate reorganization proceedings with the Tokyo DistrictJapan Court (the "Japan Court") under the Corporate Reorganization Act of Japan on February 27, 2012, and the Japan Court issued an order to commence the reorganization proceedings (the "Japan Proceedings") on March 23, 2012. On July 2, 2012, we entered into the Sponsor Agreement with the legal trustees of the ElpidaMMJ Companies and the Japan Court approved the Sponsor Agreement. Under the Sponsor Agreement, we agreed to provide certain support for the reorganization of the ElpidaMMJ Companies and the trustees agreed to prepare and seek approval from the Japan Court and the ElpidaMMJ Companies' creditors of plans of reorganization consistent with such support.


23



The trustees initially submitted the proposed plans of reorganization for the ElpidaMMJ Companies to the Japan Court on August 21, 2012 and submitted final proposed plans on October 29, 2012. On October 31, 2012, the Japan Court approved submission of the trustees' proposed plans of reorganization to creditors for approval. On February 26, 2013, the ElpidaMMJ Companies' creditors approved the reorganization plans and on February 28, 2013, the Japan Court issued an order approving the plans of reorganization. Appeals filed by certain creditors of ElpidaMMJ in Japan challenging the plan approval order issued by the Japan Court were denied.

In a related action, ElpidaMMJ filed a Verified Petition for Recognition and Chapter 15 Relief in the United States Bankruptcy Court for the District of Delaware (the "U.S. Court") on March 19, 2012 and, on April 24, 2012, the U.S. Court entered an order that, among other things, recognized Elpida'sMMJ's corporate reorganization proceeding as a foreign main proceeding pursuant to 11 U.S.C. § 1517(b). On June 25, 2013, the U.S. Court issued a recognition order, which recognized the order of the Japan Court approving Elpida'sMMJ's plan of reorganization. On November 19, 2013, the U.S. Court closed the U.S. Chapter 15 proceeding.

The plans of reorganization provide for payments by the ElpidaMMJ Companies to their secured and unsecured creditors in an aggregate amount of 200 billion yen, (or the equivalent of approximately $2.05 billion as of August 29, 2013), less certain expenses of the reorganization proceedings and certain other items. The plans of reorganization also provided for the investment by us pursuant to the Sponsor Agreement of 60 billion yen ($($615 millionmillion) paid at closing)closing in cash into ElpidaMMJ in exchange for 100% ownership of Elpida'sMMJ's equity and the use of such investment to fund the initial installment payment by the ElpidaMMJ Companies to their creditors of 60 billion yen, subject to reduction for certain items specified in the Sponsor Agreement and plans of reorganization. The initial installment payment was made to the creditors of the Elpida Companies in October 2013. The plans of reorganization also provide for 140 billion yen (or the equivalent of approximately $1.43 billion as of August 29, 2013) of additional payments by the Elpida Companies to their creditors, to be paid in six annual installments beginning December 2014, with payments of 20 billion yen (or the equivalent of approximately $205 million as of August 29, 2013) in each of the first four annual installment payments, and payments of 30 billion yen (or the equivalent of approximately $307 million as of August 29, 2013) in each of the final two annual installment payments.

Under the Sponsor Agreement, we agreed that we would, subject to certain conditions, implement and maintain a cost plus model with the Elpida Companies in support of the execution of their plans of reorganization. In connection with these commitments, we entered into a series of cost-plus agreements with Elpida and Akita, including supply agreements, research and development services agreements and general services agreements (the "Cost Plus Agreements"). The Cost Plus Agreements are intended to generate more stable operating cash flows to meet the requirements of the Elpida Companies' businesses, including the funding of the installment payments to the Elpida Companies' creditors. We anticipate that, once fully in effect, payments we make under the Cost Plus Agreements will generally cover all of Elpida and Akita's costs.

Under Elpida'sMMJ's plan of reorganization, secured creditors will recover 100% of the amount of their fixed claims and unsecured creditors will recover at least 17.4% of the amount of their fixed claims. The actual recovery of unsecured creditors will be higher, however, based, in part, on events and circumstances occurring following the plan approval. The remaining portion of the unsecured claims will be discharged, without payment, over the period that payments are made pursuant to the plans of reorganization. The secured creditors will be paid in full on or before the sixth installment payment date, while the unsecured creditors will be paid in seven installments. Akita'sMAI's plan of reorganization provides that secured creditors will recover 100% of the amount of their claims, whereas unsecured creditors will recover 19% of the amount of their claims. The secured creditors of Akita will beMAI were paid in full on the first installment payment date, while the unsecured creditors will be paid in seven installments.

Certain contingency matters related to the Elpida Companies, which are primarily comprised of outstanding litigation claims, were not treated as fixed claims under the plans of reorganization at the time the plans were filed with the Japan Court. A portion of each installment amount payable to the creditors of the Elpida Companies will be reserved for use in the event that any of these matters become fixed claims, in which case these fixed claims will be paid under the plans of reorganization in the same manner as the fixed claims of other creditors. To the extent the aggregate amounts reserved from the installment payments exceed the aggregate amounts payable with respect to these unfixed claims once they become fixed, the excess amounts reserved will be distributed to unsecured creditors with respect to their fixed claims, resulting in an increased recovery for the unsecured creditors out of the installment payments. To the extent the aggregate amounts reserved are less than the aggregate amounts payable with respect to these unfixed claims once they become fixed, the Elpida Companies would be responsible to fund any shortfall to ensure that the creditors receive the minimum recovery to which they are entitled under the plans of reorganization with respect to these claims. As a result, there is a possibility that the total amount payable by the Elpida Companies to their creditors under the plans of reorganization will exceed 200 billion yen. In addition, certain of these unfixed claims may be resolved pursuant to settlement arrangements or other post-petition agreements and a substantial portion of the amounts payable under such agreements may have to be funded by the Elpida Companies outside of the plans of reorganization.

2421




Because the plans of reorganization of the ElpidaMMJ Companies provide for ongoing payments to creditors following the closing of the ElpidaMMJ acquisition, the Japan Proceedings are continuing and the ElpidaMMJ Companies remain subject to the oversight of the Japan Court and of the trustees (including a trustee designated by us, who we refer to as the business trustee, and a trustee designated by the Japan Court, who we refer to as the legal trustee), pending completion of the reorganization proceedings. The business trustee will make decisions in relation to the operation of the businesses of the ElpidaMMJ Companies, other than decisions in relation to acts that need to be carried out in connection with the Japan Proceedings, which will be the responsibility of the legal trustee. The Japan Proceedings and oversight of the Japan Court will continue until the final creditor payment is made under the ElpidaMMJ Companies' plans of reorganization, which is scheduled to occur in December 2019, but may occur on a later date to the extent any claims of creditors remain unfixed on the final scheduled installment payment date. The ElpidaMMJ Companies may petition the Japan Court for an early termination of the Japan Proceedings once two-thirds of all payments under the plans of reorganization are made. Although such early terminations are customarily granted, there can be no assurance that the Japan Court will grant any such petition in these particular cases.

During the pendency of the Japan Proceedings, the ElpidaMMJ Companies are obligated to provide periodic financial reports to the Japan Court and may be required to obtain the consent of the Japan Court prior to taking a number of significant actions relating to their businesses, including transferring or disposing of, or acquiring, certain material assets, incurring or guaranteeing material indebtedness, settling material disputes, or entering into certain material agreements. The consent of the legal trustee may also be required for matters that would likely have a material impact on the operations or assets of the ElpidaMMJ Companies and their subsidiaries or for transfers of material assets, to the extent the matters or transfers would reasonably be expected to materially and adversely affect execution of the plans of reorganization of the ElpidaMMJ Companies. Accordingly, during the pendency of the Japan Proceedings, our ability to effectively integrate the ElpidaMMJ Companies as part of our global operations or to cause the ElpidaMMJ Companies to take certain actions that we deem advisable for their businesses could be adversely affected if the Japan Court or the legal trustee is unwilling to consent to various actions that we may wish to take with respect to the ElpidaMMJ Companies.

Patent Matters

On August 28, 2000, we filed a complaint against Rambus Inc. ("Rambus") in the U.S. District Court for the District of Delaware seeking declaratory and injunctive relief. Among other things, our complaint (as amended) alleges violation of federal antitrust laws, breach of contract, fraud, deceptive trade practices, and negligent misrepresentation. The complaint also seeks a declaratory judgment (1) that we did not infringe on certain of Rambus' patents or that such patents are invalid and/or are unenforceable, (2) that we have an implied license to those patents, and (3) that Rambus is estopped from enforcing those patents against us. On February 15, 2001, Rambus filed an answer and counterclaim in Delaware denying that we are entitled to relief, alleging infringement of the eight Rambus patents (later amended to add four additional patents) named in our declaratory judgment claim, and seeking monetary damages and injunctive relief. In the Delaware action, we subsequently added claims and defenses based on Rambus' alleged spoliation of evidence and litigation misconduct. The spoliation and litigation misconduct claims and defenses were heard in a bench trial before Judge Robinson in October 2007. On January 9, 2009, Judge Robinson entered an opinion in our favor holding that Rambus had engaged in spoliation and that the twelve Rambus patents in the suit were unenforceable against us. Rambus subsequently appealed the decision to the U.S. Court of Appeals for the Federal Circuit. On May 13, 2011, the Federal Circuit affirmed Judge Robinson's finding of spoliation, but vacated the dismissal sanction and remanded the case to the Delaware District Court for further analysis of the appropriate remedy. On January 2, 2013, Judge Robinson entered a new opinion in our favor holding that Rambus had engaged in spoliation, that Rambus' spoliation was done in bad faith, that the spoliation prejudiced us, and that the appropriate sanction was to declare the twelve Rambus patents in the suit unenforceable against us.  Separately, on March 27, 2013, Rambus filed a notice of appeal to the U.S. Court of Appeals for the Federal Circuit. On January 13, 2006, Rambus filed a lawsuit against us in the U.S. District Court for the Northern District of California. Rambus alleges that certain of our DDR2, DDR3, RLDRAM, and RLDRAM II products infringe as many as fourteen Rambus patents and seeks monetary damages, treble damages and injunctive relief. The accused products account for a significant portion of our net sales. On June 2, 2006, we filed an answer and counterclaim against Rambus alleging, among other things, antitrust and fraud claims. The Northern District of California Court stayed the trial of the patent phase of the Northern District of California case upon appeal of the Delaware spoliation issue to the Federal Circuit.


25



A number of other suits involving Rambus are currently pending in Europe alleging that certain of our SDRAM and DDR SDRAM products infringe various of Rambus' country counterparts to its European patent 525 068, including: on September 1, 2000, Rambus filed suit against Micron Semiconductor (Deutschland) GmbH in the District Court of Mannheim, Germany; on September 22, 2000, Rambus filed a complaint against us and Reptronic (a distributor of our products) in the Court of First Instance of Paris, France; on September 29, 2000, we filed suit against Rambus in the Civil Court of Milan, Italy, alleging invalidity and non-infringement. In addition, on December 29, 2000, we filed suit against Rambus in the Civil Court of Avezzano, Italy, alleging invalidity and non-infringement of the Italian counterpart to European patent 1 004 956. Additionally, on August 14, 2001, Rambus filed suit against Micron Semiconductor (Deutschland) GmbH in the District Court of Mannheim, Germany alleging that certain of our DDR SDRAM products infringe Rambus' country counterparts to its European patent 1 022 642. In the European suits against us, Rambus is seeking monetary damages and injunctive relief. Subsequent to the filing of the various European suits, the European Patent Office (the "EPO") declared Rambus' 525 068, 1 022 642, and 1 004 956 European patents invalid and revoked the patents. The declaration of invalidity with respect to the '068 and '642 patents was upheld on appeal. The original claims of the '956 patent also were declared invalid on appeal, but the EPO ultimately granted a Rambus request to amend the claims by adding a number of limitations.

On September 1, 2011, HSM Portfolio LLC and Technology Properties Limited LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and seventeen other defendants, including Elpida Memory, Inc. and Elpida Memory (USA) Inc. (collectively “Elpida”).  The complaint alleges that certain of our DRAM and image sensor products infringe two U.S. patents and that certain Elpida DRAM products infringe two U.S. patents and seeks damages, attorneys' fees, and costs. On March 23, 2012, Elpida filed a Notice of Filing and Hearing on Petition Under Chapter 15 of the U.S. Bankruptcy Code and Issuance of Provisional Relief that included an order of the U.S. Bankruptcy Court for the District of Delaware staying judicial proceedings against Elpida. Accordingly, the plaintiffs’ case against Elpida is stayed. On August 21, 2013, the Court granted a motion by the plaintiffs to amend the complaint to assert two additional patents against us and one additional patent against Elpida.

On September 9, 2011, Advanced Data Access LLC filed a patent infringement action in the U.S. District Court for the Eastern District of Texas (Tyler) against us and seven other defendants. On November 16, 2011, Advanced Data Access filed an amended complaint. The amended complaint alleged that certain of our DRAM products infringed two U.S. patents and sought injunctive relief, damages, attorneys' fees, and costs. On March 20, 2013, we executed a settlement agreement resolving this litigation. The settlement amount did not have a material effect on our business, results of operations or financial condition.

On September 14, 2011, Smart Memory Solutions LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and Winbond Electronics Corporation of America.  The complaint alleged that certain of our NOR Flash products infringed a single U.S. patent and sought injunctive relief, damages, attorneys' fees, and costs. On March 20, 2013, we executed a settlement agreement resolving this litigation. The settlement amount did not have a material effect on our business, results of operations or financial condition.

On December 5, 2011, the Board of Trustees for the University of Illinois filed a patent infringement action against us in the U.S. District Court for the Central District of Illinois. The complaint alleges that unspecified semiconductor products of ours infringe three U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. We have filed three petitions for inter-partes review by the Patent and Trademark Office, challenging the validity of each of the patents in suit. The District Court has stayed the litigation pending the outcome of the inter-partes review by the Patent Office.

On March 26, 2012, Semiconductor Technologies, LLC filed a patent infringement action in the U.S. District Court for the Eastern District of Texas (Marshall) against us. The complaint alleged that certain of our DRAM products infringed five U.S. patents and sought injunctive relief, damages, attorneys' fees, and costs. On March 20, 2013, we executed a settlement agreement resolving this litigation. The settlement amount did not have a material effect on our business, results of operations or financial condition.

On April 27, 2012, Semcon Tech, LLC filed a patent infringement action against us in the U.S. District Court for the District of Delaware. The complaint alleges that our use of various chemical mechanical planarization systems purchased from Applied Materials and others infringes a single U.S. patent and seeks injunctive relief, damages, attorneys' fees, and costs. On September 24, 2013, the Court entered an order staying our case pending the resolution of co-pending cases brought by Semcon Tech, LLC against Applied Materials and Ebara Technologies, Inc.


26



On December 7, 2007, Tessera, Inc. filed a patent infringement against Elpida Memory, Inc., Elpida Memory (USA) Inc. (collectively "Elpida"), and numerous other defendants, in the United States District Court for the Eastern District of Texas. The complaint alleges that certain Elpida products infringe four U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. Prior to answering the complaint, Elpida and other defendants filed motions to stay the case pending final resolution of a case before the International Trade Commission ("ITC") against Elpida and other respondents, alleging infringement of the same patents asserted in the Eastern District of Texas case (In The Matter of Certain Semiconductor Chips with Minimized Chip Package Size and Products Containing Same (III), ITC No. 337-TA-630 (the "ITC Action")). On February 25, 2008, the Eastern District of Texas Court granted the defendants' motion to stay the action. On December 29, 2009, the ITC issued a Notice of Final Determination in the ITC Action finding no violation by Elpida. Tessera subsequently appealed the matter to the U.S. Court of Appeals for the Federal Circuit. On May 23, 2011, the Federal Circuit affirmed the ITC's Final Determination. The Eastern District of Texas case currently remains stayed.

We are unable to predict the outcome of these suits. A court determination that our products or manufacturing processes infringe the product or process intellectual property rights of others could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing results could have a material adverse effect on our business, results of operations or financial condition.

Antitrust Matters

On May 5, 2004, Rambus, Inc. ("Rambus") filed a complaint in the Superior Court of the State of California (San Francisco County) against us and other DRAM suppliers which alleged that the defendants harmed Rambus by engaging in concerted and unlawful efforts affecting Rambus DRAM by eliminating competition and stifling innovation in the market for computer memory technology and computer memory chips.  Rambus' complaint alleged various causes of action under California state law including, among other things, a conspiracy to restrict output and fix prices, a conspiracy to monopolize, intentional interference with prospective economic advantage, and unfair competition. Rambus sought a judgment for damages of approximately $3.9$3.90 billion, joint and several liability, trebling of damages awarded, punitive damages, a permanent injunction enjoining the defendants from the conduct alleged in the complaint, interest, and attorneys' fees and costs. Trial began on June 20, 2011, and the case went to the jury on September 21, 2011. On November 16, 2011, the jury found for us on all claims. On April 2, 2012, Rambus filed a notice of appeal to the California 1st District Court of Appeal.

We were engaged in litigation with Rambus relating to certain of Rambus' patents and certain of our claims and defenses. Our lawsuits with Rambus related to patent matters were pending in the U.S. District Court for the District of Delaware, U.S. District Court for the Northern District of California, Germany, France, and Italy.

In December 2013, we settled all pending litigation between us and Rambus, including all antitrust and patent matters.  We also entered into a seven-year term patent cross-license agreement with Rambus that allows us to avoid costs of patent-related litigation during the term.  We agreed to pay Rambus up to $10 million per quarter over seven years, for a total of $280 million, beginning in the second quarter of 2014.  The primary benefits we received from these arrangements were (1) the settlement and termination of all existing litigation, (2) the avoidance of future litigation expenses and (3) the avoidance of future management and customer disruptions.  As a result, other operating expense for the first quarter of 2014 included a $233 million charge to accrue a liability, which reflects the discounted value of amounts due under this arrangement.


22



Patent Matters

On September 1, 2011, HSM Portfolio LLC and Technology Properties Limited LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and seventeen other defendants, including MMJ and Elpida Memory (USA) Inc.  On August 22, 2013, the plaintiffs filed a third amended complaint. The third amended complaint alleges that certain of our DRAM and image sensor products infringe four U.S. patents and that certain MMJ and Elpida Memory (USA) Inc. DRAM products infringe two U.S. patents and seeks damages, attorneys' fees, and costs. Trial currently is scheduled for February 22, 2016. On March 23, 2012, MMJ and Elpida Memory (USA) Inc. filed a Notice of Filing and Hearing on Petition Under Chapter 15 of the U.S. Bankruptcy Code and Issuance of Provisional Relief that included an order of the U.S. Bankruptcy Court for the District of Delaware staying judicial proceedings against MMJ and Elpida Memory (USA) Inc. Accordingly, the plaintiffs' case against MMJ and Elpida Memory (USA) was stayed.  On June 25, 2013, the U.S. Bankruptcy Court for the District of Delaware entered its Order (1) Granting Recognition of the Japanese Reorganization Plan of MMJ and the Tokyo District Court's Confirmation Orders, (2) Entrusting MMJ's U.S. Assets to Foreign Representatives and Approving Certain Plan Transactions, (3) Granting Permanent Injunction, and (4) Granting Related Relief (the "Recognition Order").  Pursuant to the Recognition Order, the plaintiffs are permanently enjoined from continuing their case against MMJ and Elpida Memory (USA) Inc. in respect of any claim or claims arising prior to the commencement of the Japan Proceeding (as defined in the Recognition Order).

On December 5, 2011, the Board of Trustees for the University of Illinois (the "University") filed a patent infringement action against us in the U.S. District Court for the Central District of Illinois. The complaint alleges that unspecified semiconductor products of ours infringe three U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. We have filed three petitions for inter-partes review by the Patent and Trademark Office, challenging the validity of each of the patents in suit. The Patent Trial and Appeal Board ("PTAB") held a hearing in connection with the three petitions on December 9, 2013. On March 10, 2014, the PTAB issued written decisions finding that each and every claim in the three patents in suit is invalid, and cancelled all claims. The University has appealed the PTAB rulings to the U.S. Court of Appeals for the Federal Circuit.

On April 27, 2012, Semcon Tech, LLC filed a patent infringement action against us in the U.S. District Court for the District of Delaware. The complaint alleges that our use of various chemical mechanical planarization systems purchased from Applied Materials infringes a single U.S. patent and seeks injunctive relief, damages, attorneys' fees, and costs. Trial is currently scheduled for August 21, 2015.

On December 7, 2007, Tessera, Inc. filed a patent infringement action against MMJ, Elpida Memory (USA) Inc., and numerous other defendants, in the United States District Court for the Eastern District of Texas. The complaint alleges that certain MMJ and Elpida Memory (USA) Inc. products infringe four U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. Prior to answering the complaint, MMJ and Elpida Memory (USA) Inc. and other defendants filed motions to stay the case pending final resolution of a case before the International Trade Commission ("ITC") against MMJ and Elpida Memory (USA) Inc. and other respondents, alleging infringement of the same patents asserted in the Eastern District of Texas case (In The Matter of Certain Semiconductor Chips with Minimized Chip Package Size and Products Containing Same (III), ITC No. 337-TA-630 (the "ITC Action")). On February 25, 2008, the Eastern District of Texas Court granted the defendants' motion to stay the action. On December 29, 2009, the ITC issued a Notice of Final Determination in the ITC Action finding no violation by MMJ and Elpida Memory (USA) Inc. Tessera, Inc. subsequently appealed the matter to the U.S. Court of Appeals for the Federal Circuit. On May 23, 2011, the Federal Circuit affirmed the ITC's Final Determination. Additionally, by operation of the Recognition Order, plaintiff in that action is permanently enjoined from continuing its case against MMJ and Elpida Memory (USA) in respect of any claim or claims arising prior to the commencement of the Japan Proceeding (as defined in the Recognition Order). On July 30, 2014, we entered into a five-year term patent cross-license agreement with Tessera, which also settled the pending litigation against MMJ and Elpida Memory (USA). The agreement, which requires us to make quarterly payments over its term, gives us "life-of-product" protection for specifically identified DRAM products and a term license for certain other products.

Among other things, the above lawsuits pertain to certain of our DDR, DDR2, DDR3, SDR SDRAM, PSRAM, RLDRAM, LPDRAM, NAND Flash, image sensor products and certain other memory products we manufacture, which account for a significant portion of our net sales.


23



Except for the Tessera matter discussed above, we are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations or financial condition.

Antitrust Matters

A number of purported class action price-fixing lawsuits have been filed against us and other DRAM suppliers. Four cases have been filed in the U.S. District Court for the Northern District of California asserting claims on behalf of a purported class of individuals and entities that indirectly purchased DRAM and/or products containing DRAM from various DRAM suppliers during the time period from April 1, 1999 through at least June 30, 2002. The complaints allege a conspiracy to increase DRAM prices in violation of federal and state antitrust laws and state unfair competition law, and/or unjust enrichment relating to the sale and pricing of DRAM products. The complaints seek joint and several damages, trebled, monetary damages, restitution, costs, interest and attorneys' fees. In addition, at least sixty-four cases have been filed in various state courts asserting claims on behalf of a purported class of indirect purchasers of DRAM. In July 2006, the Attorneys General for approximately forty U.S. states and territories filed suit in the U.S. District Court for the Northern District of California. The complaints allege, among other things, violations of the Sherman Act, Cartwright Act, and certain other states' consumer protection and antitrust laws and seek joint and several damages, trebled, as well as injunctive and other relief. On October 3, 2008, the California Attorney General filed a similar lawsuit in California Superior Court, purportedly on behalf of local California government entities, alleging, among other things, violations of the Cartwright Act and state unfair competition law. On June 23, 2010, we executed a settlement agreement resolving these purported class-action indirect purchaser cases and the pending cases of the Attorneys General relating to alleged DRAM price-fixing in the United States. Subject to certain conditions, including final court approval of the class settlements, we agreed to pay approximately $67 million in aggregate in three equal installments over a two-year period. We had paid the full amount into an escrow account by the end of the first quarter of 2013 in accordance with the settlement agreement.


27



Three putative class action lawsuits alleging price-fixing of DRAM products also have been filed against us in Quebec, Ontario, and British Columbia, Canada, on behalf of direct and indirect purchasers, asserting violations of the Canadian Competition Act and other common law claims (collectively the "Canadian Cases").  The claims were initiated between December 2004 (British Columbia) and June 2006 (Quebec). The plaintiffs seek monetary damages, restitution, costs, and attorneys' fees. The substantive allegations in these cases are similar to those asserted in the DRAM antitrust cases filed in the United States.  Plaintiffs' motion for class certification was denied in the British Columbia and Quebec cases in May and June 2008, respectively.  Plaintiffs subsequently filed an appeal of each of those decisions.  On November 12, 2009, the British Columbia Court of Appeal reversed, and on November 16, 2011, the Quebec Court of Appeal also reversed the denial of class certification and remanded the cases for further proceedings. On October 16, 2012, we entered into a settlement agreement resolving these three putative class action cases subject to certain conditions including final court approval of the settlement. The settlement amount did not have a material effect on our business, results of operations or financial condition.

On June 21, 2010, the Brazil Secretariat of Economic Law of the Ministry of Justice ("SDE") announced that it had initiated an investigation relating to alleged anticompetitive activities within the DRAM industry. The SDE's Notice of Investigation names various DRAM manufacturers and certain executives, including us, and focuses on the period from July 1998 to June 2002.

We are unable to predict the outcome of these matters and therefore cannot estimate the range of possible loss, except as noted in the above discussion of the U.S. indirect purchaser cases and the Canadian Cases above.cases. The final resolution of these alleged violations of antitrust laws could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition.

Securities Matters

On July 12, 2013, seven former shareholders of Elpida Memory, Inc.(now known as MMJ) filed a complaint against Messrs. Sakamoto, Adachi, Gomi, Shirai, Tsay-Jiu, Wataki, Kinoshita, and Takahasi in their capacity as members of the board of directors of ElpidaMMJ as of February 2013. The complaint alleges that the defendants engaged in various acts and misrepresentations to hide the financial condition of ElpidaMMJ and deceive shareholders prior to ElpidaMMJ filing a petition for corporate reorganization on February 27, 2013. The plaintiffs seek joint and several damages equal to the market value of shares owned by each of the plaintiffs on February 23, 2013, along with attorneys' fees and interest. At a hearing on September 25, 2013, the plaintiffs withdrew the complaint against Mr. Tsay-Jiu.

We are unable to predict the outcome of this matter and therefore cannot estimate the range of possible loss.  The final resolution of this matter could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition.


Commercial Matters
24



Qimonda

On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda AG ("Qimonda") insolvency proceedings, filed suit against usMTI and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void under Section 133 of the German Insolvency Act a share purchase agreement between usMicron B.V. and Qimonda signed in fall 2008 pursuant to which weMicron B.V. purchased substantially all of Qimonda's shares of Inotera Memories, Inc. (the "Inotera Shares"), representing approximately 55% of our total shares in Inotera, and seeks an order requiring us to retransfer the Inoterathose shares purchased from Qimonda to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate under Sections 103 or 133 of the German Insolvency Code a patent cross licensecross-license between us and Qimonda entered into at the same time as the share purchase agreement. A three-judge panel will render a decision after

Following a series of hearings with pleadings, arguments and witnesses. Hearings were heldwitnesses on September 25, 2012, February 5, 2013, June 11, 2013behalf of the Qimonda estate, on March 13, 2014, the Court issued judgments:  (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on such shares and July 2, 2013. An additionalall other benefits; (4) denying Qimonda’s claims against Micron Technology for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are cancelled. In addition, the Court issued interlocutory judgments ordering, among other things:  (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by it and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by it from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. We have filed a notice of appeal, and the parties have submitted briefs to the appeals court. A hearing on the matter is scheduled for November 12, 2013. February 2, 2015.

We are unable to predict the outcome of this lawsuitthe matter and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera sharesShares or equivalent monetary damages, andunspecified damages based on the benefits derived by Micron B.V. from the ownership of the Inotera Shares, and/or the termination of the patent cross license,cross-license, which could have a material adverse effect on our business, results of operation or financial condition.  As of August 29, 2013,28, 2014, the Inotera shares purchased from QimondaShares had a carrying value for purposes of $190 million.our financial reporting of $505 million and a market value of $2.06 billion.

(See "Item 1A. Risk Factors.")



ITEM 4. MINE SAFETY DISCLOSURES


Not Applicable.


2825



PART II


ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES


Market for Common Stock

Our common stock is listed on the NASDAQ Global Select Market and trades under the symbol "MU" and traded under the same symbol on the New York Stock Exchange through December 29, 2009."MU."  The following table represents the high and low closing sales prices for our common stock for each quarter of 20132014 and 2012,2013, as reported by Bloomberg L.P.:

 Fourth Quarter Third Quarter Second Quarter First Quarter Fourth Quarter Third Quarter Second Quarter First Quarter
2013        
2014:        
High $14.97
 $11.89
 $8.38
 $6.70
 $34.64
 $28.61
 $25.49
 $21.17
Low 11.68
 8.25
 5.93
 5.17
 28.59
 21.13
 20.67
 13.57
                
2012        
2013:        
High $6.89
 $8.83
 $8.88
 $7.20
 $14.97
 $11.89
 $8.38
 $6.70
Low 5.39
 5.63
 5.45
 4.33
 11.68
 8.25
 5.93
 5.17


Holders of Record

As of October 18, 2013,16, 2014, there were 2,6232,471 shareholders of record of our common stock.


Dividends

We have not declared or paid cash dividends since 1996 and do not intend to pay cash dividends for the foreseeable future.

As a result of the Japan Proceedings, for so long as such proceedings are continuing, the Elpida Companies and their subsidiaries areMMJ Group is subject to certain restrictions on dividends, loans and advances. The total net assets, less noncontrolling interests, of the Elpida Companies and their subsidiaries as of August 29, 2013 was $2,460 million. As of August 29, 2013, the Elpida Companies heldOur ability to access IMFT's cash and equivalents of $1,094 million and $556 million of current restricted cash, none of which were available for cashother assets through dividends, loans or advances, as a result of the above-described restrictions.

As of August 29, 2013, IMFT held cash and equivalents of $62 million andincluding to finance our other assets, none of which were available for cash dividends, loans or advances without the consent ofoperations, is subject to agreement by Intel.


Equity Compensation Plan Information

The information required by this item is incorporated by reference from the information set forth in Item 12 of this Annual Report on Form 10-K.



29



Issuer Purchases of Equity Securities

During the fourth quarter of 20132014, we acquired, as payment of withholding taxes or exercise prices in connection with the vesting or exercise of restricted stock and restricted stock unitequity awards, 3,8575,479 shares of our common stock at an average price per share of $13.3732.02. We retired these shares in the fourth quarter of 20132014.

Period (a) Total number of shares purchased (b) Average price paid per share (c) Total number of shares (or units) purchased as part of publicly announced plans or programs (d) Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs
           
May 31, 2013-July 4, 2013 201
 $12.49
 N/A N/A
July 5, 2013-August 1, 2013 3,455
 13.39
 N/A N/A
August 2, 2013-August 29, 2013 201
 13.83
 N/A N/A
    3,857
 13.37
    



3026



Period (a) Total number of shares purchased (b) Average price paid per share (c) Total number of shares (or units) purchased as part of publicly announced plans or programs (d) Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs
May 30, 2014July 3, 2014 1,914
 $29.65
 N/A N/A
July 4, 2014July 31, 2014 3,395
 33.42
 N/A N/A
August 1, 2014August 28, 2014 170
 30.70
 N/A N/A
    5,479
 32.02
    


Performance Graph

The following graph illustrates a five-year comparison of cumulative total returns for our common stock, the S&P 500 Composite Index and the Philadelphia Semiconductor Index (SOX) from August 31, 2008,2009, through August 31, 2013.2014. We operate on a 52 or 53 week fiscal year which ends on the Thursday closest to August 31.  Accordingly, the last day of our fiscal year varies.  For consistent presentation and comparison to the industry indices shown herein, we have calculated our stock performance graph assuming an August 31 year end.

Note:  Management cautions that the stock price performance information shown in the graph above is provided as of August 31 for the years presented and may not be indicative of current stock price levels or future stock price performance.

The performance graph above assumes $100 was invested on August 31, 20082009 in common stock of Micron Technology, Inc., the S&P 500 Composite Index and the Philadelphia Semiconductor Index (SOX).  Any dividends paid during the period presented were assumed to be reinvested.  The performance was plotted using the following data:

 2008 2009 2010 2011 2012 2013 2009 2010 2011 2012 2013 2014
Micron Technology, Inc. $100
 $174
 $152
 $139
 $146
 $320
 $100
 $88
 $80
 $84
 $184
 $442
S&P 500 Composite Index 100
 82
 86
 102
 120
 142
 100
 105
 124
 147
 174
 218
Philadelphia Semiconductor Index (SOX) 100
 88
 90
 105
 119
 140
 100
 102
 119
 135
 159
 227





3127



ITEM 6. SELECTED FINANCIAL DATA


 2014 2013 2012 2011 2010
 2013 2012 2011 2010 2009          
 (in millions except per share amounts) (in millions except per share amounts)
Net sales $9,073
 $8,234
 $8,788
 $8,482
 $4,803
 $16,358
 $9,073
 $8,234
 $8,788
 $8,482
Gross margin 1,847
 968
 1,758
 2,714
 (440) 5,437
 1,847
 968
 1,758
 2,714
Operating income (loss) 236
 (612) 761
 1,612
 (1,646) 3,087
 236
 (612) 761
 1,612
Net income (loss) 1,194
 (1,031) 190
 1,900
 (1,993) 3,079
 1,194
 (1,031) 190
 1,900
Net income (loss) attributable to Micron 1,190
 (1,032) 167
 1,850
 (1,882) 3,045
 1,190
 (1,032) 167
 1,850
Diluted earnings (loss) per share $1.13
 $(1.04) $0.17
 $1.85
 $(2.35) 2.54
 1.13
 (1.04) 0.17
 1.85
                    
Cash and short-term investments $3,101
 $2,559
 $2,160
 $2,913
 $1,485
 4,534
 3,101
 2,559
 2,160
 2,913
Total current assets 8,911
 5,758
 5,832
 6,333
 3,344
 10,245
 8,911
 5,758
 5,832
 6,333
Property, plant and equipment, net 7,626
 7,103
 7,555
 6,601
 7,089
 8,682
 7,626
 7,103
 7,555
 6,601
Total assets 19,118
 14,328
 14,752
 14,693
 11,459
 22,498
 19,118
 14,328
 14,752
 14,693
Total current liabilities 4,125
 2,243
 2,480
 2,702
 1,892
 4,811
 4,125
 2,243
 2,480
 2,702
Long-term debt 4,452
 3,038
 1,861
 1,648
 2,379
 4,955
 4,452
 3,038
 1,861
 1,648
Redeemable convertible notes 57
 
 
 
 
Total Micron shareholders’ equity 9,142
 7,700
 8,470
 8,020
 4,953
 10,771
 9,142
 7,700
 8,470
 8,020
Noncontrolling interests in subsidiaries 864
 717
 1,382
 1,796
 1,986
 802
 864
 717
 1,382
 1,796
Total equity $10,006
 $8,417
 $9,852
 $9,816
 $6,939
 11,573
 10,006
 8,417
 9,852
 9,816

On July 31, 2013, we completed our acquisition of 100% of the equity ofMMJ Acquisition, in which we acquired Elpida, Memory, Inc. ("Elpida")now known as MMJ, and 24% ownershipa controlling interest in Rexchip, Electronics Corporation ("Rexchip"), a Taiwan corporationnow known as MMT. The MMJ Group's products include mobile DRAM targeted to mobile phones and manufacturing joint venture in which Elpida and its subsidiaries have a 65% ownership interest. Elpida and Rexchip manufacture and sell DRAM products for both mobiletablets and computing (includingDRAM targeted to desktop PCs, servers, notebooks and workstations) applications.workstations. The assets of Elpida and its subsidiaries include, among others:MMJ Acquisition included a 300mm DRAM wafer fabrication facility located in Hiroshima, Japan; its approximate 65% ownership interest in Rexchip, whose assets includeJapan, a 300mm DRAM wafer fabrication facility located in Taichung City, Taiwan;Taiwan and a 100% ownership interest in Akita, whose assets include an assembly and test facility located in Akita, Japan. As a result ofIn connection with the consummation of our acquisition of Elpida and the Rexchip shares, we own approximately 89% of Rexchip's common stock. The total consideration paid for Elpida and Rexchip was $949 million andMMJ Acquisition, we recorded net assets of $2,601 million and$2.60 billion, noncontrolling interests of $168 million in connection with the transaction. Because the fair value of the net assets acquired less noncontrolling interests exceeded the consideration we paid, we recognizedand a gain on the acquisitiontransaction of $1,484 million1.48 billion in 2013. (See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Acquisition of ElpidaMicron Memory Japan, Inc." note.)

We entered into a joint venture relationship with Intel to form IMFT in 2006 and IMFS in 2007 (collectively "IM Flash") to manufacture NAND Flash memory products for the exclusive use of the members. We have owned 51% of IMFT from inception through August 29, 201328, 2014. Our ownership percentage of IMFS had increased from 51% at inception to 82% as of April 6, 2012 due to our making a series of contributions by us that were not fully matched by Intel. On April 6, 2012, we entered into a series of agreements with Intel to restructure IM Flash. WeFlash, in which we acquired Intel's remaining 18% interest in IMFS for $466 million. In addition, we acquired IMFT's assets located at our Virginia wafer fabrication facility, for which Intel received a distribution from IMFT of $139 million. For both transactions, the amounts Intel received approximated the book values of Intel's interests in the assets acquired. We consolidate IM Flash and report Intel's ownership interests as noncontrolling interests in subsidiaries. (See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Consolidated Variable Interest EntitiesEquity – Noncontrolling Interests in Subsidiaries – IM Flash" note.)

On May 7, 2010, we acquired Numonyx, Holdings B.V. ("Numonyx"), which manufactured and sold primarily NOR Flash and NAND Flash memory products. The total fair value of the consideration paid for Numonyx was $1,112 million$1.11 billion and consisted of 137.7138 million shares of our common stock issued to the Numonyx shareholders and 4.85 million restricted stock units issued to employees of Numonyx. In connection with the acquisition, we recorded net assets of $1,549 million.$1.55 billion. Because the fair value of the net assets acquired exceeded the purchase price, we recognized a gain on the acquisition of $437 million in 2010. In addition, we recognized a $51 million income tax benefit in connection with the acquisition.


3228



In the first quarter of 2009, we acquiredWe have a noncontrolling interest in Inotera, a publicly-traded DRAM manufacturer in Taiwan. In connection therewith,Through December 2012, we entered into a supply agreement with Inotera to purchase purchased 50% of Inotera’sInotera's wafer production capacity based on a margin-sharing formula among Nanya, Inotera and began purchasing substantial quantities of product in the fourth quarter of 2009.  Onus. Since January 17, 2013, we entered into agreements with Nanya and Inotera to amend the joint venture relationship involving Inotera. The amendments includedhave purchased substantially all of Inotera's DRAM output at a discount from market prices for our comparable components under a new supply agreement (the "Inotera Supply Agreement"), retroactively effective beginning on January 1,. Our costs for supply from Inotera increased in 2014 from 2013 between us and Inotera under which we are obligateddue to purchase for an initial period through January, 2016, substantially all of Inotera's output at a purchase price based on a discount from marketchanges in average selling prices for our comparable components.DRAM products and the changes in the pricing terms. The Inotera Supply Agreement has a three-year term (currently through December 2016) that contemplates annual negotiations with respect to potential successive one-year extensions. If the parties do not agree to an extension, the agreement will terminate following the end of the then-existing term plus a subsequent three-year wind-down period. In the event of a wind-down, our share of Inotera's capacity would decline over the wind-down period. In 2014, our cost of products purchased from Inotera was significantly higher than our cost of similar products manufactured in our wholly-owned facilities. We are currently in negotiations regarding the extension of the Inotera Supply Agreement. There can be no assurance that we will be able to reach an agreement. As of August 29, 2013,28, 2014, our ownership interest in Inotera was 35%33%.  (See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Equity Method Investments – Inotera" note.)

(See "Item 1A. Risk Factors" and "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements.")


3329



ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

As used herein, "we," "our," "us" and similar terms include Micron Technology, Inc. and its subsidiaries, unless the context indicates otherwise.
The following discussion contains trend information and other forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements include, but are not limited to, statements such as those made in "Overview" regarding Elpida's wafer production"Operating Expenses and expectations related to Elpida's future cash flows; "Operating Results by Business Segment" regarding increases in sales of mobile DRAM for 2014 as a result of our acquisition of Elpida; in "Operating Results by Product" regarding the timing and effect of the transition of our Singapore DRAM facility to NAND Flash production, our increases in DRAM sales for 2014 as a result of our acquisition of Elpida and the effect of Elpida inventory adjustments in acquisition accounting on cost of sales in the first quarter of 2014; in "Selling, General and Administrative"Other" regarding SG&A costsand R&D expenses for the first quarter of 2014; in "Research2015 and Development" regarding R&D costs for the first quarter of 2014;future Restructure and Asset Impairment costs; and in "Liquidity and Capital Resources" regarding our pursuit of additional financing and debt restructuring, regarding the use of cash on hand to fund any repurchases of common stock, regarding the sufficiency of our cash and investments, cash flows from operations and available financing to meet our requirements for at least through 2014,the next 12 months, regarding our pursuit of additional financing and capital spending in 2014,2015 and regarding the timing of payments for certain contractual obligations, the timing of payments in connection with the Elpida transactions and conversions of our convertible notes; and in "Recently Issued Accounting Standards" regarding the impact of recently issued accounting pronouncements.obligations. Our actual results could differ materially from our historical results and those discussed in the forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, those identified in "Item"Part I, Item 1A. Risk Factors." This discussion should be read in conjunction with the Consolidated Financial Statementsconsolidated financial statements and accompanying notes for the year ended August 29, 2013.28, 2014. All period references are to our fiscal periods unless otherwise indicated. Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31 and fiscal 2014, 2013 2012 and 20112012 each contained 52 weeks. Our fiscal 2015 will contain 53 weeks and the first quarter of fiscal 2015 will contain 14 weeks. All production data includes the production of our consolidated joint venturesIMFT and our other partnering arrangements.Inotera. All tabular dollar amounts are in millions.


Our Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is provided in addition to the accompanying consolidated financial statements and notes to assist readers in understanding our results of operations, financial condition and cash flows. MD&A is organized as follows:

Overview:  Highlights of key transactions and events.
Results of Operations:  An analysis of our financial results consisting of the following:
Consolidated results;
Operating results by business segment;
Operating results by product; and
Operating expenses and other.
Liquidity and Capital Resources:  An analysis of changes in our balance sheet and cash flows and discussion of our financial condition and potential sources of liquidity.
Off-Balance Sheet Arrangements: Contingent liabilities, commitments andDescription of off-balance sheet arrangements.
Critical Accounting Estimates:  Accounting estimates that we believe are most important to understanding the assumptions and judgments incorporated in our reported financial results and forecasts. Also includes changes in accounting standards.




34



Overview

For an overview of our business, see "Item 1 – Business – Overview." Our results of operations for 20132014 were affected by the following key transactions and events.transaction.

Acquisition of ElpidaMicron Memory Japan, Inc.

On July 31, 2013, we completed the MMJ Acquisition, in which we acquired Elpida, now known as MMJ, and a controlling interest in Rexchip, now known as MMT. In 2014, we purchased additional interests in MMT, increasing our acquisition of Elpida Memory, Inc. ("Elpida"), a Japanese corporation, pursuantownership interest to the terms and conditions of an Agreement on Support for Reorganization Companies (as amended, the "Sponsor Agreement") that we entered into on July 2, 201299.5%. In connection with the trusteesMMJ Acquisition, we recorded net assets of Elpida$2.60 billion, noncontrolling interests of $168 million and onea gain on the transaction of its subsidiaries, Akita Elpida Memory, Inc., a Japanese corporation ("Akita" and, together with Elpida,$1.48 billion in 2013. In the "Elpida Companies") pursuant to andsecond quarter of 2014, the provisional amounts recorded in connection with the Elpida Companies' pending corporate reorganization proceedings under the Corporate Reorganization Act of Japan. We paid $615 millionMMJ Acquisition were adjusted, primarily for the acquisition of 100% of Elpida's equity. On July 31, 2013, we also acquired a 24% ownership interest in Rexchip Electronics Corporation ("Rexchip''), a Taiwanese corporation and manufacturing joint venture formed by Powerchip Technology Corporation ("Powerchip") and Elpida, from Powerchip and certain of its affiliates (the "Powerchip Group") pursuant to a share purchase agreement. We paid $334 million in cash for the shares. Elpida and it's subsidiaries (the "Elpida Group") own approximately 65% of Rexchip's outstanding common stock. Therefore, aspre-petition liabilities. As a result, other non-operating expense for 2014 included these measurement period adjustments of the consummation of our acquisition of Elpida and the Rexchip shares from the Powerchip Group, we own approximately 89% of Rexchip's common stock. The provisional fair values of assets and liabilities acquired include, among other items, cash and restricted cash aggregating $1,618 million; inventories of $962 million; property, plant and equipment of $935 million; net deferred tax assets of $917 million and debt of $2,134$33 million. (See "Item 8. Financial Statements – Notes to Consolidated Financial Statements – Micron Memory Japan, Inc." note.)

Elpida's assets include, among others:The MMJ Acquisition included a 300mm DRAM wafer fabrication facility located in Hiroshima, Japan; its ownership interest in Rexchip, whose assets includeJapan, a 300mm DRAM wafer fabrication facility located in Taichung City, Taiwan;Taiwan and an assembly and test facility located in Akita, Japan. The Elpida and RexchipThese wafer fabrication facilities together representrepresented approximately one-third30% of our total wafer capacity.

Elpida's semiconductor memorycapacity for 2014. The MMJ Group's products include Mobilemobile DRAM targeted towardto mobile phones and tablets. We believe that combiningtablets, and computing DRAM targeted to desktop PCs, servers, notebooks and workstations. The operations from the complementary product portfolios of Micron and Elpida strengthens our position in the memory market and enables us to provide customers with a wider portfolio of high-quality memory solutions. We also believe that the Elpida transaction strengthens our market position in the memory industry through increased research and development and manufacturing scale, improved access to core memory market segments, and additional wafer capacity to balance among our DRAM, NAND Flash and NOR Flash memory solutions. Elpida's operationsMMJ Acquisition are included primarily in the DSGMBU and WSGCNBU segments. Our results of operations for 2013 included approximately one month of operating results from the Elpida operations, which accounted for sales of $355 million and net income of $29 million.

The Elpida Companies are currently subject to corporate reorganization proceedings under the Corporate Reorganization Act of Japan. Both of the Elpida Companies have adopted plans of reorganization which set forth the treatment of the Elpida Companies' pre-petition creditors and their claims, which plans were approved by the Elpida Companies' creditors and the Tokyo District Court in February 2013. The plans of reorganization provide for payments by the Elpida Companies to their secured and unsecured creditors in an aggregate amount of 200 billion yen (or the equivalent of approximately $2.05 billion as of August 29, 2013), less certain expenses of the reorganization proceedings and certain other items. The plans of reorganization provide for the Elpida Companies' pre-petition creditors to be paid in seven installments. The initial installment payment of 60 billion yen ($615 million as of August 29, 2013), which amount is subject to reduction for certain items specified in the Sponsor Agreement and plans of reorganization, was paid in October 2013. Substantially all of the $615 million that we paid in connection with the Elpida acquisition was deposited into accounts that are legally restricted for payment to the secured and unsecured creditors of Elpida in October 2013 and was presented as restricted cash in the amount of $556 million on our August 29, 2013 balance sheet. The remaining 140 billion yen (or the equivalent of approximately $1.43 billion as of August 29, 2013) of installment payments payable to the Elpida Companies' creditors are scheduled to be made by the Elpida Companies in six annual installments payable beginning on December 31, 2014. Pursuant to the terms of the Sponsor Agreement, we entered into a series of agreements with the Elpida Companies, including supply agreements, research and development services agreements and general services agreements, which are intended to generate more stable operating cash flows to meet the requirements of the Elpida Companies' businesses, including the funding of the installment payments to the Elpida Companies' creditors. We anticipate that, once fully in effect, payments made under these agreements will generally cover all of Elpida and Akita's costs.


3530



To mitigate the risk from the effect of changes in foreign currency exchange rates on the proposed Elpida Acquisition, we entered into a series of currency exchange contracts to hedge our exposure to yen and New Taiwan Dollar payments (the "Elpida Hedges"). These currency exchange contracts were not designated for hedge accounting and were remeasured at fair value each period with gains and losses recognized in other operating (income) expense. As a result of mark-to-market adjustments for the Elpida Hedges, we recorded losses to other non-operating expense of $228 million in 2013. As of August 29, 2013, our cumulative loss on the Elpida Hedges was $220 million.

See "Item 8. Financial Statements - Notes to Consolidated Financial Statements - Acquisition of Elpida Memory, Inc." for further details of the acquisition.

Inotera Memories, Inc.

On January 17, 2013, we entered into agreements with Nanya Technology Corporation ("Nanya") to amend the joint venture relationship involving Inotera. The amendments included a new supply agreement (the "Inotera Supply Agreement"), retroactively beginning on January 1, 2013, between us and Inotera under which we are obligated to purchase for an initial three-year term substantially all of Inotera's output at a purchase price based on a discount from market prices for our comparable components. The Inotera Supply Agreement contemplates annual negotiations with respect to potential successive one-year extensions and if in any year the parties do not agree to an extension, the agreement will terminate following the end of the then-existing term plus a subsequent three-year wind-down period. Our share of Inotera's capacity would decline over the three year wind-down period. Effective through December 31, 2012, we had rights and obligations to purchase 50% of Inotera's wafer production capacity based on a margin-sharing formula among Nanya, Inotera and us. Our cost for product purchased from Inotera under the supply agreements was $1,260 million for 2013, $646 million for 2012 and $641 million for 2011.

Under a cost-sharing arrangement effective through December 31, 2012, we generally shared DRAM process and design development costs with Nanya. As a result of the January 17, 2013 agreements, which were retroactively effective beginning on January 1, 2013, Nanya no longer participates in the joint development program. Pursuant to this cost-sharing arrangement, our R&D costs were reduced by $19 million for 2013, $138 million for 2012 and $141 million for 2011.


Results of Operations

Consolidated Results

For the year ended 2013 2012 2011 2014 2013 2012
Net sales $9,073
 100 % $8,234
 100 % $8,788
 100 % $16,358
 100 % $9,073
 100 % $8,234
 100 %
Cost of goods sold 7,226
 80 % 7,266
 88 % 7,030
 80 % 10,921
 67 % 7,226
 80 % 7,266
 88 %
Gross margin 1,847
 20 % 968
 12 % 1,758
 20 % 5,437
 33 % 1,847
 20 % 968
 12 %
                        
SG&A 562
 6 % 620
 8 % 592
 7 % 707
 4 % 562
 6 % 620
 8 %
R&D 931
 10 % 918
 11 % 791
 9 % 1,371
 8 % 931
 10 % 918
 11 %
Restructure and asset impairments 126
 1 % 10
  % (75) (1)% 40
  % 126
 1 % 10
  %
Other operating (income) expense, net (8)  % 32
  % (311) (4)% 232
 1 % (8)  % 32
  %
Operating income (loss) 236
 3 % (612) (7)% 761
 9 % 3,087
 19 % 236
 3 % (612) (7)%
   

           

        
Gain on acquisition of Elpida 1,484
 16 % 
  % 
  %
Gain on MMJ Acquisition (33)  % 1,484
 16 % 
  %
Interest income (expense), net (217) (2)% (171) (2)% (101) (1)% (329) (2)% (217) (2)% (171) (2)%
Other non-operating income (expense), net (218) (2)% 29
  % (109) (1)% 8
  % (218) (2)% 29
  %
Income tax (provision) benefit (8)  % 17
  % (203) (2)% (128) (1)% (8)  % 17
  %
Equity in net loss of equity method investees (83) (1)% (294) (4)% (158) (2)%
Equity in net income (loss) of equity method investees 474
 3 % (83) (1)% (294) (4)%
Net income attributable to noncontrolling interests (4)  % (1)  % (23)  % (34)  % (4)  % (1)  %
Net income (loss) attributable to Micron $1,190
 13 % $(1,032) (13)% $167
 2 % $3,045
 19 % $1,190
 13 % $(1,032) (13)%


36Business Segments


We have the following four business units, which are our reportable segments:

Compute and Networking Business Unit ("CNBU"): Includes DRAM and NOR Flash products sold to the compute, networking, graphics and cloud server markets.
Mobile Business Unit ("MBU"): Includes DRAM, NAND Flash and NOR Flash products sold to the smartphone, feature phone and tablet mobile-device market.
Storage Business Unit ("SBU"): Includes NAND Flash components and SSDs sold into enterprise and client storage, cloud and removable storage markets. SBU also includes NAND Flash products sold to Intel through our IMFT joint venture.
Embedded Business Unit ("EBU"): Includes DRAM, NAND Flash and NOR Flash products sold into automotive and industrial applications, as well as the connected home and consumer electronics markets.

Our other operations do not meet the thresholds of a reportable segment and are reported under All Other. In the secondthird quarter of 2013,2014, we reclassified (gains) losses from changes in currency exchange rates from other operating (income) expense, net to other non-operating income (expense), net in the consolidated statements of income. As a result, segment operating income (loss) for the comparative periods presented no longer includes the (gains) losses from changes in currency exchange rates to conform to currentreorganized our business units. All prior period presentation. (See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Business and Basis of Presentation" and "Segment Information".)amounts reflect this reorganization.

Net Sales
For the year ended 2013 2012 2011
DSG $3,519
 39% $2,691
 33% $3,203
 36%
NSG 2,841
 31% 2,853
 35% 2,196
 25%
WSG 1,221
 13% 1,184
 14% 1,959
 22%
ESG 1,194
 13% 1,054
 13% 1,002
 11%
All Other 298
 4% 452
 5% 428
 6%
  $9,073
 100% $8,234
 100% $8,788
 100%
For the year ended 2014 2013 2012
CNBU $7,333
 45% $3,462
 38% $2,667
 32%
MBU 3,627
 22% 1,214
 13% 1,176
 14%
SBU 3,480
 21% 2,824
 31% 2,842
 35%
EBU 1,774
 11% 1,275
 14% 1,097
 13%
All Other 144
 1% 298
 4% 452
 6%
  $16,358
 100% $9,073
 100% $8,234
 100%


31



Total net sales for 2014 increased 80% as compared to 2013 primarily due to higher CNBU and MBU sales resulting from the MMJ Acquisition. Net sales for all segments in 2014 also benefitted, as compared to 2013, from increases in DRAM and NAND Flash sales volumes driven primarily by higher manufacturing output as a result of improvements in product and process technology and an increased share of output from Inotera.

Total net sales for 2013 increased 10% as compared to 2012 reflecting increases in DSG, ESGCNBU, EBU and WSGMBU sales primarily due to higher levels of DRAM and NAND Flash gigabit sales volumes partially offset by declines in average selling prices. The increases in gigabit sales volumes for 2013 were primarily attributable to manufacturing efficiencies driven by improvements in product and process technology,technologies, increased DRAM supply from Inotera due to the restructuring of our supply agreement and $355 million of DRAM sales from Elpida sincethe MMJ Acquisition after its acquisition on July 31, 2013.

Total net sales decreased 6%Gross Margin

Our overall gross margin percentage improved to 33% for 20122014 from 20% for 2013 primarily due to improvements in the gross margin percentage for CNBU and MBU as a result of higher margins for DRAM products. The gross margin improvements for CNBU and MBU for 2014 as compared to 2011, reflecting declines2013 resulted primarily from the MMJ Acquisition, manufacturing cost reductions and higher average selling prices for CNBU.

Through December 2012, we purchased 50% of Inotera's wafer production capacity based on a margin-sharing formula among Nanya, Inotera and us. Since January 2013, we have purchased substantially all of Inotera's DRAM output at a discount from market prices for our comparable components under a new supply agreement (the "Inotera Supply Agreement"). Our costs for supply from Inotera increased in 2014 from 2013 due to increases in average selling prices across all reportable segmentsfor our DRAM products and the changes in the pricing terms. The Inotera Supply Agreement has a three-year term (currently through December 2016) that contemplates annual negotiations with respect to potential successive one-year extensions. If the parties do not agree to an extension, the agreement will terminate following the end of the then-existing term plus a subsequent three-year wind-down period. In the event of a wind-down, our share of Inotera's capacity would decline over the wind-down period. In 2014, our cost of products purchased from Inotera was significantly higher than our cost of similar products manufactured in our wholly-owned facilities. We are currently in negotiations regarding the extension of the Inotera Supply Agreement. There can be no assurance that we will be able to reach an agreement. Under the Inotera supply agreements, we purchased $2.68 billion, $1.26 billion, and $646 million of DRAM products in 2014, 2013 and 2012, respectively.

Our gross margin percentage on sales of DRAM products for 2014 improved from 2013 primarily due to reductions in costs and increases in average selling prices. Cost reductions for 2014 primarily reflected improvements in product and process technologies and the comparatively lower manufacturing costs of the MMJ Group, partially offset by increases in sales volumes. WSG sales decreasedhigher costs for 2012 as compared to 2011 primarily due to declines in average selling pricesproduct obtained under the Inotera supply agreements. For 2014 and in NOR Flash sales volumes, as a resultthe fourth quarter of weakness in market demand and2013, our customer group in particular, as well as a continued transition by customers from NOR Flash to NAND Flash. DSG sales decreased primarily due to lower average selling prices partially offset by increases in sales volumes. NSG and ESG sales increased due to increases in sales volumes partially offset by declines in average selling prices.

Sales for All Other segments, were primarily composed of sales of CMOS image sensors. On May 3, 2013, we sold Micron Technology Italia, S.r.l., ("MIT") a wholly-owned subsidiary, including its 200mm wafer fabrication facility assets in Avezzano, Italy, to LFoundry Marsica S.r.l. ("LFoundry"). In connection with the sale, we assigned to LFoundry our supply agreement with Aptina Imaging Corporation ("Aptina") for CMOS image sensors manufactured at the Avezzano facility. Since the sale, we have had no sales of CMOS image sensors. For 2013, 2012 and 2011, we recognized net sales of $182 million, $372 million and $349 million, respectively, from products sold to Aptina, and costcosts of goods sold for DRAM products included the sale of $219the MMJ Group's inventories recorded at fair value in the MMJ Acquisition, which was higher than the manufacturing cost of such inventories. This increased our costs of goods sold by approximately $153 million, $395 for 2014 and $41 million and $358 million, respectively. (See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Restructure and Asset Impairments.")

Gross Margin for 2013.

Our overall gross margin percentage improved to 20% for 2013 from 12% for 2012 due to improvements in the gross margin percentage for DSG,CNBU, and to a lesser extent WSG, ESGEBU, SBU and NSGMBU, primarily due to manufacturing cost reductions partially offset by declines in average selling prices. Manufacturing cost reductions for 2013 primarily resulted from improvements in product and process technologies.

Our overall gross margin percentage declined to 12% for 2012 from 20% for 2011 primarily due to decreases in the gross margin percentage for DSG and WSG as a result of significant declines in average selling prices. Cost reductions from improvements in product and process technologies in 2012 mitigated the effect of significant declines in average selling prices for all reportable operating segments.


37



Operating Results by Business Segments

DRAM Solutions Group ("DSG")CNBU

For the year ended 2013 2012 2011 2014 2013 2012
Net sales $3,519
 $2,691
 $3,203
 $7,333
 $3,462
 $2,667
Operating income (loss) 143
 (494) 290
 1,957
 160
 (458)


DSG
32



CNBU sales and operating results track closely with our average selling prices, gigabit sales volumes and cost per gigabit for our consolidated sales of DRAM products. (See "Operating Results by Product – DRAM" for further detail.) DSGCNBU sales for 2014 increased 112% as compared to 2013 primarily due to (1) the MMJ Acquisition, (2) higher average selling prices, (3) increased DRAM supply from Inotera as a result of the restructuring of our supply agreement and (4) higher output due to improvements in product and process technologies. CNBU sales for 2014 as compared to 2013 were adversely impacted by the transition of production at one of our Singapore wafer fabrication facilities from DRAM to NAND Flash. CNBU operating income for 2014 improved from 2013 primarily due to the MMJ Acquisition, higher average selling prices and manufacturing cost reductions.

CNBU sales for 2013 increased 31%30% as compared to 2012 primarily due to increases in gigabits sold partially offset by declines in average selling prices. DSG'sCNBU operating margin for 2013 improved in 2013 from 2012 primarily due to manufacturing cost reductions as a result of improved product and process technologies partially offset by declines in average selling prices. DSGCNBU results of operations for 2013 included sales of $163$153 million and operating income of $25$21 million from the acquired Elpida operations. DSGMMJ Group. CNBU sales and operating margins for 2012 were adversely impacted by a $58 million charge for a settlement with a customer.

DSGMBU

For the year ended 2014 2013 2012
Net sales $3,627
 $1,214
 $1,176
Operating income (loss) 683
 (265) (371)

In 2014, MBU sales were comprised primarily of DRAM, NAND Flash and NOR Flash, in decreasing order of revenue, with mobile DRAM products accounting for a significant majority of the sales. MBU sales for 2012 decreased 16%2014 increased 199% as compared to 20112013 primarily due significant increases in mobile DRAM sales as a result of the MMJ Acquisition. MBU operating margin for 2014 also improved from 2013 primarily due to the MMJ Acquisition and manufacturing cost reductions, which significantly outpaced declines in average selling prices partially offset by increases in gigabits sold. DSG's operating margin declined from 2011prices.

MBU sales increased 3% for 2013 as compared to 2012 primarily due to decreases in average selling prices mitigated by cost reductionshigher sales of mobile DRAM products as a result of improved product and process technologies. DSGthe MMJ Acquisition partially offset by declines in sales of wireless NOR Flash products. MBU results of operations for 2013 included sales of $192 million and operating marginsincome of $22 million from the MMJ Group. Sales of wireless NOR Flash products declined in 2014 as a result of weakness in market demand and our customer group in particular, as well as a continued transition by customers to NAND Flash. The improvement in MBU operating margin for 2013 from 2012 were adversely impacted by the $58 million charge for a settlement with a customer. In addition, DSG operating income for 2011 benefited from a $75 million gain from an allocated portion of the Samsung patent cross-license agreement.was primarily due to reductions in manufacturing, SG&A and R&D costs.

NAND Solutions Group ("NSG")SBU

For the year ended 2013 2012 2011 2014 2013 2012
Net sales $2,841
 $2,853
 $2,196
 $3,480
 $2,824
 $2,842
Operating income 201
 205
 276
 255
 173
 199

NSGSBU sales and operating results track closely with our average selling prices, gigabit sales volumes and cost per gigabit for our consolidated sales of NAND Flash products. (See "Operating Results by Product – NAND Flash" for further detail.) NSGSBU sales for 2014 increased 23% from 2013 primarily due to increases in gigabits sold partially offset by declines in average selling prices. Increases in gigabits sold for 2014 were primarily due to the transition in 2014 of production at one of our wafer fabrication facilities in Singapore from DRAM to NAND Flash and improvements in product and process technologies. SBU sells a portion of its products to Intel through our IMFT joint venture at long-term negotiated prices approximating cost. SBU sales of NAND Flash products to Intel under this arrangement were $423 million, $387 million and $718 million for 2014, 2013 and 2012, respectively. All other SBU products are sold to OEMs, resellers, retailers and other customers (including Intel), which we collectively refer to as "trade customers."

SBU sales of NAND Flash products to trade customers for 2014 increased 26% as compared to 2013 primarily due to an increase in gigabits sold partially offset by declines in average selling prices. SBU operating income for 2014 improved from 2013 primarily due to higher gigabit sales volumes as manufacturing cost reductions were essentially offset by declines in average selling prices.


33



SBU sales for 2013 were relatively unchanged from 2012 as increases in gigabits sold were partially offset by declines in average selling prices. Increases in gigabits sold for 2013 were primarily due to improvements in product and process technologies. NSG sells a portion of its products to Intel through our IM Flash joint venture at long-term negotiated prices approximating cost. All other NSG products are sold to OEMs, resellers, retailers and other customers (including Intel), which we collectively refer to as "trade customers."

On April 6, 2012, we acquired Intel's remaining ownership interest in IMFS, a joint venture between us and Intel, which operated a wafer fabrication facility in Singapore. On April 6, 2012, we also acquired the assets of IMFT located at our Virginia fabrication facility and terminated the IMFS supply agreement. Accordingly, we now obtain all of the NAND Flash output from our Singapore and Virginia wafer fabrication facilities. Prior to these acquisitions, we sold a portion of the NAND Flash output from these facilities to Intel, through our consolidated IMFS and IMFT joint ventures, at long-term negotiated prices approximating cost. On April 6, 2012, we also entered into a new supply agreement with Intel under which we sell Intel NAND Flash products from us on a cost-plus basis. Aggregate NSG sales to Intel (including sales by IMFT at prices approximating cost and sales by us under the new cost-plus supply agreement) were $849 million for 2013, $986 million for 2012 and $884 million for 2011. As a result of these April 6, 2012 transactions, in 2013 NSGSBU sales of NAND Flash products to trade customers increased and sales to Intel at long-term negotiated prices approximating cost decreased.

NSG sales of NAND Flash products to trade customersfor 2013 increased 22% for 2013 as compared to 2012 primarily due to increases in gigabits sold partially offset by declines in average selling prices. NSGOn April 6, 2012, we acquired Intel's interests and supply rights from IM Flash wafer fabrication facilities in Singapore and Virginia, resulting in subsequent increases in our sales to trade customers. SBU operating income for 2013 was essentially unchangeddeclined from 2012 as manufacturing cost reductions offset declinesprimarily due to decreases in average selling prices and increases in R&D costs.costs mitigated by manufacturing cost reductions. Manufacturing cost reductions resulted primarily from improvements in product and process technologies.


38



NSG sales of NAND Flash products to trade customers increased 50% for 2012 as compared to 2011 primarily due to an increase in gigabits sold partially offset by declines in average selling prices. NSG operating income declined from 2011 to 2012 primarily due to decreases in average selling prices mitigated by cost reductions. Cost reductions resulted primarily from improvements in product and process technologies. NSG operating income for 2011 benefited from a $57 million gain from an allocated portion of the Samsung patent cross-license agreement.

Wireless Solutions Group ("WSG")EBU

For the year ended 2013 2012 2011 2014 2013 2012
Net sales $1,221
 $1,184
 $1,959
 $1,774
 $1,275
 $1,097
Operating income (loss) (263) (368) 19
Operating income 331
 227
 129

In 2013, WSG2014, EBU sales were comprised primarily of DRAM, NAND Flash and NOR Flash in decreasing order of revenue. WSGEBU sales for 2014 increased 3% for 201339% as compared to 20122013 primarily due to increased sales volumes of DRAM and NAND Flash products partially offset by declines in average selling prices. EBU operating income for 2014 improved as compared to 2013 primarily due to higher margins on sales of mobile DRAM and NAND Flash products as a result of the acquisition of Elpida. We expect that WSG sales of mobile DRAM products will increase significantly in 2014 primarily due to our acquisition of Elpida. WSG results of operations for 2013 included sales of $192 million and operating income of $21 million from the acquired Elpida operations. Increases in WSG sales for 2013 from mobile DRAM were partially offset by declines in sales of wireless NOR Flash products as a result of weakness in market demand and our customer group in particular, as well as a continued transition by customers to NAND Flash. WSG sales in 2013 were also adversely impacted by lower sales of NAND Flash products sold in multi-chip packages. The improvement in WSG operating margin for 2013 was primarily due to reductions in manufacturing, SG&A and R&D costs.cost reductions.

In 2012, WSG2013, EBU sales were comprised of DRAM, NOR Flash NAND Flash and DRAM in decreasing order of revenue. The 40% decrease in WSG sales for 2012 as compared to 2011 was primarily due to declines in sales of wireless NOR Flash products as a result of weakness in market demand and our customer group in particular, as well as a continued transition by customers to NAND Flash. WSG sales in 2012 were also adversely impacted by lower sales of NAND Flash products sold in multi-chip packages. The decline in WSG operating margin for 2012 was primarily due to the reductions in average selling prices and in NOR Flash sales volumes. In addition, WSG operating margin for 2011 benefited from a $95 million gain from an allocated portion of the Samsung patent cross-license agreement.

Embedded Solutions Group ("ESG")

For the year ended 2013 2012 2011
Net sales $1,194
 $1,054
 $1,002
Operating income 271
 158
 236

In 2013, ESG sales were comprised of NOR Flash, DRAM and NAND Flash in decreasing order of revenue. ESGEBU sales increased 13%16% for 2013 as compared to 2012 primarily due to increased sales volumevolumes of DRAM, NAND Flash DRAM and NOR Flash products as ESGEBU continued to expand its customer base, partially offset by declines in average selling prices. ESGEBU operating income for 2013 improved from 2012 primarily due to higher gross margins as manufacturing cost reductions outpaced declines in average selling prices.

In 2012, ESGand higher sales were comprised of NOR Flash, DRAM and NAND Flash in decreasing order of revenue. The 5% increase in ESG sales for 2012 as compared to 2011 was primarily due to increased sales volume of DRAM, NAND Flash and NOR Flash products as ESG continued to expand its customer base,volumes partially offset by declines in average selling prices. ESG operating income for 2012 declined as compared to 2011 due to decreases in average selling prices and higher costs associated with underutilized capacity in our NOR Flash facilities. In addition, ESG operating margin for 2011 benefited from a $33 million gain from an allocated portion of the Samsung patent cross-license agreement.


39



Operating Results by Product

Net Sales by Product

For the year ended 2013 2012 2011 2014 2013 2012
DRAM 4,361
 48% 3,178
 39% 3,620
 41% $11,164
 68% $4,361
 48% $3,178
 39%
NAND Flash 3,589
 40% 3,627
 44% 3,193
 36% 4,468
 27% 3,589
 40% 3,627
 44%
NOR Flash 792
 9% 977
 12% 1,547
 18% 505
 3% 792
 9% 977
 12%
Other 331
 3% 452
 5% 428
 5% 221
 2% 331
 3% 452
 5%
 $9,073
 100% $8,234
 100% $8,788
 100% $16,358
 100% $9,073
 100% $8,234
 100%

In order to balance our future product mix in anticipation of the closing of the Elpida transaction,MMJ Acquisition, in the fourth quarter of 2013, we began to transition production at one of our DRAMwafer fabrication facilityfacilities in Singapore from DRAM to NAND Flash. We expect thisThis transition to NAND Flash production will occur over approximately four quarters, depending on market conditions and result inis substantially complete. During this period of transition, there was a marginal reduction in wafer production during the period of this transition.production.

DRAM

For the year ended 2013 2012 2014 2013
    
 (percentage change from prior period) (percentage change from prior period)
Net sales 37 % (12)% 156 % 37 %
Average selling prices per gigabit (11)% (45)% 6 % (11)%
Gigabits sold 55 % 59 % 142 % 55 %
Cost per gigabit (25)% (32)% (20)% (25)%


34



The increase in gigabit sales of DRAM products for 2014 as compared to 2013 was primarily due to higher production volumes resulting from the MMJ Acquisition, increased supply under the new Inotera Supply Agreement and improved product and process technologies, partially offset by the transition of one of our wafer fabrication facilities in Singapore from DRAM to NAND Flash. In 2014, DRAM products produced by our MMJ Group facilities constituted 54% of our aggregate DRAM gigabit production as compared to 9% in 2013.

In 2014, our cost of products purchased from Inotera was significantly higher than our cost of similar products manufactured in our wholly-owned facilities and were higher than our costs in 2013. DRAM products acquired from Inotera accounted for 38% of our DRAM gigabit production for 2014 as compared to 54% for 2013 and 46% for 2012.

Our gross margin percentage on sales of DRAM products for 2014 improved from 2013 primarily due to reductions in costs and increases in average selling prices. Cost reductions for 2014 primarily reflected improvements in product and process technologies and the comparatively lower manufacturing costs of the MMJ Group, partially offset by higher costs for product obtained under the Inotera supply agreement and the sale of the MMJ Group's inventories recorded in the MMJ Acquisition.

The increase in gigabit sales of DRAM products for 2013 as compared to 2012 was primarily due to increased output obtained from our Inotera joint venture under the new supply agreement, improved product and process technologies and the acquisition of ElpidaMMJ Acquisition on July 31, 2013. Effective on January 1, 2013, we entered into the new Inotera Supply Agreement under which we purchase substantially all of Inotera's output at a purchase price based on a discount from market prices for our comparable components. Prior to the new Inotera Supply Agreement we had the right to purchase 50% of Inotera's wafer production capacity based on a margin-sharing formula among Nanya, Inotera and us. (See "Overview – Inotera Memories, Inc.") Our cost of product purchased from Inotera under these supply agreements was $1,260 million for 2013, $646 million for 2012, and $641 million for 2011. Our cost of product purchased from Inotera has increased since the beginning of calendar 2013 and was higher than our cost of similar products manufactured in our wholly-owned facilities in the fourth quarter of 2013.

DRAM products acquired from Inotera accounted for 54% of our DRAM gigabit production for 2013 as compared to 46% for 2012 and 33% for 2011. As of June 30, 2013, Inotera's current liabilities exceeded its current assets by $1.0 billion, which exposes Inotera to liquidity risk. Additionally, Inotera incurred net losses of $541 million for its fiscal year ended December 31, 2012. As of June 30, 2013, Inotera was not in compliance with certain of its loan covenants, and had not been in compliance for the past several years, which may result in its lenders requiring repayment of such loans during the next year. Inotera has applied for a waiver from complying with the June 30, 2013 financial covenants. Inotera's management has implemented plans to improve its liquidity and for Inotera's six-month period ended June 30, 2013, Inotera generated net income of $91 million; however, there can be no assurance that Inotera will be successful in sufficiently improving its liquidity and complying with their loan covenants, which may result in its lenders requiring repayment of such loans during the next year.

Our gross margin percentage on sales of DRAM products for 2013 improved from 2012 primarily due to manufacturing cost reductions as a result of improvements in product and process technologytechnologies partially offset by declines in average selling prices. DRAM sales and gross margins for 2012 were adversely impacted by the effects of thea $58 million charge to revenue for a settlement with a customer.


40



We expect that our gigabit production and sales volumes of DRAM products will increase significantly in 2014 due to our acquisition of Elpida. Elpida has 300mm wafer fabrication facilities in Japan and Taiwan that are dedicated to the production of DRAM products. We expect that DRAM products produced by the acquired Elpida facilities will constitute over half of our aggregate DRAM gigabit production in the first quarter of 2014 and result in significant increases in DSG and WSG DRAM sales. In accounting for the Elpida acquisition, Elpida's inventories were recorded at fair value, based on their estimated future selling prices, estimated costs to complete and other factors, which was approximately $200 million higher than the cost of inventory recorded by Elpida prior to the acquisition. Of this amount, approximately $40 million was included in cost of goods sold for 2013 and a significant portion of the reminder is expected to be included in costs of goods sold in the first quarter of 2014.

NAND Flash

We sell a portion of our output of NAND Flash products to Intel through IM FlashIMFT at long-term negotiated prices approximating cost. (See "Operating Results by Business Segments – NAND Solutions Group"Storage Business Unit" for further detail.) We sell the remainder of our NAND Flash products to trade customers.

For the year ended 2013 2012 2014 2013
    
 (percentage change from prior period) (percentage change from prior period)
Sales to trade customers:        
Net sales 15 % 19 % 27 % 15 %
Average selling prices per gigabit (18)% (55)% (23)% (18)%
Gigabits sold 40 % 164 % 65 % 40 %
Cost per gigabit (22)% (54)% (23)% (22)%

Increases in NAND Flash gigabits sold to trade customers for 2014 as compared to 2013 were primarily due to the transition of one of our wafer fabrication facilities in Singapore from DRAM to NAND Flash production and improved product and process technologies. Our gross margin percentage on sales of trade NAND Flash products for 2014 was relatively unchanged from 2013 as manufacturing cost reductions offset declines in average selling prices. Manufacturing cost reductions for 2014 as compared to 2013 primarily resulted from improvements in product and process technologies.

Increases in NAND Flash gigabits sold to trade customers for 2013 as compared to 2012 were primarily due to improved product and process technologies, increased output available for sale to trade customers due to the restructure of our IM Flash agreement with Intel in April 2012 and the ramp-up of our fabrication facility in Singapore throughout 2012. Our gross margin percentage on sales of NAND Flash products for 2013 improved from 2012 as manufacturing cost reductions outpaced declines in average selling prices. Manufacturing cost reductions for 2013 as compared to 2012 reflect improvements in product and process technologies.

Increases in NANDNOR Flash gigabits sold to trade customers

Sales of NOR Flash products for 20122014 declined as compared to 2011 was2013 primarily due to the rampdecreases in sales of wireless NOR Flash products as a result of the IMFS fabrication facilitycontinued transition of wireless applications to NAND Flash products. Our gross margin percentage on sales of NOR Flash products for 2014 declined as compared to 2013 primarily due to costs of underutilized capacity in connection with the decrease in production of wireless products and improved product and process technologies. The new cost-plus supply agreement with Intel also contributed to the increasedecreases in gigabits sold to trade customers for 2012.average selling prices.


NOR Flash
35



Sales of NOR Flash products for 2013 declined as compared to 2012 primarily due to decreases in sales of wireless NOR Flash products as a result of weakness in demand from certain customers and the continued transition of wireless applications to NAND Flash products, which led to significant declines in average selling prices. Our gross margin percentage on sales of NOR Flash products for 2013 improved as compared to 2012 primarily due to cost reductions.

Sales of NOR Flash products for 2012 declined from 2011 primarily due to decreases in sales of wireless NOR Flash products, as a result of weakness in demand from certain customers and the continued transition of wireless applications to NAND Flash products that led to significant declines in average selling prices and sales volume. Our gross margin percentage on sales of NOR Flash products declined from 2011 to 2012 primarily due to decreases in average selling prices, inventory write-downs and costs of underutilized capacity.

Operating Expenses and Other

Selling, General and Administrative

Selling, generalSG&A expenses for 2014 increased 26% as compared to 2013 primarily due to the incremental costs resulting from the MMJ Acquisition and administrative ("higher payroll costs resulting primarily from the reinstatement of variable pay plans. We expect that SG&A")&A expenses will approximate $195 million to $205 million for the first quarter of 2015.

SG&A expenses for 2013 decreased 9% as compared to 2012 primarily due to a reduction in legal costs and lower variable pay costs partially offset by $50$50 million of consulting legal and other costs incurred in connection with the acquisition of Elpida.MMJ Acquisition.


41Research and Development



SG&AR&D expenses for 20122014 increased 5% as compared to 201147% from 2013 primarily due to a $13 million contributionthe incremental costs resulting from the MMJ Acquisition, higher payroll costs resulting primarily from the reinstatement of variable pay plans and increased resources dedicated to a university program and stock-based compensation and other amounts related to the death benefits of our former Chief Executive Officer in 2012.development efforts. We expect that SG&AR&D expenses, net of amounts reimbursable from our R&D partners, will approximate $185be approximately $395 million to $195$405 million for the first quarter of 2014, which includes costs from Elpida.

Research and Development2015.

R&D expenses for 2013 increased 1% from 2012 primarily due to lower reimbursements from Nanya under partnering arrangements offset by lower payroll costs primarily resulting from the suspension of variable pay plans and a lower volume of development wafers processed.

As a result of amounts reimbursable from Intel under a joint development program for NAND Flash and certain emerging memory technologies, R&D expenses were reduced by $137 million, $127 million and $87 million for 2014, 2013 and 2012, increased 16% from 2011 primarily due to a higher volume of development wafers processed, higher personnel costs associated with increased salary and wage rates and additional headcount for our expanded R&D operations, and higher software and materials costs.

respectively. As a result of amounts reimbursable from Nanya under a DRAM R&D cost-sharing arrangement,joint development program, R&D expenses were reduced by $19$19 million, $138 and $138 million and $141 million for 2013 2012 and 2011, respectively. The April 6, 2012, agreements with Intel expanded our NAND Flash R&D cost-sharing agreement to include certain emerging memory technologies, but did not change the cost-sharing percentage. As a result of amounts reimbursable from Intel, R&D expenses were reduced by $127 million, $87 million and $95 million for 2013, 2012 and 2011, respectively. Effective January 1, 2013, Nanya ceased participating in the DRAM joint development program. We expect that R&D expenses, net of amounts reimbursable from our R&D partners, will be approximately $340 million to $350 million for the first quarter of 2014, which includes costs from Elpida.

Our process technology R&D efforts are focused primarily on development of successively smaller line-width process technologies which are designed to facilitate our transition to next generation memory products. Additional process technology R&D efforts focus on the enablement of advanced computing and mobile memory architectures, the investigation of new opportunities that leverage our core semiconductor expertise and the development of new manufacturing materials. Product design and development efforts include our high density DDR3 and DDR4 DRAM, and Mobile Low Power DDR DRAMLPDRAM products, as well as high density and mobile NAND Flash memory (including multi-level3D NAND and triple-level cellMLC and TLC technologies), SSDs, Hybrid Memory Cubes, specialty memory, NOR Flash memory, specialty memory, solid-state drives, Hybrid Memory Cubes and other memory technologies and systems.

Restructure and Asset Impairments

For the year ended 2013 2012 2011 2014 2013 2012
Loss on impairment of LED assets $(6) $33
 $
Loss on impairment of MIT assets $62
 $
 $
 (5) 62
 
Loss on impairment of LED assets 33
 
 
Gain on termination of lease to Transform 
 (25) 
Loss on restructure of ST consortium agreement 26
 
 
 
 26
 
Gain on termination of lease to Transform (25) 
 
Gain from disposition of Japan Fabrication Facility 
 
 (54)
Other 30
 10
 (21) 51
 30
 10
 $126
 $10
 $(75) $40
 $126
 $10


36



We have taken actionsIn order to dispose of 200mm wafer manufacturing facilities and optimize operations, includingimprove efficiency and increase our workforce.focus on our core memory operations, we have entered into various restructure activities. For 2014 and 2013, ESG, WSG, NSGother restructure included charges associated with our efforts to wind down our 200mm operations primarily in Agrate, Italy and DSG recognized restructureKiryat Gat, Israel and impairment costs of $12 million, $11 million, $11 millioncharges associated with workforce optimization activities, primarily related to our MBU and $6 million, respectively. The remaining restructure and impairment costs for 2013 were allocated to segments that do not meet the quantitative thresholds of a reportable segment and are reported under All Other.EBU operating segments. As of August 29, 2013, the only significant remaining amount28, 2014, we had accrued but$14 million for unpaid for theseother restructure activities was $12 million related to our workforce optimization.optimization activity. As of August 29, 2013,28, 2014, we do not anticipate incurring any significant additional costs for these restructure activities. (See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Restructure and Asset Impairments.")

Interest Income (Expense)

InterestNet interest expense for 20132014, 20122013 and 2011,2012, included aggregate amounts of amortization of debt discount and other interest amortization expensecosts of $120$167 million, $95$122 million and $60$81 million, respectively.

Income Taxes

Income tax provision (benefit) for 2014 included $249 million of expenses related to the utilization of deferred tax assets by the MMJ Group partially offset by a $190 million benefit from increases in amount of MMJ Group's deferred tax assets expected to be realized based on our forecasted utilization of net operating losses. The remaining tax provision for 2014 primarily reflects taxes on our other non-U.S. operations. The provision (benefit) for taxes on U.S. operations for 2014 was substantially offset by changes in the valuation allowance. As of August 28, 2014, we had valuation allowances of $1.29 billion against substantially all U.S. net deferred tax assets and $1.15 billion related to our foreign subsidiaries, primarily related to net operating loss carryforwards. Our valuation allowance decreased $712 million for 2014 primarily due to the utilization of U.S. and foreign net operating losses and due to the $190 million benefit to deferred tax assets of the MMJ Group. The amount of the deferred tax asset considered realizable could be adjusted if significant positive evidence increases. Management continues to evaluate future financial performance to determine whether such performance is sufficient evidence to support reversal of the valuation allowances. Our unrecognized tax benefits increased $150 million in 2014, primarily due to transfer pricing and other matters, which was substantially offset by changes in our deferred tax asset valuation allowance.

We currently operate in several tax jurisdictions where we have arrangements that allow us to compute our tax provision at rates below the local statutory rates that expire in whole or in part at various dates through 2026.  These arrangements benefitted our tax provision in 2014, 2013 and 2012 by $286 million, $141 million and $52 million, respectively.

Income taxes for 2013 and 2012 primarily reflect taxes on our non-U.S. operations offset by benefits of $19 million and $56 million, respectively, from the favorable resolution of prior year tax matters and a change in tax laws applicable to prior years.

(See "Item 8. Financial Statements and Supplementary Data - Notes to Consolidated Financial Statements - Income Taxes.")

Equity in Net Income (Loss) of Equity Method Investees

We recognize our share of earnings or losses from the entities listed below under the equity method, generally on a two-month lag.  Equity in net income (loss) of equity method investees, net of tax, included the following:

For the year ended 2014 2013 2012
Inotera $465
 $(79) $(189)
Tera Probe 11
 
 
Other (2) (4) (105)
  $474
 $(83) $(294)

Our equity in net income (loss) of Inotera improved for 2014 as compared to 2013 primarily due to Inotera's improved operating results as a result of higher selling prices and lower manufacturing costs. Higher selling prices resulted from the new Inotera Supply Agreement coupled with an improved market.

Losses in 2012 for our other equity method investments were primarily attributable to Transform Solar Pty Ltd. As of August 30, 2012, Transform's operations were substantially discontinued. (See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Equity Method Investments.")

37



Other Operating and Non-Operating

In 2014, we settled all pending litigation between us and Rambus, including all antitrust and patent matters, and entered into a patent cross-license agreement.  As a result, other operating expense for 2014 included a $233 million charge to accrue a liability, which reflects the discounted value of amounts due under this arrangement. (See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Contingencies" note.)

Other non-operating expense for 2014 included losses from the restructure of our debt of $184 million. Other non-operating expense for 2013 included losses of $31 million from the restructure of our debt. (See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Debt" note.)

42




Equity in Net Loss of Equity Method Investees

We recognize our share of earnings orOther non-operating expense included losses from these entities underchanges in currency exchange rates of $28 million, $229 million and $6 million for 2014, 2013 and 2012, respectively. The loss for 2013 includes a $228 million loss for currency contracts to hedge our yen-denominated obligations in connection with the equity method, generally on a two-month lag.  Equity in net loss of equity method investees, net of tax, included the following:MMJ Acquisition. (See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Derivative Instruments" note.)

For the year ended 2013 2012 2011
Inotera $(79) $(189) $(112)
Other (4) (105) (46)
  $(83) $(294) $(158)
On August 15, 2014, ON Semiconductor Corporation acquired Aptina for approximately $433 million and we recognized a non-operating gain of $119 million on the sale of our shares based on our diluted ownership interest of approximately 27%.

Our equity in net income (loss) of Inotera improved for 2013 as compared to 2012 primarily due to Inotera's improved operating results as a result of higher average selling prices and lower manufacturing costs. On May 28, 2013,15, 2014, Inotera issued 634400 million common shares to Nanya and certain of its affiliates in a private placementpublic offering at a price equal to 9.4731.50 New Taiwan dollars per common share, (approximately $0.32 U.S. dollars as of May 28, 2013), which was in excess of our carrying value per share. As a result of the issuance, our ownership interest decreased from 40%35% to 35%33% and we recognized a non-operating gain of approximately $48$93 million in 2013. The change in ownership interest does not change our obligation to purchase substantially all of Inotera's output. Losses in 2012 for our other equity method investments were primarily attributable to Transform Solar Pty Ltd. which ceased operations in 2012 and has essentially been liquidated. (See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Equity Method Investments.")

Other2014.

Further discussion of other operating and non-operating income and expenses can be found in the following notes contained in "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements":

Equity Plans
Other Operating (Income) Expense, Net
Other Non-Operating Income (Expense), Net
Income Taxes

Fair Values Elpida Acquisition

The provisional fair values of assets and liabilities acquired in the acquisition of Elpida is based on estimates using information available at the closing of the acquisition. We estimated the provisional fair value of the assets and liabilities of Elpida as of July 31, 2013 using an in-use model, which reflects its value through its use in combination with other assets as a group. These provisional amounts could change as additional information become available. These changes could result in material variances between the combined entity's future financial results including variances in fair values recorded, as well as expenses associated with these items.

Determination of provisional fair values for the assets and liabilities acquired in the Elpida acquisition required significant assumptions, estimates and judgments. Many of the measurements involved significant inputs that are not observable in the market and thus represent a Level 3 measurement as defined in ASC 820. Changes in assumptions, estimates and judgments could significantly impact the asset and liabilities recorded as well as the gain recognized in the acquisition. The items involving the most significant assumptions, estimates and judgments included determining the fair value of the following:

Property, plant and equipment, including determination of values in a continued-use model;
Deferred tax assets, including projections of future taxable income and tax rates;
Inventory, including estimated future selling prices, timing of product sales and completion costs for work in process; and
Debt, including discount rate and timing of payments.




43



Liquidity and Capital Resources

Our primary sources of liquidity are cash generated from operations and financing obtained from capital markets. Specifically, in 2014, we generated cash from operations of $5.70 billion and obtained $2.21 billion of proceeds from issuance of debt. Cash generated from operations is highly dependent on selling prices for our products, which can vary significantly from period to period. We are continuously evaluating alternatives for efficiently financing our capital expenditures, dilution-management activities (including repurchases of convertible notes or equity) and ongoing operations. We expect, from time to time in the future, to engage in a variety of transactions for such purposes, including the issuance or incurrence of secured and unsecured debt and the refinancing and restructuring of existing debt.

On October 27, 2014, we announced that our Board of Directors authorized the discretionary repurchase of up to
$1.00 billion of our outstanding common stock. Any repurchases under the new authorization may be made in open market purchases, block trades, privately negotiated transactions and/or derivative transactions, subject to market conditions and our ongoing determination that it is the best use of available cash. We expect to use cash on hand to fund any repurchases. The repurchase authorization does not obligate us to acquire any common stock.

We expect that our cash and investments, cash flows from operations and available financing will be sufficient to meet our requirements at least through 2015.


38



As of 2013 2012 2014 2013
Cash and equivalents and short-term investments:        
Bank deposits $1,619
 $239
 $2,445
 $1,619
Money market funds 1,188
 2,159
 1,281
 1,188
Certificates of deposit 410
 47
Corporate bonds 112
 31
 154
 112
Government securities 72
 56
 136
 72
Commercial paper 61
 39
 107
 61
Certificates of deposit 47
 31
Asset-backed securities 2
 4
 1
 2
 $3,101
 $2,559
 $4,534
 $3,101
        
Long-term marketable investments $499
 $374
 $819
 $499
    
Restricted cash:    
Current $556
 $
Noncurrent (included in "Other noncurrent assets") 63
 3
 $619
 $3

As of August 28, 2014, $2.80 billion of our cash and equivalents and short-term investments was held by foreign subsidiaries, of which $758 million was denominated in currencies other than the U.S. dollar. To mitigate credit risk, we invest through high-credit-quality financial institutions and, by policy, generally limit the concentration of credit exposure by restricting the amount of investments with any single obligor.

Limitations on the Use of Cash and Investments

MMJ Group: Cash and equivalents and short-term investments in the table above included $1,094 millionan aggregate of $1.60 billion held by Elpida and its subsidiariesthe MMJ Group as of August 29, 201328, 2014. Substantially all of the restricted cash in the table above is held by Elpida for its installment payments to its secured and unsecured creditors. Use of cash and equivalents and restricted cash held by Elpida is subject to limitations described below.

As a result of the Japan Proceedings,corporate reorganization proceedings of the MMJ Companies entered into in March 2012 and for so long as such proceedings are continuing, the ElpidaMMJ Companies and their subsidiaries are subject to certain restrictions on dividends, loans and advances. The plans of reorganization of the ElpidaMMJ Companies prohibit the ElpidaMMJ Companies from paying dividends, including any cash dividends, to us and require that excess earnings be used in their businesses or to fund the ElpidaMMJ Companies' installment payments. These prohibitions would also effectively prevent the subsidiaries of the ElpidaMMJ Companies from paying cash dividends to us as any such dividends would have to be first paid to the ElpidaMMJ Companies which are prohibited from repaying those amounts to us as dividends under the plans of reorganization. In addition, pursuant to an order of the Japan Court, the ElpidaMMJ Companies cannot make loans or advances, other than certain ordinary course advances, to us without the consent of the Japan Court. Moreover, loans or advances by subsidiaries of the ElpidaMMJ Companies may be considered outside of the ordinary course of business and subject to approval of the legal trusteestrustee and Japan Court. As a result, the assets of the Elpida Companies and their subsidiaries,MMJ Group, while available to satisfy the ElpidaMMJ Companies' installment payments and the other obligations, capital expenditures and other operating needs of the Elpida Companies and their subsidiaries,MMJ Group, are not available for use by us in our other operations. Moreover, certain uses of the assets of the Elpida Companies,MMJ Group, including investments in certain capital expenditures and in Rexchip,MMT, may require consent of Elpida'sMMJ's trustees and/or the Japan Court. (See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Acquisition of Elpida Memory, Inc.")

IMFT:Cash and equivalents and short-term investments in the table above included $6284 million held by IMFT as of August 29, 2013 and $157 million as of August 30, 201228, 2014. Our ability to access funds held by IMFT to finance our other operations is subject to agreement by the other memberIntel and contractual limitations. Amounts held by IMFT are not anticipated to be available to finance our other operations.

Indefinitely Reinvested:As of August 29, 2013, $1,598 million of our cash and equivalents was held by foreign subsidiaries, of which $743 million was denominated in currencies other than the U.S. dollar. As of August 29, 201328, 2014, we had $1,362 million$2.70 billion of cash and equivalents including the $1,094 million at Elpida,and short-term investments that waswere held by foreign subsidiaries whose earnings were considered to be indefinitely reinvested and repatriation of these funds to the U.S. would subject these funds to U.S. federal income taxes.

To mitigate credit risk, we invest through high-credit-quality financial institutions and, by policy, generally limit the concentration of credit exposure by restricting investments with any single obligor.


44



Cash generated by operations is our primary source of liquidity. Our liquidity is highly dependent on selling prices for our products and the timing and level of our capital expenditures, both of which can vary significantly from period to period. Depending on conditions in the semiconductor memory market, our cash flows from operations and current holdings of cash and investments may not be adequate to meet our needs for capital expenditures and operations. In 2013 we obtained $1,121 million of proceeds from issuance of debt and $126 million of proceeds from equipment sale-leaseback financing. As of August 29, 2013, we had credit facilities available that provides for up to $408 million of additional financing, subject to outstanding balances of trade receivables and other conditions (See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Debt – Revolving Credit Facilities"). We have in the past and expect in the future to continue to incur additional debt to finance our capital investments, including debt incurred in connection with asset-backed financing. We expect our cash and investments, cash flows from operations and available financing will be sufficient to meet our requirements at least through 2014.

Holders of our outstanding convertible notes can convert the notes during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day Determination of the preceding calendar quarter is more than 130% of the conversion price. As of August 29, 2013, convertible notes with an aggregate principal amount of $1,465 million, contained contractual terms that require usunrecognized deferred tax liabilities related to pay cash up to the principal amount of the notes upon conversion. These notes become convertible at the option of the holders if the closing price of our common stock for the required periodsinvestments in these foreign subsidiaries is above prices ranging from $12.35 to $14.21. None of these convertible notes met the conversion criteria through the calendar quarter ended June 30, 2013. Of the notes that require us to pay cash up to the principal amount upon conversion, only the 2031A and 2031B Notes, with an aggregate principle amount of $690 million and carrying value of $530 million as of August 29, 2013, met the conversion criteria during September 2013. Through October 28, 2013, none of the 2031A or 2031B Notes had been converted by holders. We do not believe the amounts converted, if any, would be significant since the note holders would forgo the time value of the embedded conversion option. We may elect in future periods to redeem convertible notes eligible for redemption.practicable.

Operating Activities

Net cash provided by operating activities was $1,811 million5.70 billion for 2013, which reflected approximately $2,177 million generated from the production and sales of2014, due primarily to a strong market for our products net ofand our continued focus on cost-efficient operations.  Operating cash flows in 2014 also benefitted by a $366$671 million effect from increases in the amount invested in net working capital. The increase in net working capital was primarily due to an increase in accounts receivable of $409payable and accrued expenses offset by a $518 million as a result of increasesincrease in sales activities.receivables.


39



Investing Activities

Net cash used for investing activities was $1,712 million2.45 billion for 2013,2014, which consisted primarily of cash expenditures of $1,244 million2.66 billion for property plant and equipment $246and $506 million for the acquisition of available-for-sale securities (net of proceeds from sales and maturities of $678$557 million), and $226 offset by the use of $534 million forof restricted cash in connection with the settlement of hedging activities (net of proceeds from the settlement of hedging activities of $27 million). first MMJ creditor installment payment.

We believe that to develop new product and process technologies, support future growth, achieve operating efficiencies and maintain product quality, we must continue to invest in manufacturing technologies, facilities and capital equipment, and R&D. We estimate that capital spending for 20142015 will be approximately $2.6$3.6 billion to $3.2$4.0 billion. The actual amounts for 20142015 will vary depending on market conditions. As of August 29, 2013,28, 2014, we had commitments of approximately $775 million1.18 billion for the acquisition of property, plant and equipment, substantially all of which is expected to be paid within one year.

In connection with the sale of our 200mm Avezzano facility to LFoundry, on May 22, 2013, we entered into a short-term, interest-free, unsecured loan agreement with Aptina that allowed Aptina to borrow up to $45 million, drawn at their option, in three equal tranches through July 2013. Principal amounts drawn are due in three equal payments from September 2013 to January 2014. As of August 29, 2013, other current assets included $45 million for amounts due under the short-term loan agreement.

Financing Activities

Net cash providedused by financing activities was $322 million1.95 billion for 2013,2014, which included $1,121 million of proceeds from issuance of debt, $126 million of proceeds from equipment sale-leaseback financing transactions partially offset by $743 million3.84 billion for repayments of debt (including $1.20 billion for the amount in excess of principal of our convertible notes), $214479 million of payments on equipment purchase contracts and $2692 million of net distributions tocash received from noncontrolling interests.interests offset by $2.21 billion of proceeds from issuance of debt and by $265 million of proceeds from issuance of common stock under our equity plans.

2014 Debt Restructure

Throughout 2014, we reduced the dilutive effects of our convertible notes by exchanging, converting or repurchasing a portion of these notes using cash generated from operations and proceeds from issuing non-convertible debt with near investment-grade covenants. Approximately 90% of our Free Cash Flow (cash flows from operating activities less expenditures for property, plant and equipment less payments on equipment purchase contracts) generated during 2014 was used for these dilution-management activities. As a result, we eliminated convertible notes that would have been converted into 118 million shares of our common stock.

In 2014, we initiated a series of actions to restructure our debt, including exchanges, conversions and settlements, repurchases, issuances and early repayments. The following table presents the net effect of each of the actions:

  Increase (Decrease) in Principal Increase (Decrease) in Carrying Value Increase (Decrease) in Cash (Decrease) in Equity 
Loss(1)
Exchanges $585
 $282
 $
 $(238) $49
Conversions and settlements(2)
 (770) (437) (1,446) (886) 130
Repurchases (320) (269) (857) (567) 23
Issuances 2,212
 2,212
 2,157
 
 
Early repayments (336) (334) (339) 
 3
  $1,371
 $1,454
 $(485) $(1,691) $205
(1)
The loss on 2014 debt restructure activities was recorded as $184 million in other non-operating expense and $21 million in interest expense in 2014.
(2) The change in carrying value includes an increase of $275 million for the reclassification of the fair value of the equity component to debt in connection with our election to settle the conversions of the 2031B Notes in cash.

Exchanges: Exchanged $440 million in aggregate principal amount of our 2027 Notes, 2031A Notes and 2031B Notes into $1.03 billion principal amount at maturity of 2043G Notes.
Conversions and Settlement: Holders of substantially all of our remaining 2014 Notes, 2027 Notes and 2031A Notes (with an aggregate principal amount of $770 million) converted their notes and we settled the conversions in cash for $1.45 billion.

4540



On February 12, 2013, we issued $300
Repurchases: Repurchased $320 million of 1.625% Convertible Senior Notes due 2033 (the "2033E Notes") and $300 million of 2.125% Convertible Senior Notes due 2033 (the "2033F Notes" and together with the 2033E Notes, the "2033 Notes") at face value. Issuance costs for the 2033 Notes totaled $16 million. Concurrently with the issuance of the 2033 Notes, we paid $48 million to purchase capped calls to partially offset the potentially dilutive effect if the 2033 Notes were converted into shares of our common stock. Additionally, on February 12, 2013, we repurchased $464 million ofin aggregate principal amount of our 1.875% Convertible Senior2031B Notes, due June 20142032C Notes and 2032D Notes in privately-negotiated transactions for $477 million.

On August 27, 2013, we borrowed $312 million under a four-year term loan, collateralized by a security interest in certain production equipment. Principal is payable in equal quarterly installments, commencing on November 27, 2013. Interest accrues at a variable rate equal to the three-month LIBOR rate plus a margin of 3.25% per annum, payable quarterly in arrears. Also on August 27, 2013, we entered into a variable-for-fixed interest rate swap calculated on an aggregate notionalof $857 million in cash.
Issuances: Issued $600 million in principal amount equal to the scheduled outstanding balance of the loan. The interest rate swap effectively fixed the rate at 4.2% per annum. The facility agreement contains customary covenants, limitations or restrictions our ability to create liens or dispose5.875% senior notes due February 2022 and $1.15 billion in principal amount of the equipment securing the facility agreement. The facility also contains a covenant requiring us to ensure that the ratio5.500% senior notes due February 2025. Issued $462 million in principal amount of the outstanding loan to the fair market value of the equipment that secures the loan does not exceed 0.8 to 1.0. If such ratio is exceeded, we would be required to grant a security interest in additional equipment and/or prepay the loan in an amount sufficient to reduce such ratio to 0.8 to 1.0 or less. The facility agreement also contains customary events of default which could result in the acceleration of all amounts and cancellation of all commitments under the facility agreement.

On October 2, 2012, we entered into a facility agreement to obtain financing collateralized by semiconductor production equipment.  Subject to customary conditions, we could draw up to $214 million under the facility agreement.  Amounts drawn are1.258% senior notes due 2019 Notes, payable in 10 equal semi-annual installments beginning six months after the draw date.  On October 18, 2012, we drew $173commencing in July 2014.
Early Repayments: Repaid $334 million with interest at 2.4% per annum.  On January 31, 2013, we drew the remaining $41 million with interest at 2.4% per annum.  The facility agreement contains customary covenantsof notes and events of default.capital leases prior to their scheduled maturities.

On September 5, 2012,Subsequent to 2014, we entered intosettled an aggregate principal amount of $114 million of our remaining 2031B Notes for $389 million and repaid a three-year revolving credit facility. Under this credit facility, we can draw up$120 million note prior to the lesser of $255 million or 80% of the net outstanding balance of a pool of certain trade receivables. Amounts drawn would be collateralized by a security interest in such receivables. The availability of the facility is subject to certain customary conditions, including the absence of any event or circumstance that has a material adverse effect on our business or financial condition. The revolving credit facility contains customary covenants and a repayment provision in the event that the maximum aging of the receivables exceeds a specified threshold. Interest is payable monthly on any outstanding principal balance at a variable rate equal to the 30-day Singapore Interbank Offering Rate plus 2.8% per annum. its scheduled maturity.

Available Credit Facilities: As of August 29, 2013,28, 2014, we had not drawn any amounts under this facility.

On June 27, 2013, we entered into a senior secured three-year revolving credit facility, collateralized by a security interest in certain trade receivables. Under this facility, we can drawfacilities available that provide for up to 85%$408 million of the netadditional financing, subject to outstanding balancebalances of certain trade receivables subject to certain adjustments, including an availability block that has the effect of limiting the maximum committed draw amount to approximately $153 million. The revolving credit facility contains customary covenants and conditions, including as a funding condition the absence of any event or circumstance that has a material adverse effect on our business or financial condition.  Generally, interest is payable on any outstanding principal balance at a variable rate equal to the London Interbank Offered Rate (“LIBOR”) plus a spread from 1.5% to 2.0%, or at our option, at a rate equal to an alternate base rate (defined as the highest of (1) the prime rate, (2) one-month LIBOR plus 1.0% or (3) the Federal Funds Effective Rate) plus a spread from 0.5% to 1.0%.  In either case, the spread added to the applicable interest rate basis varies depending upon the amount of the monthly average undrawn availability under the facility. As of August 29, 2013, we had not drawn any amounts under this facility.

Elpida Memory, Inc.

On July 31, 2013, we completed the acquisition of Elpida and Rexchip and made payments at the closing date of approximately $615 million and $334 million, respectively. Substantially all of the $615 million we paid in connection with the acquisition of Elpida was deposited into accounts that are legally restricted for payment to the secured and unsecured creditors of Elpida in October 2013. Under their plans of reorganizations, the Elpida Companies are to make additional annual installment payments aggregating 140 billion yen (or the equivalent of approximately $1.43 billion), which are scheduled to occur from 2014 through 2019. In order to further the planned technology road maps for the Elpida and Rexchip operations, we will be required to make capital expenditures.


46



Pursuant to the Sponsor Agreement we agreed, subject to certain conditions, to provide certain support to Elpida with respect to obtaining financing for working capital purposes and capital expenditures. Under the Sponsor Agreement, we agreed, subject to certain conditions, to use reasonable best efforts to assist the Elpida Companies in financing up to 64 billion yen (or the equivalent of approximately $655 million) of eligible capital expenditures incurred through June 30, 2014, which may include us providing payment guarantees of third party financing under certain circumstances or direct financial support from Micron Technology, Inc. or one of its subsidiaries.

As of August 29, 2013, we have provided payment guarantees related to financing of capital expenditures with an outstanding borrowing of 4 billion yen (or the equivalent of approximately $41 million), through December, 2014. We have entered into an omnibus reimbursement agreement with Elpida in connection with our financial support obligations under the Sponsor Agreement, whereby Elpida and certain of its subsidiaries have agreed, among other things, to reimburse us for any amounts that we are required to pay under or in connection with the payment guarantees. These obligations under the omnibus reimbursement agreement are collateralized by approximately 93% of the Rexchip shares held by Elpida and one of its subsidiaries. In the event we are required to make any payments to Elpida's lenders under the guarantees, our rights will be subrogated to those of the lenders, including any rights to exercise remedies with respect to collateral securing the underlying loans.conditions.

(See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Acquisition of Elpida Memory, Inc."Debt" note.)

Potential Settlement Obligations of Convertible Notes

Since the closing price of our common stock for at least 20 trading days in the 30 trading day periods ended on June 30, 2014 and September 30, 2014 exceeded 130% of the initial conversion price per share of our 2032 Notes and 2033 Notes, holders of those notes have the right to convert their notes at any time through December 31, 2014. For our convertible notes, we have: (1) the requirement to pay cash for the principal amount and the option to pay either cash, shares of our common stock or any combination thereof for any remaining conversion obligation, or (2) the option to pay cash, issue shares of common stock or any combination thereof for the aggregate amount due upon conversion.

The following table summarizes the potential settlements, as of August 28, 2014, that we could be required to make if all holders converted their 2032 Notes and 2033 Notes:
  Initial Conversion Price Per Share Settlement Option for Principal Amount Outstanding Principal 
If Settled With Minimum Cash Required(1)
 
If Settled Entirely With Cash(2)
     Cash Remainder in Shares Cash
2032C Notes $9.63
 Cash and/or shares $362
 $
 38
 $1,235
2032D Notes 9.98
 Cash and/or shares 344
 
 34
 1,129
2033E Notes 10.93
 Cash 300
 300
 18
 900
2033F Notes 10.93
 Cash 300
 300
 18
 900
      $1,306
 $600
 108
 $4,164

(1)
We are required to settle the principal amount of the 2033 Notes in cash. The remaining conversion obligation paid in shares is based on our closing share price of $32.81 as of August 28, 2014.
(2)
Based on our closing share price of $32.81 as of August 28, 2014. Assumes we elect cash settlement for the entire obligation.


41



Contractual Obligations

 Payments Due by Period Payments Due by Period
As of August 29, 2013 Total Less than 1 year 1-3 years
 3-5 years
 More than 5 years
As of August 28, 2014 Total Less than 1 year 1-3 years
 3-5 years
 More than 5 years
Notes payable (1)(2)
 $5,951
 $1,285
 $852
 $1,473
 $2,341
 $7,959
 $976
 $1,001
 $1,601
 $4,381
Capital lease obligations (1)(2)
 1,366
 449
 656
 126
 135
 998
 356
 404
 115
 123
Operating leases(3) 106
 22
 26
 21
 37
 116
 22
 32
 25
 37
Purchase obligations 1,426
 1,273
 129
 13
 11
 1,869
 1,724
 117
 12
 16
Other long-term liabilities (2) (3)
 461
 155
 157
 79
 70
Other long-term liabilities(4)(5)
 1,060
 335
 411
 206
 108
Total $9,310
 $3,184
 $1,820
 $1,712
 $2,594
 $12,002
 $3,413
 $1,965
 $1,959
 $4,665
(1) Amounts includes Elpida Creditor Installment Payments, convertible notes and other notes and reflects principal and interest cash payments over the life of the obligations, including anticipated interest payments that are not recorded on our consolidated balance sheet. Any future redemption or conversion of convertible debt could impact our cash payments.
(2) Amounts represent future cash payments to satisfy other long-term liabilities recorded on our consolidated balance sheet, including $155 million for the short-term portion of these long-term liabilities.
(3) We are unable to reliably estimate the timing of future payments related to uncertain tax positions; therefore, $80 million of long-term income taxes payable has been excluded from the preceding table. However, long-term income taxes payable recorded on our consolidated balance sheet included these uncertain tax positions.
(1) Amounts include MMJ Creditor Installment Payments, convertible notes and other notes. Any future redemption or conversion of convertible debt could impact the amount and timing of our cash payments.
(2) Amounts reflect principal and interest.
(3) Amounts do not include contingent lease payments.
(4) Amounts represent future cash payments to satisfy other long-term liabilities recorded on our consolidated balance sheet, including $335 million for the current portion of these long-term liabilities.
(5) We are unable to reliably estimate the timing of future payments related to uncertain tax positions and noncurrent deferred tax liabilities; therefore, $255 million in aggregate of long-term income taxes payable and noncurrent deferred tax liabilities has been excluded from the preceding table. However, other noncurrent liabilities recorded on our consolidated balance sheet included these uncertain tax positions and noncurrent deferred tax liabilities.

The obligations disclosed above do not include contractual obligations recorded on our balance sheet as current liabilities, except for the current portion of long-term debt. The expected timing of payment amounts of the obligations discussed above is estimated based on current information. Timing and actual amounts paid may differ depending on the timing of receipt of goods or services, market prices, changes to agreed-upon amounts or timing of certain events for some obligations.

Purchase obligations include all commitments to purchase goods or services of either a fixed or minimum quantity that meet any of the following criteria: (1) they are noncancellable, (2) we would incur a penalty if the agreement was canceled, or (3) we must make specified minimum payments even if we do not take delivery of the contracted products or services ("take-or-pay"). If the obligation to purchase goods or services is noncancellable, the entire value of the contract was included in the above table. If the obligation is cancellable, but we would incur a penalty if canceled, the dollar amount of the penalty was included as a purchase obligation. Contracted minimum amounts specified in take-or-pay contracts are also included in the above table as they represent the portion of each contract that is a firm commitment.


47



On January 17, 2013, we entered into a new supply agreement with Nanya and Inotera (the "Inotera Supply Agreement"), retroactively effective beginning on January 1, 2013. Under the Inotera Supply Agreement, effective on January 1, 2013, we are obligated to purchase for an initiala three-year term (currently through December 2016) substantially all of Inotera's output at a purchase price based on a discount from market prices for our comparable components. The Inotera Supply Agreement contemplates annual negotiations with respect to potential successive one-year extensions, and if in any year the parties do not agree to an extension, the agreement will terminate following the end of the then-existing term plus a subsequent three-year wind-down period. OurIn the event of a wind-down, our share of Inotera's capacity would decline over the three year wind-down period. We purchased $1,260 million2.68 billion of DRAM products from Inotera in 20132014 under the Inotera Supply Agreement and a prior supply agreement with Inotera.Agreement. The Inotera Supply Agreement does not contain a fixed or minimum purchase quantity as quantities are based on qualified production output and pricing fluctuates as it is based on market prices. Therefore, we did not include our obligations under the Inotera Supply Agreement in the contractual obligations table above.




42



Off-Balance Sheet Arrangements

Issued and Outstanding Capped Calls: Concurrent with the offering of the 2031 Notes in July 2011, weWe have entered into capped call transactions (the "2031 Capped Calls") that have an initial strike price of approximately $9.50 per share, subject to certain adjustments,calls, which was set to the initial conversion price of the 2031 Notes.  The 2031 Capped Calls are in four equal tranches, have cap prices of $11.40, $12.16, $12.67 and $13.17 per share, and cover, subject to anti-dilution adjustments similar to those contained in the 2031 Notes, an approximate combined total of 72.6 million shares of common stock.  The 2031 Capped Calls expire on various dates between July 2014 and February 2016 and are intended to reduce the effect of potential dilution upon conversionfrom our convertible notes.  The capped calls provide for our receipt of cash or shares, at our election, from our counterparties if the 2031 Notes.

Concurrent with the offeringtrading price of the 2032C and 2032D Notes in April 2012, we entered into the 2032C and 2032D Capped Call Transactions (collectively, the "2032 Capped Calls"). The 2032C Capped Calls haveour stock is above a range of cap prices from $14.26 to $15.69 and anspecified initial strike price of, subject to certain adjustments, approximately $9.80, which is set slightly higher thanat the $9.63 conversionexpiration dates. The amounts receivable varies based on the trading price of our stock, up to specified cap prices. The dollar value of the 2032C Notes. The 2032D Capped Calls have a rangecash or shares that we would receive from the capped calls on their expiration dates ranges from $0 if the trading price of cap prices from $14.62 to $16.04 and anour stock is below the initial strike price for all of subjectthe capped calls to certain adjustments, approximately $10.16, which is set slightly higher than$864 million if the $9.98 conversiontrading price of our stock is at or above the 2032D Notes. The 2032 Capped Calls cover, subject to anti-dilution adjustments similar to those contained in the 2032 Notes, an approximate combined total of 100.6 million shares of common stock.  The 2032 Capped Calls expire on various dates between May 2016 and May 2018 and are intended to reduce the potential dilution upon conversioncap price for all of the 2032Ccapped calls. To purchase the capped calls, we paid $57 million in 2011, $103 million in 2012 and 2032D Notes.

Concurrent with the offering of the 2033 Notes$48 million in February 2013, we entered into the 2033 Capped Call Transactions.respectively. The 2033 Capped Calls have a cap price of $14.51 and an initial strike price of, subjectamounts paid were recorded as charges to certain adjustments, approximately $10.93, which is equal to the conversion price of the 2033 Notes. The 2033 Capped Calls cover, subject to anti-dilution adjustments similar to those contained in the 2033 Notes, an approximate combined total of 55.0 million shares of common stock.  The 2033 Capped Calls expire on various dates between January 2018 and February 2020 and are intended to reduce the potential dilution upon conversion of the 2033 Notes.

Settlement of Capped Calls: Concurrent with the issuance in April 2009additional capital. For further details of our 4.25% Convertible Senior Notes due 2013, we entered into capped call transactions (the "2013 Capped Calls") covering approximately 45.2 million shares of common stock with an initial strike price of approximately $5.08 per share and a cap price of $6.64 per share.  The 2013 Capped Calls expired in October, 2012 and November, 2012.  We elected cash settlement and received $24 million in 2013.

Concurrent with the offering of the 2014 Notes, we purchased capped calls with a strike price of approximately $14.23 per share and various expiration dates between November 2011 and December 2012 (the "2014 Capped Calls").  In the first six months of 2012, 2014 Capped Calls covering 30.4 million shares expired according to their terms.  In April 2012, we settled the remaining 2014 Capped Calls, covering 60.9 million shares, and received a de minimis payment.

(Seearrangements, see "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Equity – Micron Shareholders' Equity – Capped Calls" note.)




48



Critical Accounting Estimates

The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures.  Estimates and judgments are based on historical experience, forecasted events and various other assumptions that we believe to be reasonable under the circumstances.  Estimates and judgments may vary under different assumptions or conditions.  We evaluate our estimates and judgments on an ongoing basis.  Our management believes the accounting policies below are critical in the portrayal of our financial condition and results of operations and requires management's most difficult, subjective or complex judgments.

Business Acquisitions: Accounting for acquisitions requires us to estimate the fair value of consideration paid and the individual assets and liabilities acquired, which involves a number of judgments, assumptions and estimates that could materially affect the amount and timing of costs recognized.  Accounting for acquisitions can also involve significant judgment to determine when control of the acquired entity is transferred. We typically obtain independent third party valuation studies to assist in determining fair values, including assistance in determining future cash flows, appropriate discount rates and comparable market values. The items involving the most significant assumptions, estimates and judgments included determining the fair value of the following:

Property, plant and equipment, including determination of values in a continued-use model;
Deferred tax assets, including projections of future taxable income and tax rates;
Inventory, including estimated future selling prices, timing of product sales and completion costs for work in process; and
Debt, including discount rate and timing of payments.

Consolidations: We have interests in joint venture entities that are Variable Interest Entities ("VIEs").VIEs.  Determining whether to consolidate a VIE may requirerequires judgment in assessing (1) whether an entity is a VIE and (2) if we are the entity's primary beneficiary.  To determine if we are the primary beneficiary of a VIE, we evaluate whether we have (a) the power to direct the activities that most significantly impact the VIE's economic performance and (b) the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE.  Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding and financing and other applicable agreements and circumstances.  Our assessment of whether we are the primary beneficiary of our VIEs requires significant assumptions and judgment.

Contingencies: We are subject to the possibility of losses from various contingencies.  Considerable judgment is necessary to estimate the probability and amount of any loss from such contingencies.  An accrual is made when it is probable that a liability has been incurred or an asset has been impaired and the amount of loss can be reasonably estimated.  We accrue a liability and charge operations for the estimated costs of adjudication or settlement of asserted and unasserted claims existing as of the balance sheet date. In accounting for the resolution of contingencies, considerable judgment is necessary to estimate amounts pertaining to periods prior to the resolution, which are charged to operations in the period of resolution, and amounts related to future periods.


43



Income Taxes: We are required to estimate our provision for income taxes and amounts ultimately payable or recoverable in numerous tax jurisdictions around the world.  These estimates involve judgment and interpretations of regulations and are inherently complex.  Resolution of income tax treatments in individual jurisdictions may not be known for many years after completion of any fiscal year.  We are also required to evaluate the realizability of our deferred tax assets on an ongoing basis in accordance with U.S. GAAP, which requires the assessment of our performance and other relevant factors.  Realization of deferred tax assets is dependent on our ability to generate future taxable income. In recent periods, our results of operations have benefitted from increases in the amount of deferred taxes we expect to realize, primarily from the levels of capital spending and increases in the amount of taxable income we expect to realize in Japan and Taiwan.  Our income tax provision or benefit is dependent, in part, on our ability to forecast future taxable income in these and other jurisdictions.  Such forecasts are inherently difficult and involve numerous judgments including, among others, projecting future average selling prices and sales volumes, manufacturing and overhead costs, levels of capital spending and other factors that significantly impact our analyses of the amount of net deferred tax assets that are more likely than not to be realized.


49



Inventories: Inventories are stated at the lower of average cost or market value.  Cost includes labor, material and overhead costs, including product and process technology costs.  Determining market value of inventories involves numerous judgments, including projecting average selling prices and sales volumes for future periods and costs to complete products in work in process inventories.  To project average selling prices and sales volumes, we review recent sales volumes, existing customer orders, current contract prices, industry analyses of supply and demand, seasonal factors, general economic trends and other information.  When these analyses reflect estimated market values below our manufacturing costs, we record a charge to cost of goods sold in advance of when the inventory is actually sold.  Differences in forecasted average selling prices used in calculating lower of cost or market adjustments can result in significant changes in the estimated net realizable value of product inventories and accordingly the amount of write-down recorded.  For example, a 5% variance in the estimated selling prices would have changed the estimated market value of our memory inventory by approximately $154$254 million as of August 29, 2013.28, 2014.  Due to the volatile nature of the semiconductor memory industry, actual selling prices and volumes often vary significantly from projected prices and volumes and, as a result, the timing of when product costs are charged to operations can vary significantly.

U.S. GAAP provides for products to be grouped into categories in order to compare costs to market values.  The amount of any inventory write-down can vary significantly depending on the determination of inventory categories.   Our inventories have been generallyInventories are primarily categorized as memory (including DRAM, NAND Flash and NOR Flash memory.Flash) for purposes of determining lower of average cost or market. The major characteristics we consider in determining inventory categories are product type and markets.

Property, Plant and Equipment: We review the carrying value of property, plant and equipment for impairment when events and circumstances indicate that the carrying value of an asset or group of assets may not be recoverable from the estimated future cash flows expected to result from its use and/or disposition.  In cases where undiscounted expected future cash flows are less than the carrying value, an impairment loss is recognized equal to the amount by which the carrying value exceeds the estimated fair value of the assets.  The estimation of future cash flows involves numerous assumptions which require judgment by us, including, but not limited to, future use of the assets for our operations versus sale or disposal of the assets, future selling prices for our products and future production and sales volumes.  In addition, judgment is required in determining the groups of assets for which impairment tests are separately performed.

Research and Development: Costs related to the conceptual formulation and design of products and processes are expensed as R&D as incurred.  Determining when product development is complete requires judgment by us.  We deem development of a product complete once the product has been thoroughly reviewed and tested for performance and reliability.  Subsequent to product qualification, product costs are valued in inventory.

Stock-based Compensation: Stock-based compensation is estimated at the grant date based on the fair-valuefair value of the award and is recognized as expense using the straight-line amortization method over the requisite service period.  For performance-based stock awards, the expense recognized is dependent on the probability of the performance measure being achieved.  We utilize forecasts of future performance to assess these probabilities and this assessment requires considerable judgment.

Determining the appropriate fair-value model and calculating the fair value of stock-based awards at the grant date requires considerable judgment, including estimating stock price volatility, expected option life and forfeiture rates.  We develop these estimates based on historical data and market information which can change significantly over time.  A small change in the estimates used can result in a relatively large change in the estimated valuation.  We use the Black-Scholes option valuation model to value employee stock awards.  We estimate stock price volatility based on an average of its historical volatility and the implied volatility derived from traded options on our stock.


44



Recently Issued Accounting Standards

There have been no recently issued accounting pronouncements that have had or are expectedSee "Item 8. Financial Statements and Supplementary Data – Notes to have a material impact on our financial statements.Consolidated Financial Statements – Recently Issued Accounting Standards" note.





50



ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK


Interest Rate Risk

We are exposed to interest rate risk related to our indebtedness and our investment portfolio. Substantially all of our indebtedness wasis at fixed interest rates. As a result, the fair value of our debt fluctuates based on changes in market interest rates. We estimate that, as of August 29, 201328, 2014 and August 30, 2012,29, 2013, a hypothetical decrease in market interest rates of 1% would increase the fair value of our convertible notes and other notes by approximately $147$250 million and $88$147 million, respectively. The increase in interest expense caused by a 1% increase in the interest rates of our variable-rate notedebt would not be significant.

As of August 29, 201328, 2014 and August 30, 2012,29, 2013, we held debt securities of $787$1,653 million and $464$787 million, respectively, that were subject to interest rate risk. We estimate that a 0.5% increase in market interest rates would decrease the fair value of these instruments by approximately $4$6 million as of August 29, 201328, 2014 and $3$4 million as of August 30, 2012.29, 2013.


Foreign Currency Exchange Rate Risk

The information in this section should be read in conjunction with the information related to changes in the exchange rates of foreign currency in "Item 1A. Risk Factors."  Changes in foreign currency exchange rates could materially adversely affect our results of operations or financial condition.

The functional currency for all of our operations is the U.S. dollar. As a result of our foreign operations, we incur costs and carry certain assets and liabilities that are denominated in foreign currencies. The substantial majority of our revenues are transacted in the U.S. dollar; however, significant amounts of our operating expenditures and capital purchases are incurred in or exposed to other currencies, primarily the euro, the shekel, the Singapore dollar, the New Taiwan dollar, the yen and the yuan. We have established currency risk management programs for our operating expenditures and capital purchases to hedge against fluctuations in fair value and the volatility of future cash flows caused by changes in exchange rates. We utilize currency forward and option contracts in these hedging programs. Our hedging programs reduce, but do not always entirely eliminate, the impact of currency exchange rate movements. We do not use derivative financial instruments for trading or speculative purposes.

To hedge our exposure to changes in currency exchange rates from our monetary assets and liabilities, we utilize a rolling hedge strategy with currency forward contracts that generally mature within 35 days.  Based on our foreign currency exposures from monetary assets and liabilities, offset by balance sheet hedges, we estimate that a 10% adverse change in exchange rates versus the U.S. dollar would result in losses of approximately U.S.$7 million as of $19August 28, 2014 and $19 million as of August 29, 2013 and U.S. $8 million as of August 30, 2012. To hedge the exposure of changes in cash flows from changes in currency exchange rates for certain capital expenditures and forecasted operating cash flows, we utilize currency forward contracts that generally mature within 12 months and currency options that generally mature fromwithin 12 to 18 months.

UnderAs of August 28, 2018, under the terms and conditions of the ElpidaMMJ Companies' respective plans of reorganization, the Elpida Companieswe are obligated to pay 200142 billion yen (or the equivalent of $2.05$1.37 billion based on exchange rates as of August 29, 2013), less certain expenses of their reorganization proceedings and certain other items,28, 2014) to the secured and unsecuredexternal creditors (the "Elpida Creditor Installment Payments") in respect of the Elpida Companies' pre-petition creditors and their related claims. Substantially all of the $615 million we paid in connection with the acquisition of Elpida was deposited into accounts thatMMJ Companies. The installment payments are legally restricted for payment to the secured and unsecured creditors of Elpida in October 2013. The remaining 140 billion yen is due in six annual installments payable at the end of each calendar year beginning in 2014 with payments of 20 billion yen in each of 2014 through 2017, and payments of 30 billion yen in each of 2018 and 2019. To mitigate the risk that increases in exchange rates have on the payments due in 2014 and 2015, we entered into forward contracts to purchase 20 billion yen on November 28, 2014 and 10 billion yen on November 27, 2015. In addition, the ElpidaMMJ Companies' cash and equivalent balances in yen mitigate the foreign currency exchange risk associated with the yen remaining installment payments due in 2015 and after. (See "Item 8 – Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Debt.Debt – MMJ Creditor Installment Payments.") Changes in the exchange rate between the U.S. dollar and the yen could have a significant impact on our financial statements.

5145



ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA


Index to Consolidated Financial Statements


 Page
  
Consolidated Financial Statements as of August 29, 201328, 2014 and August 30, 201229, 2013 and for the fiscal years ended
August 28, 2014, August 29, 2013 and August 30, 2012 and September 1, 2011:2012:
 
  
Consolidated Statements of Operations
  
Consolidated Statements of Comprehensive Income
  
Consolidated Balance Sheets
  
Consolidated Statements of Changes in Equity
  
Consolidated Statements of Cash Flows
  
Notes to Consolidated Financial Statements
  
Report of Independent Registered Public Accounting Firm
  
Financial Statement Schedules: 
  
Schedule I – Condensed Financial Information of the Registrant
  
Schedule II – Valuation and Qualifying Accounts


5246



MICRON TECHNOLOGY, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions except per share amounts)

For the year ended August 29,
2013
 August 30,
2012
 September 1, 2011 August 28,
2014
 August 29,
2013
 August 30,
2012
Net sales $9,073
 $8,234
 $8,788
 $16,358
 $9,073
 $8,234
Cost of goods sold 7,226
 7,266
 7,030
 10,921
 7,226
 7,266
Gross margin 1,847
 968
 1,758
 5,437
 1,847
 968
            
Selling, general and administrative 562
 620
 592
 707
 562
 620
Research and development 931
 918
 791
 1,371
 931
 918
Restructure and asset impairments 126
 10
 (75) 40
 126
 10
Other operating (income) expense, net (8) 32
 (311) 232
 (8) 32
Operating income (loss) 236
 (612) 761
 3,087
 236
 (612)
            
Gain on acquisition of Elpida 1,484
 
 
Gain on MMJ Acquisition (33) 1,484
 
Interest income 14
 8
 23
 23
 14
 8
Interest expense (231) (179) (124) (352) (231) (179)
Other non-operating income (expense), net (218) 29
 (109) 8
 (218) 29
 1,285
 (754) 551
 2,733
 1,285
 (754)
            
Income tax (provision) benefit (8) 17
 (203) (128) (8) 17
Equity in net income (loss) of equity method investees (83) (294) (158) 474
 (83) (294)
Net income (loss) 1,194
 (1,031) 190
 3,079
 1,194
 (1,031)
            
Net income attributable to noncontrolling interests (4) (1) (23) (34) (4) (1)
Net income (loss) attributable to Micron $1,190
 $(1,032) $167
 $3,045
 $1,190
 $(1,032)
            
Earnings (loss) per share:            
Basic $1.16
 $(1.04) $0.17
 $2.87
 $1.16
 $(1.04)
Diluted 1.13
 (1.04) 0.17
 2.54
 1.13
 (1.04)
            
Number of shares used in per share calculations:            
Basic 1,021.7
 991.2
 988.0
 1,060
 1,022
 991
Diluted 1,056.3
 991.2
 1,007.5
 1,198
 1,057
 991















See accompanying notes to consolidated financial statements.

5347



MICRON TECHNOLOGY, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in millions)

For the year ended August 29, 2013 August 30, 2012 September 1, 2011 August 28,
2014
 August 29,
2013
 August 30,
2012
Net income (loss) $1,194
 $(1,031) $190
 $3,079
 $1,194
 $(1,031)
            
Other comprehensive income (loss), net of tax:            
Gain (loss) on derivatives, net (9) (18) 48
 (9) (9) (18)
Foreign currency translation adjustments (5) (16) 63
 (2) (5) (16)
Pension liability adjustments 3
 (1) 
Gain (loss) on investments, net (1) (24) 11
 1
 (1) (24)
Pension liability adjustments (1) 
 5
Other comprehensive income (loss) (16) (58) 127
 (7) (16) (58)
Total comprehensive income (loss) 1,178
 (1,089) 317
 3,072
 1,178
 (1,089)
Comprehensive (income) loss attributable to noncontrolling interests (5) 5
 (29) (34) (5) 5
Comprehensive income (loss) attributable to Micron $1,173
 $(1,084) $288
 $3,038
 $1,173
 $(1,084)





































See accompanying notes to consolidated financial statements.

5448



MICRON TECHNOLOGY, INC.

CONSOLIDATED BALANCE SHEETS
(in millions except par value amounts)

As of August 29,
2013
 August 30,
2012
Assets    
Cash and equivalents $2,880
 $2,459
Short-term investments 221
 100
Receivables 2,329
 1,289
Inventories 2,649
 1,812
Restricted cash 556
 
Other current assets 276
 98
Total current assets 8,911
 5,758
Long-term marketable investments 499
 374
Property, plant and equipment, net 7,626
 7,103
Equity method investments 396
 389
Intangible assets, net 386
 371
Deferred tax assets 861
 47
Other noncurrent assets 439
 286
Total assets $19,118
 $14,328
     
Liabilities and equity    
Accounts payable and accrued expenses $2,115
 $1,641
Deferred income 243
 248
Equipment purchase contracts 182
 130
Current portion of long-term debt 1,585
 224
Total current liabilities 4,125
 2,243
Long-term debt 4,452
 3,038
Other noncurrent liabilities 535
 630
Total liabilities 9,112
 5,911
     
Commitments and contingencies 

 

     
Micron shareholders' equity:    
Common stock, $0.10 par value, 3,000 shares authorized, 1,044.4 shares issued and outstanding (1,017.7 as of August 30, 2012) 104
 102
Additional capital 9,187
 8,920
Accumulated deficit (212) (1,402)
Accumulated other comprehensive income 63
 80
Total Micron shareholders' equity 9,142
 7,700
Noncontrolling interests in subsidiaries 864
 717
Total equity 10,006
 8,417
Total liabilities and equity $19,118
 $14,328



As of August 28,
2014
 August 29,
2013
Assets    
Cash and equivalents $4,150
 $2,880
Short-term investments 384
 221
Receivables 2,906
 2,329
Inventories 2,455
 2,649
Restricted cash 
 556
Other current assets 350
 276
Total current assets 10,245
 8,911
Long-term marketable investments 819
 499
Property, plant and equipment, net 8,682
 7,626
Equity method investments 971
 396
Intangible assets, net 468
 386
Deferred tax assets 816
 861
Other noncurrent assets 497
 439
Total assets $22,498
 $19,118
     
Liabilities and equity    
Accounts payable and accrued expenses $2,698
 $2,115
Deferred income 309
 243
Equipment purchase contracts 166
 182
Current debt 1,638
 1,585
Total current liabilities 4,811
 4,125
Long-term debt 4,955
 4,452
Other noncurrent liabilities 1,102
 535
Total liabilities 10,868
 9,112
     
Commitments and contingencies 

 

     
Redeemable convertible notes 57
 
     
Micron shareholders' equity:    
Common stock, $0.10 par value, 3,000 shares authorized, 1,073 shares issued and outstanding (1,044 as of August 29, 2013) 107
 104
Additional capital 7,879
 9,187
Retained earnings (accumulated deficit) 2,729
 (212)
Accumulated other comprehensive income 56
 63
Total Micron shareholders' equity 10,771
 9,142
Noncontrolling interests in subsidiaries 802
 864
Total equity 11,573
 10,006
Total liabilities and equity $22,498
 $19,118



See accompanying notes to consolidated financial statements.

5549



MICRON TECHNOLOGY, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(in millions)
 Micron Shareholders     Micron Shareholders    
 Common Stock Additional Capital
Accumulated
Deficit
Accumulated Other Comprehensive
Income (Loss)
Total Micron Shareholders' EquityNoncontrolling Interests in SubsidiariesTotal Equity Common Stock Additional Capital 
Retained Earnings (Accumulated
Deficit)
 
Accumulated Other Comprehensive
Income (Loss)
 Total Micron Shareholders' Equity Noncontrolling Interests in Subsidiaries Total Equity
 
Number
of Shares
Amount 
Number
of Shares
 Amount 
Balance at September 2, 2010 994.5
 $99
 $8,446
 $(536) $11
 $8,020
 $1,796
 $9,816
Net income       167
   167
 23
 190
Other comprehensive income (loss), net      
  
 121
 121
 6
 127
Issuance and repurchase of convertible notes     211
     211
   211
Stock-based compensation expense     76
     76
   76
Stock issued under stock plans 11.1
 1
 27
     28
   28
Contributions from noncontrolling interests           
 8
 8
Distributions to noncontrolling interests           
 (225) (225)
Repurchase and retirement of common stock (21.3) (2) (160) (1)   (163)   (163)
Acquisition of noncontrolling interests in TECH    67
     67
 (226) (159)
Purchase of capped calls     (57)     (57)   (57)
Balance at September 1, 2011 984.3
 $98
 $8,610
 $(370) $132
 $8,470
 $1,382
 $9,852
 984
 $98
 $8,610
 $(370) $132
 $8,470
 $1,382
 $9,852
Net loss  
  
  
 (1,032)   (1,032) 1
 (1,031)  
  
  
 (1,032)   (1,032) 1
 (1,031)
Other comprehensive income (loss), net         (52) (52) (6) (58)         (52) (52) (6) (58)
Contributions from noncontrolling interests           
 197
 197
           
 197
 197
Issuance of convertible notes     191
     191
   191
     191
     191
   191
Conversion of 2013 Notes 27.3
 3
 135
     138
   138
 27
 3
 135
     138
   138
Stock-based compensation expense     87
     87
   87
     87
     87
   87
Stock issued under stock plans 7.1
 1
 5
     6
   6
 8
 1
 5
     6
   6
Acquisition of noncontrolling interest in IMFS           
 (466) (466)           
 (466) (466)
Distributions to noncontrolling interests           
 (391) (391)           
 (391) (391)
Purchase and settlement of capped calls     (102)     (102)   (102)     (102)     (102)   (102)
Repurchase and retirement of common stock (1.0) 
 (6) 
   (6)   (6)
Repurchase and retirement of stock (1) 
 (6) 
   (6)   (6)
Balance at August 30, 2012 1,017.7
 $102
 $8,920
 $(1,402) $80
 $7,700
 $717
 $8,417
 1,018
 $102
 $8,920
 $(1,402) $80
 $7,700
 $717
 $8,417
Net income  
     1,190
   1,190
 4
 1,194
  
     1,190
   1,190
 4
 1,194
Other comprehensive income (loss), net         (17) (17) 1
 (16)         (17) (17) 1
 (16)
Acquisition of Elpida           
 168
 168
MMJ Acquisition           
 168
 168
Stock issued under stock plans 27.4
 2
 148
     150
   150
 27
 2
 148
     150
   150
Stock-based compensation expense     91
     91
   91
     91
     91
   91
Issuance and repurchase of convertible notes     57
     57
   57
     57
     57
   57
Contributions from noncontrolling interests           
 11
 11
           
 11
 11
Distributions to noncontrolling interests           
 (37) (37)           
 (37) (37)
Purchase and settlement of capped calls     (24)     (24)   (24)     (24)     (24)   (24)
Repurchase and retirement of common stock (0.7) 
 (5) 
   (5)   (5)
Repurchase and retirement of stock (1) 
 (5) 
   (5)   (5)
Balance at August 29, 2013 1,044.4
 $104
 $9,187
 $(212) $63
 $9,142
 $864
 $10,006
 1,044
 $104
 $9,187
 $(212) $63
 $9,142
 $864
 $10,006
Net income       3,045
   3,045
 34
 3,079
Other comprehensive income (loss), net         (7) (7)   (7)
Stock issued under stock plans 36
 4
 262
     266
   266
Stock-based compensation expense     115
     115
   115
Contributions from noncontrolling interests           
 102
 102
Settlement of capped calls     86
     86
   86
Exchange, conversion and repurchase of convertible notes     (1,691)     (1,691)   (1,691)
Acquisitions of noncontrolling interests     34
     34
 (180) (146)
Redeemable convertible notes     (57)     (57)   (57)
Distributions to noncontrolling interests           
 (18) (18)
Repurchase and retirement of stock (7) (1) (57) (104)   (162)   (162)
Balance at August 28, 2014 1,073
 $107
 $7,879
 $2,729
 $56
 $10,771
 $802
 $11,573



See accompanying notes to consolidated financial statements.

5650



MICRON TECHNOLOGY, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
For the year ended August 29,
2013
 August 30,
2012
 September 1,
2011
 August 28,
2014
 August 29,
2013
 August 30,
2012
Cash flows from operating activities            
Net income (loss) $1,194
 $(1,031) $190
 $3,079
 $1,194
 $(1,031)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:  
  
    
  
  
Depreciation expense and amortization of intangible assets 1,804
 2,141
 2,105
 2,103
 1,804
 2,141
Amortization of debt discount and other costs 122
 81
 57
 167
 122
 81
Loss on restructure of debt 195
 31
 
Stock-based compensation 115
 91
 87
(Gain) on MMJ Acquisition 33
 (1,484) 
(Gains) losses from currency hedges, net 222
 19
 (21) 27
 222
 19
Equity in net (income) loss of equity method investees (474) 83
 294
Gain from disposition of interest in Aptina (119) 
 
Gain from Inotera issuance of shares (97) (48) 
Noncash restructure and asset impairments 114
 4
 (86) (17) 112
 (6)
Stock-based compensation 91
 87
 76
Equity in net loss of equity method investees 83
 294
 158
Loss on extinguishment of debt 31
 
 113
Gain from acquisition of Elpida (1,484) 
 
Change in operating assets and liabilities, net of amounts from Elpida acquisition:  
  
  
Change in operating assets and liabilities:  
  
  
Receivables (409) 238
 54
 (518) (409) 238
Inventories 83
 258
 (357) 194
 83
 258
Accounts payable and accrued expenses 143
 (82) (88) 671
 22
 182
Customer prepayments (123) 254
 4
Deferred income (7) (56) 146
Deferred income taxes, net (7) 3
 103
 68
 (7) 3
Other noncurrent liabilities 243
 (15) (89)
Other (46) (96) 30
 29
 10
 (63)
Net cash provided by operating activities 1,811
 2,114
 2,484
 5,699
 1,811
 2,114
            
Cash flows from investing activities  
  
    
  
  
Expenditures for property, plant and equipment (1,244) (1,699) (2,550) (2,658) (1,244) (1,699)
Purchases of available-for-sale securities (924) (564) (9) (1,063) (924) (564)
Payments to settle hedging activities (253) (62) (31) (26) (253) (62)
Additions to equity method investments 
 
 (187)
Proceeds from sales and maturities of available-for-sale securities 678
 152
 1
 557
 678
 152
Cash acquired from acquisition of Elpida, net of cash paid 69
 
 
Proceeds from sales of property, plant and equipment 28
 67
 127
Proceeds from settlement of hedging activities 27
 38
 87
Additions to equity method investments 
 (187) (31)
Decrease in restricted cash 
 5
 330
 536
 
 5
Return of equity method investment 
 1
 48
Cash received from disposition of interest in Aptina 105
 
 
Other (93) (63) (14) 96
 31
 43
Net cash used for investing activities (1,712) (2,312) (2,042)
Net cash provided by (used for) investing activities (2,453) (1,712) (2,312)
            
Cash flows from financing activities  
  
    
  
  
Proceeds from issuance of debt 1,121
 1,065
 690
Proceeds from issuance of common stock under equity plans 150
 5
 28
Proceeds from equipment sale-leaseback transactions 126
 609
 268
Cash received from noncontrolling interests 11
 197
 8
Repayments of debt (743) (203) (1,215) (3,843) (743) (203)
Payments on equipment purchase contracts (214) (172) (322) (479) (214) (172)
Cash paid for capped call transactions (48) (103) (57)
Cash paid to purchase stock under equity plans (76) (5) (6)
Acquisitions of noncontrolling interests (18) 
 (466)
Distributions to noncontrolling interests (37) (391) (225) (10) (37) (391)
Cash paid to purchase common stock (5) (6) (163)
Acquisition of noncontrolling interests 
 (466) (159)
Proceeds from issuance of debt 2,212
 1,121
 1,065
Proceeds from issuance of stock under equity plans 265
 150
 5
Contributions from noncontrolling interests 102
 11
 197
Proceeds from equipment sale-leaseback transactions 14
 126
 609
Other (39) (38) (48) (115) (87) (141)
Net cash provided by (used for) financing activities 322
 497
 (1,195) (1,948) 322
 497
      
Effect of changes in currency exchange rates on cash and equivalents (28) 
 
            
Net increase (decrease) in cash and equivalents 421
 299
 (753) 1,270
 421
 299
Cash and equivalents at beginning of period 2,459
 2,160
 2,913
 2,880
 2,459
 2,160
Cash and equivalents at end of period $2,880
 $2,459
 $2,160
 $4,150
 $2,880
 $2,459
            
Supplemental disclosures  
  
    
  
  
Income taxes refunded (paid), net $4
 $13
 $(99) $(43) $4
 $13
Interest paid, net of amounts capitalized (107) (72) (59) (163) (107) (72)
Noncash investing and financing activities:  
  
    
  
  
Exchange of convertible notes 756
 
 
Equipment acquisitions on contracts payable and capital leases 443
 897
 469
 587
 443
 897
Acquisition of noncontrolling interest 127
 
 
Conversion of notes to stock, net of unamortized issuance cost 
 138
 
 
 
 138
Exchange of convertible notes 
 
 175
See accompanying notes to consolidated financial statements.

5751



MICRON TECHNOLOGY, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(All tabular amounts in millions except per share amounts)

Significant Accounting Policies

Basis of PresentationPresentation:: We are one of the world's leading providers of advanced semiconductor solutions. Through our worldwide operations, we manufacture and market a full range of DRAM, NAND Flash and NOR Flash memory, as well as other innovative memory technologies, packaging solutions and semiconductor systems for use in leading-edge computing, consumer, networking, automotive, industrial, embedded and mobile products. The accompanying consolidated financial statements include the accounts of Micron Technology, Inc. and its consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America.

Certain reclassifications have been made to prior period amounts to conform to current period presentation, including restructure and asset impairment activities prior to 2013 that were previously reported in other operating (income) expense, net. In 2013, we reclassified gains and losses from changes in currency exchange rates in order to improve comparability with our industry peers. As a result of the reclassification, $6 million of losses in both 2012 and 2011, were reclassified from the amounts previously reported in other operating (income) expense, net to other non-operating income (expense), net.presentation. Certain deferred tax assets and liabilities in prior years were corrected with corresponding changes in the valuation allowance, resulting in no change to net deferred tax assets. The changeChanges in these items waswere not material for any period presented.

Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Our fiscalFiscal years 2014, 2013 2012 and 20112012 each contained 52 weeks. Fiscal year 2015 will contain 53 weeks, and the first quarter of fiscal 2015 will contain 14 weeks. All period references are to our fiscal periods unless otherwise indicated. Our recently acquired subsidiary, Elpida Memory, Inc., has been consolidated based on its fiscal year ending on August 31, 2013.

Use of EstimatesEstimates:: The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures.  Estimates and judgments are based on historical experience, forecasted events and various other assumptions that we believe to be reasonable under the circumstances.  Estimates and judgments may differ under different assumptions or conditions.  We evaluate our estimates and judgments on an ongoing basis.  Actual results could differ from estimates.

Product WarrantyWarranty:: We generally provide a limited warranty that our products are in compliance with our specifications existing at the time of delivery.  Under our general terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items or return of, or a credit with respect to, amounts paid for such items.  Under certain circumstances, we provide more extensive limited warranty coverage than that provided under our general terms and conditions.  Our warranty obligations are not material.significant.

Revenue Recognition:Recognition: We recognize product or license revenue when persuasive evidence that a sales arrangement exists, delivery has occurred, the price is fixed or determinable and collectability is reasonably assured.  SinceIf we are unable to reasonably estimate returns and changes in market price, and thereforeor the price is not fixed or determinable, sales made under agreements allowing pricing protection or rights of return (other than for product warranty)or price protection are deferred until customers have resold the product.

Research and DevelopmentDevelopment:: Costs related to the conceptual formulation and design of products and processes are expensed as research and development as incurred.  Determining when product development is complete requires judgment.  Development of a product is deemed complete once the product has been thoroughly reviewed and has passed tests for performance and reliability.  Subsequent to product qualification, product costs are valued in inventory.  Product design and other research and development costs for certain technologies are shared with our joint venture partners.  Amounts receivable from these cost-sharing arrangements are reflected as a reduction of research and development expense.  (See "Equity Method Investments" and "Consolidated Variable Interest Entities"EquityIM Flash"Noncontrolling Interests in Subsidiaries" notes.)

Stock-based CompensationCompensation:: Stock-based compensation is measured at the grant date, based on the fair value of the award, and recognized as expense under the straight-line attribution method over the requisite service period.  We issue new shares upon the exercise of stock options or conversion of share units.  (See "Equity Plans" note.)


58



Stock RepurchasesRepurchases:: When we repurchase and retire our common stock, any excess of the repurchase price paid over par value is allocated between paid-in capital and retained earnings.

Functional CurrencyCurrency:: The U.S. dollar is the functional currency for all of our consolidated operations.


52



Financial InstrumentsInstruments:: Cash equivalents include highly liquid short-term investments with original maturities to us of three months or less that are readily convertible to known amounts of cash.  Investments with original maturities greater than three months and remaining maturities less than one year are included in short-term investments.  Investments with remaining maturities greater than one year are included in long-term marketable investments.  The carrying value of investment securities sold is determined using the specific identification method.

Derivative and Hedging InstrumentsInstruments:: We use derivative financial instruments to manage certain exposuresa portion of our exposure to fluctuatingchanges in currency exchange rates from our monetary assets and liabilities or future cash flows and to reduce the volatility that changes in interest rates.rates on variable-rate debt have on our earnings. Our currency derivatives consist primarilyhave consisted of forward and option currency contracts and interest rate swap contracts. We do not use derivative instruments for trading or speculative purposes. Derivative instruments are measured at their fair values and recognized as either assets or liabilities. The accounting for changes in the fair value of derivative instruments is based on the intended use of the derivative and the resulting designation. For derivative instruments that are not designated as hedges for accounting purpose, gains or losses from changes in fair values are recognized in other non-operating income (expense). For derivative instruments designated as cash-flow hedges, the effective portion of the gain or loss is included as a component of other comprehensive income (loss), and the ineffective or excluded portion of the gain or loss is included in other non-operating income (expense). The amounts in accumulated other comprehensive income (loss) for these cash flow hedges are reclassified into earnings in the same line items of the consolidated statements of operation and in the same periods in which the underlying transactions affect earnings.  Effectiveness is measured by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the forecasted cash flows of the hedged item. For the effectiveness assessment of our cash-flow hedges, changes in the time value are excluded for forward contracts and included for options.contracts.

We seek to enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty under these arrangements have been presented in our consolidated balance sheet on a net basis.

(See "Derivative Financial Instruments – Currency Derivatives with Hedge Accounting Designation"Instruments" note.)

InventoriesInventories:: Inventories are stated at the lower of average cost or market value.  Cost includes depreciation, labor, material and overhead costs, including product and process technology costs.  Determining market values of inventories involves numerous judgments, including projecting future average selling prices, and sales volumes for future periods and costs to complete products in work in process inventories.  When market values are below costs, we record a charge to cost of goods sold to write down inventories to their estimated market value in advance of when the inventories are actually sold.  Inventories are primarily categorized as memory (including DRAM, NAND Flash and NOR Flash) for purposes of determining lower of average cost or market. The major characteristics considered in determining inventory categories for purposes of determining the lower of cost or market value are product type and markets. PriorWe remove amounts from inventory and charge such amounts to the third quartercost of 2013, inventory was categorized as memory (primarily DRAM and NAND Flash and NOR Flash) and imaging products for purposes of determining lower ofgoods sold on an average cost or market. Due to the sale on May 3, 2013 of Micron Technology Italia, S.r.l. ("MIT") and our assignment to LFoundry Marsica S.r.l. ("LFoundry") of our supply agreement with Aptina Imaging Corporation ("Aptina") for CMOS image sensors, we ceased manufacturing CMOS image sensors subsequent to that date and no longer have imagining inventory for purposes of determining lower of average cost or market.basis.

Product and Process TechnologyTechnology:: Costs incurred to (1) acquire product and process technology, or to(2) patent technology and (3) maintain patent technology are capitalized and amortized on a straight-line basis over periods ranging up to 1012.5 years.  We capitalize a portion of the costs incurred to patent technology based on the historical and projected patents issued as a percent of patents we file.  Capitalized product and process technology costs are amortized over the shorter of (i)(1) the estimated useful life of the technology, (ii)(2) the patent term or (iii)(3) the term of the technology agreement.  Fully-amortized assets are removed from product and process technology and accumulated amortization.

Property, Plant and EquipmentEquipment:: Property, plant and equipment areis stated at cost and depreciated using the straight-line method over estimated useful lives of generally 10 to 30 years for buildings, generally 5 to 7 years for equipment and generally 3 to 5 years for software.  Assets held for sale are carried at the lower of cost or estimated fair value and are included in other noncurrent assets.  When property, plant or equipment is retired or otherwise disposed, the net book value of the asset is removed and we recognize any gain or loss in our results of operations.


59



We capitalize interest on borrowings during the active construction period of capital projects.  Capitalized interest is added to the cost of the underlying assets and amortized over the useful lives of the assets.




53



Variable Interest Entities

We have interests in entities that are Variable Interest Entities ("VIEs").VIEs. If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments.

Unconsolidated Variable Interest Entities

Inotera: Inotera Memories, Inc. ("Inotera") is a VIE because its equity is not sufficient to permit it to finance its activities without additional support from its shareholders. In the second quarter of 2013, we entered into agreements with Nanya Technology Corporation ("Nanya") and Inotera to amend the joint venture relationship involving Inotera, including a new supply agreement between us and Inotera. We have determined that we do not have the power to direct the activities of Inotera that most significantly impact its economic performance, primarily due to (1) limitations on our governance rights that require the consent of other parties for key operating decisions and (2) Inotera's dependence on Nanya for financing and the ability of Inotera to operate in Taiwan. Therefore, we do not consolidate Inotera and we account for our interest under the equity method.

Transform: Transform Solar Pty Ltd. ("Transform") is a VIE because its equity is not sufficient to permit it to finance its activities without additional financial support from us or its parent, Origin Energy Limited ("Origin"). We have determined that we do not have the power to direct the activities of Transform that most significantly impact its economic performance, primarily due to limitations on our governance rights that require the consent of Origin for key operating decisions. Therefore, we do not consolidate Transform and we account for our interest under the equity method. As of August 30, 2012, Transform's operations were substantially discontinued.

For further information regarding our VIEs that we account for under the equity method, see See "Equity Method Investments"Investments – Inotera" note.

EQUVO Entities: EQUVO HK Limited and EQUVA Capital 1 Pte. Ltd. (together, the "EQUVO Entities") are special purpose entities created to facilitate equipment sale-leaseback financing transactions between us and a consortium of financial institutions that fund the sale-leaseback transactions ("Financing Entities").institutions. Neither we nor the Financing Entitiesfinancing entities have an equity interest in the EQUVO Entities. The EQUVO Entities are VIEs because their equity is not sufficient to permit them to finance their activities without additional support from the Financing Entitiesfinancing entities and because the third-party equity holder lacks characteristics of a controlling financial interest. By design, the arrangements with the EQUVO Entities are merely financing vehicles and we do not bear any significant risks from variable interests with the EQUVO Entities. Therefore, we have determined that we do not have the power to direct the activities of the EQUVO Entities that most significantly impact their economic performance and we do not consolidate the EQUVO Entities.

SC Hiroshima Energy Corporation: SC Hiroshima Energy Corporation ("SCHE") is an entity created to construct and operate a cogeneration, electrical power plant to support our wafer manufacturing facility in Hiroshima, Japan. SCHE is a VIE due to the nature of its tolling agreements with us and our purchase and call options for SCHE's assets. We do not have an equity ownership interest in SCHE. We do not control the operation and maintenance of the plant, which we have determined are the activities of SCHE that most significantly impactsimpact its economic performance. Therefore, we do not consolidate SCHE.

Consolidated Variable Interest Entities

IMFT: IM Flash Technologies, LLC ("IMFT")IMFT is a VIE because all of its costs are passed to us and its other member, Intel, Corporation ("Intel"), through product purchase agreements and IMFT is dependent upon us or Intel for any additional cash requirements.  We determined that we have the power to direct the activities of IMFT that most significantly impact its economic performance.  The primary activities of IMFT are driven by the constant introduction of product and process technology. Because we perform a significant majority of the technology development, we have the power to direct its key activities.  In addition, IMFT manufactures certain products exclusively for us using our technology.  We also determined that

60



we have the obligation to absorb losses and the right to receive benefits from IMFT that could potentially be significant to it.  Therefore,As a result, we have determined that we have the power to direct the activities of IMFT that most significantly impact its economic performance and, therefore, we consolidate IMFT.

IMFS: Prior to April 6, 2012, IM Flash Singapore, LLP ("IMFS")IMFS was a VIE because all of its costs were passed to us and its other member, Intel, through product purchase agreements and IMFS was dependent upon us or Intel for any additional cash requirements.  Prior to April 6, 2012, we determined that we had the power to direct the activities of IMFS that most significantly impacted its economic performance.  Additionally, since 2010, we had significantly greater economic exposure than Intel as a result of our significantly higher ownership interest in IMFS.  Therefore, we consolidated IMFS. On April 6, 2012, we acquired Intel's remaining interests in IMFS and it ceased to be a VIE.

MP Mask: MP Mask Technology Center, LLC ("MP Mask") is a VIE because substantially all of its costs are passed to us and its other member, Photronics, Inc. ("Photronics"), through product purchase agreements and MP Mask is dependent upon us or Photronics for any additional cash requirements.  We determined that we have the power to direct the activities of MP Mask that most significantly impact its economic performance, primarily because (1) of our tie-breaking voting rights over key operating decisions and (2) nearly all key MP Mask activities are driven by our supply needs.  We also determined that we have the obligation to absorb losses and the right to receive benefits from MP Mask that could potentially be significant to it.  Therefore,As a result, we have determined that we have the power to direct the activities of MP Mask that most significantly impact its economic performance and, therefore, we consolidate MP Mask.

54



For further information regarding our consolidated VIEs, see "Consolidated Variable Interest Entities"(See "Equity – Noncontrolling Interests in Subsidiaries" note.)


Recently Issued Accounting Standards

There have been no recentlyIn May 2014, the Financial Accounting Standards Board ("FASB") issued accounting pronouncementsAccounting Standard Update ("ASU") 2014-09 – Revenue from Contracts with Customers, which will supersede nearly all existing revenue recognition guidance under U.S. GAAP.  The core principal of this ASU is that have hadan entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  This ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.  This ASU will be effective for us in our first quarter of 2018.  Early adoption is not permitted. The ASU allows for either full retrospective or modified retrospective adoption. We are expected to have a material impactevaluating the transition method that will be elected and the potential effects of the adoption of this ASU on our financial statements.


Acquisition of ElpidaMicron Memory Japan, Inc.

On July 31, 2013, we completedacquired Elpida, now known as MMJ, and a controlling interest in Rexchip, now known as MMT, for an aggregate of $949 million in cash (collectively, "the MMJ Acquisition"). The MMJ Acquisition included (1) the acquisition of Elpida Memory, Inc., a Japanese corporation, pursuant to the termsMMJ, including its 65% interest in MMT and conditions of an Agreement on Support for Reorganization Companies (as amended, the "Sponsor Agreement") that we entered into on July 2, 2012, with the trustees of Elpida and one of its subsidiaries, Akita Elpida Memory, Inc., a Japanese corporation ("Akita" and, together with Elpida, the "Elpida Companies") pursuant to and in connection with the Elpida Companies' corporate reorganization proceedings under the Corporate Reorganization Act of Japan. We paid $615 million for the acquisition of Elpida, of which substantially all was deposited into accounts that are legally restricted for payment to the secured and unsecured creditors of the Elpida Companies in October 2013. As of August 29, 2013, the amount held in the restricted accounts was presented as restricted cash. Of the $615 million paid at closing, $18 million was applied from amounts we had deposited into an escrow account in July 2012 as a condition to the execution of the Sponsor Agreement.

On July 31, 2013, we also completed(2) the acquisition of an additional 24% ownership interest in Rexchip Electronics Corporation ("Rexchip"), a Taiwanese corporation and manufacturing joint venture formed by Elpida andMMT from Powerchip Technology Corporation ("Powerchip") from Powerchip and certain of its affiliates (the "Powerchip Group""MMT Share Purchase") pursuant to a share purchase agreement. We paid $334 million in cash for the shares. Elpida owns, directly and indirectly through a subsidiary, approximately 65% of Rexchip's outstanding common stock. Therefore,. The MMJ Acquisition was treated as a resultsingle business combination because: (1) the two transactions were entered into and closed contemporaneously, and (2) the MMT Share Purchase was negotiated in contemplation of the consummation of our acquisition of ElpidaMMJ and its completion was contingent on the Rexchip shares fromclosing of the Powerchip Group,acquisition of MMJ.

In 2014, we own approximately 89%purchased additional interests in MMT, increasing our ownership interest to 99.5%. (See "Equity – Noncontrolling Interest in Rexchip.Subsidiaries – MMT" note.)
 
Elpida's assets include, among others:The MMJ Acquisition included a 300mm DRAM wafer fabrication facility located in Hiroshima, Japan; its approximate 65% ownership interest in Rexchip, whose assets includeJapan, a 300mm DRAM wafer fabrication facility located in Taichung City, Taiwan;Taiwan and a 100% ownership interest in Akita, whose assets include an assembly and test facility located in Akita, Japan. Elpida's semiconductor memory productsThe operations from the MMJ Acquisition, which are included primarily in our MBU and CNBU segments, include mobilethe manufacture of Mobile DRAM targeted towardto mobile phones and tablets. We believe that combining the complementary product portfolios of Microntablets and Elpida strengthens our position in the memory marketcomputing DRAM targeted to desktop PCs, servers, notebooks and enables us to provide customers with a wider portfolio of high-quality memory solutions. We also believe that our acquisition of Elpida strengthens our market position in the memory industry through increased research and development and manufacturing scale, improved access to core memory market segments, and additional wafer capacity to balance among our DRAM, NAND Flash and NOR Flash memory solutions.workstations.

The Elpida Acquisition and Rexchip share purchase are treated as a single business combination because (1) the two transactions were entered into and closed contemporaneously and (2) the Rexchip share purchase was negotiated in contemplation of the Elpida acquisition and its completion was contingent on the closing of the Elpida acquisition.


61



We estimated the provisional fair valuevalues of the assets and liabilities of Elpida and it's subsidiaries (the "Elpida Group")the MMJ Group as of the July 31, 2013 acquisition date using an in-use model, which reflects its value through its use in combination with other assets as a group. TheseIn the second quarter of 2014, the provisional amounts could change as additional information becomes available.

The considerationrecorded in connection with the MMJ Acquisition were adjusted, primarily for pre-petition liabilities, and provisionalwe recognized a charge in 2014 for these measurement period adjustments. The valuation of assets acquired and liabilities assumed arewere as follows:


55



Assets acquired and liabilities assumed:  
Cash and equivalents $999
Receivables 697
Inventories 962
Restricted cash 557
Other current assets 142
Property, plant and equipment 935
Equity method investment 40
Intangible assets 10
Deferred tax assets 811
Other noncurrent assets 66
   
Accounts payable and accrued expenses (387)
Equipment purchase contracts (22)
Current portion of long-term debt (673)
Long-term debt (1,461)
Other noncurrent liabilities (75)
   
Total net assets acquired 2,601
   
Noncontrolling interests in Elpida: 168
  

Consideration 949
   
Gain on acquisition $1,484

Because the fair value of the net assets acquired less noncontrolling interests exceeded the purchase price, we recognized a gain on the acquisition of $1,484 million.  The yen-denominated purchase price was fixed on July 2, 2012 when we entered into the Sponsor Agreement. We believe the fair value exceeded the purchase price because of increases in working capital from improvements in market conditions in the DRAM industry between July 2, 2012 and July 31, 2013, when we completed the acquisition. These conditions resulted in significant increases in U.S. dollar equivalent net assets of Elpida.

The fair value of the noncontrolling interest in the table above primarily relates to Rexchip and was derived based on the purchase price we paid the Powerchip Group for their 24% ownership interest.
Assets acquired and liabilities assumed:  
Cash and equivalents $999
Receivables 697
Inventories 962
Restricted cash 557
Other current assets 142
Property, plant and equipment 935
Equity method investment 40
Intangible assets 10
Deferred tax assets 811
Other noncurrent assets 66
Accounts payable and accrued expenses (387)
Equipment purchase contracts (22)
Current portion of long-term debt (673)
Long-term debt (1,461)
Other noncurrent liabilities (75)
Total net assets acquired 2,601
Noncontrolling interests in MMJ 168
Consideration 949
Preliminary gain on acquisition recognized in 2013 1,484
Adjustment for primarily pre-petition liabilities (33)
Final gain on acquisition $1,451

Our results of operations for 2013 include $355 million of net sales and $46 million of operating income (losses) from the ElpidaMMJ Group's operations after the July 31, 2013 acquisition date. Included in the selling, general and administrative expenses in the results of operations for 2013 are transaction costs of $50 million incurred in connection with this acquisition.the MMJ Acquisition.


62



The acquisition of MMJ was pursuant to the terms and conditions of an Agreement on Support for Reorganization Companies (as amended, the "Sponsor Agreement") that we entered into in July 2012 with the trustees of the MMJ Companies pursuant to and in connection with the MMJ Companies' corporate reorganization proceedings under the Corporate Reorganization Act of Japan. As a result of the Japan Proceedings, for so long as such proceedings are continuing, the ElpidaMMJ Companies and their subsidiaries are subject to certain restrictions on dividends, loans and advances. The plans of reorganization of the ElpidaMMJ Companies prohibit the ElpidaMMJ Companies from paying dividends, including any cash dividends, to us and require that excess earnings be used in their businesses or to fund the ElpidaMMJ Companies' installment payments. These prohibitions would also effectively prevent the subsidiaries of the ElpidaMMJ Companies from paying cash dividends to us as any such dividends would have to be first paid to the ElpidaMMJ Companies which are prohibited from repaying those amounts to us as dividends under the plans of reorganization. In addition, pursuant to an order of the Japan Court, the ElpidaMMJ Companies cannot make loans or advances, other than certain ordinary course advances, to us without the consent of the Japan Court. Moreover, loans or advances by subsidiaries of the ElpidaMMJ Companies may be considered outside of the ordinary course of business and subject tomay require consent of MMJ's trustees or, in certain cases, approval ofby the legal trustees and Japan Court. As a result, the assets of the ElpidaMMJ Companies, and their subsidiaries, while available to satisfy the ElpidaMMJ Companies' installment payments and the other obligations, capital expenditures and other operating needs of the ElpidaMMJ Companies, and their subsidiaries, are not available for use by us in our other operations. Moreover, certainCertain uses of the assets of the ElpidaMMJ Companies, including investments in certain capital expenditures and in Rexchip,MMT, may require consent of Elpida'sMMJ's trustees and/or, in certain cases, approval by the Japan Court. Disposition of certain assets of the MMJ Companies may also require consent of one or more of the secured creditors.


Total net assets, less noncontrolling interests, of the Elpida Companies and their subsidiaries as of August 29, 2013 were $2,460 million. As of August 29, 2013, the Elpida Companies held cash and equivalents of $1,094 million and $556 million of current restricted cash, none of which were available for cash dividends, loans or advances as a result of the above-described restrictions. The restricted cash was held in accounts that are controlled by the trustees and are legally restricted for payment of secured and unsecured creditors of the Elpida Companies pursuant to the plans of reorganization.
56



Unaudited Pro Forma Financial Information

The following unaudited pro forma financial information presents the combined results of operations as if the ElpidaMMJ Acquisition had occurred on September 2, 2011.  The pro forma financial information includes the accounting effects of the business combination, including adjustments to the amortization of intangible assets, depreciation of property, plant and equipment, interest expense and elimination of intercompany activities.  The historical results of operations of the ElpidaMMJ Group for the eleven months ended May 31, 2013 included a gain of $1,692 million1.69 billion for the forgiveness of debt related to liabilities subject to compromise upon approval of the bankruptcy by the creditors ofand the Tokyo DistrictJapan Court and, for the year ended June 30, 2012, included a $2,828 million2.83 billion loss for impairment of long-lived assets. No adjustment wasadjustments were made to the unaudited pro forma financial information for these items, consistent with the requirements for preparation forof the pro forma financial information. The unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the ElpidaMMJ Acquisition occurred on September 2, 2011.

 2013 2012
For the year ended 2013 2012
Net sales $12,494
 $11,492
 $12,494
 $11,492
Net income (loss) 3,725
 (4,422) 3,825
 (4,439)
Net income (loss) attributable to Micron 3,670
 (4,454) 3,770
 (4,471)
    
Earnings (loss) per share:        
Basic $3.59
 $(4.49) $3.69
 $(4.51)
Diluted 3.47
 (4.49) 3.57
 (4.51)

The unaudited pro forma financial information for 2013 includes our results for the year ended August 29, 2013,, which includes one month of results from the ElpidaMMJ Group following the closing of the ElpidaMMJ Acquisition, and the results of the ElpidaMMJ Group, including the adjustments described above, for the eleven months ended May 31, 2013. The pro forma information for 2012 includes our results for the year ended August 30, 2012 and the results of the ElpidaMMJ Group, including the adjustments described above, for the year ended June 30, 2012.


Investments

The fair values of available-for-sale investments, which approximated amortized costs, were as follows:

As of 2014 2013
Money market funds $1,281
 $1,188
Corporate bonds 561
 414
Certificates of deposit 437
 349
Government securities 420
 168
Asset-backed securities 128
 97
Commercial paper 107
 61
Marketable equity securities 1
 6
  $2,935
 $2,283


6357



Investments

As of August 29, 2013 and August 30, 2012, available-for-sale investments, including cash equivalents, were as follows:

As of 2013 2012
  Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value
Money market funds $1,188
 $
 $
 $1,188
 $2,159
 $
 $
 $2,159
Corporate bonds 414
 1
 (1) 414
 233
 1
 
 234
Certificates of deposit 349
 
 
 349
 31
 
 
 31
Government securities 168
 
 
 168
 144
 
 
 144
Asset-backed securities 97
 
 
 97
 77
 
 
 77
Commercial paper 61
 
 
 61
 39
 
 
 39
Marketable equity securities 6
 
 
 6
 10
 
 
 10
  $2,283
 $1
 $(1) $2,283
 $2,693
 $1
 $
 $2,694

As of August 29, 2013, no available-for-sale security had been in a loss position for longer than 12 months. During 2013 and 2012, we recognized other-than-temporary impairments of our marketable equity securities of $4 million and $11 million, respectively.

The table below presents the amortized cost and fair value of available-for-sale debt securities including cash equivalents, as of August 29, 2013by contractual maturity:

 Amortized Cost Fair Value
Money market funds not due at a single maturity date $1,188
 $1,188
As of 2014
Money market funds $1,281
Due in 1 year or less 596
 596
 835
Due in 1 - 2 years 224
 224
 438
Due in 2 - 4 years 253
 253
 351
Due after 4 years 16
 16
 29
 $2,277
 $2,277
 $2,934

Net unrealized holding gains reclassified out of accumulated other comprehensive income from sales of available-for-sale securities were $31 million for 2012 and were not significant for any other period presented. Proceeds from the sales of available-for-sale securities for 2014, 2013 and 2012 and 2011 were$355 million, $526 million, and $149 million and $1 million, respectively. Gross realized gains from sales of available-for-sale securities were $34 million for 2012 and gross realized gains and losses for all other periods presented were not significant.




64



Receivables

As of 2013 2012
Trade receivables (net of allowance for doubtful accounts of $5 and $5, respectively)
 $2,069
 $933
Income and other taxes 74
 80
Related party receivables 8
 63
Other 178
 213
  $2,329
 $1,289

Related party receivables primarily included amounts due from Aptina related to certain manufacturing services agreements. (See "Equity Method Investments" note.)
As of 2014 2013
Trade receivables (net of allowance for doubtful accounts of $3 and $5, respectively) $2,524
 $2,069
Income and other taxes 104
 74
Other 278
 186
  $2,906
 $2,329

As of August 29, 201328, 2014 and August 30, 201229, 2013, other receivables included $2 million and $63 million, respectively, from our currency hedges. As of August 29, 2013 and August 30, 2012, other receivables included $3470 million and $34 million, respectively, due from Intel for amounts related to NAND Flash and certain emerging memory technologies product design and process development activities under cost-sharing agreements.  As of August 30, 2012, other receivables also included $17 million due from Nanyaagreements for amounts related to DRAM product designNAND Flash and process development activities under a cost-sharing agreement.certain emerging memory technologies.  (See "Derivative Financial Instruments," "Consolidated Variable Interest Entities" and "Equity Method Investments" notes.– Noncontrolling Interests in Subsidiaries – IMFT" note.)


Inventories

As of 2013 2012 2014 2013
Finished goods $796
 $512
 $898
 $796
Work in process 1,719
 1,148
 1,372
 1,719
Raw materials and supplies 134
 152
 185
 134
 $2,649
 $1,812
 $2,455
 $2,649


Property, Plant and Equipment

As of 2013 2012 2014 2013
Land $86
 $92
 $86
 $86
Buildings (includes $209 and $196, respectively, for capital leases) 4,835
 4,714
Equipment (includes $1,305 and $919, respectively, for capital leases) 15,600
 15,653
Buildings (includes $289 and $209, respectively, from capital leases) 5,093
 4,835
Equipment (includes $1,108 and $1,305, respectively, from capital leases) 17,781
 15,600
Construction in progress 84
 43
 114
 84
Software 315
 323
 358
 315
 20,920
 20,825
 23,432
 20,920
Accumulated depreciation (includes $463 and $253, respectively, for capital leases) (13,294) (13,722)
Accumulated depreciation (includes $693 and $463, respectively, from capital leases) (14,750) (13,294)
 $7,626
 $7,103
 $8,682
 $7,626

58



Depreciation expense was $1,7211,993 million, $2,0531,721 million and $2,0262,053 million for 20132014, 20122013 and 20112012, respectively. Other noncurrent assets included buildings, equipment, and other assets classified asland held for saledevelopment of $2257 million as of August 29, 201328, 2014 and $25$54 million as of August 30, 2012 and land held for development of $54 million as of August 29, 2013.

As of August 29, 2013,28, 2014, production equipment and buildings with carrying values of $476 million and land with a carrying value of $541$43 million were pledged as collateral under various notes payable. (See "Debt – Other Notes Payable" note.)




65



Equity Method Investments

As of 2013 2012 2014 2013
 Investment Balance Ownership Percentage Investment Balance Ownership Percentage Investment Balance Ownership Percentage Investment Balance Ownership Percentage
Inotera(1) $344
 35% $370
 40% $914
 33% $344
 35%
Tera Probe 40
 40% 
 % 48
 40% 40
 40%
Other 12
 Various
 19
 Various
 9
 Various
 12
 Various
 $396
  
 $389
  
 $971
  
 $396
  
(1) Entity is a variable interest entity.

As of August 28, 2014, substantially all of our maximum exposure to loss from our VIEs that were not consolidated was the $914 million carrying value of our investment in Inotera.  We may also incur losses in connection with our rights and obligations to purchase substantially all of Inotera's wafer production capacity under a supply agreement with Inotera.

We recognize our share of earnings or losses from these entities under theour equity method investees generally on a two-month lag.  Equity in net income (loss) of equity method investees, net of tax, included the following:

For the year ended 2013 2012 2011 2014 2013 2012
Inotera $(79) $(189) $(112) $465
 $(79) $(189)
Tera Probe 11
 
 
Other (4) (105) (46) (2) (4) (105)
 $(83) $(294) $(158) $474
 $(83) $(294)

The summarized financial information in the tables below reflects aggregate amounts for all of our equity method investees. Financial information is presented for equity method investments as of the respective dates and for the periods through which we recorded our proportionate share of each investee's results of operations. Summarized results of operations are presented only for the periods subsequent to the acquisition or through the disposition of our ownership interest.interests.

As of 2013 2012 2014 2013
Current assets $1,018
 $724
 $2,233
 $1,018
Noncurrent assets 2,634
 3,024
 2,502
 2,634
Current liabilities 1,912
 2,519
 1,417
 1,912
Noncurrent liabilities 435
 155
 254
 435
For the years ended 2013 2012 2011
Net sales $1,788
 $1,798
 $1,839
Gross margin 1
 (451) (268)
Operating loss (203) (751) (559)
Net loss (188) (793) (594)

Transform began using the liquidation basis of accounting in June 2012. Transform's statement of net assets (liabilities) in liquidation included $9 million of assets and $8 million of liabilities as of August 29, 2013 and $29 million of assets and $14 million of liabilities as of August 30, 2012, which were excluded from the table above. Additionally, Transform's statement of changes in net assets (liabilities) in liquidation for the fourth quarter of 2012 included a decrease in the estimated fair values of net assets of $67 million. Activity for 2013 was not significant. (See "Transform" below).

As of August 29, 2013, our maximum exposure to loss from our involvement with our equity method investments that were VIEs was $344 million and primarily included our Inotera investment balance.  We may also incur losses in connection with our rights and obligations to purchase substantially all of Inotera's wafer production capacity under a supply agreement with Inotera.
For the years ended 2014 2013 2012
Net sales $3,382
 $1,788
 $1,798
Gross margin 1,576
 1
 (451)
Operating income (loss) 1,371
 (203) (751)
Net income (loss) 1,339
 (188) (793)


6659



Inotera

We have partnered with Nanya in Inotera, a TaiwaneseTaiwan DRAM memory company, since the first quarter of 2009.  In March 2012, we contributed $170 million to Inotera, which increased our ownership percentage to 40%. On May 28,In 2013, Inotera issued 634 million common shares to Nanya and certain of its affiliates in a private placement at a price equal to 9.47 New Taiwan dollars per share, (approximately $0.32 U.S. dollars), which was in excess of our carrying value per share. As a result of the issuance, our ownership interest decreased from 40% to 35% and we recognized a non-operating gain of $48$48 million in 2013. On May 15, 2014, Inotera issued 400 million common shares in a public offering at a price equal to 31.50 New Taiwan dollars per share, which was in excess of our carrying value per share. As a result of the issuance, our ownership interest decreased from 35% to 33% and we recognized a non-operating gain of $93 million in 2014. As of August 29, 2013,28, 2014, we held a 35%33% ownership interest in Inotera, Nanya and certain of its affiliates held a 36%33% ownership interest and the remaining ownership interest in Inotera was publicly held.

As of August 29, 201328, 2014, the market value of our equity interest in Inotera was $854 million3.72 billion based on the closing trading price of its shares51.90 New Taiwan dollars per share in an active market. As of August 29, 201328, 2014 and August 30, 201229, 2013, there were gains of $44 million and $4944 million, respectively, in accumulated other comprehensive income (loss) for cumulative translation adjustments from our equity investment in Inotera.

The net carrying value of our initial and subsequent investments was less than our proportionate share of Inotera's equity at the time of those investments.  These differences are being amortized as a net credit to our earnings through equity in net income (loss) of equity method investees (the "Inotera Amortization").  For both 2012, and 2011, we recognized $48$48 million of Inotera Amortization. AsAmortization and as of August 30, 2012, the remaining amount of unrecognized Inotera Amortization was not significant.

As of June 30, 2013, Inotera's current liabilities exceeded its current assets by $1.0 billion, which exposes Inotera to liquidity risk. Additionally, Inotera incurred net losses of $541 million for its fiscal year endedThrough December 31, 2012. As of June 30, 2013, Inotera was not in compliance with certain of its loan covenants, and had not been in compliance for the past several years, which may result in its lenders requiring repayment of such loans during the next year. Inotera has applied for a waiver from complying with the June 30, 2013 financial covenants. Inotera's management has implemented plans to improve its liquidity and for Inotera's six-month period ended June 30, 2013, Inotera generated net income of $91 million; however, there can be no assurance that Inotera will be successful in sufficiently improving its liquidity and complying with their loan covenants, which may result in its lenders requiring repayment of such loans during the next year.

In the second quarter of 2012, we loanedpurchased $133 million50% toof Inotera's wafer production capacity based on a margin-sharing formula among Nanya, Inotera under a 90-day note with a stated annual interest rate of 2% to facilitate the purchase of capital equipment necessary to implement new process technology. The loan was repaid to us with accrued interest in March 2012.

Onand us. Since January 17, 2013, we entered into agreements with Nanya and Inotera to amend the joint venture relationship involving Inotera. The amendments includedhave purchased substantially all of Inotera's DRAM output at a discount from market prices for our comparable components under a new supply agreement (the "Inotera Supply Agreement"), retroactively effective beginning on January 1,. Our costs for supply from Inotera increased in 2014 from 2013 between us and Inotera under which we are obligateddue to purchase for an initial period through January, 2016, substantially all of Inotera's output at a purchase price based on a discount from marketchanges in average selling prices for our comparable components.DRAM products and the changes in the pricing terms. The Inotera Supply Agreement has a three-year term (currently through December 2016) that contemplates annual negotiations with respect to potential successive one-year extensions and if in any yearextensions. If the parties do not agree to an extension, the agreement will terminate following the end of the then-existing term plus a subsequent three-year wind-down period. OurIn the event of a wind-down, our share of Inotera's capacity would decline over the three year wind-down period. Under applicable accounting guidance,In 2014, our cost of products purchased from Inotera was significantly higher than our cost of similar products manufactured in our wholly-owned facilities. We are currently in negotiations regarding the extension of the Inotera Supply Agreement is treated as containingAgreement. There can be no assurance that we will be able to reach an embedded operating lease with respect to Inotera's production assets duringagreement. Under the initial three-year term of the lease. Effective through December 31, 2012, we had rights and obligations to purchase 50% of Inotera's wafer production capacity based on a margin-sharing formula among Nanya, Inotera and us. Under thesesupply agreements, we purchased $1,260$2.68 billion, $1.26 billion and $646 million, $646 million, and $641 million of DRAM products in 2014, 2013 2012 and 2011 respectively. In 2012 we recognized losses on our purchase commitment under the Inotera Supply Agreement of $17 million, $19 million and $40 million in our fourth, second and first quarters, respectively. In 2011, we recognized purchase commitment losses of $28 million, $3 million, $12 million and $11 million in the fourth, third, second and first quarters, respectively.

UnderPursuant to a cost-sharing arrangementDRAM R&D joint development program with Nanya, which was effective through December 31, 2012, we generally shared DRAM process and design development costs with Nanya. As a result of the January 17, 2013 agreements, which were retroactively effective beginning on January 1, 2013, Nanya no longer participates in the joint development program. Pursuant to the cost-sharing arrangement, our research and development ("R&D")&D costs were reduced by $19$19 million, $138 and $138 million, and $141 million in 2013 and 2012, and 2011, respectively.  In addition, we recognized royalty revenue from Nanya of $3 million, $11 million, and $25 millionceased participating in 2013, 2012 and 2011, respectively, for sales ofthe DRAM products manufactured by or for Nanya on process nodes of 50nm or higher.joint development program after December 31, 2012.


67



Tera Probe

On July 31,In 2013, as part of the MMJ Acquisition, we acquired as an asset of Elpida, a 40% interest in Tera Probe, Inc. ("Tera Probe"), a Japanese-based company mainly engaged inwhich provides semiconductor wafer testing and contract wafer-level package testing services. Our investment in Tera Probe was valued at $40 million, based on the aggregate trading price of the shares in an active market on the acquisition date (Level 1 fair value measurements).probe services to us and others. The initial net carrying value of our investment was less than our proportionate share of Tera Probe's equity at the time of our investment, and the difference is being amortized as a net credit to our earnings through equity in net income (loss) of equity method investees (the "Tera Probe Amortization"). As of August 29, 2013, $35 million28, 2014, the remaining balance of unamortizedthe Tera Probe Amortization was being recognized$26 million and is expected to be amortized over a weighted-average period of 76 years.

As of August 29, 2013,28, 2014, the market value of our equity interest in Tera Probe was $39 million based on the closing trading price of Tera Probe's shares1,087 yen per share in an active market the market value ofand was $9 million below our equity interest was $30 million.carrying value. We evaluated our investment in Tera Probe and concluded that the decline in the market value below our carrying value was not an other-than-temporary impairment primarily because of the limited amount of time the fair value was below the carrying value the subsequent recovery and historical volatility of theTera Probe's stock price.

Tera Probe performs probe servicesWe incurred manufacturing costs for certain2014 and 2013 of our manufacturing processes. Included in cost of goods sold$117 million and $13 million, respectively, for 2013 is $13 million for probe services performed by Tera Probe.


60



Other

Transform: In the second quarter of 2010, we acquired a 50% interest in Transform, a developer, manufacturer and marketer of photovoltaic technology and solar panels, from Origin. As of August 29, 2013,28, 2014, we and Origin each held a 50% ownership interest in Transform.  As a result of the ongoing challenging global environment in the solar industry and unfavorable worldwide supply and demand conditions, on May 25,In 2012, the Board of Directors of Transform approved a liquidation plan. Asplan and as a result, of the liquidation plan, we recognized a charge of $69$69 million in 2012. As of August 30, 2012, Transform's operations were substantially discontinued.

Other noncurrent assets as ofAptina: We held an equity interest in Aptina until August 30, 2012 included $2615, 2014. On August 15, 2014, ON Semiconductor Corporation acquired Aptina for approximately $433 million for a portion of our Boise, Idaho manufacturing facilities leased to Transform and other noncurrent liabilities included $26 million for deferred rent revenue on the fully-paid lease. In 2013, Transform terminated the lease and, as a result, we recognized a non-operating gain of $25$119 million from the termination.

During 2012 and 2011, we and Origin each contributed $17 million and $30 million, respectively, of cash to Transform.  We recognized net sales of $13 million and $20 million in 2012 and 2011, respectively, for transition services provided to Transform. Revenue based on our sales to Transformdiluted ownership interest of approximately 27%. The gain approximated costs. Revenue and associated costs for 2013 were not significant.

Aptina: Other equity method investments included a 31% equity interest in Aptina. The amountour share of cumulative loss we recognized fromthe consideration because the carrying value of our investment had been reduced to zero in Aptina through the second quarter of 2012, reduced our investment balance to zero andat which time we ceased recognizing our proportionate share of Aptina's losses.

Through May 3, 2013, we manufactured components for CMOSComplementary Metal-Oxide Semiconductor ("CMOS") image sensors for Aptina under a wafer supply agreement.  Subsequent to May 3, 2013, we provided various services for Aptina under a service agreement. For 2014, 2013 2012 and 2011,2012, we recognized net sales of $182$43 million,, $372 $182 million and $349$372 million,, respectively, from products sold to and services performed for Aptina, and cost of goods sold of $219$37 million,, $395 $219 million and $358$395 million,, respectively. On May 3,In 2013, we assigned to LFoundry Marsica L.r.l. ("LFoundry") our supply agreement with Aptina to manufacture components for image sensors at our 200mm200mm Avezzano facility. (See "Restructure and Asset Impairments - Micron Technology Italia, S.r.l."Impairments" note.)

In connection with the sale of our 200mm Avezzano facility to LFoundry on May 22,in 2013, we entered into a short-term, interest-free, unsecured loan agreement with Aptina that allowed Aptina to borrow up to $45 million, drawn at their option, in three equal tranches through July 2013. Principal amounts drawn are due in three equal payments from September 2013 to January 2014.Aptina. As of August 29, 2013,, other current assets included $45 million for amounts due under the short-term loan agreement.agreement, which was repaid in 2014.




68



Intangible Assets

As of 2013 2012 2014 2013
 
Gross
Amount
 
Accumulated
Amortization
 
Gross
Amount
 
Accumulated
Amortization
 
Gross
Amount
 
Accumulated
Amortization
 
Gross
Amount
 
Accumulated
Amortization
Product and process technology $642
 $(269) $575
 $(234) $809
 $(341) $642
 $(269)
Customer relationships 127
 (114) 127
 (98) 1
 (1) 127
 (114)
Other 
 
 1
 
 $769
 $(383) $703
 $(332) $810
 $(342) $769
 $(383)

During 20132014 and 2012,2013, we capitalized $100$177 million and $47$100 million,, respectively, for product and process technology with weighted-average useful lives of 76 years and 107 years, respectively. Amortization expense was $83110 million, $8883 million and $7988 million for 20132014, 20122013 and 20112012, respectively.  Annual amortization expense is estimated to be $90 million for 2014, $73112 million for 2015, $6598 million for 2016, $5488 million for 2017 and, $4477 million for 2018 and $31 million for 2019.


Accounts Payable and Accrued Expenses

As of 2013 2012 2014 2013
Accounts payable $1,048
 $818
 $1,119
 $1,048
Related party payables 374
 130
 673
 374
Salaries, wages and benefits 267
 290
 456
 267
Customer advances 140
 141
 98
 140
Income and other taxes 47
 25
 71
 47
Other 239
 237
 281
 239
 $2,115
 $1,641
 $2,698
 $2,115

As of August 29, 201328, 2014 and August 30, 201229, 2013, related party payables included $345660 million and $130345 million, respectively, due to Inotera primarily for the purchase of DRAM products under the Inotera Supply Agreement. As of August 28, 2014 and August 29, 2013, related party payables also included $2913 million and $29 million, respectively, due to Tera Probe for probe services performed. (See "Equity Method Investments" note.)

61



As of August 28, 2014, customer advances included $90 million for amounts received from a customer in 2014 under a DRAM supply agreement to be applied to purchases at market pricing through September 2016. As of August 28, 2014, other noncurrent liabilities included $90 million from this DRAM supply agreement. As of August 29, 2013 and August 30, 2012, customer advances included $134$134 million and $139 million, respectively, for amounts received from Intel, to beall of which was applied to Intel's future purchases of NAND Flash in 2014 under a NAND Flash supply agreement. In addition, as of August 30, 2012, other noncurrent liabilities included $120 million, respectively, from this agreement. (See "Consolidated Variable Interest Entities"EquityIM Flash"Noncontrolling Interests in Subsidiaries – IMFT" note.)

As of August 30, 2012, other accounts payable and accrued expenses included $51 million of liabilities associated with currency hedges executed in connection with the Sponsor Agreement and Rexchip Share Purchase Agreement. As of August 29, 2013 and August 30, 2012, other accounts payable and accrued expenses included $8 million and $14 million, respectively, due to Intel for NAND Flash product design and process development and licensing fees pursuant to cost-sharing agreements. (See "Derivative Financial Instruments" and "Consolidated Variable Interest Entities – IM Flash" notes.)




69



Debt

As of 2013 2012
Elpida creditor installment payments $1,644
 $
Capital lease obligations 1,252
 883
2014 convertible senior notes 465
 860
2027 convertible senior notes 147
 141
2031A convertible senior notes 277
 265
2031B convertible senior notes 253
 243
2032C convertible senior notes 463
 451
2032D convertible senior notes 369
 361
2033E convertible senior notes 272
 
2033F convertible senior notes 260
 
Other notes payable 635
 58
  6,037
 3,262
Less current portion 1,585
 224
  $4,452
 $3,038
      2014 2013
Instrument(1)
 Stated Rate Effective Rate Current Long-Term Total Current Long-Term Total
MMJ creditor installment payments N/A
 6.25% $192
 $939
 $1,131
 $527
 $1,117
 $1,644
Capital lease obligations(2)
 N/A
 N/A
 323
 588
 911
 407
 845
 1,252
2014 convertible senior notes 1.875% 7.88% 
 
 
 465
 
 465
2019 senior notes 1.258% 1.97% 92
 324
 416
 
 
 
2022 senior notes 5.875% 6.14% 
 600
 600
 
 
 
2025 senior notes 5.500% 5.56% 
 1,150
 1,150
 
 
 
2027 convertible senior notes 1.875% 6.95% 
 
 
 
 147
 147
2031A convertible senior notes 1.500% 6.55% 
 
 
 
 277
 277
2031B convertible senior notes(3)
 1.875% 6.98% 362
 
 362
 
 253
 253
2032C convertible senior notes(4)
 2.375% 5.95% 
 314
 314
 
 463
 463
2032D convertible senior notes(4)
 3.125% 6.33% 
 288
 288
 
 369
 369
2033E convertible senior notes(4)(5)
 1.625% 4.50% 278
 
 278
 
 272
 272
2033F convertible senior notes(4)(5)
 2.125% 4.93% 265
 
 265
 
 260
 260
2043G convertible senior notes 3.000% 6.76% 
 636
 636
 
 
 
Other notes payable 2.289% 3.40% 126
 116
 242
 186
 449
 635
      $1,638
 $4,955
 $6,593
 $1,585
 $4,452
 $6,037
(1)
We have either the obligation or the option to pay cash for the aggregate amount due upon conversion for all of our convertible notes. Since it is our current intent to settle in cash the principal amount of all of our convertible notes upon conversion, the dilutive effect of such notes on earnings per share is computed under the treasury stock method.
(2) Weighted-average imputed rate of 4.3% and 4.1% as of August 28, 2014 and August 29, 2013, respectively.
(3)
Amount recorded for 2014 includes the debt and equity components, which was reclassified as a result of our obligation to settle the conversions of the 2031B Notes.
(4)
Since the closing price of our common stock for at least 20 trading days in the 30 trading day period ending on June 30, 2014 exceeded 130% of the initial conversion price per share, holders have the right to convert their notes at any time during the calendar quarter ended September 30, 2014. The closing price of our common stock also exceeded the thresholds for the calendar quarter ended September 30, 2014; therefore, these notes are convertible by the holders through December 31, 2014.
(5) As a result of these notes being convertible at the option of the holder through September 30, 2014, and because the terms of these notes would require us to pay cash for the principal amount of any converted notes, amounts are classified as current.

Our senior notes are unsecured obligations ranking equally in right of payment with all of our other existing and future unsecured indebtedness, and are effectively subordinated to all of our other existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness.  TheOur parent company, MTI, has $3.89 billion of debt including all of our convertible notes, the 2022 Notes and the Intel note of Micron Technology, Inc. ("MTI") of $2,531 million2025 Notes, which are structurally subordinated to $1,863 million$1.57 billion of othercapital lease obligations and notes payable of its subsidiaries and capital lease obligations.subsidiaries. MTI guarantees certain debt obligations of its subsidiaries. MTI does not guarantee the ElpidaMMJ creditor installment payments.  MTI's guarantees of its subsidiary debt obligations are unsecured obligations ranking equally in right of payment with all of itsMTI's other existing and future unsecured indebtedness.


62



2014 Debt Restructure

In 2014, we initiated a series of actions to restructure our debt, including exchanges, conversions and settlements, repurchases, issuances and early repayments. The following table presents the net effect of each of the actions:

  Increase (Decrease) in Principal Increase (Decrease) in Carrying Value Increase (Decrease) in Cash (Decrease) in Equity 
Loss(1)
Exchanges $585
 $282
 $
 $(238) $49
Conversions and settlements (770) (437) (1,446) (886) 130
Repurchases (320) (269) (857) (567) 23
Issuances 2,212
 2,212
 2,157
 
 
Early repayments (336) (334) (339) 
 3
  $1,371
 $1,454
 $(485) $(1,691) $205
(1)
The loss on 2014 debt restructure activities was recorded as $184 million in other non-operating expense and $21 million in interest expense in 2014.

Exchanges: Exchanged $440 million in aggregate principal amount of our 2027 Notes, 2031A Notes and 2031B Notes into $1.03 billion principal amount at maturity of 2043G Notes.
Conversions and Settlements: Holders of substantially all of our remaining 2014 Notes, 2027 Notes and 2031A Notes (with an aggregate principal amount of $770 million) converted their notes and we settled the conversions in cash for $1.45 billion.
Repurchases: Repurchased $320 million in aggregate principal amount of our 2031B Notes, 2032C Notes and 2032D Notes in privately-negotiated transactions for an aggregate of $857 million in cash.
Issuances: Issued $600 million in principal amount of 5.875% senior notes due February 2022 and $1.15 billion in principal amount of 5.500% senior notes due February 2025. Issued $462 million in principal amount of 1.258% senior notes due 2019 Notes, payable in 10 semi-annual installments commencing in July 2014.
Early Repayments: Repaid $334 million of notes and capital leases prior to their scheduled maturities. (See "Other Notes Payable" below.)

Subsequent to 2014, we settled an aggregate principal amount of $114 million of our remaining 2031B Notes for $389 million in cash and repaid a $120 million note prior to its scheduled maturity. (See "Other Notes Payable" below.)

The following discussion provides further details of our 2014 debt restructure activities:

Exchanges: During 2014, in a series of separate non-cash transactions, we exchanged portions of our 2027 Notes, 2031A Notes and 2031B Notes (collectively, the "Exchanged Notes") into 2043G Notes (collectively, the "Exchange Transactions"). In connection with the Exchange Transactions, which were accounted for as extinguishments, we issued to holders of the Exchanged Notes new 2043G Notes with an aggregate principal amount at issuance of $820 million, which accrete up to a principal amount at maturity of $1.03 billion (see further discussion in "2043G Notes" below). The liability and equity components of the Exchanged Notes had previously been stated separately within debt and additional capital in our consolidated balance sheet. As a result, our accounting for the Exchanged Notes affected debt and equity. In connection with the Exchange Transactions, we recognized a loss of $49 million based primarily on the difference between the carrying values and the fair values of the debt components of the Exchanged Notes, of which $38 million was included in other non-operating expense for 2014. The fair value of the debt component of each of the Exchanged Notes was determined as if they were stand-alone instruments using interest rates for similar nonconvertible debt issued by entities with credit ratings comparable to ours at the time of issuance (based on Level 2 fair value measurements). The table below summarizes the Exchange Transactions:


63



  Principal Amount Carrying Value of Debt Equity
Amounts reduced in connection with the Exchanged Notes:      
2027 Notes $80
 $68
 $51
2031A Notes 155
 125
 148
2031B Notes 205
 152
 212
  440
 345
 411
Amounts added in connection with the issued notes:      
2043G Notes 1,025
 627
 173
       
Net increase (decrease) as a result of the Exchange Transactions $585
 $282
 $(238)

Conversions and Settlements: During 2014, we initiated a series of actions resulting in a number of debt conversions and settlements. Those actions included the following:

ElpidaTermination of Conversion Rights of our 2027 Notes – On November 7, 2013, we announced the termination of the conversion rights for our remaining 2027 Notes, effective on December 13, 2013. Prior to such effective date, substantially all of the holders of our 2027 Notes exercised their option to convert their notes and, in each case, we elected to settle the conversion amount entirely in cash.

Redemption of our 2031A Notes – On November 7, 2013, we called for the redemption of our remaining 2031A Notes effective on December 7, 2013. Prior to such effective date, substantially all of the holders of our 2031A Notes exercised their option to convert their notes and, in each case, we elected to settle the conversion amount entirely in cash.

Redemption of our 2014 Notes – On January 31, 2014, we called for the redemption of our remaining 2014 Notes effective on March 3, 2014. Prior to such effective date, substantially all of the holders of our 2014 Notes exercised their option to convert their notes and, in each case, we elected to settle the conversion amount entirely in cash.

Redemption of our 2031B Notes – On July 23, 2014, we called for the redemption of our remaining 2031B Notes with a principal amount of $114 million effective on August 22, 2014. Prior to such effective date, substantially all of the holders of our 2031B Notes exercised their option to convert their notes and, in each case, we elected to settle the conversion amount entirely in cash. All conversions of the 2031B Notes were settled in the first quarter of 2015.

As a result of our elections to settle the conversion amounts in cash, each of the settlement obligations became derivative debt liabilities subject to mark-to-market accounting treatment. Under the terms of the indentures for the above notes, cash settlement amounts for these derivative debt liabilities were determined based on the shares underlying the converted notes multiplied by the volume-weighted-average price of our common stock over a period of 20 consecutive trading days, beginning three days after the holder's election to convert their notes. Therefore, we reclassified the fair values of the equity components of each of the converted notes from additional capital to derivative debt liabilities within current debt in our consolidated balance sheet. In connection with the above, we used an aggregate of $1.45 billion in cash in 2014 and $389 million in 2015 to settle conversion activities. A summary of the conversion activities for these notes is as follows:


64



  Debt Principal (Increase) Decrease in Carrying Value of Debt 
Equity Component Reclassified To Debt(1)
 
Loss(2)
2014 Notes $485
 $478
 $341
 $9
2027 Notes 95
 80
 58
 42
2031A Notes 190
 154
 217
 70
2031B Notes(3)
 
 (275) 270
 9
  $770
 $437
 $886
 $130
(1) Based on Level 2 fair value measurements.
(2) The loss on conversion and settlement activities was recorded as $120 million in other non-operating expense and $10 million in interest expense in 2014.
(3) In the first quarter of 2015, we used an aggregate of $389 million in cash to settle the remaining 2031B Notes. In connection therewith, we incurred an additional charge of $24 million for the settlement of the 2031B Notes in the first quarter of 2015.

Repurchases: During 2014, we repurchased $320 million in aggregate principal amount of our 2031B Notes, 2032C Notes and 2032D Notes in privately-negotiated transactions for an aggregate of $857 million in cash, collectively referred to herein as the "Repurchased Notes." In connection with the Repurchased Notes, we recognized losses (based on Level 2 fair value measurements) of $23 million in 2014, which were included in other non-operating expense.

The liability and equity components of the Repurchased Notes had previously been stated separately within debt and additional capital in our consolidated balance sheet. As a result, our accounting for the Repurchased Notes affect debt and equity. The table below summarizes amounts reduced in 2014 in connection with the Repurchased Notes:

  Principal Amount Carrying Value of Debt Equity
2031B Notes $26
 $19
 $43
2032C Notes 188
 161
 316
2032D Notes 106
 89
 208
  $320
 $269
 $567

Issuances: During 2014, as part of our debt restructure activities, we issued the following senior notes:

5.875% Senior Notes due February 2022: On February 10, 2014, we issued $600 million in principal amount of the 2022 Notes. Issuance costs for the 2022 Notes totaled $14 million.

The 2022 Notes contain covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our domestic restricted subsidiaries (which are generally subsidiaries in the U.S. in which we own at least 80% of the voting stock) to (1) create or incur certain liens and enter into sale and lease-back transactions, (2) create, assume, incur or guarantee certain additional secured indebtedness and unsecured indebtedness of certain of our domestic restricted subsidiaries, and (3) consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our assets, to another entity. These covenants are subject to a number of limitations, exceptions and qualifications.

Cash Redemption at Our Option: Prior to February 15, 2017, we may redeem the 2022 Notes, in whole or in part, at a price equal to the principal amount of the 2022 Notes to be redeemed plus a make-whole premium as described in the indenture governing the 2022 Notes, together with accrued and unpaid interest. On or after February 15, 2017, we may redeem the 2022 Notes, in whole or in part, at prices above the principal amount that decline over time, as specified in the indenture, together with accrued and unpaid interest. Additionally, prior to February 15, 2017, we may use the net cash proceeds of one or more equity offerings to redeem up to 35% of the aggregate principal amount of the 2022 Notes at a price equal to 105.875% of the principal amount together with accrued and unpaid interest.

5.500% Senior Notes due February 2025: On July 28, 2014, we issued $1.15 billion in principal amount of the 2025 Notes. Issuance costs for the 2025 Notes totaled $13 million.


65



The 2025 Notes contain covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our domestic restricted subsidiaries (which are generally subsidiaries in the U.S. in which we own at least 80% of the voting stock) to (1) create or incur certain liens and enter into sale and lease-back transactions, (2) create, assume, incur or guarantee certain additional secured indebtedness and unsecured indebtedness of certain of our domestic restricted subsidiaries, and (3) consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our assets, to another entity. These covenants are subject to a number of limitations, exceptions and qualifications.

Cash Redemption at Our Option: Prior to August 1, 2019, we may redeem the 2025 Notes, in whole or in part, at a price equal to the principal amount of the 2025 Notes to be redeemed plus a make-whole premium as described in the indenture governing the 2025 Notes, together with accrued and unpaid interest. On or after August 1, 2019, we may redeem the 2025 Notes, in whole or in part, at prices above the principal amount that decline over time, as specified in the indenture, together with accrued and unpaid interest. Additionally, prior to August 1, 2017, we may use the net cash proceeds of one or more equity offerings to redeem up to 35% of the aggregate principal amount of the 2025 Notes at a price equal to 105.5% of the principal amount together with accrued and unpaid interest.

2013 Debt Restructure

During 2013, we repurchased $464 million of aggregate principal amount of our 2014 Notes for $477 million in cash in privately negotiated transactions. The liability and equity components of the 2014 Notes had previously been stated separately within debt and additional capital in our consolidated balance sheet. As a result, the repurchase resulted in the derecognition of $431 million in debt for the principal amount (net of $33 million of debt discount) and $15 million in additional capital for the equity component. We recognized a loss of $31 million (based on Level 2 fair value measurements) in 2013, which was included in other non-operating expense.

MMJ Creditor Installment Payments

The Elpida Companies are currently subject to corporate reorganization proceedings underUnder the Corporate Reorganization Act of Japan. Both of the Elpida Companies have adoptedMMJ Companies' plans of reorganization, which set forth the treatment of the ElpidaMMJ Companies' pre-petition creditors and their claims, which plansthe MMJ Companies were approved byrequired to pay 200 billion yen, less certain expenses of the Elpidareorganization proceedings and other items, to their secured and unsecured creditors in seven annual installment payments (the "MMJ Creditor Installment Payments"). The MMJ Creditor Installment Payments do not provide for interest and were recorded at fair value in the MMJ Acquisition. The fair-value discount is accreted to interest expense over the term of the installment payments.

Under the MMJ Companies' corporate reorganization proceedings, the secured creditors of MMJ will recover 100% of their amount of their fixed claims in 6 annual installment payments through December 2018 and the Tokyo District Court in February 2013. Under Elpida's plan of reorganization, securedunsecured creditors will recover 100%at least 17.4% of the amount of their fixed claims andin 7 annual installment payments through December 2019. In October 2013, we paid the first installment payment of 51 billion yen to the reorganization creditors of the MMJ Companies. The secured creditors of MAI were paid in full with a portion of the first installment payment made in October 2013, while the unsecured creditors of MAI will recover at least 17.4%19% of the amount of their fixed claims. The actual recovery of unsecured creditors will be higher, however, based on events and circumstances that occur following the plan approval.claims in 7 installment payments through December 2019. The remaining portion of the unsecured claims of the creditors of the MMJ Companies not recovered pursuant to the Reorganization Proceedings will be discharged, without payment, overthrough December 2019.

The following table presents the period that payments are made pursuant to the plansremaining amounts of reorganization. The plans of reorganization provide for the Elpida Companies' pre-petition creditors to be paidMMJ Creditor Installment Payments (stated in seven installments. Elpida's secured creditors will be paid in full on or before the sixth installment payment date, while the unsecured creditors will be paid in seven installments. Akita's plan of reorganization provides that secured creditors will recover 100% ofJapanese yen and U.S. dollars) and the amount of their claims, whereas unsecured creditors will recover at least 19% of the amount of their claims. The secured creditors of Akita will be paid in full on the first installment payment date, while the unsecured creditors will be paid in seven installments.

Under the terms and conditions of the Elpida Companies' respective plans of reorganization, the Elpida Companies are obligated to pay 200 billion yen (or the equivalent of $2.05 billion based on exchange ratesunamortized discount as of August 29, 2013), less certain expenses of their reorganization proceedings and certain other items, to the secured and unsecured creditors (the "Elpida Creditor Installment Payments") in respect of the Elpida Companies' pre-petition creditors and their related claims. Substantially all of the $615 million we paid in connection with the acquisition of Elpida was deposited into accounts that are legally restricted for payment to the secured and unsecured creditors of Elpida in October 2013. The remaining 140 billion yen is due in six annual installments payable at the end of each calendar year beginning in 2014, with payments of 20 billion yen in each of 2014 through 2017, and payments of 30 billion yen in each of 2018 and 2019. 28, 2014:

  MMJ Creditor Installment Payments
2015 ¥20,330
 $196
2016 20,197
 194
2017 20,063
 193
2018 19,928
 192
2019 28,674
 276
2020 33,024
 318
  142,216
 1,369
Less unamortized discount (24,700) (238)
MMJ Creditor Installment Payments ¥117,516
 $1,131

66



Pursuant to the terms of the Sponsor Agreement, we entered into a series of agreements with the ElpidaMMJ Companies, including supply agreements, research and development services agreements and general services agreements, which are intended to generate more stable operating cash flows to meet the requirements of the ElpidaMMJ Companies' businesses, including the funding of the ElpidaMMJ Creditor Installment Payments.


70



The remaining 140 billion yen of installment payments are also to be deposited into accounts that are legally restricted for settlement of the Elpida Creditor Installment Payments and will be directed by the trustees of the Elpida Companies to the secured and unsecured creditors of the Elpida Companies. A portion of the amounts are also subject to adjustment for certain expenses of the reorganization proceedings and certain other items. Additionally, settlements of certain pre-petition intercompany obligations between Elpida, Akita and Rexchip are included in the amounts scheduled to be deposited into the restricted cash account, but are eliminated in consolidation and therefore are excluded from our consolidated obligation to the secured and unsecured creditors of the Elpida Group. Also, a portion of each installment amount payable to the creditors of the Elpida Companies will continue to be restricted by the trustees of the Elpida Companies in the event that any outstanding claims, which were not treated as fixed claims under the plans of reorganization at the time the plans were filed with the Japan Court, become fixed claims. These fixed claims will be paid under the plans of reorganization in the same manner as the fixed claims of other creditors. To the extent the aggregate amounts reserved from the installment payments exceed the aggregate amounts payable with respect to these unfixed claims once they become fixed, the excess amounts reserved will be distributed to unsecured creditors with respect to their fixed claims, resulting in an increased recovery for the unsecured creditors out of the installment payments. To the extent the aggregate amounts reserved are less than the aggregate amounts payable with respect to these unfixed claims once they become fixed, the Elpida Companies would be responsible to fund any shortfall to ensure that the creditors receive the minimum recovery to which they are entitled under the plans of reorganization with respect to these claims. As a result, there is a possibility that the total amount payable by the Elpida Companies to their creditors under the plans of reorganization will exceed 200 billion yen. In addition, certain of these unfixed claims may be resolved pursuant to settlement arrangements or other post-petition agreements and a substantial portion of the amounts payable under such agreements may have to be funded by the Elpida Companies outside of the plans of reorganization.

The Elpida Creditor Installment Payments were recognized at the acquisition date fair value, which reflects the present value of the Elpida Creditor Installment Payments, discounted using a rate based on indices of leveraged loan markets, adjusted for security-specific risks of the installment payments. As of August 29, 2013, the discount is being accreted to interest expense over the remaining term of the Elpida Creditor Installment Payments, resulting in an effective interest rate of 6.25%.

The following table presents the amounts scheduled under the Sponsor Agreement to be restricted for settlement of the Elpida Creditor Installment Payments, the estimated amounts payable to the secured and unsecured creditors of the Elpida Companies (stated in Japanese yen and U.S. dollars) and the amount of unamortized discount.

As of August 29, 2013 Scheduled Deposits of Restricted Cash Estimated Payments to Elpida Creditors
July 31, 2013 ¥60,000
 ¥
 $
2014 
 52,270
 532
2015 20,000
 20,267
 206
2016 20,000
 20,135
 205
2017 20,000
 20,003
 204
2018 20,000
 19,871
 202
2019 30,000
 28,508
 290
2020 30,000
 32,242
 330
  ¥200,000
 ¥193,296
 $1,969
Less unamortized discount     (325)
Elpida Creditor Installment Payments     $1,644


71



Capital Lease Obligations

We have various capital lease obligations due in periodic installments with a weighted-average remaining term of 4.04.1 years and weighted-average effective interest rates of 4.1%as of 2013 and 4.9% as of 2012.August 28, 2014. In 2013, we received $126 million in proceeds from equipment sale-leaseback transactions and as a result recorded capital lease obligations aggregating $126 million at a weighted-average effective interest rate of 4.3%, payable in periodic installments through July 2017. On July 31, 2013, in connection with our acquisition of the Elpida Companies and purchase of the Rexchip shares from Powerchip, we recorded $377 million of capital lease obligations at a weighted-average effective interest rate of 3.2%, payable in periodic installments with a weighted-average remaining term of 5.5 years. In 2012, we received $609 million in proceeds from equipment sale-leaseback transactions and as a result recorded capital lease obligations aggregating $609 million at a weighted-average effective interest rate of 4.2%, payable in periodic installments through August, 2016.


Convertible Notes With Debt and Equity Components

The accountingAccounting standards for convertible debt instruments that may be fully or partially settled in cash upon conversion require the debt and equity components to be separately accounted for in a manner that reflects oura nonconvertible borrowing rate when interest expense is recognized in subsequent periods. The amount initially recorded as debt is based on the fair value of the debt component as a standalone instrument, determined using an average interest rate for similar nonconvertible debt issued by entities with credit ratings comparablesimilar to ours at the time of issuance. The difference between the debt recorded at inception and its principal amount is to be accreted to principal through interest expense through the estimated life of the note.

Conversion prices per share and the conversion value in excessThe terms of principal for our convertible notes were as follows:give holders the right to require us to repurchase all or a portion of their notes at a date or dates earlier than the contractual maturity of the notes or upon the occurrence of certain events or circumstances. In these cases, we amortize any initial debt discount or imputed interest over the period from issuance of the notes through the earliest date that holders can require us to repurchase all or a portion of their notes. As a result, the period of amortization can be significantly shorter than the contractual maturity. (See "Holder Put Date" in the table below.)

  Initial Conversion 
Conversion Price Per Share Threshold(2)
 
Conversion Value
in Excess of Principal(3)
  Outstanding Principal Price Per Share 
Number of Shares(1)
  2013 2012
2014 Notes $485
 14.23 34.1
 18.50 $
 $
2027 Notes 175
 10.90 16.1
 14.17 43
 
2031A Notes 345
 9.50 36.3
 12.35 148
 
2031B Notes 345
 9.50 36.3
 12.35 148
 
2032C Notes 550
 9.63 57.1
 12.52 225
 
2032D Notes 450
 9.98 45.1
 12.97 162
 
2033E Notes 300
 10.93 27.4
 14.21 72
 
2033F Notes 300
 10.93 27.4
 14.21 72
 
(1)Shares issuable, upon conversion, forAs of August 28, 2014, the principal amount of the notes.
(2)Holders may convert their notes during any calendar quarter if the closingtrading price of our common stock for at least 20 trading days in a 30 trading day period ending on the last trading day of the immediately preceding calendar quarter is 130% ofwas higher than the initial conversion price per share.
(3)Based onprices of all of our closing share priceoutstanding convertible notes. As a result, the conversion values were in excess of $13.57 and $6.18principal amounts for such notes. The following table summarizes certain features of our convertible notes outstanding as of August 29, 2013 and August 30, 2012, respectively.28, 2014:

  Holder Put Date Outstanding Principal Underlying Shares Initial Conversion Price Per Share 
Conversion Price Per Share Threshold(1)
 
Conversion Value in Excess of Principal(2)
2032C Notes May 2019 $362
 38
 $9.63
 $12.52
 $873
2032D Notes May 2021 344
 34
 9.98
 12.97
 785
2033E Notes February 2018 300
 27
 10.93
 14.21
 600
2033F Notes February 2020 300
 27
 10.93
 14.21
 600
2043G Notes(3)
 November 2028 1,025
 35
 29.16
 37.91
 128
    $2,331
 161
     $2,986
(1)
Holders have the right to convert all or a portion of their notes at a date or dates earlier than the contractual maturity if, during any calendar quarter, the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the initial conversion price.
(2)
Based on our closing share price of $32.81 as of August 28, 2014.
(3)
The original principal amount of $820 million accretes up to $917 million in November 2028 and $1.03 billion at maturity in 2043.


7267



The debt and equity components of all of our convertible notes outstanding as of August 29, 201328, 2014 were required to be accounted for separately. Principal and carrying amounts of the liability components for our convertible notes were as follows:

As of 2013 2012 2014 2013
 
Term
(Years)(1)
 Outstanding Principal Unamortized Discount Net Carrying Amount Outstanding Principal Unamortized Discount Net Carrying Amount 
Term
(Years)(1)
 Outstanding Principal Unamortized Discount Net Carrying Amount Outstanding Principal Unamortized Discount Net Carrying Amount
2014 Notes 1 $485
 $(20) $465
 $949
 $(89) $860
 N/A $
 $
 $
 $485
 $(20) $465
2027 Notes 4 175
 (28) 147
 175
 (34) 141
 N/A 
 
 
 175
 (28) 147
2031A Notes 5 345
 (68) 277
 345
 (80) 265
 N/A 
 
 
 345
 (68) 277
2031B Notes(2) 7 345
 (92) 253
 345
 (102) 243
N/A 114
 (27) 362
 345
 (92) 253
2032C Notes 6 550
 (87) 463
 550
 (99) 451
 5 362
 (48) 314
 550
 (87) 463
2032D Notes 8 450
 (81) 369
 450
 (89) 361
 7 344
 (56) 288
 450
 (81) 369
2033E Notes 4 300
 (28) 272
 
 
 
 3 300
 (22) 278
 300
 (28) 272
2033F Notes 6 300
 (40) 260
 
 
 
 5 300
 (35) 265
 300
 (40) 260
2043G Notes 14 1,025
 (389) 636
 
 
 
 $2,445
 $(577) $2,143
 $2,950
 $(444) $2,506
(1)(1)
Expected term for amortization of the remaining debt discount as of August 28, 2014. The expected term of the 2031B Notes was not applicable because substantially all of the holders had exercised their option to convert their notes, which were settled in cash in the first quarter of 2015.
(2) As holders had elected to convert these notes and we elected to settle the conversions in cash, net carrying amount for 2014 included the debt and equity components, which was reclassified as a result of our obligation to settle the conversions of the remaining debt discount as of August 29, 2013.2031B Notes.

Carrying amounts of the equity components, which are included in additional capital in the accompanying consolidated balance sheets, for our convertible notes, were as follows:

As of 2013 2012 2014 2013
2014 Notes $353
 $368
 $
 $353
2027 Notes 40
 40
 
 40
2031A Notes 89
 89
 
 89
2031B Notes 109
 109
 
 109
2032C Notes 101
 101
 67
 101
2032D Notes 90
 90
 69
 90
2033E Notes 30
 
2033F Notes 42
 
2033E Notes (excludes $22 million as of 2014 in mezzanine equity) 8
 30
2033F Notes (excludes $35 million as of 2014 in mezzanine equity) 7
 42
2043G Notes 173
 
 $324
 $854


7368



Interest expense for our convertible notes consisting of contractual interest and amortization of discount and issuance costs aggregated $132 million, $156 million and $124 million for 2014, 2013 and 2012. Interest expense by note was as follows:

For the year ended 2013 2012 2011
Contractual interest expense:      
2014 Notes, stated rate of 1.875% $13
 $18
 $19
2027 Notes, stated rate of 1.875% 3
 3
 3
2031A Notes, stated rate of 1.5% 5
 5
 1
2031B Notes, stated rate of 1.875% 6
 6
 1
2032C Notes, stated rate of 2.375% 13
 5
 
2032D Notes, stated rate of 3.125% 14
 5
 
2033E Notes, stated rate of 1.625% 3
 
 
2033F Notes, stated rate of 2.125% 3
 
 
  60
 42
 24
       
Amortization of discount and issuance costs:      
2014 Notes, effective rate of 7.9% 37
 47
 46
2027 Notes, effective rate of 6.9% 7
 6
 5
2031A Notes, effective rate of 6.5% 12
 11
 1
2031B Notes, effective rate of 7.0% 10
 10
 1
2032C Notes, effective rate of 6.0% 14
 5
 
2032D Notes, effective rate of 6.3% 9
 3
 
2033E Notes, effective rate of 4.5% 4
 
 
2033F Notes, effective rate of 4.9% 3
 
 
  96
 82
 53
  $156
 $124
 $77
  Contractual Interest Amortization of Discount and Issuance Costs
For the year ended 2014 2013 2012 2014 2013 2012
2014 Notes $2
 $13
 $18
 $14
 $37
 $47
2027 Notes 1
 3
 3
 2
 7
 6
2031A Notes 1
 5
 5
 3
 12
 11
2031B Notes 3
 6
 6
 5
 10
 10
2032C Notes 11
 13
 5
 12
 14
 5
2032D Notes 13
 14
 5
 8
 9
 3
2033E Notes 5
 3
 
 7
 4
 
2033F Notes 6
 3
 
 6
 3
 
2043G Notes 24
 
 
 9
 
 
  $66
 $60
 $42
 $66
 $96
 $82

20142019 Notes

In May 2007,On December 20, 2013, we issued $1.3 billion of aggregate$462 million in principal amount of the 20142019 Notes. The 2019 Notes due June 2014,mature on January 15, 2019 and are collateralized by certain equipment, which had a carrying value of which $464$190 million was repurchased on February 12, 2013 and $351 million was extinguished in 2011 in connection with debt restructures (see "Debt Restructure" below). as of August 28, 2014. The initial conversion rate of the 2014 Notes is 70.2679 shares of common stock per $1,000 principal amount, or approximately $14.23 per share. Interest is payable in June and December of each year.

Conversion Rights: Holders may convert their 2014 Notes under the following circumstances: (1) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is more than 130% of the conversion price of the 2014 Notes (approximately $18.50 per share); (2) if the 2014 Notes have been called for redemption; (3) if specified distributions or corporate events occur, as set forth in the indenture for the 2014 Notes; (4) if the trading price of the 2014 Notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the 2014 Notes during the periods specified in the indenture; or (5) at any time on or after March 1, 2014.

We have the option to pay cash, issue shares of common stock or any combination thereof for the aggregate amount due upon conversion. It is our intent to settle the principal amount of the 20142019 Notes is payable in cash upon conversion. As a result, upon conversion10 semi-annual installments in January and July of each year, commencing in July 2014. The Export-Import Bank of the 2014 Notes, onlyUnited States (the "Ex-Im Bank") guaranteed payment of all regularly scheduled installment payments of principal of, and interest on, the amounts payable in excess2019 Notes. We paid $23 million to Ex-Im Bank for its guarantee upon issuance of the principal amounts2019 Notes.

The 2019 Notes contains covenants which are customary for financings of this type, including negative covenants that limit or restrict our ability to create liens or dispose of the 2014 Notes are consideredequipment securing the 2019 Notes. Events of default also include, among others, the occurrence of any event or circumstance that, in diluted earnings per sharethe reasonable judgment of Ex-Im Bank, is likely materially and adversely to affect our ability to perform any payment obligation, or any of our other material obligations under the treasury stock method.indenture, the 2019 Notes or under any other related transaction documents to which Ex-Im Bank is a party.

Cash Redemption at Our OptionOption:: We At any time prior to the maturity date of the 2019 Notes, we may redeem for cash the 20142019 Notes, if the last reported sale price of our common stock has been at least 130% of the conversion price (approximately $18.50 per share) for at least 20 trading days during any 30 consecutive trading-day period. The redemption price is the principal amount to be redeemed, plus accrued and unpaid interest.

Cash Repurchase at the Option of the Holder: Upon a change in controlwhole or a termination of trading, as defined in the indenture, holders may require us to repurchase for cash all or a portion of their 2014 Notes at a repurchase price equal to the principal amount, plus accrued and unpaid interest, if any.


74



2027 Notes

In connection with a debt restructure in 2011 (see "Debt Restructure" below), we issued $175 million of the 2027 Notes due June 2027. The initial conversion rate is 91.7431 shares of common stock per $1,000 principal amount or approximately $10.90 per share, and is subject to adjustment upon the occurrence of certain events specified in the indenture.

Conversion Rights: Holders may convert their 2027 Notes under the following circumstances: (1) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is more than 130% of the conversion price (approximately $14.17 per share); (2) if the 2027 Notes have been called for redemption; (3) if specified distributions or corporate events occur; (4) if the trading price of the 2027 Notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the 2027 Notes during the period specified in the indenture; (5) upon our election to terminate the conversion right of the 2027 Notes; or (6) after March 1, 2027.

Upon conversion, we will pay cash up to the aggregate principal amount and shares of common stock or cash, at our option, for any remaining conversion obligation. As a result of the conversion provisions in the indenture, upon conversion of the 2027 Notes, only the amounts payable in excess of the principal amounts of the 2027 Notes are considered in diluted earnings per share under the treasury stock method.

Cash Redemption at Our Option: We may redeem for cash the 2027 Notes on or after June 1, 2014part, at a price equal to the principal amount of the 2019 Notes to be redeemed plus a make-whole premium as described in the indenture, together with accrued and unpaid interest.

Cash Repurchase at the Option of the Holder: We may be required by the holders of the 2027 Notes to repurchase for cash the 2027 Notes on June 1, 2017. The repurchase price is equal to the principal amount, plus accrued and unpaid interest. Upon a change in control or a termination of trading, as defined in the indenture, we may be required by the holders of the 2027 Notes to repurchase for cash all or a portion of their 2027 Notes at a repurchase price equal to the principal amount plus accrued and unpaid interest.

Termination of Conversion Rights: We may elect to terminate the conversion right of the 2027 Notes if the daily volume weighted average price of our common stock is greater than or equal to 130% of the conversion price (approximately $14.17 per share) for at least 20 trading days during any 30 consecutive trading day period. If we terminate the conversion right prior to June 1, 2014 and any 2027 Notes are converted in connection with the termination, we will pay a make-whole premium equal to the accrued interest as of the conversion date plus the present value of remaining interest that would have been paid through June 1, 2014, discounted using a U.S. Treasury bond with an equivalent term. Subject to the terms of the indenture, we may, at our election, deliver shares of common stock in lieu of cash with respect to this make-whole payment.

2031A and 2031B Notes

On July 26, 2011, we issued $345 million of the 2031A Notes and $345 million of 2031B Notes (collectively referred to as the "2031 Notes"), each due August 2031. The initial conversion rate for the 2031 Notes is 105.2632 sharesDuring 2014, we exchanged $205 million of common stock per $1,000 principal amount, equivalent to an initial conversion price of approximately $9.50 per share of common stock. Interest is payable in February and August of each year.

Conversion Rights: Holders may convert their 2031 Notes under the following circumstances: (1) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price of the 2031 Notes (approximately $12.35 per share); (2) if the 2031 Notes are called for redemption; (3) if specified distributions or corporate events occur, as set forth in the indenture for the 2031 Notes; (4) if the trading price of the 2031 Notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the 2031 Notes during the periods specified in the indenture; or (5) at any time after May 1, 2031.

Upon conversion, we will pay cash up to the lesser of the aggregate principal amount andin the conversion value and cash, sharesExchange Transaction, repurchased $26 million of common stock or a combination ofaggregate principal amount for cash and shares of common stock, at our option,called for any remaining conversion obligations. As a resultthe redemption of the conversion provisions in the indenture, upon conversionremaining $114 million of the 2031 Notes, only the amounts payable in excess of the principal amounts of the 2031 Notes are considered in diluted earnings per share under the treasury stock method.


75



Cash Redemption at Our Option: We may redeem for cash the 2031A Notes on or after August 5, 2013 and the 2031B Notes on or after August 5, 2014 if the last reported sale price of our common stock has been at least 130% of the conversion price (approximately $12.35 per share) for at least 20 trading days during any 30 consecutive trading day period. The redemption price will equal theaggregate principal amount plus accrued and unpaid interest. If we redeem the 2031A Notes prioreffective on August 22, 2014. Prior to August 5, 2015, or the 2031B Notes prior to August 5, 2016, we will also pay a make-whole premium in cash equal to the present valuesuch effective date, substantially all of all remaining scheduled payments of interest on the 2031 Notes from the redemption date to August 5, 2015 for the 2031A Notes and through August 5, 2016 for the 2031B Notes, using a discount rate equal to 150 basis points.

Cash Repurchase at the Option of the Holder: We may be required by the holders of the 2031 Notes to repurchase for cash all or a portion of the 2031A Notes on August 1, 2018 and all or a portion of the 2031B Notes on August 1, 2020. The repurchase price is equal to the principal amount, plus accrued and unpaid interest. Upon a changehad converted their notes, which were settled in control or a terminationcash with payments of trading, as defined$389 million in the indenture, we may be required by the holdersfirst quarter of the 2031 Notes to repurchase for cash all or a portion of their 2031 Notes at a repurchase price equal to the principal amount plus accrued and unpaid interest.2015.

2032C and 2032D Notes

On April 18, 2012, we issued $550 million of the 2032C Notes and $450 million of the 2032D Notes, (collectively referred to as the "2032 Notes"), each due May 2032. The initial conversion rate for the 2032C Notes is 103.8907 shares of common stock per $1,000 principal amount, equivalent to an initial conversion price of approximately $9.63 per share of common stock. The initial conversion rate for the 2032D Notes is 100.1803 shares of common stock per $1,000 principal amount, equivalent to an initial conversion price of approximately $9.98 per share of common stock. Interest is payable in May and November of each year. During 2014, we repurchased in privately-negotiated transactions $188 million and $106 million of aggregate principal amounts of the 2032C and 2032D Notes, respectively, for cash.


69



Conversion Rights: Holders may convert their 2032 Notes under the following circumstances: (1) if the 2032 Notes are called for redemption; (2) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price of the 2032 Notes (approximately $12.52 per share for the 2032C Notes and $12.97 per share for the 2032D Notes) of the 2032C or 2032D Notes;; (3) if the trading price of the 2032C or 2032D2032 Notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the 2032C or 2032D2032 Notes during the periods specified in the indenture; (4) if specified distributions or corporate events occur, as set forth in the indenture for the 2032 Notes; or (5) at any time after February 1, 2032.

We have the option to pay cash, issue shares of common stock or any combination thereof for the aggregate amount due upon conversion. It is our intent to settle the principal amount of the 2032 Notes in cash upon any conversion. As a result, upon conversion of the 2032 Notes, only the amounts payable in excess of the principal amounts upon conversion of the 2032 Notes are considered in diluted earnings per share under the treasury stock method.

Cash Redemption at Our Option: We may redeem for cash the 2032C Notes on or after May 1, 2016 and the 2032D Notes on or after May 1, 2017 if the volume weighted average price of our common stock has been at least 130% of the conversion price (approximately $12.52 per share for the 2032C Notes and $12.97 per share for the 2032D Notes) for at least 20 trading days during any 30 consecutive trading day period. The redemption price will equal the principal amount plus accrued and unpaid interest. If we redeem the 2032C Notes prior to May 4, 2019, or the 2032D Notes prior to May 4, 2021, we will also pay a make-whole premium in cash equal to the present value of all remaining scheduled payments of interest from the redemption date to May 4, 2019 for the 2032C Notes, or to May 4, 2021 for the 2032D Notes, using a discount rate equal to 150 basis points.1.50%.

Cash Repurchase at the Option of the Holder: We may be required by the holders of the 2032 Notes to repurchase for cash all or a portion of the 2032C Notes on May 1, 2019 and all or a portion of the 2032D Notes on May 1, 2021. The repurchase2021 at a price is equal to the principal amount plus accrued and unpaid interest. Upon a change in control or a termination of trading, as defined in the indenture, holders of the 2032 Notes may require us to repurchase for cash all or a portion of their 2032 Notes at a repurchase price equal to the principal amount plus accrued and unpaid interest.


76



2033E and 2033F Notes

On February 12, 2013, we issued $300$300 million of Convertible Senior Notes due February 2033 (the "2033E Notes") and $300 million of Convertible Senior Notes due February 2033 (the "2033F Notes" and together with the 2033E Notes and $300 million of the "2033 Notes"). Issuance costs for the 2033 Notes totaled $16 million.2033F Notes. The initial conversion rate for the 2033 Notes is 91.4808 shares of common stock per $1,000$1,000 principal amount, equivalent to an initial conversion price of approximately $10.93 per share of common stock. Interest is payable in February and August of each year.

Upon issuance of the 2033 Notes, we recorded $526 million of debt, $72 million of additional capital and $14 million of deferred debt issuance costs (included in other noncurrent assets). The amount recorded as debt was based on the fair value of the debt component as a standalone instrument and was determined using an average interest rate for similar nonconvertible debt issued by entities with credit ratings comparable to ours at the time of issuance (Level 2 fair value measurements). The difference between the debt recorded at inception and the principal amount ($31 million for the 2033E Notes and $43 million for the 2033F Notes) is being accreted to principal as interest expense through February 2018 for the 2033E Notes and February 2020 for the 2033F Notes, the expected life of the notes.

Conversion Rights: Holders may convert their 2033 Notes under the following circumstances: (1) if the 2033 Notes are called for redemption; (2) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price (approximately $14.21 per share) of the 2033 Notes;Notes (approximately $14.21 per share); (3) if the trading price of the 2033 Notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the 2033 Notes during the periods specified in the indenture; (4) if specified distributions or corporate events occur, as set forth in the indenture for the 2033 Notes; or (5) at any time after November 15, 2032.

Upon conversion, we will pay cash equal to the lesser of the aggregate principal amount and the conversion value of the notes being converted and cash, shares of common stock or a combination of cash and shares of common stock, at our option, for any remaining conversion obligation. As a result, upon conversion of the 2033 Notes, only the amounts payable in excess of the principal amounts upon conversion of the 2033 Notes are considered in diluted earnings per share under the treasury stock method.

Cash Redemption at Our Option: We may redeem for cash the 2033E Notes on or after February 20, 2018 and the 2033F Notes on or after February 20, 2020. The redemption2020 at a price will equal the principal amount plus accrued and unpaid interest.

Cash Repurchase at the Option of the Holder: We may be required by the holders of the 2033 Notes to repurchase for cash all or a portion of the 2033E Notes on February 15, 2018 and on February 15, 2023 and all or a portion of the 2033F Notes on February 15, 2020 and on February 15, 2023. The repurchase2023 at a price is equal to the principal amount plus accrued and unpaid interest. Upon a change in control or a termination of trading, as defined in the indenture, holders of the 2033 Notes may require us to repurchase for cash all or a portion of their 2033 Notes at a repurchase price equal to the principal amount plus accrued and unpaid interest.


70



2043G Notes

In connection with the Exchange Transactions, on November 12, 2013, we issued $1.03 billion principal amount of the 2043G Notes. Each $1,000 of principal amount at maturity had an original issue price of $800. An amount equal to the difference between the original issue price and the principal amount at maturity will accrete in accordance with a schedule set forth in the indenture.  The initial conversion rate for the 2043G Notes is 34.2936 shares of common stock per $1,000 principal amount at maturity, equivalent to an initial conversion price of approximately $29.16 per share of common stock.

Upon issuance of the 2043G Notes, we recorded $627 million of debt, $173 million of additional capital and $5 million of deferred debt issuance costs (included in other noncurrent assets). The amount recorded as debt was based on the fair value of the debt component as a standalone instrument and was determined using an interest rate for similar nonconvertible debt issued by entities with credit ratings comparable to ours at the time of issuance (Level 2 fair value measurements). We recorded a debt discount of $398 million for the difference between the debt recorded at inception and the principal amount at maturity. Holders of the 2043G Notes have the right to require us to repurchase all or a portion of their notes on November 15, 2028 at the accreted principal amount, which is scheduled to be $917 million at such date. We have the option to pay cash, issue shares of common stock or any combination thereof, for the aggregate amount due upon conversion. It is our current intent to settle in cash the principal amount of the 2043G Notes upon conversion. As a result, the dilutive effect of the 2043G Notes in earnings per share is computed under the treasury stock method.

Conversion Rights: Holders may convert their 2043G Notes under the following circumstances: (1) if the 2043G Notes are called for redemption; (2) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price of the 2043G Notes (approximately $37.91 per share); (3) if the trading price of the 2043G Notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the 2043G Notes during the periods specified in the indenture; (4) if specified distributions or corporate events occur, as set forth in the indenture; or (5) at any time after August 15, 2043.

Cash Redemption at Our Option: Prior to November 20, 2018, we may redeem for cash the 2043G Notes if the closing price of our common stock is more than 130% of the conversion price for at least 20 trading days in the 30 consecutive trading days ending within five trading days prior to the date on which we provide notice of redemption at a redemption would equal to the principal amount at maturity plus accrued and unpaid interest. On or after November 20, 2018, we may redeem for cash the 2043G Notes without regard to the closing price of our common stock at a price equal the accreted principal amount plus accrued and unpaid interest. If we redeem the 2043G Notes prior to November 20, 2018, we are required to pay in cash a make-whole premium as specified in the indenture.

Cash Repurchase at the Option of the Holder: Holders of the 2043G Notes may require us to repurchase for cash all or a portion of the 2043G Notes on November 15, 2028 at a price equal to the accreted principal amount at such date plus accrued and unpaid interest. Holders of the 2043G Notes may also require us to repurchase for cash all or a portion of their 2043G Notes at a price equal to the accreted principal amount plus accrued and unpaid interest upon a change in control or a termination of trading, as defined in the indenture.

Other Notes Payable

On August 27, 2013, we borrowed $312 million under a four-year term loan, collateralized by a security interest in certain production equipment. Principal iswas payable in equal quarterly installments, commencing on November 27, 2013. Interest accruesaccrued at a variable rate equal to the three-month London Interbank Offered Rate (“LIBOR”("LIBOR") rate plus a margin of 3.25% per annum, payable quarterly in arrears.annum. Also on August 27, 2013, we entered into a variable-for-fixed interest rate swap calculated on an aggregate notional amount equal to the scheduled outstanding balance of the loan. The interest rate swap effectively fixed the rate at 4.2% per annum. The facility agreement contains customary covenants, limitations or restrictions our ability to create liens or dispose ofOn August 27, 2014, we repaid the equipment securing the facility agreement. The facility also contains a covenant requiring us to ensure that the ratio of the outstanding loan to the fair marketremaining carrying value of $252 million of this note prior to its scheduled maturity and terminated the equipment that secures the loan does not exceed 0.8 to 1.0. If such ratio is exceeded, we are required to grant a charge over additional equipment and/or prepay the loan in an amount sufficient to reduce such ratio to 0.8 to 1.0 or less. The facility agreement also contains customary events of default which could result in the acceleration of all amounts and cancellation of all commitments under the facility agreement. As of August 29, 2013, the outstanding balance was $309 million.interest rate swaps.


77



On October 2, 2012, we entered into a facility agreement to obtain financing collateralized by semiconductorcertain production equipment.  Subject to customary conditions, we could draw up to $214 million under the facility agreement.  Amounts drawn arewere payable in 10 equal semi-annual installments beginning six months after the draw date.  On October 18, 2012, we drew $173$173 million with interest at 2.4% per annum.  On January 31, 2013, we drew the remaining $41available amount under the facility of $41 million with interest at 2.4% per annum. TheOn July 31, 2014, we repaid $32 million of this facility agreement contains customary covenantsprior to its scheduled maturity and events of default. Asas of August 29, 2013,28, 2014, the outstanding principal balance was $191$120 million. On October 17, 2014, subsequent to fiscal 2014, we repaid the remaining carrying value of $120 million. on this facility prior to its scheduled maturity date.


71



On July 31, 2013, in connection with our acquisition of the Elpida Companies and purchase of the Rexchip shares from Powerchip,MMJ Acquisition, we recorded a note payable of $120$120 million,, which is collateralized by buildingcertain property, plant and certain production equipment.  The note is denominated in New Taiwan dollars. Principal on the note is payable in equal quarterly installments through May 2016 and accrued interest is payable monthly.2016. Interest accrues at a variable rate of 0.85% above the secondary market rate for 90-day90-day New Taiwan dollar commercial paper, subject to a minimum interest rate of 2.50% per annum. As of August 29, 2013,28, 2014, the outstanding balance was $110$70 million.

On February 27, 2014, in connection with our acquisition of an additional 9.9% interest in MMT, we recorded a $127 million. note payable to the seller for the present value of the monthly installments, due from March 2014 through December 2014. (See "Equity – Noncontrolling Interests in Subsidiaries – MMT" note.) As of August 28, 2014, the outstanding balance was $52 million.

In connection with the IM Flash joint venture agreements, on April 6, 2012, we borrowed $65$65 million under a two-yeartwo-year senior unsecured promissory note from Intel, payable in approximately equal quarterly installments with interest at a rate of three-month LIBOR minus 50 basis points. The proceeds of the loan are to be used to fund purchases of equipment relatingnote was fully repaid in 2014 according to the research and development or manufacturing of certain emerging memory technologies. As of August 29, 2013, the outstanding balance was $25 million.scheduled terms. (See "Consolidated Variable Interest Entities"EquityIM Flash"Noncontrolling Interests in Subsidiaries – IMFT" note.)

Revolving Credit Facilities

On September 5, 2012, we entered into a three-year revolving credit facility. Under this credit facility, we can draw up to the lesser of $255 million or 80% of the net outstanding balance of certain trade receivables. Amountsreceivables, with any amounts drawn would be collateralized by a security interest in such receivables. The availability of the facility is subject to certain customary conditions, including the absence of any event or circumstance that has a material adverse effect on our business or financial condition. The revolving credit facility contains customary covenants and a repayment provision in the event that the maximum aging of the receivables exceeds a specified threshold. Interest is payable monthly on any outstanding principal balance at a variable rate equal to the 30-day Singapore Interbank Offering Rate plus 2.8% per annum. As of August 29, 2013,28, 2014, we had not drawn any of the $255 millionamounts available under this facility.

On June 27, 2013, we entered into a senior secured three-yearthree-year revolving credit facility, collateralized by a security interest in certain trade receivables. Under this facility, we can draw up to 85% of the net outstanding balance of certain trade receivables, subject to certain adjustments, including an availability block that has the effect of limiting the maximum committed draw amount to approximately $153 million.$153 million. The revolving credit facility contains customary covenants and conditions, including as a funding condition the absence of any event or circumstance that has a material adverse effect on our business or financial condition.  Generally, interest is payable on any outstanding principal balance at a variable rate equal to the LIBOR plus a spread from 1.5% to 2.0%, or at our option, at a rate equal to an alternate base rate (defined as the highest of (1) the prime rate, (2) one-month LIBOR plus 1.0% or (3) the Federal Funds Effective Rate) plus a spread from 0.5% to 1.0%. In either case, the spread added to the applicable interest rate basis varies depending upon the amount of the monthly average undrawn availability under the facility. As of August 29, 2013,28, 2014, we had not drawn any of the $153 millionamounts available under this facility.

2013 Notes Conversion

In 2012, we provided a written notice that we would redeem our 2013 convertible senior notes on June 4, 2012. As of June 4, 2012, the entire $139 million of principal amount of the 2013 Notes had been converted by holders into 27.3 million shares. We were required to pay a make-whole premium of $9 million, which is reflected in interest expense.


78



Debt Restructure

On February 12, 2013, we repurchased $464 million of aggregate principal amount of our 2014 Notes for $477 million in privately negotiated transactions. The liability and equity components of the 2014 Notes were stated separately pursuant to the accounting standards for convertible debt instruments that may be fully or partially settled in cash upon conversion. Accordingly, the repurchase resulted in the derecognition of $431 million in debt for the principal amount (net of $33 million of debt discount) and $15 million in additional capital for the equity component. We recognized a charge of $31 million associated with the early repurchase, based on the estimated $462 million fair value of the debt component and the $431 million carrying value (net of unamortized discount) of the notes repurchased. The fair value of the debt component was estimated using an interest rate for non-convertible debt, with terms similar to the debt component of the 2014 Notes on a stand-alone basis issued by entities with credit ratings similar to ours at the repurchase date (Level 2 fair value measurements).

In the first quarter of 2011, in connection with a series of debt restructure transactions with certain holders of our convertible notes, we recognized a loss of $111 million as follows:

$15 million on the exchange of $175 million in aggregate principal amount of our 2014 Notes for $175 million in aggregate principal amount of new 2027 Notes;
$17 million (including transaction fees) on the repurchase of $176 million in aggregate principal amount of our 2014 Notes for $171 million in cash; and
$79 million (including transaction fees) on the repurchase of $91 million in aggregate principal amount of our 2013 Notes for $166 million in cash.

Maturities of Notes Payable and Future Minimum Lease Payments

As of August 29, 2013,28, 2014, maturities of notes payable including(including the ElpidaMMJ Creditor Installment Payments,Payments) and future minimum lease payments under capital lease obligations were as follows:

As of August 29, 2013 Notes Payable Capital Lease Obligations
2014 $1,203
 $449
 Notes Payable Capital Lease Obligations
2015 367
 349
 $803
 $356
2016 356
 307
 352
 301
2017 500
 85
 320
 103
2018 869
 41
 602
 60
2019 and thereafter 2,263
 135
Discounts and interest, respectively (773) (114)
2019 684
 55
2020 and thereafter 3,628
 123
Unamortized discounts and interest, respectively (707) (87)
 $4,785
 $1,252
 $5,682
 $911




7972



Commitments

As of August 29, 201328, 2014, we had commitments of approximately $775 million1.18 billion for the acquisition of property, plant and equipment.  We lease certain facilities and equipment under operating leases.  Total rental expense was $4157 million, $4841 million and $6948 million for 20132014, 20122013 and 20112012, respectively.  As of August 29, 2013, minimumMinimum future rental commitments areas of August 28, 2014 were as follows:

As of August 29, 2013 Operating Lease Commitments
2014 $22
 Operating Lease Commitments
2015 14
 $22
2016 12
 18
2017 11
 14
2018 10
 13
2019 and thereafter 37
2019 12
2020 and thereafter 37
 $106
 $116


Contingencies

We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations or financial condition.

Patent Matters

As is typical in the semiconductor and other high technology industries, from time to time others have asserted, and may in the future assert, that our products or manufacturing processes infringe their intellectual property rights.

We are engaged in litigation with Rambus Inc. ("Rambus") relating to certain of Rambus' patents and certain of our claims and defenses. Our lawsuits with Rambus related to patent matters are pending in the U.S. District Court for the District of Delaware, U.S. District Court for the Northern District of California, Germany, France, and Italy. On August 28, 2000, we filed a complaint against Rambus in the U.S. District Court for the District of Delaware seeking declaratory and injunctive relief. The complaint alleges, among other things, various anticompetitive activities and also seeks a declaratory judgment that certain Rambus patents are invalid and/or unenforceable. Rambus subsequently filed an answer and counterclaim in Delaware alleging, among other things, infringement of twelve Rambus patents and seeking monetary damages and injunctive relief. We subsequently added claims and defenses based on Rambus' alleged spoliation of evidence and litigation misconduct. The spoliation and litigation misconduct claims and defenses were heard in a bench trial before Judge Robinson in October 2007. On January 9, 2009, Judge Robinson entered an opinion in our favor holding that Rambus had engaged in spoliation and that the twelve Rambus patents in the suit were unenforceable against us. Rambus subsequently appealed the decision to the U.S. Court of Appeals for the Federal Circuit. On May 13, 2011, the Federal Circuit affirmed Judge Robinson's finding of spoliation, but vacated the dismissal sanction and remanded the case to the Delaware District Court for analysis of the remedy based on the Federal Circuit's decision. On January 2, 2013, Judge Robinson entered a new opinion in our favor holding that Rambus had engaged in spoliation, that Rambus' spoliation was done in bad faith, that the spoliation prejudiced us, and that the appropriate sanction was to declare the twelve Rambus patents in the suit unenforceable against us.  On March 27, 2013, Rambus filed a notice of appeal to the U.S. Court of Appeals for the Federal Circuit. Separately, on January 13, 2006, Rambus filed a lawsuit against us in the U.S. District Court for the Northern District of California alleging that certain of our DDR2, DDR3, RLDRAM and RLDRAM II products infringe as many as fourteen Rambus patents and seeking monetary damages, treble damages, and injunctive relief. The Northern District of California Court stayed the trial of the patent phase of the Northern District of California case upon appeal of the Delaware spoliation issue to the Federal Circuit.


80



On September 1, 2011, HSM Portfolio LLC and Technology Properties Limited LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and seventeen other defendants, including Elpida Memory, Inc. and Elpida Memory (USA) Inc. (collectively "Elpida"). The complaint alleges that certain of our DRAM and image sensor products infringe two U.S. patents and that certain Elpida DRAM products infringe two U.S. patents and seeks damages, attorneys' fees, and costs. On March 23, 2012, Elpida filed a Notice of Filing and Hearing on Petition Under Chapter 15 of the U.S. Bankruptcy Code and Issuance of Provisional Relief that included an order of the U.S. Bankruptcy Court for the District of Delaware staying judicial proceedings against Elpida. Accordingly, the plaintiffs' case against Elpida is stayed. On August 21, 2013, the Court granted a motion by the plaintiffs to amend the complaint to assert two additional patents against us and one additional patent against Elpida.

On September 9, 2011, Advanced Data Access LLC filed a patent infringement action in the U.S. District Court for the Eastern District of Texas (Tyler) against us and seven other defendants. On November 16, 2011, Advanced Data Access filed an amended complaint. The amended complaint alleged that certain of our DRAM products infringed two U.S. patents and sought injunctive relief, damages, attorneys' fees, and costs. On March 20, 2013, we executed a settlement agreement resolving this litigation. The settlement amount did not have a material effect on our business, results of operations or financial condition.

On September 14, 2011, Smart Memory Solutions LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and Winbond Electronics Corporation of America.  The complaint alleged that certain of our NOR Flash products infringed a single U.S. patent and sought injunctive relief, damages, attorneys' fees, and costs. On March 20, 2013, we executed a settlement agreement resolving this litigation. The settlement amount did not have a material effect on our business, results of operations or financial condition.

On December 5, 2011, the Board of Trustees for the University of Illinois filed a patent infringement action against us in the U.S. District Court for the Central District of Illinois. The complaint alleges that unspecified semiconductor products of ours infringe three U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. We have filed three petitions for inter-partes review by the Patent and Trademark Office, challenging the validity of each of the patents in suit. The District Court has stayed the litigation pending the outcome of the inter-partes review by the Patent Office.

On March 26, 2012, Semiconductor Technologies, LLC filed a patent infringement action in the U.S. District Court for the Eastern District of Texas (Marshall) against us. The complaint alleged that certain of our DRAM products infringed five U.S. patents and sought injunctive relief, damages, attorneys' fees, and costs. On March 20, 2013, we executed a settlement agreement resolving this litigation. The settlement amount did not have a material effect on our business, results of operations or financial condition.

On April 27, 2012, Semcon Tech, LLC filed a patent infringement action against us in the U.S. District Court for the District of Delaware. The complaint alleges that our use of various chemical mechanical planarization systems purchased from Applied Materials and others infringes a single U.S. patent and seeks injunctive relief, damages, attorneys' fees, and costs. On September 24, 2013, the Court entered an order staying our case pending the resolution of co-pending cases brought by Semcon Tech, LLC against Applied Materials and Ebara Technologies, Inc.

On December 7, 2007, Tessera, Inc. filed a patent infringement against Elpida Memory, Inc., Elpida Memory (USA) Inc. (collectively "Elpida"), and numerous other defendants, in the United States District Court for the Eastern District of Texas. The complaint alleges that certain Elpida products infringe four U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. Prior to answering the complaint, Elpida and other defendants filed motions to stay the case pending final resolution of a case before the International Trade Commission ("ITC") against Elpida and other respondents, alleging infringement of the same patents asserted in the Eastern District of Texas case (In The Matter of Certain Semiconductor Chips with Minimized Chip Package Size and Products Containing Same (III), ITC No. 337-TA-630 (the "ITC Action")). On February 25, 2008, the Eastern District of Texas Court granted the defendants' motion to stay the action. On December 29, 2009, the ITC issued a Notice of Final Determination in the ITC Action finding no violation by Elpida. Tessera Inc. subsequently appealed the matter to the U.S. Court of Appeals for the Federal Circuit. On May 23, 2011, the Federal Circuit affirmed the ITC's Final Determination. The Eastern District of Texas case currently remains stayed.

Among other things, the above lawsuits pertain to certain of our SDRAM, DDR, DDR2, DDR3, RLDRAM, NAND Flash, NOR Flash and image sensor products, which account for a significant portion of our net sales.


81



We are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss, except as noted in the discussion of the Advanced Data Access LLC, Smart Memory Solutions LLC and Semiconductor Technologies, LLC matters above. A court determination that our products or manufacturing processes infringe the intellectual property rights of others could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations or financial condition.

Antitrust Matters

On May 5, 2004, Rambus, Inc. ("Rambus") filed a complaint in the Superior Court of the State of California (San Francisco County) against us and other DRAM suppliers which alleged that the defendants harmed Rambus by engaging in concerted and unlawful efforts affecting Rambus DRAM by eliminating competition and stifling innovation in the market for computer memory technology and computer memory chips.  Rambus' complaint alleged various causes of action under California state law including, among other things, a conspiracy to restrict output and fix prices, a conspiracy to monopolize, intentional interference with prospective economic advantage, and unfair competition. Rambus sought a judgment for damages of approximately $3.9$3.90 billion, joint and several liability, trebling of damages awarded, punitive damages, a permanent injunction enjoining the defendants from the conduct alleged in the complaint, interest, and attorneys' fees and costs. Trial began on June 20, 2011, and the case went to the jury on September 21, 2011. On November 16, 2011, the jury found for us on all claims. On April 2, 2012, Rambus filed a notice of appeal to the California 1st District Court of Appeal.

We were engaged in litigation with Rambus relating to certain of Rambus' patents and certain of our claims and defenses. Our lawsuits with Rambus related to patent matters were pending in the U.S. District Court for the District of Delaware, U.S. District Court for the Northern District of California, Germany, France, and Italy.

In December 2013, we settled all pending litigation between us and Rambus, including all antitrust and patent matters.  We also entered into a seven-year term patent cross-license agreement with Rambus that allows us to avoid costs of patent-related litigation during the term.  We agreed to pay Rambus up to $10 million per quarter over seven years, for a total of $280 million, beginning in the second quarter of 2014.  The primary benefits we received from these arrangements were (1) the settlement and termination of all existing litigation, (2) the avoidance of future litigation expenses and (3) the avoidance of future management and customer disruptions.  As a result, other operating expense for the first quarter of 2014 included a $233 million charge to accrue a liability, which reflects the discounted value of amounts due under this arrangement.


73



Patent Matters

As is typical in the semiconductor and other high technology industries, from time to time others have asserted, and may in the future assert, that our products or manufacturing processes infringe their intellectual property rights.

On September 1, 2011, HSM Portfolio LLC and Technology Properties Limited LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and seventeen other defendants, including MMJ and Elpida Memory (USA) Inc.  On August 22, 2013, the plaintiffs filed a third amended complaint. The third amended complaint alleges that certain of our DRAM and image sensor products infringe four U.S. patents and that certain MMJ and Elpida Memory (USA) Inc. DRAM products infringe two U.S. patents and seeks damages, attorneys' fees, and costs. Trial currently is scheduled for February 22, 2016. On March 23, 2012, MMJ and Elpida Memory (USA) Inc. filed a Notice of Filing and Hearing on Petition Under Chapter 15 of the U.S. Bankruptcy Code and Issuance of Provisional Relief that included an order of the U.S. Bankruptcy Court for the District of Delaware staying judicial proceedings against MMJ and Elpida Memory (USA) Inc. Accordingly, the plaintiffs' case against MMJ and Elpida Memory (USA) was stayed.  On June 25, 2013, the U.S. Bankruptcy Court for the District of Delaware entered its Order (1) Granting Recognition of the Japanese Reorganization Plan of MMJ and the Tokyo District Court's Confirmation Orders, (2) Entrusting MMJ's U.S. Assets to Foreign Representatives and Approving Certain Plan Transactions, (3) Granting Permanent Injunction, and (4) Granting Related Relief (the "Recognition Order").  Pursuant to the Recognition Order, the plaintiffs are permanently enjoined from continuing their case against MMJ and Elpida Memory (USA) Inc. in respect of any claim or claims arising prior to the commencement of the Japan Proceeding (as defined in the Recognition Order).

On December 5, 2011, the Board of Trustees for the University of Illinois (the "University") filed a patent infringement action against us in the U.S. District Court for the Central District of Illinois. The complaint alleges that unspecified semiconductor products of ours infringe three U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. We have filed three petitions for inter-partes review by the Patent and Trademark Office, challenging the validity of each of the patents in suit. The Patent Trial and Appeal Board ("PTAB") held a hearing in connection with the three petitions on December 9, 2013. On March 10, 2014, the PTAB issued written decisions finding that each and every claim in the three patents in suit is invalid, and cancelled all claims. The University has appealed the PTAB rulings to the U.S. Court of Appeals for the Federal Circuit.

On April 27, 2012, Semcon Tech, LLC filed a patent infringement action against us in the U.S. District Court for the District of Delaware. The complaint alleges that our use of various chemical mechanical planarization systems purchased from Applied Materials infringes a single U.S. patent and seeks injunctive relief, damages, attorneys' fees, and costs. Trial is currently scheduled for August 21, 2015.

On December 7, 2007, Tessera, Inc. filed a patent infringement action against MMJ, Elpida Memory (USA) Inc., and numerous other defendants, in the United States District Court for the Eastern District of Texas. The complaint alleges that certain MMJ and Elpida Memory (USA) Inc. products infringe four U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. Prior to answering the complaint, MMJ and Elpida Memory (USA) Inc. and other defendants filed motions to stay the case pending final resolution of a case before the International Trade Commission ("ITC") against MMJ and Elpida Memory (USA) Inc. and other respondents, alleging infringement of the same patents asserted in the Eastern District of Texas case (In The Matter of Certain Semiconductor Chips with Minimized Chip Package Size and Products Containing Same (III), ITC No. 337-TA-630 (the "ITC Action")). On February 25, 2008, the Eastern District of Texas Court granted the defendants' motion to stay the action. On December 29, 2009, the ITC issued a Notice of Final Determination in the ITC Action finding no violation by MMJ and Elpida Memory (USA) Inc. Tessera, Inc. subsequently appealed the matter to the U.S. Court of Appeals for the Federal Circuit. On May 23, 2011, the Federal Circuit affirmed the ITC's Final Determination. Additionally, by operation of the Recognition Order, plaintiff in that action is permanently enjoined from continuing its case against MMJ and Elpida Memory (USA) in respect of any claim or claims arising prior to the commencement of the Japan Proceeding (as defined in the Recognition Order). On July 30, 2014, we entered into a five-year term patent cross-license agreement with Tessera, which also settled the pending litigation against MMJ and Elpida Memory (USA). The agreement, which requires us to make quarterly payments over its term, gives us “life-of-product” protection for specifically identified DRAM products and a term license for certain other products. We capitalized an intangible asset for the term of the agreement and also recorded a $66 million charge to cost of goods sold in the fourth quarter of 2014.

Among other things, the above lawsuits pertain to certain of our DDR, DDR2, DDR3, SDR SDRAM, PSRAM, RLDRAM, LPDRAM, NAND Flash, image sensor products and certain other memory products we manufacture, which account for a significant portion of our net sales.


74



Except for the Tessera matter discussed above, we are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations or financial condition.

Antitrust Matters

At least sixty-eight purported class action price-fixing lawsuits have been filed against us and other DRAM suppliers in various federal and state courts in the United States and in Puerto Rico on behalf of indirect purchasers alleging a conspiracy to increase DRAM prices in violation of federal and state antitrust laws and state unfair competition law, and/or unjust enrichment relating to the sale and pricing of DRAM products during the period from April 1999 through at least June 2002. The complaints seek joint and several damages, trebled, in addition to restitution, costs and attorneys' fees. A number of these cases were removed to federal court and transferred to the U.S. District Court for the Northern District of California for consolidated pre-trial proceedings. In July 2006, the Attorneys General for approximately forty U.S. states and territories filed suit in the U.S. District Court for the Northern District of California. The complaints allege, among other things, violations of the Sherman Act, Cartwright Act, and certain other states' consumer protection and antitrust laws and seek joint and several damages, trebled, as well as injunctive and other relief. On October 3, 2008, the California Attorney General filed a similar lawsuit in California Superior Court, purportedly on behalf of local California government entities, alleging, among other things, violations of the Cartwright Act and state unfair competition law. On June 23, 2010, we executed a settlement agreement resolving these purported class-action indirect purchaser cases and the pending cases of the Attorneys General relating to alleged DRAM price-fixing in the United States. Subject to certain conditions, including final court approval of the class settlements, we agreed to pay approximately $67 million in aggregate in three equal installments over a two-year period. We had paid the full amount into an escrow account by the end of the first quarter of 2013 in accordance with the settlement agreement.

Three putative class action lawsuits alleging price-fixing of DRAM products also have been filed against us in Quebec, Ontario, and British Columbia, Canada, on behalf of direct and indirect purchasers, asserting violations of the Canadian Competition Act and other common law claims (collectively the "Canadian Cases").  The claims were initiated between December 2004 (British Columbia) and June 2006 (Quebec). The plaintiffs seek monetary damages, restitution, costs, and attorneys' fees. The substantive allegations in these cases are similar to those asserted in the DRAM antitrust cases filed in the United States.  Plaintiffs' motion for class certification was denied in the British Columbia and Quebec cases in May and June 2008, respectively.  Plaintiffs subsequently filed an appeal of each of those decisions.  On November 12, 2009, the British Columbia Court of Appeal reversed, and on November 16, 2011, the Quebec Court of Appeal also reversed the denial of class certification and remanded the cases for further proceedings. On October 16, 2012, we entered into a settlement agreement resolving these three putative class action cases subject to certain conditions including final court approval of the settlement. The settlement amount did not have a material effect on our business, results of operations or financial condition.

On June 21, 2010, the Brazil Secretariat of Economic Law of the Ministry of Justice ("SDE") announced that it had initiated an investigation relating to alleged anticompetitive activities within the DRAM industry. The SDE's Notice of Investigation names various DRAM manufacturers and certain executives, including us, and focuses on the period from July 1998 to June 2002.

We are unable to predict the outcome of these matters and therefore cannot estimate the range of possible loss, except as noted in the above discussion of the U.S. indirect purchaser cases and the Canadian Cases above.cases. The final resolution of these alleged violations of antitrust laws could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition.

82




Securities Matters

On July 12, 2013, seven former shareholders of Elpida Memory, Inc. (“Elpida”)(now known as MMJ) filed a complaint against Messrs. Sakamoto, Adachi, Gomi, Shirai, Tsay-Jiu, Wataki, Kinoshita, and Takahasi in their capacity as members of the board of directors of ElpidaMMJ as of February 2013. The complaint alleges that the defendants engaged in various acts and misrepresentations to hide the financial condition of ElpidaMMJ and deceive shareholders prior to ElpidaMMJ filing a petition for corporate reorganization on February 27, 2013. The plaintiffs seek joint and several damages equal to the market value of shares owned by each of the plaintiffs on February 23, 2013, along with attorneys’attorneys' fees and interest. At a hearing on September 25, 2013, the plaintiffs withdrew the complaint against Mr. Tsay-Jiu.

We are unable to predict the outcome of this matter and therefore cannot estimate the range of possible loss.  The final resolution of this matter could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition.


Commercial Matters
75



Qimonda

On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda AG ("Qimonda") insolvency proceedings, filed suit against usMTI and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void under Section 133 of the German Insolvency Act a share purchase agreement between usMicron B.V. and Qimonda signed in fall 2008 pursuant to which weMicron B.V. purchased substantially all of Qimonda's shares of Inotera Memories, Inc. (the "Inotera Shares"), representing approximately 55% of our total shares in Inotera, and seeks an order requiring us to retransfer the Inoterathose shares purchased from Qimonda to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate under Sections 103 or 133 of the German Insolvency Code a patent cross licensecross-license between us and Qimonda entered into at the same time as the share purchase agreement. A three-judge panel will render a decision after

Following a series of hearings with pleadings, arguments and witnesses. Hearings were heldwitnesses on September 25, 2012, February 5, 2013, June 11, 2013behalf of the Qimonda estate, on March 13, 2014, the Court issued judgments:  (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on such shares and July 2, 2013. An additionalall other benefits; (4) denying Qimonda’s claims against Micron Technology for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are cancelled. In addition, the Court issued interlocutory judgments ordering, among other things:  (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by it and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by it from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. We have filed a notice of appeal, and the parties have submitted briefs to the appeals court. A hearing on the matter is scheduled for November 12, 2013. February 2, 2015.

We are unable to predict the outcome of this lawsuitthe matter and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera sharesShares or equivalent monetary damages, andunspecified damages based on the benefits derived by Micron B.V. from the ownership of the Inotera Shares, and/or the termination of the patent cross license,cross-license, which could have a material adverse effect on our business, results of operation or financial condition.  As of August 29, 2013,28, 2014, the Inotera shares purchased from QimondaShares had a carrying value in equity method investments for purposes of $190 million.our financial reporting of $505 million and a market value of $2.06 billion.

Other

In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations or financial condition.


Redeemable Convertible Notes

Under the terms of the indentures of the 2033E and 2033F Notes, upon conversion, we would be required to pay cash equal to the lesser amount of (1) the aggregate principal amount or (2) the conversion value of the notes being converted (we could pay cash, shares of common stock or a combination thereof, at our option, for the remainder, if any, of our conversion obligation). Additionally, the 2033E and 2033F Notes were convertible at the option of the holders as of August 28, 2014. Therefore, the 2033E and 2033F Notes were classified as current debt and the aggregate difference of $57 million between the principal amount and the carrying value was classified as redeemable convertible notes in the mezzanine section of the accompanying consolidated balance sheet as of August 28, 2014. (See "Debt" note.)




8376



Shareholders' Equity

Repurchase of Common Stock

On July 26, 2011, we paid $150 million to repurchase 19.7 million shares of our common stock at $7.60 per share.Micron Shareholders' Equity

Capped Calls

Issued and Outstanding Capped Calls:Calls In July 2011, we: We have entered into capped call transactions (the "2031 Capped Calls") that have an initial strike pricecalls, which was set to equal, subject to certain adjustments, the initial conversion price of the 2031 Notes. The 2031 Capped Calls are in four equal tranches. In April 2012, we entered into capped call transactions (the "2032C Capped Calls" and "2032D Capped Calls," collectively the "2032 Capped Calls") that have an initial strike price which was set to be, subject to certain adjustments, slightly higher than the initial conversion prices of the 2032C Notes and the 2032D Notes.  The 2032C and 2032D Capped Calls are each in four tranches. On February 6, 2013 and February 12, 2013, we entered into capped call transactions (the "2033E Capped Calls" and "2033F Capped Calls," collectively the "2033 Capped Calls") that have an initial strike price which was set to equal, subject to certain adjustments, the initial conversion price of the 2033 Notes.  We paid $57 million, $103 million and $48 million, to purchase the 2031, 2032 and 2033 Capped Calls, respectively. The capped calls transactions are considered capital transactions and the related cost was recorded as a charge to additional capital. The 2031, 2032 and 2033 Capped Calls are intended to reduce the effect of potential dilution upon conversionfrom our convertible notes.  The capped calls provide for our receipt of cash or shares, at our election, from our counterparties if the trading price of our stock is above a specified initial strike price at the expiration date. The amount receivable varies based on the trading price of our stock, up to a specified cap price. The dollar value of the cash or shares that we would receive from the capped calls upon their expiration date ranges from $0 if the trading price of our stock is below the initial strike price for all of the capped calls to $864 million if the trading price of our stock is at or above the cap price for all of the capped calls.  We paid $57 million in 2011 to purchase the 2031 Capped Calls, $103 million in 2012 to purchase the 2032 Capped Calls and $48 million in 2013 to purchase the 2033 Notes, respectively and may be settled in shares or cash, at our election.Capped Calls. The amounts paid were recorded as charges to additional capital.

The following table presents information related to the issued and outstanding capped calls as of August 29, 2013.28, 2014:

Capped Calls 
   
Strike Price1
 Cap Price Range Common Shares Covered 
Value at Expiration2
 Expiration Dates  Low High  Minimum Maximum
2031 Jul 2014 -Feb 2016 $9.50
 $11.40
 $13.17
 72.6
 $
 $207
2032C May 2016 -Nov 2017 9.80
 14.26
 15.69
 56.3
 
 307
2032D Nov 2016 -May 2018 10.16
 14.62
 16.04
 44.3
 
 244
2033E Jan 2018 -Feb 2018 10.93
 14.51
 14.51
 27.5
 
 98
2033F Jan 2020 -Feb 2020 10.93
 14.51
 14.51
 27.5
 
 98
            228.2
 $
 $954
1    Initial strike prices are subject to certain adjustments
Capped Calls 
   Strike Price Cap Price Range Underlying Common Shares 
Value at Expiration(1)
 Expiration Dates  Low High  Minimum Maximum
2031 Jul 2015Feb 2016 $9.50
 $12.67
 $13.17
 34
 $
 $117
2032C May 2016Nov 2017 9.80
 14.26
 15.69
 56
 
 307
2032D Nov 2016May 2018 10.16
 14.62
 16.04
 44
 
 244
2033E Jan 2018Feb 2018 10.93
 14.51
 14.51
 27
 
 98
2033F Jan 2020Feb 2020 10.93
 14.51
 14.51
 27
 
 98
            188
 $
 $864
2(1) 
Settlement in cash on the respective expiration dates would result in us receiving an amount ranging from zero, if the market price per share of our common stock is at or below the respective low strike price, to the respective maximum amount if the market price per share of our common stock is at or above the respective high cap price. If share settlement were elected, the number of shares repurchasedreceived would be determined by the value of the capped calls at the time of settlement divided by the share price on the settlement date. Settlement of the capped calls prior to the expiration dates may be for an amount less than the maximum value at expiration.

SettlementUnwind of Capped Calls: CallsConcurrent with:In May 2014, we and the issuance in April 2009counterparties agreed to terminate and unwind a portion of our 4.25% Convertible Senior Notes due 2013, we entered into capped call transactions (the "20132031 Capped Calls") covering approximately 45.2 million shares of common stock with an initial strike price of approximately $5.08 per share and a cap price of $6.64 per share.  The 2013 Capped Calls expired in October 2012 and November 2012.Calls. We elected cashshare settlement and received $243 million shares of our stock, equivalent to approximately $86 million based on the trading stock price at the time of the unwind. The shares were retired from treasury stock in 2013.2014.

Concurrent with the offeringRestrictions on Net Assets

As a result of the Japan Proceedings, for so long as such proceedings are continuing, the MMJ Group is subject to certain restrictions on dividends, loans and advances. In addition, our ability to access IMFT's cash and other assets through dividends, loans or advances, including to finance our other operations, is subject to agreement by Intel. As a result, our total restricted net assets (net assets less intercompany balances and noncontrolling interests) as of August 28, 2014 Notes, we purchased capped calls with a strike pricewere $3.10 billion for the MMJ Group, which included cash and equivalents of approximately $14.23 per share$1.60 billion, and various expiration dates between November 2011$793 million for IMFT.

(See "Micron Memory Japan, Inc." note and December 2012 (the "2014 Capped Calls""IMFT" below.).  In the first six months of 2012, 2014 Capped Calls covering 30.4 million shares expired according to their terms.  In April 2012, we settled the remaining 2014 Capped Calls, covering 60.9 million shares, and received a de minimis payment.


8477



Accumulated Other Comprehensive Income (Loss)

The components ofChanges in accumulated other comprehensive income (loss), net of tax, attributable to Micron shareholders at the end of each year, as well as other comprehensive income by component for the year ended August 29, 201328, 2014, were as follows:

  As of August 30,
2012
 Other Comprehensive Income (Loss) As of August 29,
2013
Cumulative foreign currency translation adjustments $49
 $(5) $44
Gain (loss) on derivatives, net 31
 (10) 21
Gain (loss) on investments, net 1
 (1) 
Pension liability adjustments (1) (1) (2)
Accumulated other comprehensive income $80
 $(17) $63
  Cumulative Foreign Currency Translation Adjustments Gains (Losses) on Derivative Instruments, Net Gains (Losses) on Investments, Net Pension Liability Adjustments Total
Balance as of August 29, 2013 $44
 $21
 $
 $(2) $63
Other comprehensive income before reclassifications 1
 (4) 4
 1
 2
Amount reclassified out of accumulated other comprehensive income (3) (4) (3) 1
 (9)
Tax effects 
 (1) 
 1
 
Other comprehensive income (loss) (2) (9) 1
 3
 (7)
Balance as of August 28, 2014 $42
 $12
 $1
 $1
 $56

Noncontrolling Interests in Subsidiaries

As of 2014 2013
  Noncontrolling Interest Balance Noncontrolling Interest Percentage Noncontrolling Interest Balance Noncontrolling Interest Percentage
IMFT(1)
 $693
 49% $601
 49%
MP Mask(1)
 93
 50% 92
 50%
MMT 9
 <l%
 155
 11%
Other 7
 Various
 16
 Various
  $802
   $864
  
(1) Entity is a variable interest entity.

IMFT

Since inception in 2006 through August 28, 2014, we have owned 51% of IMFT, a venture between us and Intel to manufacture NAND Flash memory products and certain emerging memory technologies for the exclusive use of the members. IMFT is governed by a Board of Managers and the number of managers appointed by each member to the board varies based on the members' respective ownership interests, which is based on cumulative contributions to IMFT. The IMFT joint venture agreement extends through 2024 and includes certain buy-sell rights with an Intel put right, commencing in January 2015, and our call right commencing in January 2018, pursuant to which Intel may elect to sell to us, or we may elect to purchase from Intel, Intel's interest in IMFT. If Intel elects to sell to us, we would set the closing date of the transaction within two years following such election and could elect to receive financing of the purchase price from Intel for one to two years from the closing date.

IMFT manufactures NAND Flash memory products using designs and technology we develop with Intel. We generally share with Intel the costs of product design, other NAND Flash R&D costs and R&D costs of certain emerging memory technologies. Our R&D expenses were reduced by reimbursements from Intel of $137 million, $127 million and $87 million for 2014, 2013 and 2012, respectively.

We sell a portion of our products to Intel through our IMFT venture at long-term negotiated prices approximating cost. Sales of NAND Flash products to Intel under this arrangement were $423 million, $387 million and $718 million for 2014, 2013 and 2012, respectively. Receivables from Intel for sales of NAND Flash products as of August 28, 2014 and August 29, 2013, were $66 million and $68 million, respectively.


78



The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets, excluding intercompany balances:

As of 2014 2013
Assets    
Cash and equivalents $84
 $62
Receivables 73
 76
Inventories 48
 49
Other current assets 5
 4
Total current assets 210
 191
Property, plant and equipment, net 1,545
 1,382
Other noncurrent assets 47
 46
Total assets $1,802
 $1,619
     
Liabilities  
  
Accounts payable and accrued expenses $92
 $88
Deferred income 8
 9
Equipment purchase contracts 14
 78
Current portion of long-term debt 21
 6
Total current liabilities 135
 181
Long-term debt 71
 13
Other noncurrent liabilities 110
 118
Total liabilities $316
 $312
Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Our ability to access IMFT's cash and other assets through dividends, loans or advances, including to finance our other operations, is subject to agreement by Intel. Creditors of IMFT have recourse only to IMFT's assets and do not have recourse to any other of our assets.

The following table presents IMFT's distributions to and contributions from its shareholders:

For the year ended 2014 2013 2012
IMFT distributions to Micron $10
 $38
 $439
IMFT distributions to Intel 10
 37
 391
Micron contributions to IMFT 106
 12
 48
Intel contributions to IMFT 102
 11
 46

IMFS

We partnered with Intel to form IMFS in 2007 to manufacture NAND Flash memory products for the exclusive use of the members. Our ownership percentage of IMFS had increased from 51% at inception to 82% in April 2012 due to a series of contributions by us that were not fully matched by Intel. In April 2012, we entered into a series of agreements with Intel and acquired Intel's remaining 18% interest in IMFS for $466 million. In addition, we acquired IMFT's assets located at our Virginia wafer fabrication facility, for which Intel received a distribution from IMFT of $139 million. For both transactions, the amounts Intel received approximated the book values of Intel's interests in the assets acquired. Additionally, we received a $300 million deposit from Intel, substantially all of which was applied to Intel's purchases of NAND Flash products from 2012 to 2014 under a supply agreement. In 2012, Micron and Intel paid capital contributions to IMFS of $103 million and $131 million, respectively.

IMFS sold products to the joint venture members generally in proportion to their ownership interests at long-term negotiated prices approximating cost. IMFS sales of NAND Flash product to Intel for 2012 were $158 million and as a result of the April 2012 agreements, Intel had no continuing rights to the output from the IMFS and Virginia facilities.


79



MP Mask

In 2006, we formed a joint venture with Photronics to produce photomasks for leading-edge and advanced next generation semiconductors.  The MP Mask joint venture agreement allows either party to terminate the joint venture in either May 2016, provided notice is given prior to May 2015, or in each five-year successive period following May 2016, provided such notice is given at least twelve months prior to the end of the successive five-year period. At inception and through August 28, 2014, we owned approximately 50% and Photronics owned approximately 50% of MP Mask.  We contributed $21 million to MP Mask and Photronics contributed $20 million to MP Mask in 2012. We purchase a substantial majority of the photomasks produced by MP Mask pursuant to a supply arrangement.

The following table presents the assets and liabilities of MP Mask included in our consolidated balance sheets:

As of 2014 2013
Current assets $24
 $26
Noncurrent assets (primarily property, plant and equipment) 203
 182
Current liabilities 28
 25
Noncurrent liabilities 14
 
Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Creditors of MP Mask have recourse only to MP Mask's assets and do not have recourse to any other of our assets.

In February 2012, we sold to Photronics for $35 million a photomask production facility we had leased to them under an operating lease. The proceeds were equal to our net carrying value and no gain or loss was realized from the sale.

MMT

As of August 29, 2013, noncontrolling interests in MMT were 11%. In 2014, we purchased additional interests in MMT for an aggregate of $146 million, and as of August 28, 2014, noncontrolling interests in MMT were less than 1%. Substantially all of the MMT shares purchased in 2014 were financed with a short-term loan from a seller. As a result of the purchases of MMT shares in 2014, in aggregate, noncontrolling interests decreased by $180 million and additional capital increased by $34 million. (See "Debt – Other Notes Payable" note.)


Derivative Financial Instruments

We are exposed to currency exchange rate risk for monetary assets and liabilities held or denominated in foreign currencies, primarily the euro, shekel, Singapore dollar and yen.  We are also exposed to currency exchange rate risk for capital expenditures and operating cash flows, primarily denominated in the euro and yen.  In connection with the Elpida Installment Payments, we are exposed to significant currency exchange rate risk for the yen. Additionally, we are exposed to interest rate fluctuation risk on our four-year note payable, under which we borrowed $312 million on August 27, 2013 at a variable interest rate. We use derivative instruments to manage a portion of our exposuresexposure to changes in currency exchange rates and variable interest rates.  For exposures associated withfrom our monetary assets and liabilities and to reduce the volatility that changes in interest rates on variable-rate debt have on our earnings. We also have convertible note settlement obligations which became derivative instruments as a result of our elections to settle conversions in cash. We do not use derivative instruments for speculative purpose.

Derivative Instruments without Hedge Accounting Designation

Currency Derivatives: We use derivative instruments to manage a portion of our exposure to changes in currency exchange rates from our monetary assets and liabilities. Our primary objective in entering into currency derivatives is to reduce the volatility that changes in currency exchange rates have on our earnings.  For exposures associated with our capital expenditures and operating cash flows, our primary objective of entering into currency derivatives is to reduce the volatility that changes in currency exchange rates have on future cash flows. For exposures associated with our yen-denominated Elpida Installment Payments, our primary objective for entering into currency derivatives is to mitigate risks if those currencies strengthen relative to the U.S. dollar, while preserving some ability for us to benefit if those currencies weaken. For exposures associated with our variable-rate debt, our primary objective is to reduce the volatility that changes in interest rates have on interest expense.

Our currency derivatives consist primarily of forward contractsTo hedge our exposures to monetary assets and currency options and our interest rate derivative consists of interest rate swap agreements.  These derivatives expose us to credit risk to the extent the counterparties may be unable to meet the terms of the derivative instrument.  As of August 29, 2013, our maximum exposure to loss due to credit risk if counterparties fail completely to perform according to the terms of the contracts, wasliabilities, we generally equal to the fair value of our assets for these contracts as listed in the tables below.  We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading risk across multiple major financial institutions.  In addition, we monitor the potential risk of loss with any one counterparty resulting from this type of credit risk on an ongoing basis.  We also seek to mitigate risk through master netting arrangements (see "Master Netting Arrangements" below).

We have the following risk management programs:

Derivatives without Hedge Accounting Designation

We utilize a rolling hedge strategy with currency forward contracts that generally mature within 35 days to hedge our exposure to changes in currency exchange rates from our monetary assets and liabilities.days.  At the end of each reporting period, monetary assets and liabilities held or denominated in currencies other than the U.S. dollar are remeasured in U.S. dollars and the associated outstanding forward contracts are marked-to-market.  Currency forward contracts are valued at fair values based on the middle of bid and ask prices of dealers or exchange quotations (Level 2 fair value measurements). Currency options are valuedIn connection with the currency exchange rate risk associated with the MMJ Acquisition in July 2013, we entered into currency exchange transactions (the "MMJ Acquisition Hedges"). The MMJ Acquisition Hedges were not designated for hedge accounting and were remeasured at their fair value using a modified Black-Scholes option valuation model using inputseach period. We recorded losses from the MMJ Acquisition Hedges of $228 million in 2013 and gains of $8 million in 2012. To mitigate the risk of the current spot rate, strike price, risk-free interest rate, maturity, volatilityyen strengthening against the U.S. dollar on the MMJ creditor installment payments due in December 2014 and credit-risk spread (Level 2 fair value measurements).  These options are marked-to-market at the end of each reporting period. December 2015, we entered into forward contracts to purchase 20 billion yen on November 28, 2014 and 10 billion yen on November 27, 2015.

80



Realized and unrealized gains and losses on derivative instrumentscurrency derivatives without hedge accounting designation as well as the change in the underlying monetary assets and liabilities due to changes in currency exchange rates are included in other non-operating income (expense).


85



In connection with the currency exchange rate risk associated with our acquisition of Elpida and the Rexchip shares from the Powerchip Group, we entered into currency exchange transactions (the "Elpida Hedges" and the "Rexchip Hedges" and, together, the "Elpida Acquisition Hedges"). The Elpida Acquisition Hedges were not designated for hedge accounting and were remeasured at fair value each period with gains and losses reflected in other non-operating income (expense). We recorded losses from the Elpida Acquisition Hedges in 2013 of $228 million and gains in 2012 of $8 million. To mitigate the risk that increases in exchange rates have on the payments due in 2014 and 2015, we entered into forward contracts to purchase 20 billion yen on November 28, 2014 and 10 billion yen on November 27, 2015.

We entered intoInterest Rate Swaps: As of August 29, 2013 we were party to interest rate swap contracts thatscheduled to mature in 4 yearsAugust 2017 to hedge against the variability of future interest payments due on our $312 million floating ratevariable-rate debt, which effectively converted the variable-rate debt to fixed-rate debt. We designated 80% of the swaps as cash flow hedges and the remaining 20% were not designated for hedge accounting treatment. Changes inOn August 27, 2014, we repaid the fairremaining carrying value of $252 million of the undesignated portion are includednote prior to its scheduled maturity and terminated the interest rate swaps.

Convertible Notes Settlement Obligations: In connection with our debt restructure activities in interest income (expense).2014, holders elected to convert substantially all of the outstanding 2014 Notes, 2027 Notes, 2031A Notes and 2031B Notes. As a result of our elections to settle the conversion amounts in cash, each of the settlement obligations became derivative debt liabilities subject to mark-to-market accounting treatment for a period of approximately 30 days, beginning on the date we notified the holder of our intention to settle the obligation in cash through the settlement date. The fair values of the interest rate swaps are calculated by discountingunderlying derivative settlement obligations were initially determined using the expected future cash flows based on inputs that are readily available in publicly quoted marketsBlack-Scholes option valuation model (Level 2 fair value measurements). The Black-Scholes model requires the input of assumptions, including the stock price, expected stock-price volatility, estimated option life, risk-free interest rate and dividend rate. The subsequent measurements and final settlement amounts of our convertible notes settlement obligations were based on the volume-weighted average stock price (Level 1 fair value measurements). Changes in fair values of the derivative settlement obligations were included in other non-operating income (expense), net.

Total gross notional amounts and fair values for currency derivatives and interest rate swapsderivative instruments without hedge accounting designation were as follows:

 
Notional Amount
(in U.S. Dollars)
 Fair Value of 
Notional Amount(1)
 Fair Value of
Current Assets(1)(2)
 
Noncurrent Assets(3)
 
Current Liabilities(4)
 
Noncurrent Liabilities(5)
As of August 28, 2014          
Currency forward contracts:          
Yen $554
 $
 $
 $(12) $(6)
Singapore dollar 330
 
 
 
 
Euro 245
 
 
 (1) 
Shekel 62
 
 
 (1) 
 $1,191
        
          
Convertible notes settlement obligations 12
 
 
 (389) 
 
Notional Amount
(in U.S. Dollars)
 
Current Assets(1)(2)
 
Noncurrent Assets(2)
 
(Current Liabilities)(3)
 
 $
 $
 $(403) $(6)
 
Currency forward contracts:                  
Yen $336
 $1
 $3
 $
 $336
 $1
 $3
 $
 $
Singapore dollar 218
 
 
 
 218
 
 
 
 
Euro 217
 1
 
 (1) 217
 1
 
 (1) 
Shekel 78
 
 
 (1) 78
 
 
 (1) 
Currency options:        
New Taiwan dollar 351
 
 
 
Interest rate swap contracts 62
 
 
 
 62
 
 
 
 
Currency options - New Taiwan dollar 351
 
 
 
 
 $1,262
 $2
 $3
 $(2) $1,262
 $2
 $3
 $(2) $
        
As of August 30, 2012  
  
    
Forward contracts:        
Singapore dollar $251
 $
 $
 $(1)
Euro 173
 2
 
 (1)
Shekel 65
 
 
 (1)
Yen 18
 
 
 
Currency options:        
Yen 5,050
(4 
) 
57
 
 
New Taiwan dollar 342
 2
 
 
 $5,899
 $61
 $
 $(3)
(1)
Notional amounts of forward, option and interest rate swap contracts in U.S. dollars and convertible notes settlement obligations in shares.
(2)
Included in receivables - other.
(2)(3)
Included in other noncurrent assets.
(3)(4)
Included in accounts payable and accrued expenses - other.other for forward, option and interest rate swap contracts and in current debt for convertible notes settlement obligations.
(4)(5) 
Notional amount includes purchased options of $2,527 million and sold options of $2,523 million for the Elpida Hedges.
Included in other noncurrent liabilities.

For currency forward contracts and options without hedge accounting designation, we recognized net losses of $222 million for 2013, net losses of $17 million for 2012 and net gains of $21 million for 2011, which were included in other non-operating income (expense).


8681



DerivativesNet gains (losses) for derivative instruments without hedge accounting designation were as follows:

For the year ended 2014 2013 2012 Location
Convertible notes settlement obligations $(59) $
 $
 Other non-operating income (expense)
Foreign exchange contracts (27) (222) (17) Other non-operating income (expense)

Derivative Instruments with Cash Flow Hedge Accounting Designation

Currency Derivatives:We utilize currency forward contracts that generally mature within 12 months and currency options that generally mature fromwithin 12 to 18 months to hedge our exposure to changes in cash flows from changes in currency exchange rates for certain capital expenditures and forecasted operating cash flows.  Currency forward contracts are valuedmeasured at their fair valuesvalue based on market-based observable inputs including currency exchange spot and forward rates, interest rate and credit risk spread (Level 2 fair value measurements).  Currency options are valuedmeasured at their fair value using a modified Black-Scholes option valuation model using inputs of the current spot rate, strike price, risk-free interest rate, maturity, volatility and credit-risk spread (Level 2 fair value measurements). We entered into

Interest Rate Swaps: As noted above in "Derivative Instruments without Hedge Designation – Interest Rate Swaps," we were party to interest rate swap contracts thatscheduled to mature in 4 yearsAugust 2017 to hedge against the variability in future interest payments due on our $312 million floating ratevariable-rate debt and we designated 80% of the swaps as cash flow hedges. The fair valuesOn August 27, 2014, we repaid the remaining carrying value of $252 million of the note prior to its scheduled maturity and terminated the interest rate swaps have been calculated by discounting the expected future cash flows based on inputs that are readily available in publicly quoted markets (Level 2 fair value measurements).swaps. Amounts reclassified from accumulated other comprehensive income (loss) were not significant.

For derivativesderivative instruments designated as cash flow hedges, the effective portion of the realized and unrealized gain or loss on the derivatives is included as a component of accumulated other comprehensive income (loss).  For derivatives hedging capital expenditures, the amountsAmounts in accumulated other comprehensive income (loss) for these cash flow hedges are reclassified into earnings in the same line items of the consolidated statements of operation and in the same periods in which the underlying transactions affect earnings. Amounts in accumulated other comprehensive income (loss) for inventory purchases are reclassified to earnings when inventory is sold. Amounts in accumulated other comprehensive income (loss) for interest rate swaps are reclassified to earnings when the related interest payments affect earnings. The ineffective or excluded portion of the realized and unrealized gain or loss is included in other non-operating income (expense).  Total gross notional amounts and fair values for derivativesderivative instruments with cash flow hedge accounting designation were as follows:

 
Notional Amount 
(in U.S. Dollars)
 Fair Value of 
Notional Amount 
(in U.S. Dollars)
 
Fair Value of Current Liabilities(1)
As of August 28, 2014    
Currency forward contracts:    
Yen $94
 $(2)
Euro 24
 
 
Notional Amount 
(in U.S. Dollars)
 
Current Assets(1)
 
(Current Liabilities)(2)
 $118
 $(2)
As of August 29, 2013      
  
Currency forward contracts:          
Yen $6
 $
 $(1) $6
 $(1)
Euro 6
 
 
 6
 
Currency options:      
Yen 21
 
 (2)
Interest swap contracts: 250
 
 
Interest swap contracts 250
 
Currency options - Yen 21
 (2)
 $283
 $
 $(3) $283
 $(3)
As of August 30, 2012  
  
  
Currency forward contracts:      
Yen $108
 $2
 $
Euro 35
 
 
Currency options:      
Yen 32
 
 $
 $175
 $2
 $
(1)
Included in receivables - other.
(2) 
Included in accounts payable and accrued expenses - other.

For 20132014, 20122013 and 2011,2012, we recognized losses of $4 million, $8 million of net pre-tax derivative losses,and $9 million of net derivative losses and $49 million of net derivative gains,, respectively, in accumulated other comprehensive income (loss) from the effective portion of cash flow hedges.  The ineffective and excluded portions of cash flow hedges recognized in other non-operating income (expense) were not significant in 2014, 2013 2012 or 2011.  In2012.  For 2014, 2013 and 2012, we reclassified gains of $4 million, $1 million and $9$9 million,, respectively, of net gains were reclassified from accumulated other comprehensive income (loss) to earnings. As of August 29, 2013, the amount28, 2014, $8 million of pre-tax net derivative gains from cash flow hedges included in accumulated other accumulated comprehensive income (loss) is expected to be reclassified into earnings in the next 12 months was $4 million.months.


8782



Derivative Counterparty Credit Risk and Master Netting Arrangements

Our derivative instruments expose us to credit risk to the extent the counterparties may be unable to meet the terms of the derivative instrument.  As of August 28, 2014, our maximum exposure to loss due to credit risk if counterparties fail completely to perform according to the terms of the contracts was generally equal to the fair value of our assets for these contracts as listed in the tables above.  We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading risk across multiple financial institutions.  In addition, we monitor the potential risk of loss with any one counterparty resulting from this type of credit risk on an ongoing basis.

We also seek to enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty under these arrangements have been presented in our consolidated balance sheet on a net basis. The following table presents the grossAs of August 28, 2014 amounts of our derivative assets and liabilities and the net amounts recorded in our consolidated balance sheet:

As of August 29, 2013 
Current Assets(1)
 
Noncurrent Assets(2)
 
(Current Liabilities)(3)
Gross amount $2
 $3
 $(5)
Gross amounts offset in the statement of financial position (1) 
 1
Net amounts presented in the statement of financial position $1
 $3
 $(4)
(1)Included in receivables - other.
(2)Included in other noncurrent assets.
(3)Included in accounts payable and accrued expenses - other.netted were not significant.




88



Fair Value Measurements

Accounting standards establish three levels of inputs that may be used to measure fair value: quoted prices in active markets for identical assets or liabilities (referred to as Level 1), inputs other than Level 1 that are observable for the asset or liability either directly or indirectly (referred to as Level 2) and unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities (referred to as Level 3).

Fair Value Measurements on a Recurring Basis

All marketable debt and equity investments are classified as available-for-sale and are carried at fair value. Assets measured at fair value on a recurring basis were as follows:

As of 2013 2012 2014 2013
 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Total Level 1 Level 2 Total
Cash equivalents:                            
Money market funds $1,188
 $
 $
 $1,188
 $2,159
 $
 $
 $2,159
 $1,281
 $
 $1,281
 $1,188
 $
 $1,188
Certificates of deposit 
 38
 
 38
 
 27
 
 27
 
 402
 402
 
 38
 38
Commercial paper 
 35
 
 35
 
 29
 
 29
 
 22
 22
 
 35
 35
Government securities 
 
 
 
 
 5
 
 5
 1,188
 73
 
 1,261
 2,159
 61
 
 2,220
 1,281
 424
 1,705
 1,188
 73
 1,261
Short-term investments:                            
Corporate bonds 
 112
 
 112
 
 31
 
 31
 
 154
 154
 
 112
 112
Government securities 
 72
 
 72
 
 51
 
 51
 
 136
 136
 
 72
 72
Commercial paper 
 26
 
 26
 
 10
 
 10
 
 85
 85
 
 26
 26
Certificates of deposit 
 9
 
 9
 
 4
 
 4
 
 8
 8
 
 9
 9
Asset-backed securities 
 2
 
 2
 
 4
 
 4
 
 1
 1
 
 2
 2
 
 221
 
 221
 
 100
 
 100
 
 384
 384
 
 221
 221
Long-term marketable investments:                            
Corporate bonds 
 302
 
 302
 
 203
 
 203
 
 407
 407
 
 302
 302
Government securities 
 96
 
 96
 
 88
 
 88
 
 284
 284
 
 96
 96
Asset-backed securities 
 95
 
 95
 
 73
 
 73
 
 127
 127
 
 95
 95
Marketable equity securities 6
 
 
 6
 5
 5
 
 10
 1
 
 1
 6
 
 6
 6
 493
 
 499
 5
 369
 
 374
 1
 818
 819
 6
 493
 499
Restricted cash:                            
Certificates of deposit 
 302
 
 302
 
 
 
 
 
 27
 27
 
 302
 302
 
 302
 
 302
 
 
 
 
 
 27
 27
 
 302
 302
                            
 $1,194
 $1,089
 $
 $2,283
 $2,164
 $530
 $
 $2,694
 $1,282
 $1,653
 $2,935
 $1,194
 $1,089
 $2,283


83



Government securities consist of securities issued directly by or deemed to be guaranteed by government entities such as U.SU.S. and non U.S. agency securities, government bonds and treasury securities. Level 2 securities are valued using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from our pricing services. As of August 29, 2013,28, 2014, no adjustments were made to such pricing information.

Fair Value Measurements on a Nonrecurring Basis

In connection with the Exchange Transactions, we determined the fair value for the debt component of the Exchanged Notes as if it were a stand-alone instrument using an interest rate for similar nonconvertible debt issued by entities with credit ratings comparable to ours at the time of issuance (Level 2). In connection with the debt conversions and settlements in 2014, we determined the initial fair value of the equity component of the converted notes that was reclassified to debt using the Black-Scholes option valuation model (Level 2). The Black-Scholes model requires the input of assumptions, including the stock price, expected stock-price volatility, estimated option life, risk-free interest rate and dividend rate. The subsequent measurements of our convertible notes settlement obligations were based on the value-weighted average stock price (Level 1). Changes in fair values of the derivatives settlement obligations were included in other non-operating income (expense).

Our non-marketable securities, equity method investments, and non-financial assets such as intellectual property and property, plant and equipment are carried at cost unless impairment is deemed to have occurred.


89



During the third quarter of 2012, the Board of Directors of Transform approved a liquidation plan. As a result, we impaired our investment in Transform to the estimated liquidation values for its assets and liabilities measured using unobservable inputs (Level 3). The fair values of Transform's primary assets, were semiconductor equipment and a manufacturing facility. The fair values for semiconductor equipmentfacility, were based on quotations obtained from equipment dealers, which consider the remaining useful life and configuration of the equipment. Fair value for the facility was determined based onequipment and sales of similar manufacturing facilities, and properties in comparable markets.markets, respectively. Based on our valuation of Transform's net assets, we recognized an other-than-temporary impairment charge of $69 million in equity in net income (losses) of equity method investees.

In connection with our restructure and asset impairment charges, the fair value of our 200mm wafer fabrication equipment in Kiryat Gat, Israel was determined primarily based on the expected proceeds of the sale and the fair value of a supply agreement to manufacture NOR flash memory at the facility (Level 3 fair value measurement). The fair values of our MIT assets and our Light-emitting Diode ("LED") production assets were based on quotations obtained from equipment dealers, which consider the remaining useful life and configuration of the equipment (Level 3 fair value measurement). (See "Restructure and Asset Impairments" note.)

Fair Value of Financial Instruments

Amounts reported as cash and equivalents, receivables, and accounts payable and accrued expenses approximate fair value. The estimated fair value and carrying value of debt instruments (carrying value excludes the equity and mezzanine components of our convertible notes, which are classified in equity) were as follows:

As of 2013 2012 2014 2013
 
Fair
Value
 
Carrying
Value
 
Fair
Value
 
Carrying
Value
 
Fair
Value
 
Carrying
Value
 
Fair
Value
 
Carrying
Value
Convertible notes $4,167
 $2,506
 $2,669
 $2,321
 $5,886
 $2,143
 $4,167
 $2,506
Elpida creditor installment payments and other notes2,269
 2,279
 56
 58
MMJ creditor installment payments and other notesMMJ creditor installment payments and other notes3,634
 3,539
 2,269
 2,279

The fair values of our convertible debt instrumentsnotes were determined based on inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, including the trading price of our convertible notes, when available, our stock price and interest rates based on similar debt issued by parties with credit ratings similar to ours (Level 2).  The fair value of our other debt instruments was estimated based on discounted cash flows using inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, including interest rates based on similar debt issued by parties with credit ratings similar to ours (Level 2).




84



Equity Plans

As of August 29, 201328, 2014, we had an aggregate of 160.2161 million shares of common stock reserved for the issuance of stock options and restricted stock awards, of which 83.862 million shares were subject to outstanding awards and 76.499 million shares were available for future awards.  Awards are subject to terms and conditions as determined by our Board of Directors.

Stock Options

Our stock options are generally exercisable in increments of either one-fourth or one-third per year beginning one year from the date of grant. Stock options issued after SeptemberFebruary 2014 generally expire eight years from the date of grant. Options issued from October 2004 to February 2014 generally expire six years from the date of grant. All other options expire ten years from the grant date.

Option activity for 20132014 is summarized as follows:

 Number of Shares Weighted-Average Exercise Price Per Share 
Weighted-Average Remaining Contractual Life
(In Years)
 Aggregate Intrinsic Value Number of Shares Weighted-Average Exercise Price Per Share 
Weighted-Average Remaining Contractual Life
(In Years)
 Aggregate Intrinsic Value
Outstanding at August 30, 2012 95.7
 $8.42
  
Outstanding at August 29, 2013 71
 $7.41
  
Granted 17.8
 6.62
   12
 22.61
  
Exercised (22.8) 6.60
   (32) 8.27
  
Cancelled or expired (19.9) 12.47
   (3) 9.27
  
Outstanding at August 29, 2013 70.8
 7.41
 3.3 $439
Outstanding at August 28, 2014 48
 10.57
 3.8 $1,078
            
Exercisable at August 29, 2013 31.2
 $8.21
 1.8 $170
Expected to vest after August 29, 2013 37.6
 6.78
 4.4 255
Exercisable at August 28, 2014 14
 $6.88
 2.4 $362
Expected to vest after August 28, 2014 33
 11.92
 4.3 692

90




The weighted-average grant-date fair value per share was $3.349.64, $3.183.34 and $4.463.18 for options granted during 20132014, 20122013 and 20112012, respectively. The total intrinsic value was $103421 million, $6103 million, and $356 million for options exercised during 20132014, 20122013 and 20112012, respectively.

The fair values of option awards were estimated at each grant date using the Black-Scholes option valuation model.  The Black-Scholes model requires the input of assumptions, including the expected stock-price volatility and estimated option life.  The expected volatilities utilized were based on implied volatilities from traded options on our stock and on historical volatility.  The expected lives of options granted were based, in part, on historical experience and on the terms and conditions of the options.  The risk-free interest rates utilized were based on the U.S. Treasury yield in effect at each grant date.  No dividends were assumed in estimated option values.  Assumptions used in the Black-Scholes model are presented below:

For the year ended 2013 2012 2011 2014 2013 2012
Average expected life in years 5.1
 5.1
 5.1
 4.9
 5.1
 5.1
Weighted-average expected volatility 59% 66% 56% 48% 59% 66%
Weighted-average risk-free interest rate 0.7% 0.9% 1.8% 1.6% 0.7% 0.9%


85



Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")

As of August 29, 201328, 2014, there were 13.013 million shares of Restricted Stock Awards outstanding, of which 3.41 million were performance-based Restricted Stock Awards.  For service-based Restricted Stock Awards, restrictions generally lapse in one-fourth increments during each year of employment after the grant date.  For performance-based Restricted Stock Awards, vesting is contingent upon meeting certain performance goals.  Restricted Stock Awards activity for 20132014 is summarized as follows:

  Number of Shares Weighted-Average Grant Date Fair Value Per Share
Outstanding at August 30, 2012 9.4
 $6.87
Granted 6.6
 6.23
Restrictions lapsed (2.5) 7.06
Cancelled (0.5) 7.29
Outstanding at August 29, 2013 13.0
 6.49
     
Expected to vest after August 29, 2013 11.9
 $6.41

Restricted Stock Awards granted for 2013, 2012 and 2011 were as follows:
  Number of Shares Weighted-Average Grant Date Fair Value Per Share
Outstanding at August 29, 2013 13
 $6.49
Granted 7
 21.88
Restrictions lapsed (6) 6.29
Cancelled (1) 8.75
Outstanding at August 28, 2014 13
 15.08
     
Expected to vest after August 28, 2014 13
 $14.91

For the year ended 2013 2012 2011 2014 2013 2012
Service-based awards 5.4
 3.9
 4.4
Performance-based awards 1.2
 1.9
 1.2
Weighted-average grant-date fair values per share $6.23
 $5.43
 $8.72
 $21.88
 $6.23
 $5.43
Aggregate fair values at vesting date 115
 17
 32

The aggregate fair value at the lapse date of awards for which restrictions lapsed during 2013, 2012 and 2011 was $17 million, $32 million and $43 million, respectively.


91



Stock-based Compensation Expense

For the year ended 2013 2012 2011 2014 2013 2012
Stock-based compensation expense by caption:            
Cost of goods sold $27
 $23
 $20
 $39
 $27
 $23
Selling, general and administrative 45
 47
 38
 50
 45
 47
Research and development 18
 17
 17
 25
 18
 17
Other operating (income) expense 1
 
 1
Other 1
 1
 
 $91
 $87
 $76
 $115
 $91
 $87
            
Stock-based compensation expense by type of award:            
Stock options $57
 $57
 $44
 $61
 $57
 $57
Restricted stock awards 34
 30
 32
 54
 34
 30
 $91
 $87
 $76
 $115
 $91
 $87

Stock-based compensation expense of $69 million and $56 million was capitalized and remained in inventory as of August 29, 201328, 2014 and August 30, 201229, 2013, respectively. As of August 29, 201328, 2014, $136$275 million of total unrecognized compensation costs, net of estimated forfeitures, related to non-vested awards was expected to be recognized through the fourth quarter of 20172018, resulting in a weighted-average period of 1.21.4 years. Stock-based compensation expense in the above presentation does not reflect any significant income tax benefits, which is consistent with our treatment of income or loss from our U.S. operations.  (See "Income Taxes" note.)




86



Employee Benefit Plans

We have employee retirement plans at our U.S. and international sites.  Details of the more significant plans are discussed as follows:

Employee Savings Plan for U.S. Employees

We have 401(k) retirement plans ("RAM Plans") under which U.S. employees may contribute up to 75% of their eligible pay (subject to IRS annual contribution limits) to various savings alternatives, none of which include direct investment in our common stock.  We match in cash eligible contributions from employees up to 5% of the employee's annual eligible earnings. Contribution expense for the RAM Plans was $4144 million, $41 million and $2641 million in 2014, 2013 2012 and 2011,2012, respectively.

Retirement Plans

We have pension plans in various countries worldwide.countries.  The pension plans are only available to local employees and are generally government mandated.  We have determined that these pensionAs of August 28, 2014, the projected benefit obligations of our plans arewas $164 million and plan assets were $90 million. As of August 29, 2013, the projected benefit obligations of our plans was $196 million and plan assets were $116 million. Pension expense was not materialsignificant for separate disclosure.2014, 2013 or 2012.


Restructure and Asset Impairments

For the year ended 2013 2012 2011 2014 2013 2012
Loss on impairment of LED assets $(6) $33
 $
Loss on impairment of MIT assets $62
 $
 $
 (5) 62
 
Loss on impairment of LED assets 33
 
 
Loss on restructure of ST consortium agreement 26
 
 
Gain on termination of lease to Transform (25) 
 
 
 (25) 
Gain from disposition of Japan Fabrication Facility 
 
 (54)
Loss on restructure of ST Consortium agreement 
 26
 
Other 30
 10
 (21) 51
 30
 10
 $126
 $10
 $(75) $40
 $126
 $10


92



In order to optimize operations, improve efficiency and increase our focus on our core memory operations, we have entered into various restructure activities. For 2014, our MBU and EBU operating segments recorded restructure and asset impairment charges of $21 million and $20 million, respectively. For 2013, restructure and asset impairment charges of $1220 million, $1114 million, $1112 million and $612 million were recorded by our ESG, WSG, NSGSBU, EBU, MBU and DSG operating segments. For 2012, restructure and asset impairment charges of $6 million and $3 million were recorded by our WSG and ESGCNBU operating segments, and a gain of $1 million was recorded by our NSG operating segment. For 2011, restructure and asset impairment charges of $23 million, $21 million, $21 million and $4 million were recorded by our DSG, NSG, WSG and ESG operating segments.respectively. Our other segments that do not meet the quantitative thresholds of a reportable segment are reported under All Other and recorded the remaining restructure and asset impairment charges. (See "Segments" note.) As of August 29, 2013,28, 2014, we had accrued $1214 million for unpaid other restructure activities related to our workforce optimization activity.activities. As of August 29, 2013,28, 2014, we do not anticipate incurring any significant additional costs for these restructure activities.

Micron Technology Italia, S.r.l. ("MIT")For 2014 and 2013, other restructure included charges associated with workforce optimization activities and with our efforts to wind down our 200mm operations primarily in Agrate, Italy and Kiryat Gat, Israel.

On May 3,For 2013, we sold MIT, a wholly-owned subsidiary, including its 200mm wafer fabrication facility assets in Avezzano, Italy, to LFoundry. In exchange for the sharesalso recognized charges of MIT, we received consideration from LFoundry valued at $35$33 million, substantially all of which was under a 7-year, non-interest bearing term note. Under the terms of the agreements, we assigned to LFoundry our supply agreement with Aptina for CMOS image sensors manufactured at the Avezzano facility.

The assets and liabilities of MIT, and related imager inventories, were classified as held for sale in 2013 and we recorded an impairment loss of $62 million to write down the assets and liabilities to their estimated fair values. The fair values were determined primarily based on the estimated fair value of proceeds from the sale to LFoundry (Level 3 fair value measurement). The carrying values of the MIT assets and liabilities sold, after the effects of the write down, were as follows:

Other current assets $75
Other noncurrent assets 37
Accounts payable and accrued expenses (43)
Other noncurrent liabilities (34)
  $35

Light-emitting Diode ("LED")

In 2013, we discontinued the development activities of our LED operations. In connection therewith, we recognized a charge of $33 million primarily to write downimpair certain production assets used in the development of LED technology, $62 million to impair the expected proceeds fromassets of MIT, a wholly-owned subsidiary, to their sale. Fair value for these assets was based on quotations obtained from equipment dealers, which considerestimated fair values in connection with the remaining useful lifesale of MIT to LFoundry, and configuration$26 million in connection with the restructure of the equipment (Level 3 fair value measurement).

STMicroelectronics S.r.l. ("ST") Consortium Agreement

In 2013, we restructured a consortium agreement with ST, whereby certain assets and approximately 500 employees from our Agrate, Italy fabrication facility were transferred to ST. The consortium agreement supports the R&D activities of us and ST and the manufacturing of semi-finished and advanced commercial semiconductor devices. In connection therewith,For 2013, we also recognized a restructure chargegain of $26$25 million for 2013, primarily from transfers related to the termination of equipment.

Lease to Transform

In May 2012, the Board of Directors of Transform approved a liquidation plan. In connection therewith, Transform terminated a lease with Transform, an equity method investee, to a portion of our manufacturing facilities in Boise, Idaho and we recognized a gain of $25 million in 2013.Idaho.

(See "Fair Value Measurements" note.)




9387



Japan Fabrication Facility

On June 2, 2011, we sold our wafer fabrication facility in Japan (the "Japan Fab") to Tower Semiconductor Ltd. ("Tower"). Under the arrangement, Tower paid $40 million in cash, approximately 1.3 million ordinary shares of Tower (subsequent to a 1 for 15 reverse stock split on August 6, 2012), and $20 million in installment payments, which we received in 2012. The net carrying value of assets sold and liabilities transferred to Tower on the transaction date prior to the effects of the transaction was $23 million and we recorded a gain of $54 million (net of transaction costs of $3 million) in connection with the sale of the Japan Fab. We also recorded a tax provision of $74 million related to the gain on the sale and to write down certain deferred tax assets associated with the Japan Fab. In connection with the sale of the Japan Fab, we entered into a supply agreement for Tower to manufacture products for us in the facility through approximately May 2014.

Other Restructure and Asset Impairment Activities

In order to improve efficiency, labor productivity and competitiveness, we initiated certain limited activities for workforce optimization in 2013. In connection therewith, we incurred charges of $17 million for severance and other employee-related costs in 2013.

In September 2013, we entered into an agreement to sell our 200mm wafer fabrication equipment in Kiryat Gat, Israel to Intel and to terminate the related facility lease with Intel. Through a series of arrangements, Intel will continue to manufacture wafers for us through 2014. We recognized an impairment charge of $14 million in 2013 to write down the value of these assets to their estimated fair values. The fair value of $38 million was determined primarily based on the expected proceeds of the sale and the fair value of a supply agreement to manufacture NOR flash memory at the facility (Level 3 fair value measurement).


Other Operating (Income) Expense, Net

For the year ended 2013 2012 2011 2014 2013 2012
Rambus settlement $233
 $
 $
(Gain) loss on disposition of property, plant and equipment $(3) $5
 $(17) 10
 (3) 5
Samsung patent cross-license agreement 
 
 (275)
Other (5) 27
 (19) (11) (5) 27
 $(8) $32
 $(311) $232
 $(8) $32

In 2011,December 2013, we entered intosettled all pending litigation between us and Rambus, including all antitrust and patent matters.  As a 10-year patent cross-license agreement with Samsung Electronics Co. Ltd. ("Samsung").  Otherresult, other operating incomeexpense for 20112014 included gainsa $233 million charge to accrue a liability, which reflects the discounted value of $275 million for cash received from Samsungamounts due under the agreement. The license is a life-of-patents license for existing patents and applications, and a 10-year term license for all other patents.this arrangement. (See "Contingencies" note.)

Other operating expense for 2012 included $17 million from the termination of a lease with IMFT and a charge of $10 million to write off a receivable in connection with resolution of certain prior year tax matters.


Other Non-Operating Income (Expense), Net

For the year ended 2013 2012 2011 2014 2013 2012
Loss on restructure of debt $(184) $(31) $
Gain (loss) from changes in currency exchange rates $(229) $(6) $(6) (28) (229) (6)
Loss on extinguishment of debt (31) 
 (113)
Gain (loss) from investments (5) 35
 (3)
Gain from disposition of interest in Aptina 119
 
 
Gain from issuance of Inotera shares 48
 
 
 93
 48
 
Other (1) 
 13
 8
 (6) 35
 $(218) $29
 $(109) $8
 $(218) $29


94



Loss on extinguishment of debt for 2013 resulted from the early repurchase of a portion of our 2014 Notes. Loss on extinguishment of debt for 2011 included $111 million recognized in connection with a series of debt restructure transactions with certain holders of our convertible notes. (See "Debt" note.)

Other non-operating income for 2011 included $15 million for the termination of our debt guarantee obligation that we recorded in connection with our acquisition of Numonyx.


Income Taxes

For the year ended 2013 2012 2011 2014 2013 2012
Income (loss) before taxes, net income attributable to noncontrolling interests and equity in net income (loss) of equity method investees:      
Income (loss) before income taxes, net income attributable to noncontrolling interests and equity in net income (loss) of equity method investees:      
Foreign $2,619
 $839
 $274
U.S. $446
 $(1,028) $257
 114
 446
 (1,028)
Foreign 839
 274
 294
 $2,733
 $1,285
 $(754)
 $1,285
 $(754) $551
      
Income tax (provision) benefit:            
Current:            
Foreign $(46) $(17) $(22)
U.S. federal $
 $14
 $
 (3) 
 14
Foreign (17) (22) (89)
State 
 
 (1) (2) 
 
 (17) (8) (90) (51) (17) (8)
Deferred:            
Foreign (81) 9
 25
U.S. federal 
 
 
 4
 
 
Foreign 9
 25
 (113)
 9
 25
 (113) (77) 9
 25
Income tax (provision) benefit $(8) $17
 $(203) $(128) $(8) $17


88



Income tax (provision) benefit computed using the U.S. federal statutory rate reconciled to income tax (provision) benefit was as follows:

For the year ended 2013 2012 2011 2014 2013 2012
U.S. federal income tax (provision) benefit at statutory rate $(450) $264
 $(193) $(956) $(450) $264
Change in unrecognized tax benefits (152) 2
 52
State taxes, net of federal benefit (39) 6
 9
Gain on MMJ Acquisition (11) 520
 
Change in valuation allowance (370) (373) 103
 544
 (418) (368)
Transaction costs to acquire Elpida (38) 
 
Gain on acquisition of Elpida 520
 
 
Foreign operations 282
 104
 (119)
Foreign tax rate differential 474
 339
 77
Tax credits 36
 2
 17
 11
 36
 2
State taxes, net of federal benefit 6
 9
 (5)
Debt repurchase premium 
 
 (20)
Transaction costs related to the MMJ Acquisition 
 (38) 
Other 6
 11
 14
 1
 (5) (19)
Income tax (provision) benefit $(8) $17
 $(203) $(128) $(8) $17


95



Deferred income taxes reflect the net tax effects of temporary differences between the bases of assets and liabilities for financial reporting and income tax purposes.purposes as well as carryforwards.  Deferred tax assets and liabilities consist of the following as of the end of the periods shown below:following:

As of 2013 2012 2014 2013
Deferred tax assets:        
Net operating loss and credit carryforwards $4,048
 $1,733
Net operating loss and tax credit carryforwards $3,162
 $4,048
Property, plant and equipment 373
 16
 284
 313
Accrued salaries, wages and benefits 107
 99
 152
 107
Deferred income 39
 39
Other accrued liabilities 113
 8
Other 138
 92
 104
 169
Gross deferred tax assets 4,705
 1,979
 3,815
 4,645
Less valuation allowance (3,215) (1,522) (2,443) (3,155)
Deferred tax assets, net of valuation allowance 1,490
 457
 1,372
 1,490
        
Deferred tax liabilities:        
Debt discount (294) (182) (291) (294)
Unremitted earnings on certain subsidiaries (126) (111) (115) (126)
Product and process technology (74) (61) (29) (74)
Other (14) (38) (67) (14)
Deferred tax liabilities (508) (392) (502) (508)
        
Net deferred tax assets $982
 $65
 $870
 $982
        
Reported as:        
Current deferred tax assets (included in other current assets) $123
 $19
 $228
 $123
Noncurrent deferred tax assets 861
 47
 816
 861
Current deferred tax liabilities (included in accounts payable and accrued expenses) (2) 
 (4) (2)
Noncurrent deferred tax liabilities (included in other noncurrent liabilities) 
 (1) (170) 
Net deferred tax assets $982
 $65
 $870
 $982


89



As of August 28, 2014, we had a valuation allowance of $1.29 billion against substantially all U.S. net deferred tax assets, primarily related to net operating loss carryforwards. The valuation allowance is based on our assessment of the deferred tax assets that it isare more likely than not that certain deferred tax assets will notto be realized. We have aAs of August 28, 2014, we had partial valuation allowanceallowances of $979 million for Japan and $179 million for our other foreign subsidiaries against substantially all U.S. net deferred tax assets, as well as $1.5 billionprimarily related to our foreign subsidiaries. Elpida represents $912 million of the net deferred tax assets.

operating loss carryforwards. As of August 29, 2013, our federal and state28, 2014, we had $3.95 billion of net operating loss carryforwards were $4.2in Japan of which $2.76 billion is subject to a valuation allowance. Our valuation allowance decreased $712 million in 2014 primarily due to the utilization of U.S. and $2.2 billion, respectively.  Ifforeign net operating losses as well as adjustments based on management's reassessment of the amount of foreign net operating losses that are more likely than not utilizedto be realized.

As of August 28, 2014, our federal, state and stateforeign net operating loss carryforwards will expire at various dates through 2033.  carryforward amounts and expiration periods as reported to tax authorities, were as follows:

Year of Expiration U.S. Federal State Japan Other Foreign Total
2015 - 2019 $
 $102
 $83
 $513
 $698
2020 - 2024 
 179
 3,862
 872
 4,913
2025 - 2029 2,081
 934
 
 
 3,015
2030 - 2033 1,812
 493
 
 
 2,305
Indefinite 
 
 
 39
 39
  $3,893
 $1,708
 $3,945
 $1,424
 $10,970

As of August 29, 2013,28, 2014, our federal and state tax credit carryforwardscarryforward amounts and expiration periods were $238 million and $203 million, respectively.  If not utilized our federal and state tax credit carryforwards will expire at various dates through 2033.  as follows:

As of August 29, 2013, our foreign net operating loss carryforwards were $7.0 billion, of which $5.9 billion pertains to Elpida. Our foreign net operating loss carryforwards will expire at various dates through 2023. We have placed a valuation allowance against $4.7 billion of these foreign net operating loss carryforwards, of which $3.8 billion pertains to Elpida.  This partial valuation allowance against foreign net operating loss carryforwards, which is primarily attributable to Elpida, results from our current projections of taxable income, being more likely than not, insufficient to utilize the full amount of the net operating loss deferred tax assets.
Year of Tax Credit Expiration Federal State Total
2015 - 2019 $9
 $69
 $78
2020 - 2024 91
 55
 146
2025 - 2029 78
 38
 116
2030 - 2034 72
 
 72
Indefinite 
 31
 31
  $250
 $193
 $443

We have approximately $67not recognized deferred tax assets of $207 million of net for excess tax benefits that arose directly from tax deductions related to excess stockequity compensation benefits, which are not recorded as deferred tax assets.greater than amounts recognized for financial reporting. These excess stock compensation benefits will be credited to additional paid-in capital when recognized.if realized. We use the "with and without" method, as described in ASC 740, for purposes of determining when excess tax benefits have been realized.


96



The changes in valuation allowance of $1,693 million and $315 million in 2013 and 2012, respectively, are primarily due to uncertainties of realizing certain U.S. and foreign net operating losses and certain tax credit carryforwards. Elpida represents $1,292 million of the change in the valuation allowance during 2013.

Provision has been made for deferred taxes on undistributed earnings of non-U.S. subsidiaries to the extent that dividend payments from such companies are expected to result in additional tax liability.liabilities.  Remaining undistributed earnings of $1.8$4.91 billion as of August 29, 201328, 2014 have been indefinitely reinvested; therefore, no provision has been made for taxes due upon remittanceon approximately $6.55 billion of these earnings.the excess of the financial reporting amount over the tax basis of investments in foreign subsidiaries that are indefinitely reinvested. Determination of the amount of unrecognized deferred tax liability onliabilities related to investments in these unremitted earningsforeign subsidiaries is not practicable.


90



Below is a reconciliation of the beginning and ending amount of unrecognized tax benefits:

For the year ended 2013 2012 2011 2014 2013 2012
Beginning unrecognized tax benefits $77
 $121
 $88
 $78
 $77
 $121
Increases related to tax positions taken during current year 152
 4
 6
Foreign currency translation increases (decreases) to tax positions 1
 4
 (9)
Settlements with tax authorities (8) (29) (2) (1) (8) (29)
Decreases related to tax positions from prior years 
 (14) (3) (1) 
 (14)
Foreign currency translation increases (decreases) to tax positions 4
 (9) 6
Increases related to tax positions taken during current year 4
 6
 28
Lapse of statute of limitations (1) 
 
Increases related to tax positions from prior years 
 2
 4
 
 
 2
Unrecognized tax benefits acquired in current year 1
 
 
 
 1
 
Ending unrecognized tax benefits $78
 $77
 $121
 $228
 $78
 $77

Included in the unrecognized tax benefits balance as of August 28, 2014, August 29, 2013, and August 30, 2012 were $66 million, $63 million and September 1, 2011 were $63$66 million,, $66 million and $113 million, respectively, of unrecognized income tax benefits, which if recognized, would affect our effective tax rate.  The increase in unrecognized tax benefits in fiscal 2014 primarily related to transfer pricing and other matters which were substantially offset by changes in our deferred tax asset valuation allowance. We recognize interest and penalties related to income tax matters within income tax expense. As of August 28, 2014, August 29, 2013, and August 30, 2012 and September 1, 2011, the amount accrued for interest and penalties related to uncertain tax positions was $1619 million, $1216 million and $1612 million, respectively.

We are unable to reasonably estimate possible increases The resolution of tax audits or decreaseslapses of statute of limitations could reduce our unrecognized tax benefits. Although each matter is individually insignificant and the timing of final resolution is uncertain, the estimated potential reduction in uncertainour unrecognized tax positions that may occur withinbenefits in the next 12 months dueranges from $0 to the uncertainty of the timing of the resolution and/or closure on audits.  However, we do not anticipate any such change would be significant.$77 million, including interest and penalties.

We currently operate in several tax jurisdictions where we have arrangements that allow us to compute our tax provision at rates below the local statutory rates that expire in whole or in part at various dates through 2026.  These arrangements benefitted our tax provision in 20132014, 20122013 and 20112012 by$286 million ($0.24 per diluted share), $141 million ($0.13 per diluted share), and $52 million ($0.05 per diluted share) and $72 million ($0.07 per diluted share), respectively.

We and our subsidiaries file income tax returns with the U.S. federal government, various U.S. states and various foreign jurisdictions throughout the world.  Our U.S. federal and state tax returns remain open to examination for 20092010 through 2013.2014.  In addition, tax yearsreturns open to examination in multiple foreign taxing jurisdictions range from the years 2005 to 2013.  We are currently under examination in various taxing jurisdictions in which we conduct business operations.2014.  We believe that adequate amounts of taxes and related interest and penalties have been provided for, and any adjustments as a result of the examinations are not expected to materially adversely affect our business, results of operations or financial condition.




97



Earnings Per Share

For the year ended 2013 2012 2011 2014 2013 2012
Net income (loss) available to Micron shareholders – Basic and Diluted $1,190
 $(1,032) $167
Net income (loss) available to Micron shareholders – Basic $3,045
 $1,190
 $(1,032)
Dilutive effect related to equity method investment (2) 
 
Net income (loss) available to Micron shareholders – Diluted $3,043
 $1,190
 $(1,032)
            
Weighted-average common shares outstanding – Basic 1,021.7
 991.2
 988.0
 1,060
 1,022
 991
Net effect of dilutive equity awards, convertible notes and escrow shares 34.6
 
 19.5
Dilutive effect of equity plans and convertible notes 138
 35
 
Weighted-average common shares outstanding – Diluted 1,056.3
 991.2
 1,007.5
 1,198
 1,057
 991
            
Earnings (loss) per share:            
Basic $1.16
 $(1.04) $0.17
 $2.87
 $1.16
 $(1.04)
Diluted 1.13
 (1.04) 0.17
 2.54
 1.13
 (1.04)


91



Listed below are the potential common shares, as of the end of the periods shown, that could dilute basic earnings per share in the future that were not included in the computation of diluted earnings per share because to do so would have been antidilutive:

For the year ended 2013 2012 2011 2014 2013 2012
Employee stock plans 39.9
 104.8
 81.4
Equity plans 7
 40
 105
Convertible notes 186.0
 257.6
 182.7
 26
 186
 258

Our 2031B Notes, 2033 Notes and 2043 Notes, and, to the extent our 2027 Notes 2031and 2031A Notes and 2033 Noteswere outstanding during the periods presented, contain terms that upon conversion require us to settle the aggregate principal amount in cash and the remainder of our conversion obligation amount in either shares of our common stock or cash, at our election. Our 2032 Notes, and, to the extent our 2014 Notes and 2032 Noteswere outstanding during the periods presented, contain terms that upon conversion provide us the option to pay cash, issue shares of common stock or any combination thereof for the aggregate amount due. It is our current intent to settle the principal amount of the 2014 Notes andour 2032 Notes in cash upon conversion. As a result of these conversion terms, the 279.8 millionshares underlying the 2014 Notes, 2027 Notes, 2031 Notes, 2032 Notes, and 2033 Notes areand 2043 Notes were considered in diluted earnings per share for the period they were outstanding during 2014 under the treasury stock method. (See "Debt" note.)


Consolidated Variable Interest Entities

IM Flash

We partnered with Intel to form IMFT in 2006 and IMFS in 2007 to manufacture NAND Flash memory products for the exclusive use of the members. IMFT (and IMFS prior to April 6, 2012) is governed by a Board of Managers. The number of managers appointed by each member to the board varies based on the members' respective ownership interests. The members' ownership percentage is based on contributions to the partnership. We have owned 51% of IMFT from inception through August 29, 2013. Our ownership percentage of IMFS had increased from 51% at inception to 82% as of April 6, 2012 due to a series of contributions by us that were not fully matched by Intel.

On April 6, 2012, we entered into a series of agreements with Intel to restructure IM Flash. We acquired Intel's remaining 18% interest in IMFS for $466 million. In addition, we acquired IMFT's assets located at our Virginia wafer fabrication facility, for which Intel received a distribution from IMFT of $139 million. For both transactions, the amounts Intel received approximated the book values of Intel's interests in the assets acquired. Additionally, we received a $300 million deposit from Intel which may be applied either to Intel's purchases of NAND Flash under a supply agreement or, under certain circumstances, refunded. As of August 29, 2013, $134 million of the deposit remained to be applied or refunded.

The agreements also provided for the following:

expansion of the scope of the IMFT joint venture to include certain emerging memory technologies;
supply of NAND Flash memory products and certain emerging memory products to Intel on a cost-plus basis and termination of IMFS's supply agreement with us and Intel;
extension of IMFT's joint venture agreement through 2024;

98



certain buy-sell rights, commencing in 2015, pursuant to which Intel may elect to sell to us, or we may elect to purchase from Intel, Intel’s interest in IMFT (if Intel so elects, we would set the closing date of the transaction within two years following such election and could elect to receive financing from Intel for one to two years);
financing of $65 million provided by Intel to us under a two-year senior unsecured promissory note, payable with interest in approximately equal quarterly installments (as of August 29, 2013, $25 million of the note was outstanding); and
termination of IMFT's lease to use approximately 50% of our Virginia fabrication facility, which resulted in a charge to other operating expense of $17 million in 2012.

The following table presents IM Flash's distributions to and contributions from its members ("IM Flash" includes both IMFT and IMFS for all periods prior to April 6, 2012 and includes only IMFT for the period after April 6, 2012):

For the year ended 2013 2012 2011
IM Flash distributions to Micron $38
 $439
 $234
IM Flash distributions to Intel 37
 391
 225
Micron contributions to IM Flash 12
 151
 1,580
Intel contributions to IM Flash 11
 177
 

IM Flash sells products to the joint venture members generally in proportion to their ownership interests at long-term negotiated prices approximating cost. Due to the changes in ownership, our share of IMFS output grew from 51% in the first quarter of 2011 to 78% in the second quarter of 2012. As a result of our restructuring of IM Flash on April 6, 2012, Intel has no continuing rights to the output from the IMFS and Virginia facilities. Intel continues to receive output from IMFT in proportion to its ownership interest at long-term negotiated prices approximating cost and, subsequent to April 6, 2012, also purchases NAND Flash products from us under a cost-plus supply arrangement. Aggregate sales of NAND Flash products to Intel (including sales by IMFT at prices approximating cost and sales by us under the cost-plus supply agreement) were $849 million, $986 million and $884 million for 2013, 2012 and 2011, respectively. Receivables from Intel for sales of NAND Flash products as of August 29, 2013 and August 30, 2012, were $198 million and $103 million, respectively.

As a result of changes to the timing of the passage of title in the IMFT supply agreement with Intel, effective April 6, 2012, sales are now recognized upon completion of wafer fabrication, rather than after backend assembly and test are completed. As a result, we sold $97 million of backend inventories, which generated a one-time increase in NAND sales and reduction in work in process inventories in 2012.


99



The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets, excluding intercompany balances:

As of 2013 2012
Assets    
Cash and equivalents $62
 $157
Receivables 76
 78
Inventories 49
 67
Other current assets 4
 5
Total current assets 191
 307
Property, plant and equipment, net 1,382
 1,342
Other noncurrent assets 46
 36
Total assets $1,619
 $1,685
     
Liabilities  
  
Accounts payable and accrued expenses $88
 $104
Deferred income 9
 10
Equipment purchase contracts 78
 58
Current portion of long-term debt 6
 6
Total current liabilities 181
 178
Long-term debt 13
 18
Other noncurrent liabilities 118
 129
Total liabilities $312
 $325
Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Our ability to access IMFT's cash and other assets through cash dividends, loans or advances, including to finance our other operations, is subject to agreement by Intel. Creditors of IMFT have recourse only to its assets and do not have recourse to any other of our assets.

IM Flash manufactures NAND Flash memory products using designs and technology we develop with Intel. We generally share product design and other NAND Flash R&D costs with Intel. The April 6, 2012 agreements with Intel expanded our NAND Flash R&D cost-sharing agreement with Intel to include certain emerging memory technologies, but did not change the cost-sharing percentage. R&D expenses were reduced by reimbursements from Intel of $127 million, $87 million and $95 million for 2013, 2012 and 2011, respectively.

MP Mask

In 2006, we formed a joint venture with Photronics to produce photomasks for leading-edge and advanced next generation semiconductors.  At inception and through August 29, 2013, we owned 50.01% and Photronics owned 49.99% of MP Mask.  We contributed $21 million to MP Mask and Photronics contributed $20 million to MP Mask in 2012. In connection with the formation of the joint venture, we received $72 million in 2006 in exchange for entering into a license agreement with Photronics, which is being recognized over the term of the 10-year agreement.  Deferred income and other noncurrent liabilities included an aggregate of $19 million and $26 million as of August 29, 2013 and August 30, 2012, respectively, related to this agreement. We purchase a substantial majority of the reticles produced by MP Mask pursuant to a supply arrangement.

Total MP Mask assets and liabilities included in our consolidated balance sheets were as follows:

As of 2013 2012
Current assets $26
 $19
Noncurrent assets (primarily property, plant and equipment) 182
 170
Current liabilities 25
 12
Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.


100



Creditors of MP Mask have recourse only to the assets of MP Mask and do not have recourse to any other of our assets.

Through February 24, 2012, we leased to Photronics a facility to produce photomasks under an operating lease. On February 24, 2012, we sold the facility to Photronics for $35 million. The proceeds were equal to our net carrying value and no gain or loss was realized from the sale.


Segment Information

In the third quarter of 2014, we reorganized our business units. All prior period amounts reflect this reorganization. Factors used to identify our segments include, among others, markets, customers and products.  Segment information reported herein is consistent with how it is reviewed and evaluated by our chief operating decision makers. Factors used to identify our segments include, among others, products, technologies and customers.  We have the following four business units, which are our reportable segments:

DRAM Solutions GroupCompute and Networking Business Unit ("DSG"CNBU"): Includes DRAM and NOR Flash products sold to the PC, consumer electronics,compute, networking, graphics and cloud server markets.
NAND Solutions GroupMobile Business Unit ("NSG"): Includes high-volume NAND Flash products sold into data storage, personal music players, and the high-density computing market, as well as NAND Flash products sold to Intel through our IM Flash joint venture.
Wireless Solutions Group ("WSG"MBU"): Includes DRAM, NAND Flash and NOR Flash products including multi-chip packages, sold to the mobile devicesmartphone, feature phone and tablet mobile-device market.
Storage Business Unit ("SBU"): Includes NAND Flash components and SSDs sold into enterprise and client storage, cloud and removable storage markets. SBU also includes NAND Flash products sold to Intel through our IMFT joint venture.
Embedded Solutions GroupBusiness Unit ("ESG"EBU"): Includes DRAM, NAND Flash and NOR Flash products sold into automotive and industrial applications, as well as NORthe connected home and NAND Flash sold to consumer electronics networking, PC and server markets.

Our other operations do not meet the quantitative thresholds of a reportable segment and are reported under All Other.

Certain operating expenses directly associated with the activities of a specific reportable segment are charged to that segment. Other indirect operating expenses (income) are generally allocated to the reportable segments based on their respective percentage of cost of goods sold or forecasted wafer production. In 2013, we reclassifiedThe unallocated amount in 2014 related to the (gains) losses from changes in currency exchange rates from other operating (income) expense, net to other non-operating income (expense), net in the consolidated statements of income. As a result, the (gains) losses from changes in currency exchange rates have been reclassified out of operating income (loss) for our segments for 2012 and 2011.Rambus settlement.

We do not identify or report internally our assets or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items or taxes to operating segments.  There are no differences in the accounting policies for segment reporting and our consolidated results of operations.

For the year ended 2013 2012 2011
Net sales:      
DSG $3,519
 $2,691
 $3,203
NSG 2,841
 2,853
 2,196
WSG 1,221
 1,184
 1,959
ESG 1,194
 1,054
 1,002
All Other 298
 452
 428
  $9,073
 $8,234
 $8,788
       
Operating income (loss):      
DSG $143
 $(494) $290
NSG 201
 205
 276
WSG (263) (368) 19
ESG 271
 158
 236
All Other (116) (113) (60)
  $236
 $(612) $761


10192



For the year ended 2014 2013 2012
Net sales:      
CNBU $7,333
 $3,462
 $2,667
MBU 3,627
 1,214
 1,176
SBU 3,480
 2,824
 2,842
EBU 1,774
 1,275
 1,097
All Other 144
 298
 452
  $16,358
 $9,073
 $8,234
       
Operating income (loss):      
CNBU $1,957
 $160
 $(458)
MBU 683
 (265) (371)
SBU 255
 173
 199
EBU 331
 227
 129
All Other 94
 (59) (111)
Unallocated (233) 
 
  $3,087
 $236
 $(612)

Depreciation and amortization expense was as follows:

For the year ended 2013 2012 2011 2014 2013 2012
DSG $708
 $770
 $750
NSG 553
 651
 513
WSG 295
 374
 512
ESG 189
 211
 196
CNBU $878
 $687
 $755
MBU 475
 293
 372
SBU 512
 551
 649
EBU 226
 215
 228
All Other 68
 138
 130
 11
 67
 140
Depreciation and amortization expense included in operating income (loss) 1,813
 2,144
 2,101
 2,102
 1,813
 2,144
Other amortization 113
 78
 61
 168
 113
 78
Total depreciation and amortization expense $1,926
 $2,222
 $2,162
 $2,270
 $1,926
 $2,222


Product Sales

For the year ended 2013 2012 2011 2014 2013 2012
DRAM $4,361
 $3,178
 $3,620
 $11,164
 $4,361
 $3,178
NAND Flash 3,589
 3,627
 3,193
 4,468
 3,589
 3,627
NOR Flash 792
 977
 1,547
 505
 792
 977
Other 331
 452
 428
 221
 331
 452
 $9,073
 $8,234
 $8,788
 $16,358
 $9,073
 $8,234




93



Certain Concentrations

MarketMarkets with concentrations as a percent of net sales were approximately as follows:
For the year ended 2013 2012 2011
Computing (including desktop PCs, servers, notebooks and workstations) 30% 25% 30%
Mobile 15% 15% 25%
Consumer electronics 15% 20% 15%
Solid state drives 15% 10% 5%
Networking and storage 10% 10% 15%
For the year ended 2014 2013 2012
Compute and graphics 30% 20% 15%
Mobile 20% 15% 15%
Solid state drives and other storage 20% 25% 25%
Automotive, industrial, medical and other embedded 10% 15% 15%
Server 10% 10% 10%

Customer concentrations included net sales to Kingston of 10% for 2014, net sales to Intel of 10%, 12% and 10%12% for 2013 2012 and 2011,2012, respectively, and net sales to Hewlett-Packard Company ("HP")HP of 10% for 2013. Substantially all of our sales to Kingston are included in 2013. Substantiallyour CNBU segment, substantially all of our sales to Intel are included in the NSGour SBU segment and substantially all of our sales to HP are included in the DSGour CNBU and NSGSBU segments.

Certain of the raw materials and production equipment we use in manufacturing semiconductor products are available from multiple sources and in sufficient supply; however, only a limited number of suppliers are capable of delivering certain raw materials and production equipment that meet our standards. In some cases, materials are provided by a single supplier.


102



Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, money market accounts, certificates of deposit, fixed-rate debt securities, trade receivables and derivative contracts. We invest through high-credit-quality financial institutions and, by policy, generally limit the concentration of credit exposure by restricting investments with any single obligor. A concentration of credit risk may exist with respect to receivables as a substantial portion of our customers are affiliated with the computing industry. We perform ongoing credit evaluations of customers worldwide and generally do not require collateral from our customers. Historically, we have not experienced significant losses on receivables. A concentration of risk may also exist with respect to derivatives as the number of counterparties to our currency and interest rate swap hedges is limited and the notional amount isamounts are relatively large. We seek to mitigate such risk by limiting our counterparties to major financial institutions.institutions and through entering into master netting arrangements. The 2031 Capped Calls, 2032 Capped Calls and 2033 Capped Callscapped calls expose us to credit risk to the extent the counterparties may be unable to meet the terms of the agreements. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading the risk across several major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored on an ongoing basis. (See "Shareholders' Equity – Capped Calls" note.)


Geographic Information

Geographic net sales based on customer ship-to location were as follows:

For the year ended 2013 2012 2011 2014 2013 2012
China $3,783
 $2,936
 $2,983
 $6,715
 $3,783
 $2,936
United States 1,512
 1,262
 1,363
 2,551
 1,512
 1,262
Asia Pacific (excluding China, Taiwan and Malaysia) 1,342
 1,241
 1,518
Taiwan 980
 1,022
 744
 2,313
 980
 1,022
Asia Pacific (excluding China, Taiwan and Japan) 1,791
 946
 1,327
Japan 1,253
 589
 460
Europe 820
 827
 924
 1,252
 820
 827
Malaysia 193
 546
 737
Other 443
 400
 519
 483
 443
 400
 $9,073
 $8,234
 $8,788
 $16,358
 $9,073
 $8,234


94



Net property, plant and equipment by geographic area werewas as follows:

As of 2013 2012 2011 2014 2013
United States $3,282
 $3,041
Singapore $3,225
 $3,270
 $3,569
 3,101
 3,225
United States 3,041
 3,246
 3,487
Japan 615
 2
 1
 1,221
 615
Taiwan 761
 307
China 350
 328
 179
 242
 350
Taiwan 307
 
 
Israel 28
 59
 94
Italy 18
 163
 190
Other 42
 35
 35
 75
 88
 $7,626
 $7,103
 $7,555
 $8,682
 $7,626




103



Quarterly Financial Information (Unaudited)
(in millions except per share amounts)

2014 Fourth Quarter Third Quarter Second Quarter First Quarter
Net sales $4,227
 $3,982
 $4,107
 $4,042
Gross margin 1,385
 1,368
 1,403
 1,281
Operating income 828
 839
 869
 551
Net income 1,151
 806
 741
 381
Net income attributable to Micron 1,150
 806
 731
 358
         
Earnings per share:        
Basic $1.08
 $0.76
 $0.69
 $0.34
Diluted 0.96
 0.68
 0.61
 0.30

The results of operations for the first quarter of 2014 included a $233 million charge to accrue a liability for the settlement of all pending litigation between us and Rambus, including all antitrust and patent matters, which reflects the discounted value of amounts due under the arrangement. (See "Contingencies" note.)

The results of operations in the first, second, third and fourth quarters of 2014 included losses of $92 million, $80 million, $16 million and $17 million, respectively, for losses on restructure of debt. (See "Debt – 2014 Debt Restructure" note.)

The results of operations for the fourth quarter of 2014 included a gain of $93 million from the issuance of shares by Inotera, which reduced our ownership interest from 35% to 33%. (See "Equity Method Investments – Inotera" note.)

The results of operations for the fourth quarter of 2014 included a gain of $119 million from the sale of interest in Aptina to ON Semiconductor Corporation. (See "Equity Method Investments – Other" note.)

The results of operations for the fourth quarter of 2014 included a $66 million charge associated with a license agreement with Tessera executed in the fourth quarter of 2014. (See "Contingencies" note.)

The results of operations for the fourth quarter of 2014 included a $190 million income tax benefit from increases in the amounts of the MMJ Group's deferred tax assets expected to be realized based on our forecasted utilization of net operating losses. (See "Income Taxes" note.)


95



2013 Fourth Quarter Third Quarter Second Quarter First Quarter
Net sales $2,843
 $2,318
 $2,078
 $1,834
Gross margin 708
 556
 366
 217
Operating income (loss) 207
 149
 (23) (97)
Net income (loss) 1,710
 43
 (284) (275)
Net income (loss) attributable to Micron 1,708
 43
 (286) (275)
         
Earnings (loss) per share:  
  
  
  
Basic $1.65
 $0.04
 $(0.28) $(0.27)
Diluted 1.51
 0.04
 (0.28) (0.27)

The results of operations for the fourth quarter of 2013 includeincluded a gain of $1,484 million1.48 billion for the acquisition of Elpida.MMJ Acquisition. The fourth quarter of 2013 includes Elpida'sthe MMJ Group's results of operation from the July 31, 2013 acquisition date. (See "Acquisition of Elpida""Micron Memory Japan, Inc." note.)

The results of operations for the fourth quarter of 2013 includeincluded a gain of $48 million from the issuance of shares by Inotera, which reduced our ownership interest from 39.7%40% to 35.5%35%. (See "Equity Method Investment -Investments – Inotera" note.)

The results of operations for the fourth, third, second and first quarters of 2013 includeincluded losses of $3 million, $47 million, $120 million and $58 million, respectively, for the ElpidaMMJ Acquisition Hedges. (See "Derivatives - Elpida Acquisition Hedges""Derivative Instruments – Derivative Instruments without Hedge Accounting Designation" note.)

In 2013 we took action to dispose of 200mm wafer manufacturing facilities and optimize operations including our workforce. The results of operations for the fourth, third and second quarters of 2013 include charges of $32 million, $55 million and $60 million, respectively, for the restructure and asset impairments. The results of operations for the first quarter of 2013 included a credit of $21 million for restructure activities. (See "Restructure and Asset Impairments" note.)

The results of operations in the second quarter of 2013 included a loss of $31 million loss on extinguishment of debt. (See "Debt -– 2013 Debt Restructure" note.)

2012 Fourth Quarter Third Quarter Second Quarter First Quarter
Net sales $1,963
 $2,172
 $2,009
 $2,090
Gross margin 219
 234
 210
 305
Operating loss (149) (188) (204) (71)
Net loss (242) (320) (282) (187)
Net loss attributable to Micron (243) (320) (282) (187)
         
Loss per share:  
  
  
  
Basic $(0.24) $(0.32) $(0.29) $(0.19)
Diluted (0.24) (0.32) (0.29) (0.19)

As a result of the ongoing challenging global environment in the solar industry and unfavorable worldwide supply and demand conditions, on May 25, 2012, the Board of Directors of Transform approved a liquidation plan. As a result of the liquidation plan, we recognized a charge of $69 million in the third quarter of 2012. (See "Equity Method Investment - Other - Transform" note.)

On March 23, 2012, we entered into a settlement agreement with Oracle pursuant to which we agreed to make a payment of $58 million to Oracle for a settlement and full release of all claims and a dismissal with prejudice of their suit against us. The settlement amount was accrued and charged to operations in the second quarter of 2012.

104




Income taxes for the third quarter of 2012 included a tax benefits of $42 million related to the favorable resolution of a certain prior year tax matter, which was previously reserved as an uncertain tax position.



10596



Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders
of Micron Technology, Inc.

In our opinion, the consolidated financial statements listed in the accompanying index appearing under Item 8 present fairly, in all material respects, the financial position of Micron Technology, Inc. and its subsidiaries at August 29, 201328, 2014 and August 30, 2012,29, 2013, and the results of their operations and their cash flows for each of the three years in the period ended August 29, 201328, 2014 in conformity with accounting principles generally accepted in the United States of America. In addition, in our opinion, the financial statement schedules listed in the accompanying index appearing under Item 8 present fairly, in all material respects, the information set forth therein when read in conjunction with the related consolidated financial statements. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of August 29, 2013,28, 2014, based on criteria established in Internal Control - Integrated Framework (1992)(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company's management is responsible for these financial statements and financial statement schedules, for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in Management'sManagement’s Report on Internal Control over Financial Reporting appearing inunder Item 9A. Our responsibility is to express opinions on these financial statements, on the financial statement schedules, and on the Company's internal control over financial reporting based on our integrated audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

As described in Management’s Report on Internal Control over Financial Reporting appearing in Item 9A, management has excluded Elpida Memory, Inc. (“Elpida”) and its subsidiaries, including Rexchip Electronics Corporation from its assessment of internal control over financial reporting as of August 29, 2013 because it was acquired by the Company in a purchase business combination on July 31, 2013. We have also excluded Elpida and its subsidiaries from our audit of internal control over financial reporting. Elpida and its subsidiaries are consolidated entities whose total assets and total revenues represent 27% and 4%, respectively, of the related consolidated financial statement amounts as of and for the year ended August 29, 2013.


/s/ PricewaterhouseCoopers LLP



San Jose, CA
October 28, 201327, 2014

10697



ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE


None.



ITEM 9A. CONTROLS AND PROCEDURES


An evaluation was carried out under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report.  Based upon that evaluation, the principal executive officer and principal financial officer concluded that those disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms and that such information is accumulated and communicated to our management, including the principal executive officer and principal financial officer, to allow timely decision regarding disclosure.

During the fourth quarter of 2013,2014, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


Management's Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.  Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.

Internal control over financial reporting cannot provide absolute assurance regarding the prevention or detectionBecause of misstatements because ofits inherent limitations.  These inherent limitations, are known by management and considered in the design of our internal control over financial reporting which reduce, thoughmay not eliminate, this risk.prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in "Internal Control – Integrated Framework" (1992)(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.  Based on this evaluation, management concluded that our internal control over financial reporting was effective as of August 29, 2013.28, 2014.  The effectiveness of our internal control over financial reporting as of August 29, 201328, 2014 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report, which is included in Part II, Item 8, of this Form 10-K.

Management's evaluation of the effectiveness of its internal control over financial reporting as of August 29, 2013 excluded Elpida Memory, Inc. ("Elpida") and its subsidiaries, including Rexchip Electronics Corporation from its assessment of internal control over financial reporting as of August 29, 2013 because it was acquired by us in a purchase business combination on July 31, 2013. Elpida and its subsidiaries are consolidated entities whose total assets and total revenues represent 27% and 4%, respectively, of the related consolidated financial statement amounts as of and for the year ended August 29, 2013.


ITEM 9B. OTHER INFORMATION


None.


10798



PART III


ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE


ITEM 11. EXECUTIVE COMPENSATION


ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS


ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE


ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES


Certain information concerning our executive officers is included under the caption, "Directors and Executive Officers of the Registrant," in Part I, Item 1 of this report.  Other information required by Items 10, 11, 12, 13 and 14 will be contained in our Proxy Statement which will be filed with the Securities and Exchange Commission within 120 days after August 29, 201328, 2014 and is incorporated herein by reference.



10899



PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES


The following documents are filed as part of this report:
1. Financial Statements:  See Index to Consolidated Financial Statements under Item 8.
2. Certain Financial Statement Schedules have been omitted since they are either not required, not applicable or the information is otherwise included.
3. Exhibits.
Exhibit Number Description of Exhibit
1.4 Purchase Agreement dated as of April 12, 2012, by and among Micron Technology, Inc. and Morgan Stanley & Co. LLC and J.P. Morgan Securities, LLC, as representatives of the initial purchasers (1)
1.5 Purchase Agreement, dated as of February 6, 2013, by and among Micron Technology, Inc. and Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Goldman, Sachs & Co., as representatives of the initial purchasers (2)
2.1* English Translation of Agreement on Support for Reorganization Companies with Nobuaki Kobayashi and Ykio Sakamoto, the trustees of Elpida Memory, Inc. and its wholly-owned subsidiary, Akita Elpida Memory, Inc. dated July 2, 2012 (3)
2.2* Share Purchase Agreement dated July 2, 2012, among Micron Technology, Inc., Micron Semiconductor B.V, Powerchip Technology Corporation, Li-Hsin Investment Co. Ltd., Quantum Vision Corporation, Maxchip Electronics Corporation and Dr. Frank Huang (4)
2.3* English Translation of Agreement Amending Agreement on Support for Reorganization Companies, dated October 29, 2012, by and among Micron Technology, Inc. and Nobuaki Kobayashi and Yukio Sakamoto, the trustees of Elpida Memory, Inc. and Akita Elpida Memory, Inc. (5)
2.4* English Translation of Agreement Amending Agreement on Support for Reorganization Companies, dated July 31, 2013, by and among Micron Technology, Inc. and Nobuaki Kobayashi and Yukio Sakamoto, the trustees of Elpida Memory, Inc. and Akita Elpida Memory, Inc. (6)
2.5 English Translation of the Reorganization Plan of Elpida Memory, Inc. (6)
3.1 Restated Certificate of Incorporation of the Registrant (7)
3.2 Bylaws of the Registrant, as amendedAmended and Restated (8)
4.1 Indenture dated November 3, 2010, by and between Micron Technology, Inc. and Wells Fargo Bank, National Association (9)
4.2Form of Note (included in Exhibit 4.1) (9)
4.3 Indenture dated as of April 18, 2012, by and between Micron Technology, Inc. and U.S. Bank National Association, as Trustee for 2.375% Convertible Senior Notes due 2032 (1)
4.34.4 Indenture dated as of April 18, 2012, by and between Micron Technology, Inc. and U.S. Bank National Association, as Trustee for 3.125% Convertible Senior Notes due 2032 (1)
4.44.5 Form of 2032C Note (included in Exhibit 4.2)4.3) (1)
4.54.6 Form of 2032D Note (included in Exhibit 4.3)4.4) (1)
4.64.7 Indenture dated as of May 23, 2007, by and between Micron Technology, Inc. and Wells Fargo Bank, National Association, as trustee (10)
4.74.8 Convertible Senior Indenture between the Company and Wells Fargo Bank, National Association, dated as of April 15, 2009 (11)
4.84.9 Form of 4.25% Convertible Senior Note due October 15, 2013 (included in Exhibit 4.7)4.8) (11)
4.94.10 Indenture dated July 26, 2011, by and between Micron Technology, Inc. and U.S. Bank National Association, as Trustee for 1.50% Convertible Senior Notes due 2031 (12)
4.104.11 Indenture dated July 26, 2011, by and between Micron Technology, Inc. and U.S. Bank National Association, as Trustee for 1.875% Convertible Senior Notes due 2031 (12)
4.114.12 Form of 2031A Note (included in Exhibit 4.9) (12)
4.12Form of 2031B Note (included in Exhibit 4.10) (12)
4.13 Indenture, dated asForm of February 12, 2013, by and between Micron Technology, Inc. and U.S. Bank National Association, as trustee (2)2031B Note (included in Exhibit 4.11) (12)
4.14 Indenture, dated as of February 12, 2013, by and between Micron Technology, Inc. and U.S. Bank National Association, as trustee (2)

109100



4.15 Indenture, dated as of February 12, 2013, by and between Micron Technology, Inc. and U.S. Bank National Association, as trustee (2)
4.16Form of 2033E Note (included in Exhibit 4.11)4.14) (2)
4.164.17 Form of 2033F Note (included in Exhibit 4.12)4.15) (2)
4.18Indenture, dated as of November 12, 2013, by and between the Company & U.S. Bank National Association (13)
4.19Form of New Note (included in Exhibit 4.18) (13)
4.20Indenture dated as of December 16, 2013, by and among Micron Semiconductor Asia Pte., Ltd., Wells Fargo Bank, National Association, and Export-Import Bank of the United States (14)
4.21Indenture dated as of February 10, 2014, by and between Micron Technology, Inc. and U.S. Bank National Association, as Trustee (15)
4.22Form of Note (included in Exhibit 4.21) (15)
4.23Indenture, dated as of July 28, 2014, by and between Micron Technology, Inc. and U.S. Bank National Association, as Trustee (16)
4.24Form of Note (included in Exhibit 4.23) (16)
10.1 Executive Officer Performance Incentive Plan, as Amended (13)(17)
10.310.2 1994 Stock Option Plan, as Amended (13)(17)
10.410.3 1994 Stock Option Plan Form of Agreement and Terms and Conditions (14)(18)
10.510.4 1997 Nonstatutory Stock Option Plan, as Amended (4)
10.610.5 1998 Non-Employee Director Stock Incentive Plan, as Amended (13)(17)
10.61998 Nonstatutory Stock Option Plan, as Amended (4)
10.7 1998 Nonstatutory2001 Stock Option Plan, as Amended (4)
10.8 2001 Stock Option Plan as Amended (4)
10.92001 Stock Option Plan Form of Agreement (15)(19)
10.102002 Employment Inducement Stock Option Plan, as Amended (13)
10.1110.9 2004 Equity Incentive Plan, as Amended (16)and Restated
10.1210.10 2004 Equity Incentive Plan Forms of Agreement and Terms and Conditions (17)
10.11Amended and Restated 2007 Equity Incentive Plan (20)
10.122007 Equity Incentive Plan Forms of Agreement (21)
10.13 Nonstatutory Stock Option Plan, as Amended (4)
10.14 Nonstatutory Stock Option Plan Form of Agreement and Terms and Conditions (14)(18)
10.15Lexar Media, Inc. 1996 Stock Option Plan, as Amended (17)
10.16 Lexar Media, Inc. 2000 Equity Incentive Plan, as Amended (13)(17)
10.21*10.17Numonyx Holdings B.V. Equity Incentive Plan (22)
10.18Numonyx Holdings B.V. Equity Incentive Plan Forms of Agreement (22)
10.19* Patent License Agreement dated September 15, 2006, by and among Toshiba Corporation, Acclaim Innovations, LLC and Micron Technology, Inc. (18)(23)
10.22*Omnibus Agreement dated as of February 27, 2007, between Micron Technology, Inc. and Intel Corporation (17)
10.23*Limited Liability Partnership Agreement dated as of February 27, 2007, between Micron Semiconductor Asia Pte. Ltd. And Intel Technology Asia Pte. Ltd. (17)
10.24*Supply Agreement dated as of February 27, 2007, between Micron Semiconductor Asia Pte. Ltd. And IM Flash Singapore, LLP (17)
10.25*10.20* Amended and Restated Limited Liability Company Operating Agreement of IM Flash Technologies, LLC dated as of February 27, 2007, between Micron Technology, Inc. and Intel Corporation (17)(24)
10.26*Supply Agreement dated as of February 27, 2007, between Intel Technology Asia Pte. Ltd. and IM Flash Singapore, LLP (17)
10.2710.21 Form of Indemnification Agreement between the Registrant and its officers and directors (19)(14)
10.2810.22 Form of Severance Agreement between the Company and its officers (20)(25)
10.2910.23 Form of Agreement and Amendment to Severance Agreement between the Company and its officers (21)(26)
10.36*10.24* Master Agreement dated as of November 18, 2005, between Micron Technology, Inc. and Intel Corporation (22)(27)
10.38*Manufacturing Services Agreement dated as of January 6, 2006, between Micron Technology, Inc. and IM Flash Technologies, LLC (22)
10.40*MTV Lease Agreement dated as of January 6, 2006, between Micron Technology, Inc. and IM Flash Technologies, LLC (22)
10.41*10.25* Product Designs Assignment Agreement dated January 6, 2006, between Intel Corporation and Micron Technology, Inc. (22)(27)
10.42*NAND Flash Supply Agreement, effective as of January 6, 2006, between Apple Computer, Inc. and Micron Technology, Inc. (22)
10.43*10.26* Supply Agreement dated as of January 6, 2006, between Micron Technology, Inc. and IM Flash Technologies, LLC (22)(27)
10.44*10.27* Supply Agreement dated as of January 6, 2006, between Intel Corporation and IM Flash Technologies, LLC (22)(27)
10.4510.28 Capped Call Confirmation (Reference No. CEODL6) by and between Micron Technology, Inc. and Morgan Stanley & Co. International plc (10)
10.4610.29 Capped Call Confirmation (Reference No. 53228800) by and between Micron Technology, Inc. and Credit Suisse International (10)

101



10.47
10.30 Capped Call confirmation (Reference No. 53228855) by and between Micron Technology, Inc. and Credit Suisse International (10)
10.48Amended and Restated 2007 Equity Incentive Plan

110



10.492007 Equity Incentive Plan Forms of Agreement (23)
10.50Severance Agreement dated April 9, 2008, between Micron Technology, Inc. and Ronald C. Foster (24)
10.51*10.31* Master Agreement dated as of April 21, 2008, by and between Nanya Technology Corporation and Micron Technology, Inc. (25)(28)
10.52*Joint Venture Agreement dated as of April 21, 2008, by and between Micron Semiconductor B.V. and Nanya Technology Corporation (25)
10.54*Joint Development Program Agreement dated as of April 21, 2008, by and between Nanya Technology Corporation and Micron Technology, Inc. (25)
10.55*10.32* Technology Transfer and License Agreement for 68-50nm Process Nodes, dated as of April 21, 2008, by and between Micron Technology, Inc. and Nanya Technology Corporation (25)(28)
10.56*Technology Transfer and License Agreement dated as of April 21, 2008, by and between Micron Technology, Inc. and Nanya Technology Corporation (25)
10.58*Technology Transfer Agreement dated as of May 13, 2008, by and among Nanya Technology Corporation, Micron Technology, Inc. and MeiYa Technology Corporation (25)
10.60Micron Guaranty Agreement, dated April 21, 2008, by and between Nanya Technology Corporation and Micron Semiconductor B.V. (25)
10.61TECH Facility Agreement dated March 31, 2008, among TECH Semiconductor Singapore Pte. Ltd. And ABN Amro Bank N.V., Citibank, N.A., Singapore Branch, Citigroup Global Markets Singapore Pte Ltd., DBS Bank Ltd and Oversea-Chinese Banking Corporation Limited, as Original Mandated Lead Arrangers (25)
10.62Guarantee dated March 31, 2008, by Micron Technology, Inc. as Guarantor in favor of ABN Amro Bank N.V., Singapore Branch acting as Security Trustee (25)
10.6310.33 Form of Severance Agreement (26)(29)
10.64Lexar Media, Inc. 1996 Stock Option Plan, as Amended (13)
10.66*Loan Agreement dated November 26, 2008, by and among Micron Semiconductor B.V., Micron Technology, Inc., and Nan Ya Plastics Corporation (13)
10.67Loan Agreement dated November 26, 2008, by and between Micron Technology, Inc. and Inotera Memories, Inc. (13)
10.69Micron Guaranty Agreement, dated November 26, 2008, by Micron Technology, Inc. in favor of Nanya Technology Corporation (13)
10.7010.34 Share Purchase Agreement by and among Micron Technology, Inc. as the Buyer Parent, Micron Semiconductor B.V., as the Buyer, Qimonda Ag as the Seller Parent and Qimonda Holding B.V., as the Seller Sub dated as of October 11, 2008 (13)(17)
10.71*10.35* Master Agreement dated November 26, 2008, among Micron Technology, Inc., Micron Semiconductor B.V., Nanya Technology Corporation, MeiYa Technology Corporation and Inotera Memories, Inc. (13)(17)
10.72*Joint Venture Agreement, dated November 26, 2008, by and between Micron Semiconductor B.V. and Nanya Technology Corporation (13)
10.73*10.36* Facilitation Agreement, dated November 26, 2008, by and between Micron Semiconductor B.V., Nanya Technology Corporation and Inotera Memories, Inc. (13)(17)
10.74*10.37* Supply Agreement dated November 26, 2008, by and among Micron Technology, Inc., Nanya Technology Corporation and Inotera Memories, Inc. (13)(17)
10.75*10.38* Amended and Restated Joint Development Program Agreement dated November 26, 2008, by and between Nanya Technology Corporation and Micron Technology, Inc. (13)(17)
10.76*10.39* Amended and Restated Technology Transfer and License Agreement, dated November 26, 2008, by and between Micron Technology, Inc. and Nanya Technology Corporation (13)(17)
10.77*10.40* Technology Transfer Agreement dated November 26, 2008, by and among Nanya Technology Corporation, Micron Technology, Inc. and Inotera Memories, Inc. (13)(17)
10.78*10.41* Technology Transfer Agreement for 68-50nm Process Nodes, dated October 11, 2008, by and between Micron Technology, Inc. and Inotera Memories, Inc. (13)(17)
10.8110.42 Capped Call Confirmation (Reference No. SDB 1630322480) dated as of April 8, 2009, by and between Micron Technology, Inc. and Goldman, Sachs & Co. (27)(30)
10.8210.43 Capped Call Confirmation (Reference No. CGPWK6) dated as of April 8, 2009, by and between Micron Technology, Inc. and Morgan Stanley & Co International plc (27)(30)
10.8310.44 Capped Call Confirmation (Reference No. 325758) dated as of April 8, 2009, by and between Micron Technology, Inc. and Deutsche Bank AG, London Branch (27)

111



(30)
10.84Amendment Agreement, dated September 25, 2009, to TECH Facility Agreement dated March 31, 2008, among TECH Semiconductor Singapore Pte. Ltd. And ABN Amro Bank N.V., Citibank, N.A., Singapore Branch, Citigroup Global Markets Singapore Pte Ltd, DBS Bank Ltd and Oversea-Chinese Banking Corporation Limited, as Original Mandated Lead Arrangers (28)
10.85Supplemental Deed dated September 25, 2009, to Guarantee, dated March 31, 2008, by Micron Technology, Inc. as Guarantor in favor of ABN Amro Bank N.V., Singapore Branch acting as Security Trustee (28)
10.86Loan Agreement dated as of November 25, 2009, by and among Micron Semiconductor B.V., Micron Technology, Inc., and Mai Liao Power Corporation (29)
10.87*10.45* Amended and Restated Joint Venture Agreement between Micron Semiconductor, B.V. and Nanya Technology Corporation dated January 11, 2010 (30)
10.88Share Purchase Agreement among Micron Technology, Inc., Micron Semiconductor, B.V., Intel Corporation, Intel Technology Asia Pte Ltd, STMicroelectronics N.V., Redwood Blocker S.a.r.l. and PK Flash, LLC dated February 9, 2010 (30)
10.89*Framework Agreement among Micron Technology, Inc., STMicroelectronics N.V. and Numonyx B.V. dated February 9, 2010 (30)
10.90Stockholder Rights and Restrictions Agreement by and among Micron Technology, Inc., Intel Corporation, Intel Technology Asia Pte Ltd, STMicroelectronics N.V., Redwood Blocker S.a.r.l. and PK Flash LLC, dated as of May 7, 2010 (31)
10.91*10.46* Second Amended and Restated Technology Transfer and License Agreement between MTI and Nanya Technology Corp. (NTC) dated July 2, 2010 (32)
10.92*10.47* Joint Development Program and Cost Sharing Agreement between MTI and Nanya Technology Corp. (NTC) dated July 2, 2010 (32)
10.93Equity Transfer Agreement between Numonyx B.V. and Hynix dated July 29, 2010 (32)
10.94*Guarantee, Charge and Deposit Document between Numonyx B.V. and DBS Bank Ltd. dated August 31, 2010 (32)
10.99Numonyx Holdings B.V. Equity Incentive Plan (33)
10.100Numonyx Holdings B.V. Equity Incentive Plan Forms of Agreement (33)
10.10110.48 Purchase Agreement dated July 20, 2011, between Micron Technology, Inc. and Morgan Stanley & Co. LLC, as representative of the initial purchasers (12)
10.10210.49 Form of Capped Call Confirmation dated as of July 20, 2011, between the Company and Société Genérale (34)(33)
10.10310.50 Form of Capped Call Confirmation dated as of July 22, 2011 (34)(33)
10.104*10.51* 2012 Master Agreement by and among Intel Corporation, Intel Technology Asia PTE LTD, Micron Technology, Inc., Micron Semiconductor Asia PTE LTD, IM Flash Technologies, LLC and IM Flash Singapore, LLP dated February 27, 2012 (35)(34)
10.105*IMFS Business Sale Agreement by and among Intel Technology Asia PTE LTD, Micron Semiconductor Asia PTE LTD and IM Flash Singapore, LLP dated February 27, 2012 (35)
10.107*10.52* MTV Asset Purchase and Sale Agreement dated April 6, 2012, among Micron Technology, Inc., Intel Corporation and IM Flash Technologies, LLC (36)(35)
10.108*10.53* Second Amended and Restated Limited Liability Company Operating Agreement of IM Flash Technologies, LLC dated April 6, 2012, between Micron Technology, Inc. and Intel Corporation (37)(36)
10.109*10.54* Amendment to the Master Agreement dated April 6, 2012, between Intel Corporation and Micron Technology, Inc. (37)(36)
10.110*10.55* Amended and Restated Supply Agreement dated April 6, 2012, between Intel Corporation and IM Flash Technologies, LLC (37)(36)
10.111*10.56* Amended and Restated Supply Agreement dated April 6, 2012, between Micron Technology, Inc. and IM Flash Technologies, LLC (37)(36)
10.112*10.57* Product Supply Agreement dated April 6, 2012, among Micron Technology, Inc., Intel Corporation and Micron Semiconductor Asia PTE LTD (37)(36)

102



10.113*
10.58* Wafer Supply Agreement dated April 6, 2012, among Micron Technology, Inc., Intel Corporation and Micron Singapore (37)(36)
10.114*10.59* Deposit Agreement dated April 6, 2012, between Micron Technology, Inc. and Intel Corporation (37)(36)
10.11510.60 First Amendment to the Limited Liability Partnership Agreement dated April 6, 2012, between Micron Semiconductor Asia PTE LTD and Intel Technology PTE LTD (37)(36)
10.11610.61 Form of Capped Call Confirmation (1)

112



10.117Currency Exchange Confirmation (Ref. No. SBD3616575404-3537679183) dated July 3, 2012, by and between Micron Technology, Inc. and J. Aron & Company, an affiliate of the Goldman Sachs Group, Inc. (4)
10.118Currency Exchange Confirmation (Ref. No. SBD3616575406-3537683027) dated July 3, 2012, by and between Micron Technology, Inc. and J. Aron & Company, an affiliate of the Goldman Sachs Group, Inc. (4)
10.119Currency Exchange Confirmation (Ref. No. SBD3616575405-3537682647) dated July 3, 2012, by and between Micron Technology, Inc. and J. Aron & Company, an affiliate of the Goldman Sachs Group, Inc. (4)
10.120Currency Exchange Confirmation (Ref. No. 8000031078419 (LHFCZGIJ00)) dated July 2, 2012, by and between Micron Technology, Inc. and JPMorgan Chase Bank, N.A. (4)
10.121Currency Exchange Confirmation (Ref. No.8878658 / 578383) dated July 11, 2012, by and between Micron Technology, Inc. and HSBC Bank USA, N.A. (4)
10.122*10.62* Supply Agreement, dated January 17, 2013, by and among Micron Technology, Inc., Micron Semiconductor Asia Pte. Ltd. and Inotera Memories, Inc. (38)(37)
10.123*10.63* Joint Venture Agreement, dated January 17, 2013, by and among Micron Semiconductor B.V., Numonyx Holdings B.V., Micron Technology Asia Pacific, Inc. and Nanya Technology Corporation (38)(37)
10.124*10.64* Facilitation Agreement, dated January 17, 2013, by and among Micron Semiconductor B.V., Numonyx Holdings B.V., Micron Technology Asia Pacific, Inc., Nanya Technology Corporation and Inotera Memories, Inc. (38)(37)
10.12510.65 Micron Guaranty Agreement, dated January 17, 2013, by Micron Technology, Inc. in favor of Nanya Technology Corporation (38)(37)
10.126*10.66* Technology Transfer and License Option Agreement for 20NM Process Node, dated January 17, 2013, by and between Micron Technology, Inc. and Nanya Technology Corporation (39)(38)
10.127*10.67* Omnibus IP Agreement, dated January 17, 2013, by and between Nanya Technology Corporation and Micron Technology, Inc. (38)(37)
10.128*10.68* Second Amended and Restated Technology Transfer and License Agreement for 68-50NM Process Nodes, dated January 17, 2013, by and between Micron Technology, Inc. and Nanya Technology Corporation (39)(38)
10.129*10.69* Third Amended and Restated Technology Transfer and License Agreement, dated January 17, 2013, by and between Micron Technology, Inc. and Nanya Technology Corporation (38)(37)
10.130*10.70* Omnibus IP Agreement, dated January 17, 2013, by and between Micron Technology, Inc. and Inotera Currency Option Transaction 590297603-2 Trade Date March 26, 2013, by and between Micron Technology, Inc. and Deutsche Bank AG, London Branch (38)(37)
10.13110.71 Currency Option Transaction 590297603-2 Trade Date March 26, 2013, by and between Micron Technology, Inc. and Deutsche Bank AG, London Branch (36)(35)
10.13210.72 Currency Option Transaction 590297604-2 Trade Date March 26, 2013, by and between Micron Technology, Inc. and Deutsche Bank AG, London Branch (36)(35)
10.13310.73 Currency Option Transaction 590297605-2 Trade Date March 26, 2013, by and between Micron Technology, Inc. and Deutsche Bank AG, London Branch (36)(35)
10.13410.74 Currency Option Transaction 590332910-1 Trade Date March 26, 2013, by and between Micron Technology, Inc. and Deutsche Bank AG, London Branch (36)(35)
10.13510.75 Currency Option Transaction 590332913-1 Trade Date March 26, 2013, by and between Micron Technology, Inc. and Deutsche Bank AG, London Branch (36)(35)
10.13610.76 Currency Option Transaction 590332916-1 Trade Date March 26, 2013, by and between Micron Technology, Inc. and Deutsche Bank AG, London Branch (36)(35)
10.13710.77 Foreign Exchange Forward and Currency Option Transactions (Ref. No. 5371036; 5371039) dated March 26, 2013, by and between Micron Technology, Inc. and Morgan Stanley Bank, N.A. (36)(35)
10.13810.78 Currency Exchange Confirmation (Ref. No. SDB2634749868-2634749919) dated March 26, 2013, by and between Micron Technology, Inc. and J. Aron & Company, an affiliate of the Goldman Sachs Group, Inc. (36)(35)
10.139*10.79* English Translation of Front-End Manufacturing Supply Agreement, dated July 31, 2013, by and between Micron Semiconductor Asia Pte. Ltd. and Elpida Memory, Inc. (40)(39)
10.140*10.80* English Translation of Research and Development Engineering Services Agreement, dated July 31, 2013, by and between Micron Technology, Inc. and Elpida Memory, Inc. (6)
10.141*10.81* English Translation of General Services Agreement, dated July 31, 2013, by and between Micron Semiconductor Asia Pte. Ltd. and Elpida Memory, Inc. (40)(39)
10.14210.82 Form of Capped Call Confirmation (2)
21.110.83 SubsidiariesPurchase Agreement, dated as of February 5, 2014, by and among Micron Technology, Inc. and Morgan Stanley & Co. LLC, Goldman, Sachs & Co. and Credit Suisse Securities (USA) LLC, as representatives of the Registrantinitial purchasers (40)
23.110.84 ConsentRegistration Rights Agreement, dated as of Independent Registered Public Accounting FirmFebruary 10, 2014, by and among Micron Technology, Inc. and Morgan Stanley & Co. LLC, Goldman, Sachs & Co. and Credit Suisse Securities (USA) LLC, as representatives of the initial purchasers (15)

113103



23.210.85Purchase Agreement, dated as of July 23, 2014, by and among Micron Technology, Inc. and Morgan Stanley & Co LLC, Goldman, Sachs & Co. and Credit Suisse Securities (USA) LLC, as representatives of the initial purchasers (41)
10.86Registration Rights Agreement dated as of July 28, 2014, by and among Micron Technology, Inc. and Morgan Stanley & Co. LLC, Goldman, Sachs & Co. and Credit Suisse Securities (USA) LLC, as representatives of the initial purchasers (16)
21.1Subsidiaries of the Registrant
23.1 Consent of Independent Registered Public Accounting Firm
31.1 Rule 13a-14(a) Certification of Chief Executive Officer
31.2 Rule 13a-14(a) Certification of Chief Financial Officer
32.1 Certification of Chief Executive Officer Pursuant to 18 U.S.C. 1350
32.2 Certification of Chief Financial Officer Pursuant to 18 U.S.C. 1350
99.1Financial Statements of Inotera Memories, Inc. as of December 31, 2011 and 2012 and for each of the years in the three-year period ended December 31, 2012.
101.INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Extension Label Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
_______________

114104




_______________
(1) Incorporated by reference to Current Report on Form 8-K dated April 12, 2012
(2) Incorporated by reference to Current Report on Form 8-K dated February 6, 2013
(3) Incorporated by reference to Current Report on Form 8-K/A dated July 2, 2012, and filed October 31, 2012
(4) Incorporated by reference to Annual Report on Form 10-K for the fiscal year ended August 30, 2012
(5) Incorporated by reference to Current Report on Form 8-K dated October 29, 2012
(6) Incorporated by reference to Current Report on Form 8-K dated July 31, 2013
(7) Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended May 31, 2001
(8) Incorporated by reference to Current Report on Form 8-K dated July 17, 2013April 9, 2014
(9) Incorporated by reference to Current Report on Form 8-K dated November 3, 2010
(10) Incorporated by reference to Current Report on Form 8-K dated May 17, 2007
(11) Incorporated by reference to Current Report on Form 8-K dated April 15, 2009
(12) Incorporated by reference to Current Report on Form 8-K dated July 26, 2011
(13) Incorporated by reference to Current Report on Form 8-K dated November 12, 2013
(14)Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended February 27, 2014
(15)Incorporated by reference to Current Report on Form 8-K dated February 10, 2014
(16)Incorporated by reference to Current Report on Form 8-K dated July 28, 2014
(17)Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended December 4, 2008
(14)(18) Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended March 3, 2005
(15)(19) Incorporated by reference to Current Report on Form 8-K dated April 3, 2005
(16)(20) Incorporated by reference to Registration Statement on Form S-8 (Reg. No. 333-190010)333-196293)
(17)(21)Incorporated by reference to Registration Statement on Form S-8 (Registration No. 333-148357)
(22)Incorporated by reference to Registration Statement on Form S-8 (Reg. No. 333-167536)
(23)Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended November 30, 2006
(24) Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended March 1, 2007
(18)Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended November 30, 2006
(19)Incorporated by reference to Proxy Statement for the 1986 Annual Meeting of Shareholders
(20)(25) Incorporated by reference to Annual Report on Form 10-K for the fiscal year ended August 28, 2003
(21)(26) Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended February 27, 1997
(22)(27) Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended December 1, 2005
(23)Incorporated by reference to Registration Statement on Form S-8 (Registration No. 333-148357)
(24)Incorporated by reference to Current Report on Form 8-K dated April 9, 2008
(25)(28) Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended May 29, 2008
(26)(29) Incorporated by reference to Current Report on Form 8-K dated October 26, 2007
(27)(30) Incorporated by reference to Current Report on Form 8-K dated April 8, 2009
(28)Incorporated by reference to Current Report on Form 8-K dated September 25, 2009
(29)Incorporated by reference to Current Report on Form 8-K dated November 25, 2009
(30)Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended March 4, 2010
(31) Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended June 3,March 4, 2010
(32) Incorporated by reference to Annual Report on Form 10-K for the fiscal year ended September 2, 2010
(33) Incorporated by reference to Registration Statement on Form S-8 (Reg. No. 333-167536)
(34)Incorporated by reference to Annual Report on Form 10-K for the fiscal year ended September 1, 2011
(35)(34) Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended March 1, 2012
(36)(35) Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended May 30, 2013
(37)(36) Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended May 31, 2012
(38)(37) Incorporated by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended February 28, 2013
(39)(38) Incorporated by reference to Quarterly Report on Form 10-Q/A Amendment 2 for the fiscal quarter ended February 28, 2013
(40)(39) Incorporated by reference to Current Report on Form 8-K/A dated July 31, 2013, and filed October 2, 2013
(40)Incorporated by reference to Current Report on Form 8-K dated February 5, 2014
(41)Incorporated by reference to Current Report on Form 8-K dated July 23, 2014

* Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Commission.


115105



SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boise, State of Idaho, on the 28th27th day of October 20132014.
 Micron Technology, Inc.
 By:/s/ Ronald C. Foster
  
Ronald C. Foster
Vice President of Finance and Chief Financial Officer
  (Principal Financial and Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
SignatureTitleDate
   
/s/ D. Mark DurcanChief Executive OfficerOctober 28, 201327, 2014
(D. Mark Durcan)(Principal Executive Officer) 
   
/s/ Ronald C. FosterVice President of Finance,October 28, 201327, 2014
(Ronald C. Foster)Chief Financial Officer 
 (Principal Financial and 
 Accounting Officer) 
   
/s/ Robert L. BaileyDirectorOctober 28, 201327, 2014
(Robert L. Bailey)  
   
   
/s/ Richard M. BeyerDirectorOctober 28, 201327, 2014
(Richard M. Beyer)  
   
   
/s/ Patrick J. ByrneDirectorOctober 28, 201327, 2014
(Patrick J. Byrne)  
   
   
/s/ Warren EastDirectorOctober 28, 201327, 2014
(Warren East)  
   
   
/s/ Mercedes JohnsonDirectorOctober 28, 201327, 2014
(Mercedes Johnson)  
   
   
/s/ Lawrence N. MondryDirectorOctober 28, 201327, 2014
(Lawrence N. Mondry)  
   
   
/s/ Robert E. SwitzChairman of the BoardOctober 28, 201327, 2014
(Robert E. Switz)Director 

116106



SCHEDULE I
CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT

MICRON TECHNOLOGY, INC.
(Parent Company Only)

CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(in millions)

For the year ended August 29,
2013
 August 30,
2012
 September 1, 2011 August 28,
2014
 August 29,
2013
 August 30,
2012
Net sales $4,404
 $4,590
 $6,141
 $5,819
 $4,404
 $4,590
Cost of goods sold 3,721
 4,194
 5,338
 3,514
 3,721
 4,194
Gross margin 683
 396
 803
 2,305
 683
 396
            
Selling, general and administrative 238
 281
 213
 264
 238
 281
Research and development 921
 917
 761
 1,389
 921
 917
Other operating (income) expense, net 77
 18
 (376) 251
 77
 18
Operating income (loss) (553) (820) 205
 401
 (553) (820)
            
Gain on acquisition of Elpida 1,484
 
 
Interest income and (expense), net (189) (160) (92)
Gain on MMJ Acquisition (33) 1,484
 
Interest income (expense), net (209) (189) (160)
Other non-operating income (expense), net (248) 17
 (97) (86) (248) 17
 494
 (963) 16
 73
 494
 (963)
            
Income tax (provision) benefit (1) 8
 (48) 18
 (1) 8
Equity in earnings (loss) of subsidiaries 703
 29
 244
 2,956
 703
 29
Equity in net loss of equity method investees (6) (106) (45) (2) (6) (106)
Net income (loss) attributable to Micron 1,190
 (1,032) 167
 3,045
 1,190
 (1,032)
Other comprehensive income (loss) (17) (52) 121
 (7) (17) (52)
Comprehensive income (loss) attributable to Micron $1,173
 $(1,084) $288
 $3,038
 $1,173
 $(1,084)






















See accompanying notes to condensed financial statements.

117107




SCHEDULE I
CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT

MICRON TECHNOLOGY, INC.
(Parent Company Only)

CONDENSED BALANCE SHEETS
(in millions except par value amounts)
As of August 29,
2013
 August 30,
2012
 August 28,
2014
 August 29,
2013
Assets        
Cash and equivalents $1,202
 $2,012
 $1,249
 $1,202
Short-term investments 221
 100
 384
 221
Receivables 159
 210
 114
 159
Notes and accounts receivable from subsidiaries 826
 1,278
 1,767
 826
Finished goods 88
 96
 84
 88
Work in process 332
 333
 228
 332
Raw materials and supplies 43
 65
 68
 43
Other current assets 30
 31
 215
 30
Total current assets 2,901
 4,125
 4,109
 2,901
Investment in subsidiaries 7,465
 4,722
 10,149
 7,465
Long-term marketable investments 499
 374
 819
 499
Noncurrent notes receivable from and prepaid expenses to subsidiaries 573
 738
 111
 573
Property, plant and equipment, net 1,613
 1,876
 1,519
 1,613
Equity method investments 12
 20
 9
 12
Other noncurrent assets 472
 444
 595
 472
Total assets $13,535
 $12,299
 $17,311
 $13,535
        
Liabilities and equity        
Accounts payable and accrued expenses $650
 $721
 $758
 $650
Short-term debt and accounts payable to subsidiaries 416
 557
 619
 416
Current portion of long-term debt 646
 154
Current debt 1,077
 646
Other current liabilities 44
 83
 38
 44
Total current liabilities 1,756
 1,515
 2,492
 1,756
Long-term debt 2,438
 2,781
 3,231
 2,438
Other noncurrent liabilities 199
 303
 760
 199
Total liabilities 4,393
 4,599
 6,483
 4,393
        
Commitments and contingencies 

 

 

 

        
Redeemable convertible notes 57
 
    
Micron shareholders' equity:        
Common stock, $0.10 par value, 3,000 shares authorized, 1,044.4 shares issued and outstanding (1,017.7 as of August 30, 2012) 104
 102
Common stock, $0.10 par value, 3,000 shares authorized, 1,073 shares issued and outstanding (1,044 as of August 29, 2013) 107
 104
Other equity 9,038
 7,598
 10,664
 9,038
Total Micron shareholders' equity 9,142
 7,700
 10,771
 9,142
Total liabilities and equity $13,535
 $12,299
 $17,311
 $13,535


See accompanying notes to condensed financial statements.

118108



SCHEDULE I
CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT

MICRON TECHNOLOGY, INC.
(Parent Company Only)

CONDENSED STATEMENTS OF CASH FLOWS
(in millions)

For the year ended August 29,
2013
 August 30,
2012
 September 1,
2011
 August 28,
2014
 August 29,
2013
 August 30,
2012
Net cash (used in) provided by operating activities $(347) $(48) $123
Net cash (used for) provided by operating activities $888
 $(347) $(48)
            
Cash flows from investing activities            
Purchases of available-for-sale securities (924) (559) (29) (1,047) (924) (559)
Cash paid for the acquisition of Elpida (596) 
 
Expenditures for property, plant, and equipment (281) (682) (421) (323) (281) (682)
Cash contributions to subsidiaries (121) (23) (84)
Expenditures for intangible assets (43) (34) (40)
Payments to settle hedging activities (256) (51) (30) (27) (256) (51)
Cash paid for MMJ Acquisition 
 (596) 
Loan to equity method investee (45) 
 
 
 (45) 
Expenditures for intangible assets (34) (40) (45)
Cash contributions to subsidiaries (23) (84) (767)
Cash paid to terminate lease to IMFT 
 
 (107)
Additions to equity method investments 
 (17) (31) 
 
 (17)
Cash paid to terminate lease to IMFT 
 (107) 
Acquisition of additional interest in subsidiaries 
 
 (159)
Proceeds from sales and maturities of available-for-sale securities 557
 678
 151
Proceeds from repayment of loans to subsidiaries, net 851
 556
 206
 379
 851
 556
Proceeds from sales and maturities of available-for-sale securities 678
 151
 1
Cash distributions from subsidiaries 38
 499
 234
 227
 38
 499
Cash received from disposition of interest in Aptina 105
 
 
Proceeds from receipt of loan payments 56
 
 
Proceeds from sales of property, plant and equipment 38
 63
 120
 45
 38
 63
Proceeds from settlement hedging activities 38
 26
 54
Proceeds from settlement of hedging activities 23
 38
 26
Other 9
 (28) (10) 7
 9
 (28)
Net cash used for investing activities (507) (273) (877) (162) (507) (273)
            
Cash flows from financing activities            
Repayments of debt (2,469) (777) (117)
Cash paid to purchase stock under equity plans
 (76) (5) (6)
Payments on equipment purchase contracts (69) (73) (41)
Payments of licensing obligations (47) (31) (18)
Debt issuance costs (33) (17) (21)
Cash paid for capped call transactions 
 (48) (103)
Proceeds from issuance of debt 693
 1,113
 690
 1,750
 693
 1,113
Proceeds from issuance of common stock 150
 5
 28
Proceeds from issuance of stock under equity plans
 265
 150
 5
Proceeds from equipment sale-leaseback transactions 126
 439
 202
 
 126
 439
Cash received for capped call transactions 24
 
 
 
 24
 
Repayments of debt (777) (117) (557)
Payments on equipment purchase contracts (73) (41) (51)
Cash paid for capped call transactions (48) (103) (57)
Payments of licensing obligations (31) (18) (29)
Debt issuance costs, net (17) (21) (20)
Cash paid to purchase common stock (5) (6) (163)
Other 2
 
 
 1
 2
 
Net cash provided by (used for) financing activities 44
 1,251
 43
 (678) 44
 1,251
      
Effect of changes in currency exchange rates on cash and cash equivalents (1) 
 
            
Net increase (decrease) in cash and equivalents (810) 930
 (711) 47
 (810) 930
Cash and equivalents at beginning of period 2,012
 1,082
 1,793
 1,202
 2,012
 1,082
Cash and equivalents at end of period $1,202
 $2,012
 $1,082
 $1,249
 $1,202
 $2,012

See accompanying notes to condensed financial statements.

119109



MICRON TECHNOLOGY, INC.
SCHEDULE I
CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT


NOTES TO CONDENSED FINANCIAL STATEMENTS
(All tabular amounts in millions)


Basis of Presentation

Micron, Technology, Inc., ("Micron") a Delaware corporation, was incorporated in 1978.  Micron is the parent company of it'sits consolidated subsidiaries and, together with it'sits consolidated subsidiaries, is one of the world's leading providers of advanced semiconductor solutions.

These condensed financial statements have been prepared on a parent-only basis. Under this parent-only presentation, Micron's investments in its consolidated subsidiaries are presented under the equity method of accounting. In accordance with Rule 12-04 of Regulation S-X, these parent-only financial statements do not include all of the information and footnotes required by Generally Accepted Accounting Principles (GAAP) in the United States (U.S.) for annual financial statements. Because these parent-only financial statements and notes do not include all of the information and footnotes required by GAAP in the U.S. for annual financial statements, these parent-only financial statements and other information included should be read in conjunction with Micron's audited Consolidated Financial Statements contained within Part II, Item 8 of this Form 10-K for the year ended August 29, 2013.28, 2014.


Long-Term Debt

As of 2013 2012
Capital lease obligations $553
 $556
2014 convertible senior notes 465
 860
2027 convertible senior notes 147
 141
2031A convertible senior notes 277
 265
2031B convertible senior notes 253
 243
2032C convertible senior notes 463
 451
2032D convertible senior notes 369
 361
2033E convertible senior notes 272
 
2033F convertible senior notes 260
 
Intel senior note 25
 58
  3,084
 2,935
Less current portion 646
 154
  $2,438
 $2,781
      2014 2013
Instrument(1)
 Stated Rate Effective Rate Current Long-Term Total Current Long-Term Total
Capital lease obligations(2)
 N/A
 N/A
 $172
 $233
 $405
 $156
 $397
 $553
2014 convertible senior notes 1.875% 7.88% 
 
 
 465
 
 465
2022 senior notes 5.875% 6.14% 
 600
 600
 
 
 
2025 senior notes 5.500% 5.56% 
 1,150
 1,150
 
 
 
2027 convertible senior notes 1.875% 6.95% 
 
 
 
 147
 147
2031A convertible senior notes 1.500% 6.55% 
 
 
 
 277
 277
2031B convertible senior notes(3)
 1.875% 6.98% 362
 
 362
 
 253
 253
2032C convertible senior notes(4)
 2.375% 5.95% 
 314
 314
 
 463
 463
2032D convertible senior notes(4)
 3.125% 6.33% 
 288
 288
 
 369
 369
2033E convertible senior notes(4)(5)
 1.625% 4.50% 278
 
 278
 
 272
 272
2033F convertible senior notes(4)(5)
 2.125% 4.93% 265
 
 265
 
 260
 260
2043G convertible senior notes 3.000% 6.76% 
 636
 636
 
 
 
Other 1.650% 1.65% 
 10
 10
 25
 
 25
      $1,077
 $3,231
 $4,308
 $646
 $2,438
 $3,084
(1)
Micron has either the obligation or the option to pay cash for the aggregate amount due upon conversion for all of its convertible notes. Since it is Micron's current intent to settle in cash the principal amount of all of its convertible notes upon conversion, the dilutive effect of such notes on earnings per share is computed under the treasury stock method.
(2) Weighted-average imputed rate of 4.7% and 4.7% as of August 28, 2014 and August 29, 2013, respectively.
(3)
Amount recorded for 2014 includes the debt and equity components, which was reclassified as a result of Micron's obligation to settle the conversions of the 2031B Notes.
(4)
Since the closing price of Micron's common stock for at least 20 trading days in the 30 trading day period ending on June 30, 2014 exceeded 130% of the initial conversion price per share, holders have the right to convert their notes at any time during the calendar quarter ended September 30, 2014. The closing price of Micron's common stock also exceeded the thresholds for the calendar quarter ended September 30, 2014; therefore, these notes are convertible by the holders through December 31, 2014.

110



(5) As a result of these notes being convertible at the option of the holder through September 30, 2014, and because the terms of these notes would require Micron to pay cash for the principal amount of any converted notes, amounts are classified as current.

Micron'Micron's senior notes are unsecured obligations ranking equally in right of payment with all of Micron's other existing and future unsecured indebtedness, and are effectively subordinated to all of Micron's other existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness.  The convertible notes, 2022 Notes and the Intel note2025 Notes of Micron are structurally subordinated to $1,863 million$1.57 billion of other notes payable of its subsidiaries and capital lease obligations. MTI guarantees certain debt obligations of its subsidiaries. MTI does not guarantee the ElpidaMMJ creditor installment payments. As of August 29, 2013,28, 2014, Micron had guaranteed $701610 million of debt obligations of its subsidiaries. Micron's guarantees of its subsidiary debt obligations are unsecured obligations ranking equally in right of payment with all of its other existing and future unsecured indebtedness.


120



Capital Lease Obligations

We haveMicron has various capital lease obligations due in periodic installments with a weighted-average remaining term of 2.92 years and weighted-average effective interest rates of 4.7% as of August 29, 2013 and 4.8% as of August 30, 2012.. In 2013, weMicron received $126 million in proceeds from equipment sale-leaseback transactions and, as a result, recorded capital lease obligations aggregating $126 million atwith a weighted-average effective interest rate of 4.3%, payable in periodic installments through July 2017. In 2012, we received $439 million in proceeds from equipment sale-leaseback transactions and as a result recorded capital lease obligations aggregating $439 million at a weighted-average effective interest rate of 4.1%, payable in periodic installments through August, 2016.

As of August 28, 2014 and August 29, 2013, and August 30, 2012,Micron had production equipment with a carrying valuevalues of$305 million and $458 million and $491 million, respectively, was collateral for Micron'sunder capital leases.

Convertible Senior Notes and IntelOther Senior NoteNotes

For further information, see "Item"Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Debt" to Micron's consolidated financial statements.

Maturities of Notes Payable and Future Minimum Lease Payments

As of August 29, 2013,28, 2014, maturities of notes payable and future minimum lease payments under capital lease obligations were as follows:

As of August 29, 2013 Notes Payable Capital Lease Obligations
2014 $510
 $181
 Notes Payable Capital Lease Obligations
2015 
 180
 $389
 $188
2016 
 200
 
 200
2017 175
 30
 
 30
2018 645
 3
 300
 3
2019 and thereafter 1,645
 8
2019 362
 3
2020 and thereafter 3,320
 6
Discounts and interest, respectively (444) (49) (468) (25)
 $2,531
 $553
 $3,903
 $405


Commitments

Micron has provided various financial guarantees which are issued in the normal course of business on behalf of its subsidiaries. These contracts include debt guarantees and guarantees on certain banking facilities. Micron enters into these arrangements to facilitate commercial transactions with third parties by enhancing the value of the transaction to the third party. Micron has entered into agreements covering purchases or sales, as applicable, by Micron or anycertain activities of its subsidiaries, and occasionally Micron may be required to perform under such agreements on behalf of its subsidiaries.

111



As of August 29, 2013,28, 2014, the maximum potential amount of future payments Micron could have been required to make under its debt guarantees was approximately $705610 million. Substantially all of this amount relates to guarantees for debt of wholly-owned entities whereby Micron would be obligated to perform under the guarantee if a subsidiary were to default on the terms of their debt arrangements. In the event of performance under the guarantee, Micron would be permitted to seek reimbursement from the subsidiary company(s) through liquidation of the assets collateralized by the various debt instruments. At the time these contracts were entered into, the collateralized assets approximated the value of the outstanding guarantees. The majority of these guarantees expire at various times between December 2014 and January 20182019. Micron also guarantees credit facilities of certain of its subsidiaries that provide for up to $408 million of additional financing. As of August 29, 2013,28, 2014, no amounts had been drawn under these credit facilities.

121



Micron guarantees certain banking facilities for its wholly-owned consolidated entities. Substantially all of these guarantees relate to bank overdraft protections. The maximum potential amount of future payments Micron could be required to make under these guarantees varies based on the extent of potential overdrafts. Micron's business processes substantially mitigate the risk of wholly-owned subsidiaries over draftingoverdrafting their bank accounts. The majority of these guarantees have no contractual expiration.

We have agreed, subject to certain conditions, to provide certain support to Elpida with respect to obtaining financing for working capital purposes and capital expenditures. In addition, we agreed, subject to certain conditions, to use reasonable best efforts to assist the Elpida Companies in financing up to 64 billion yen (or the equivalent of approximately $655 million) of eligible capital expenditures incurred through June 30, 2014, which may include us providing payment guarantees of third party financing under certain circumstances or direct financial support from Micron Technology, Inc. or one of its subsidiaries. For further information, see "Item 8. Financial Statements and Supplementary Data – Acquisition of Elpida Memory, Inc." to Micron's consolidated financial statements.


Contingencies

As is typical in the semiconductor and other high technology industries, from time to time others have asserted, and may in the future assert, that Micron and it'sits subsidiaries' products or manufacturing processes infringe their intellectual property rights. Micron has accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date. We areMicron is currently a party to various litigation regarding patent, antitrust, securities, commercial and other matters arising from the normal course of business, none of which is expected to have a material adverse effect on Micron's business, results of operations or financial condition.matters. Micron is a party to the matters listed in the "Contingencies" note in the consolidated financial statements, with the exception of the patent infringement case Tessera Inc. filed on December 7, 2007 against Elpida Memory, Inc., Elpida Memory (USA) Inc., and numerous other defendants, and the complaint filed on July 12, 2013 by seven former shareholders of Elpida (now known as MMJ) against the board of directors of ElpidaMMJ as of February 2013.2013 and the patent infringement case Tessera Inc., which was resolved on July 30, 2014. For further information, see the"Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements "Contingencies" note.– Contingencies" to Micron's consolidated financial statements.


Redeemable Convertible Notes

For further information, see "Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Redeemable Convertible Notes" to Micron's consolidated financial statements.


Related Party Transaction

Substantially all of Micron's activities relate to manufacturing services performed for a subsidiary and to royalties received from its subsidiaries for use of product and process technology. Micron's net sales to consolidated subsidiaries were $5.64 billion, $4.19 billion and $4.15 billion for 2014, 2013 and 2012, respectively. Gross margins on manufacturing activities are commensurate with market rates for such services. Transactions between Micron and its consolidated subsidiaries are eliminated in consolidation.

Micron engages in various transactions with its equity method investees and eliminates the profits or losses on those transactions to the extent of its ownership interest until such time as the profits or losses are realized. As of August 29, 2013,28, 2014, Micron held a 31% ownership interest in Aptina Imaging Corporation ("Aptina") and a 50% ownership interest in Transform Solar Pty Ltd.and, until August 15, 2014, an equity interest in Aptina. Net sales for 2014, 2013 and 2012 also included sales to consolidated subsidiaries of $4,19043 million, $4,148182 million and $5,718 million for 2013, 2012 and 2011, respectively. Net sales for 2013, 2012 and 2011 also included $182 million, $372 million and $349 million, respectively, from products sold to and services performed for Aptina.

On August 15, 2014, ON Semiconductor Corporation acquired Aptina for approximately $433 million and Micron recognized a non-operating gain of $119 million on the sale of productsits shares based on its diluted ownership interest of approximately 27%. The gain approximated Micron's share of the consideration because the carrying value of its investment had been reduced to Aptina.zero since the second quarter of 2012, at which time Micron ceased recognizing its proportionate share of Aptina's losses. For further information regarding transactions between Micron and its equity method investees, see the"Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements "Equity– Equity Method Investments – Other" note.to Micron's consolidated financial statements.

122112



SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS
(in millions)

MICRON TECHNOLOGY, INC.

Balance at
Beginning of
Year
 Business Acquisitions 
Charged
(Credited) to
Costs and
Expenses
 

Deductions/
Write-Offs
 
Balance at
End of
Year
Balance at
Beginning of
Year
 Business Acquisitions 
Charged
(Credited) to
Costs and
Expenses
 

Deductions/
Write-Offs
 
Balance at
End of
Year
Allowance for Doubtful Accounts                  
Year ended August 28, 2014$5
 $
 $
 $(2) $3
Year ended August 29, 2013$5
 $
 $1
 $(1) $5
5
 
 1
 (1) 5
Year ended August 30, 20123
 
 5
 (3) 5
3
 
 5
 (3) 5
Year ended September 1, 20114
 
 
 (1) 3
                  
Deferred Tax Asset Valuation Allowance 
  
  
  
  
 
  
  
  
  
Year ended August 28, 2014$3,155
 $
 $(544) $(168) $2,443
Year ended August 29, 2013$1,522
 $1,292
 $370
 $31
 $3,215
1,470
 1,292
 418
 (25) 3,155
Year ended August 30, 20121,207
 
 373
 (58) 1,522
1,169
 
 368
 (67) 1,470
Year ended September 1, 20111,263
 
 (103) 47
 1,207

Certain deferred tax assets and liabilities in prior years were corrected with corresponding changes in the valuation allowance, resulting in no change to net deferred tax assets. The changeChanges in these items waswere not material for any period presented.


123113